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RNAs are important effectors in the process of gene expression. In 
bacteria, the levels of the transcripts have to be rapidly adjusted in response to 
constantly changing environmental demands. The cellular concentration of a 
given RNA is the result of the balance between its synthesis and degradation. 
RNA degradation is a complex process encompassing multiple pathways. 
Ribonucleases are the enzymes that directly process and degrade RNA 
transcripts, regulating their cellular amounts. The rate at which RNA decay 
occurs depends on the availability of ribonucleases and their specificities 
according to the sequence and/or the structural elements of the RNA molecule. 
Several other factors modulate RNA degradation, namely polyadenylation, which 
plays a multifunctional role in RNA metabolism. Additionally, small non-coding 
RNAs are crucial regulators of gene expression, and can directly modulate the 
stability of their mRNA targets. In many cases this regulation is dependent on 
Hfq, an RNA binding protein which can act in concert with polyadenylation 
enzymes and is often necessary for the activity of the sRNAs. 
 
The first objective of this Doctoral work was to study the importance of 
the endoribonucleases RNase III and RNase E on the regulation of the sRNA 
MicA in Salmonella Typhimurium. MicA is a trans-encoded sRNA, which down-
regulates porin expression in stationary-phase. Its main targets in Salmonella are 
the outer membrane protein OmpA and the LamB maltoporin. In a previous 
study, we have analyzed the expression profile of MicA under different growth 
conditions and used distinct Salmonella RNase mutants to evaluate the 
contribution of each of these enzymes in the turnover of this sRNA. In order to 
further analyse the role of the two main Salmonella endoribonucleases, RNase III 
and RNase E, in the degradation of MicA, both enzymes were overexpressed and 
purified. The parallel analysis of the in vivo sRNA decay in the absence of each of 
 
 
xxii 
the two RNases and the in vitro activity of both enzymes using MicA as a 
substrate, revealed that both endoribonucleases are involved in the control of 
MicA sRNA levels. However, MicA was shown to be cleaved by RNase III when 
it is in complex with its targets, while RNase E was the responsible for the control 
of free-MicA levels in the cell. This study allowed us to propose a model for MicA 
degradation in which RNase III and RNase E perform a different role in the decay 
of this sRNA.  
 
In the second part of this Dissertation the aim was to examine the role of 
SraL sRNA in S. Typhimurium. SraL was originally identified in E. coli, and was 
afterwards detected in Salmonella, particularly in late stationary phase of growth. 
SraL has been little studied and its biological function was not known at the 
beginning of this study. Several approaches are currently available to determine 
the biological role of the sRNAs. In the present work, a proteomic analysis of 
Salmonella strains expressing different SraL levels in the cell enabled the detection 
of several SraL putative targets. The majority of the changes were detected in 
proteins involved in several pathways of carbohydrates metabolism, especially 
those involving glucose. Moreover, the study of the influence of glucose in SraL 
levels revealed a dependence of the expression of this sRNA on the concentration 
of this sugar in the growth medium.  
 
In the proteomic analysis, one of the proteins most affected by the 
different levels of SraL in the cell was the chaperone Trigger Factor. This putative 
biological function of SraL was investigated further in the third part of this 
Doctoral work. Trigger factor is the first chaperone encountered co-translationally 
by most of the nascent amino-acid chains and cooperates with DnaK and GroEL 
in the folding of newly synthesized proteins. In this study, it was shown that this 
regulation occurs at the level of the mRNA. The region of interaction between the 
Abstract 
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sRNA and the mRNA target was predicted by using several bioinformatic tools. 
Mutagenesis experiments have shown that SraL interacts with the 5’-UTR of tig 
mRNA few nucleotides upstream of its Shine Dalgarno sequence.  
The main ribonucleases involved in the post-transcriptional regulation of 
SraL were previously identified. In the present work, several experiments were 
performed to study how this sRNA is regulated at the transcriptional level. The 
results presented in this Dissertation identified the central regulator of general 
stress response RpoS (σS) as a transcriptional regulator of this sRNA. By using 
Chromatin immunoprecipitation assays, RpoS was shown to bind directly to the 
SraL promoter region.  
 
The work developed during this Dissertation provided important results 
that contributed for a better understanding of the biological role of two highly 
conserved sRNAs, MicA and SraL sRNAs, and their pathways of regulation in the 
human pathogen Salmonella Typhimurium.  
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Os RNAs constituem importantes moléculas efetoras no processo de 
expressão génica. Em bactérias, os níveis dos transcritos têm que ser rapidamente 
ajustados em resposta às constantes mudanças no meio ambiente. A concentração 
celular de um dado RNA é determinada pelo balanço entre a sua síntese e a sua 
degradação. A degradação do RNA é um processo bastante complexo e que 
envolve numerosos passos. As ribonucleases (RNases) são as enzimas 
responsáveis pela regulação da quantidade dos transcritos de RNA, uma vez que 
atuam no seu processamento e na sua degradação. A taxa de degradação do RNA 
depende da disponibilidade destas enzimas e também das suas especificidades, 
de acordo com a sequência e/ou elementos estruturais das moléculas de RNA. 
Vários outros fatores modulam igualmente a degradação do RNA. A 
poliadenilação desempenha variadas funções durante o metabolismo do RNA. 
Adicionalmente, os pequenos RNAs não-codificantes são também reguladores 
essenciais da expressão génica, visto que modulam diretamente a estabilidade 
dos seus RNAs mensageiros (mRNA) alvos. Na maioria dos casos documentados, 
esta regulação é dependente do chaperone Hfq. Esta proteína tem a capacidade de 
se ligar ao RNA e pode eventualmente atuar em conjunto com as enzimas de 
poliadenilação. Para além disso, o Hfq é normalmente necessário para a própria 
atividade dos pequenos RNAs. 
 
 O primeiro objectivo do trabalho desenvolvido durante esta Dissertação 
centrou-se no estudo da importância das endoribonucleases RNase III e RNase E 
na degradação de um pequeno RNA, denominado MicA, em Salmonella 
Typhimurium. Este pequeno RNA regula negativamente a expressão de porinas 
em fase estacionária. Até à data existem dois alvos descritos para este pequeno 
RNA em Salmonella: a proteína de membrana externa OmpA; e a maltoporina 
LamB. Num estudo realizado anteriormente, analisámos a expressão do MicA em 
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diferentes condições de crescimento e usando mutantes de diversas RNases de 
Salmonella de modo a avaliar a contribuição de cada uma destas enzimas no 
decaímento deste pequeno RNA. Com vista a analisar com maior detalhe o papel 
das duas principais endoribonucleases de Salmonella na degradação deste 
pequeno RNA, sobre-expressámos e purificámos ambas as enzimas de Salmonella. 
A análise paralela dos resultados obtidos no estudo da degradação deste pequeno 
RNA in vivo na ausência de ambas as RNases e dos resultados obtidos no estudo 
da atividade in vitro de ambas as enzimas revelou que ambas as 
endoribonucleases estão envolvidas no controlo dos níveis de expressão do MicA. 
Os estudos efetuados revelaram que o MicA é degradado pela RNase III quando 
forma complexos com os seus RNAs mensageiros alvos. Adicionalmente, a RNase 
E é responsável pelo controlo dos níveis do pequeno RNA livre na célula. Os 
resultados obtidos permitiram-nos propor um modelo de degradação do MicA, 
no qual a RNase III e a RNase E desempenham funções diferentes no decaímento 
deste pequeno RNA.  
 
Na segunda parte da presente Dissertação o principal objetivo foi estudar 
e compreender a função de outro pequeno RNA de Salmonella, denominado SraL. 
Este pequeno RNA foi originalmente identificado em Escherichia coli. Mais tarde 
foi também detetado em Salmonella, maioritariamente na fase estacionária tardia 
de crescimento. Tinham sido já efetuados alguns estudos tendo como base este 
pequeno RNA. Contudo, aquando do ínicio deste estudo, a sua função biológica 
na célula não tinha sido ainda identificada. Presentemente conhecem-se vários 
métodos que permitem a determinação da função biológica dos pequenos RNAs. 
Neste estudo, foi afetuada uma análise proteómica de várias estirpes de 
Salmonella a expressar diferentes níveis de SraL na célula. Esta abordagem 
permitiu a deteção de vários alvos putativos deste pequeno RNA. Grande parte 
das proteínas afetadas pelos diferentes níveis de SraL na célula estão envolvidas 
Resumo 
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em vários passos do metabolismo dos hidratos de carbono, especialmente os que 
envolvem a glucose. O estudo da influência da glucose nos níveis do SraL foi 
também realizado e revelou que a expressão deste pequeno RNA é dependente 
da concentração deste açucar no meio de crescimento.  
 A análise proteómica revelou também o Trigger Factor como sendo outro 
alvo putativo do pequeno RNA SraL. Na terceira parte deste trabalho foi 
investigada com maior detalhe esta função biológica do SraL. O Trigger Factor é o 
primeiro chaperone que se liga co-traducionalmente à maioria das cadeias de 
aminoácidos. Esta proteína coopera com outros dois chaperones, DnaK e GroEL, 
no correto enrolamento das cadeias polipeptídicas recém-sintetisadas. Durante 
este estudo foi demonstrado que esta regulação se dá ao nível do RNA 
mensageiro. A região de interação entre o pequeno RNA e o mRNA alvo foi 
determinada usando várias ferramentas bioinformáticas. Experiências de 
mutagénese mostraram que o SraL interage com a região não traduzida a 5’ do 
mRNA do tig, alguns nucleótidos antes da sua sequência Shine-Dalgarno.  
 Num estudo anteriormente realizado identificámos as principais 
ribonucleases envolvidas na regulação pós-transcricional do SraL. No presente 
estudo, foram efetuadas várias abordagens com vista a compreender como é que 
este pequeno RNA é regulado transcricionalmente. Com base nos resultados 
apresentados nesta Dissertação, identificámos o regulador central da resposta ao 
stress RpoS (σS) como sendo o regulador transcricional do SraL. Utilizando 
ensaios de Chromatin immunoprecipitation mostrou-se que o RpoS se liga 
diretamente à região promotora do SraL.  
 
 O trabalho desenvolvido durante esta Dissertação apresenta resultados 
importantes que contribuem para uma melhor compreensão da função biológica 
de dois pequenos RNAs altamente conservados, denominados MicA e SraL. Para 
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além disso, alguns dos processos de regulação destes pequenos RNAs no 
organismo patogénico Salmonella Typhimurium foram também estudados.   
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This Dissertation is divided into five chapters. 
 
Chapter one consists of a general introduction on RNA degradation mechanisms, 
where are highlighted the main differences between the RNA degradation 
pathways for the two main Gram-negative and Gram-positive bacterial models, 
Escherichia coli and Bacillus subtilis. This chapter encompasses not only the 
importance of ribonucleases but also of other players such as small non-coding 
RNAs, the RNA-chaperone Hfq and Poly(A) Polymerase. Part of this section was 
published in WIREs RNA and the author of this thesis is the first author of this 
manuscript. 
 
Chapter two describes the investigation of the role of the endoribonucleases III 
and E in the degradation of MicA sRNA, alone and coupled with its targets. From 
this work resulted a publication in Nucleic Acids Research in which the author of 
this dissertation played a major contribution and was considered first author.  
 
Chapter three focused in the biological function of SraL in Salmonella 
Typhimurium. Proteomic were performed to identify possible targets of this 
sRNA. The proteomic results that seemed more relevant were validates by RT-
PCR and Northern blot analyses. The importance of the regulation of SraL over 
the putative targets identified is discussed. The results described in this chapter 
gave the preliminary data necessary for the work reported in chapter four, and 
has also information that will be instrumental for other publications. 
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In chapter four one of the biological roles inferred in the previous chapter for 
SraL in Salmonella Typhimurium was also studied in detail and the transcriptional 
regulator of SraL sRNA was also determined. The work of this chapter was 
accepted with modifications in RNA and the author of this dissertation is the first 
author of the manuscript.  
 
To finalize, chapter five comprises an integrated discussion of the global results 
obtained during this Dissertation, including future perspectives. 
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5 
INTRODUCTION 
Bacteria have evolved complex regulatory networks in order to adjust 
their physiology and survive in face of constantly changing environmental 
conditions. Maintenance of cellular functions relies on the proper expression of 
genetic information, in which the RNA molecules play a key role. Among RNAs, 
mRNAs constitute the molecular link between genes and proteins. Because the 
cellular concentration of a given transcript depends on the rates of its synthesis 
and degradation, both transcription and degradation control the levels of each 
protein in the cell. Regulating gene expression at the messenger level is of utmost 
importance for guaranteeing versatility in the context of the small genome size 
found in prokaryotes where transcription and translation are coupled. Survival 
and development in challenging growth conditions require a rapid adaptation of 
gene expression. In this regard, control of transcription and degradation of 
mRNA requires less energy and proceeds much faster than translation and 
protein degradation processes (Russell, 2007). The rate of turnover is not related 
to the length of the gene; the stability of the gene transcripts seems to be 
regulated by determinants located in specific mRNA segments and the segments 
that decay more rapidly can be located anywhere in the mRNA. Moreover, 
distinct processing may confer differential stability upon the fragments of a 
polycistronic transcript. The complexity of the RNA degradation process was 
further revealed with the discovery of non-coding RNAs. Previously overlooked, 
sRNAs are now known to exert significant regulatory effect on gene expression, 
and have thus attracted increasing interest due to their regulatory functions, as 
well as their role in bacterial adaptation and virulence (Repoila and Darfeuille, 
2009; Shimoni et al., 2007). Furthermore, the regulation of their cellular levels 
constitutes an upstream control of gene expression. 
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In the Introduction chapter is presented the current knowledge on 
prokaryotic RNA degradation mechanisms. Several questions are discussed like: 
which are the main players involved? What is their mode of action? Are there any 
differences between bacterial species? After a brief overview of the genome-wide 
studies of RNA decay, prokaryotic RNA degradation mechanisms are described. 
The RNA features and the structural details of ribonucleases, the enzymes that 
process and degrade RNA, are also discussed. Finally, additional factors which 
have an impact on RNA stability are focused. Together, these key events 
determine the ultimate fate of an RNA molecule. 
 
RNA DECAY: GLOBAL APPROACHES 
The development of transcriptome analysis has enabled the monitoring of 
intracellular RNA levels at the genomic scale. The rate of degradation of a given 
RNA can be estimated by determining its half-life in the cell. Combining 
inhibition of transcription with microarray technology has proven to be a 
powerful tool for assessing genome-wide mRNA decay. Most of these global 
studies in microorganisms have been carried out on the model yeast 
Saccharomyces cerevisiae (García-Martínez et al., 2004; Molin et al., 2009; Wang et al., 
2002). mRNA half-lives ranging from 3 to more than 100 min have been observed 
for this eukaryotic microorganism (Wang et al., 2002), with a majority of 
transcripts displaying half-lives in the range of 10–20 min (Grigull et al., 2004). 
Although the available literature is less abundant for prokaryotes, shorter half-
lives, with mean values of less than 10 min, have been reported for the bacterial 
models Escherichia coli (Bernstein et al., 2002; Selinger et al., 2003) and Bacillus 
subtilis (Hambraeus et al., 2003). Slightly lower values have been obtained during 
the exponential growth of Lactococcus lactis (Redon et al., 2005) and Staphylococcus 
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aureus (Anderson et al., 2006). The short half-life of bacterial mRNAs is a key 
factor to allow the rapid adaptation to changing environmental conditions. 
Altogether these global studies not only report average values in the 
same range of magnitude but also highlight a wide variation of half-lives among 
mRNAs. Furthermore, global stabilities have been observed to be dependent on 
growth conditions (Anderson et al., 2006; Redon et al., 2005). For example, the 
average half-life for mRNAs in L. lactis increases from 5.8 to 19.4 min when 
comparing exponential and carbon starvation phases, respectively (Redon et al., 
2005). It has also been noted that genes which share related biological functions 
usually display similar messenger decay rates (Bernstein et al., 2002; Hambraeus 
et al., 2003; Selinger et al., 2003). For instance, most house-keeping genes have long 
half-lives. Proteins which are central in E. coli protein–protein interaction network 
also tend to be encoded by stable transcripts (Janga and Babu, 2009). 
The majority of RNA molecules are subjected to regulation and, as is the 
case for mRNA, their decay can be influenced by growth conditions. 
Independently of the conditions, the two RNA categories involved in protein 
synthesis, that is, ribosomal and transfer RNAs, are considered to be more stable 
than mRNA. Although sRNAs were initially believed to be rather stable RNAs, it 
has since been shown that they can also be quite susceptible to degradation 
(Massé et al., 2003a; Viegas and Arraiano, 2008). Plasmid-encoded antisense RNAs 
have a wide range of half-lives, spanning from less than 2 min to more than 32 
min (Vogel et al., 2003). While studies undertaken to date have mainly focused on 
the identification of new sRNAs, tools for assessing sRNA differential expression 
and stability are becoming increasingly available (Hutzinger et al., 2010) and this 
will greatly impact the current knowledge of gene expression. 
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BACTERIAL RNA DEGRADATION MECHANISMS 
The original model and the initiator RNase E 
Turnover of RNA molecules involves cleavage reactions that are carried 
out by RNases, a diverse collection of cellular enzymes, whose functions and 
properties have been elucidated through the study of mutants (Arraiano et al., 
2010; Arraiano et al., 1988). Although E. coli possesses a plethora of RNases only a 
few are devoted to the RNA degradation. The conventional model for RNA decay 
in this bacterium usually begins with an endonucleolytic cleavage at one or more 
internal sites on the RNA molecule (Figure 1A). Two endonucleases have been 
associated with the initial cleavage event: RNase III and RNase E. However, 
RNase E is believed to be the main endonuclease involved in the RNA turnover in 
E. coli (Arraiano et al., 2010). In fact, a recent report shows that in the absence of 
RNase E 60% of the annotated coding sequences were either increased or 
decreased in their steady-state levels (Stead et al., 2011). In contrast, only 12% of 
the coding sequences were affected by the absence of RNase III (Stead et al., 2011). 
RNase E is an essential single-stranded endonuclease that exhibits a 
preference for A/U-rich regions in close proximity to stem-loops (Mackie, 1992; 
McDowall et al., 1994). This characteristic is also shown by its paralogue, RNase 
G. This endonuclease, which has a strong resemblance with the amino-terminal 
portion of RNase E (McDowall et al., 1993), is also involved in the degradation 
and processing of RNA (Carpousis et al., 2009). Both enzymes display higher 
activity over substrates bearing a monophosphorylated than over substrates with 
a triphosphorylated 5’-end (Carpousis et al., 2009). This selectivity results from an 
RNase E 5’-sensing pocket that binds a monophosphorylated 5’-terminus, while 
the active site binds and cleaves the RNA internally (Callaghan et al., 2005). 
Nonetheless, some substrates are cleaved by RNase E regardless of the 5’-
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phosphorylation status. This occurs in molecules with multiple single-stranded 
sites that allow the direct entry of RNase E through a different pathway, called 
‘bypass’ or ‘internal entry’ (Baker and Mackie, 2003; Kime et al., 2010).  
RppH is an RNA pyrophosphohydrolase that removes the 
pyrophosphate from the 5’-termini and preferentially acts on single-stranded 
RNA. The discovery of this enzyme presented an alternative pathway in which 
the initial event is non-nucleolytic (Deana et al., 2008). Conversion of 5’-
triphosphate to 5’-monophosphate by RppH provides the ideal substrate for 
RNase E, and the preference of RppH for single-stranded RNA explains why 5’-
stem-loops are mediators of stability. Ribosome loading is also known to mediate 
RNA stability. A poor ribosome binding site, possibly by increasing the distance 
between the actively translating ribosomes, exposes putative internal cleavage 
sites and may increase message instability. 
The catalytic domain of RNase E lies in the N-terminal region, which is 
highly conserved and essential for cell viability (Kaberdin et al., 1998). The C-
terminus forms a scaffold for interactions with other proteins, which together 
form the degradosome, the main RNA degradative complex in E. coli (Liou et al., 
2001). The RNA degradosome can undergo changes in composition depending on 
the growth or stress conditions (Gao et al., 2006; Prud'homme-Genereux et al., 
2004). For instance, two different RNA helicases are known to associate with 
RNase E depending on the temperature (Prud'homme-Genereux et al., 2004; Py et 
al., 1996). This remodelling of the degradosome strongly affects its RNA target 
spectrum (Gao et al., 2006). In E. coli under normal growth conditions, the major 
components of the degradosome, in addition to RNase E, are the exonuclease 
PNPase, the helicase RhlB and the glycolytic enzyme enolase (Carpousis et al., 
1994; Py et al., 1996). Pseudomonas syringae, on the other hand, has selected RNase 
R as a degradosome component, despite possessing PNPase (Purusharth et al., 
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2005). This complex of enzymes assures the coordination of the endo- and 
exonucleolytic degradation of an RNA molecule. After the initial endonucleolytic 
cleavage step the upstream fragment, lacking the 3’-terminal hairpin, can be 
readily digested by 3’-exonucleases. The activity of these enzymes is impaired by 
a 3’-stem-loop, which protects the majority of the primary transcripts (Andrade et 
al., 2009). The downstream fragment generated after the initial endonucleolytic 
cleavage is usually more prone to degradation. It bears a monophosphorylated 5’-
end and therefore may be the ideal substrate for an additional cleavage by RNase 
E. The turnover of malEF transcript illustrates how the endo- and exonucleolytic 
enzymes can act in a concerted way. PNPase degradation of malEF is only 
accomplished in the presence of RNase E and RhlB, indicating that the 
degradosome participates in its degradation (Stickney et al., 2005).  
Three exonucleases are mainly involved in RNA decay in E. coli: PNPase, 
RNase R and RNase II (Figure 1A). All of these enzymes degrade RNA 
processively and non-specifically from the 3’-end. While PNPase is a 
phosphorolytic exonuclease yielding nucleoside diphosphates as reaction 
products, both RNase R and RNase II catalyse the hydrolysis of the RNA 
substrates, producing nucleoside monophosphates. Among the three, only RNase 
R is able to digest structured RNA by itself (Andrade et al., 2009). The degrading 
activity of PNPase or RNase II is stalled by the presence of secondary structures 
(Spickler and Mackie, 2000). However, PNPase can also proceed through 
extensive folded RNA when acting in association with other proteins. Its 
association with the helicase RhlB or integration into the degradosome allows the 
unwinding of the RNA stem-loops (Liou et al., 2002). Surprisingly, the PNPase 
homologue of Thermus termophilus, whose optimal temperature is 65ºC, has been 
reported to completely degrade RNAs with stable intramolecular secondary 
structures without the aid of a helicase (Falaleeva et al., 2008). Nonetheless, both 
PNPase and RNase R require a minimal 3’-overhang of 7–10 unpaired nucleotides 
Introduction 
 
 
11 
in order to be able to bind and initiate digestion of an RNA molecule (Vincent and 
Deutscher, 2006). By providing a single-stranded platform for the initiation of the 
exonucleolytic attack, the degradation of RNA molecules containing 3’-stem-
loops is stimulated by the addition of poly(A) tails to the 3’-end of the RNA 
molecules (for details see below the ‘Polyadenylation’ section). These poly(A) tails 
constitute the preferred substrate for PNPase and RNase II (Lisitsky and Schuster, 
1999; Marujo et al., 2000). 
None of the three 3’-exonucleases seems to be indispensable for E. coli 
growth at optimal temperature. However the combined absence of both PNPase 
and RNase II or PNPase and RNase R is lethal for the cell, indicating some 
overlapping role between these exonucleases (Cheng and Deutscher, 2003). For 
instance, both RNase R and PNPase are involved in the degradation of rRNA 
fragments, whose accumulation was proposed to lead to cell death (Cheng and 
Deutscher, 2003). A transcriptome analysis revealed that, although RNase II 
accounts for 90% of exonuclease activity in the cell, PNPase probably plays a 
greater role in mRNA degradation than previously thought (Deutscher and 
Reuven, 1991; Mohanty and Kushner, 2003). RNase II is the major exonuclease 
involved in E. coli RNA decay and other enterobacteriaceae but, this enzyme is 
absent in several other bacterial species, such as B. subtilis, Legionella pneumophila 
and Streptococcus pneumoniae, in which RNase R is the only hydrolytic 3’–5’ 
exonuclease (Charpentier et al., 2008; Domingues et al., 2009). In B. subtilis the 
RNA decay is primarily phosphorolytic and this major activity is attributed to 
PNPase (Arraiano et al., 2010). Regarding the main exonucleases, PNPase is the 
only one found in Streptomyces, thus constituting an essential protein in these 
organisms (Bralley et al., 2006). Conversely, the unique exonuclease in Mycoplasma 
genitalium is RNase R, which is thus essential (Hutchison et al., 1999).  
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The degradative action of the ribonucleases described above releases 
RNA fragments of 2–5 nucleotides, whose accumulation may be deleterious to the 
cell (Ghosh and Deutscher, 1999). E. coli possesses another exonuclease, termed 
oligoribonuclease, which acts as a scavenger of these short oligoribonucleotides 
(Niyogi and Datta, 1975) (see Figure 1A). This essential enzyme processively 
hydrolyses RNA in the 3’–5’ direction. Overall, oligoribonuclease is a finishing 
enzyme in RNA metabolism, and the presence of proteins with analogous 
functions seems to be widespread. Two homologues, NrnA and NrnB, have been 
described in B. subtilis (Fang et al., 2009). 
The case of the double-stranded specific RNase III 
 Even though RNase E has been considered the main enzyme in E. coli that 
catalyses the initial cleavage event, the RNase III family of enzymes has emerged 
as an important group of endonucleases in the control of RNA stability 
(Jaskiewicz and Filipowicz, 2008). RNase III deletion in E. coli causes a slow 
growth phenotype (Babitzke et al., 1993), while its homologue in B. subtilis is 
essential for viability (Herskovitz and Bechhofer, 2000). A second B. subtilis 
RNase III-like enzyme (called Mini-III) has been described (Redko et al., 2008). 
Both enzymes seem to act mostly in bacteriophage mRNA and rRNA processing, 
since no endogenous mRNA targets are known (Bechhofer, 2009). Interestingly, a 
recent study performed using the human pathogen S. aureus revealed the 
existence of an overlapping sense/antisense RNA processing by the activity of 
RNase III (Lasa et al., 2012). This process also occurs in other Gram-positive 
bacteria such as B. subtilis, Listeria monocytogenes and Enterococcus faecalis. 
RNase III is specific for double-stranded RNA and its role in RNA 
turnover has been associated with the removal of protective stem-loop structures 
that act as degradation barriers (Arraiano et al., 2010) (Figure 1A). Additionally, 
RNase III has recently been implicated in the decay of sRNA/mRNA complexes, 
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which constitute an optimal substrate for this enzyme, upon translational 
silencing (Viegas and Arraiano, 2008; Viegas et al., 2010). This phenomenon 
closely resembles siRNA–direct RNA cleavage in eukaryotes, a process that 
involves enzymes of the RNase III family.  
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FIGURE 1 - Mechanisms of RNA decay in the Gram-negative and Gram-positive 
bacterial models. (A) In E. coli the decay of the majority of transcripts starts with an 
endonucleolytic cleavage by RNase E. The enzyme has a preference for 5’-
monophosphorylated substrates. A possible pathway for RNase E cleavage involves a 
primary cleavage by the RNA pyrophosphohydrolase RppH, which converts the 5’-
triphosphorylated terminus of primary transcripts to monophosphate. However, some 
substrates are cleaved by RNase E regardless of the 5’-phosphorylation status, through an 
alternative pathway called ‘bypass’ or ‘internal entry’, which involves the direct entry of 
RNase E at single-stranded sites. RNase III is double-stranded specific and can also initiate 
the decay of structured RNAs. After endonucleolytic cleavage, breakdown products are 
ready for exonucleolytic digestion by any of the three main exonucleases in this bacterium. 
Unlike RNase R, both RNase II and PNPase are sensitive to secondary structures. 
Exonucleolytic activity is promoted by the 3’-polyadenylation of substrates. The activity of 
PAP I, the main polyadenylating enzyme in E. coli, is modulated by the RNA-chaperone 
Hfq. PNPase can synthesize heteropolymeric tails that also facilitate degradation. Cycles of 
polyadenylation and exonucleolytic degradation have been proposed as one way to 
overcome secondary structures. A minor alternative pathway in the cell is the direct 
exonucleolytic degradation of full length transcripts (represented by a dashed arrow). 
Exonucleolytic degradation releases short fragments which are subsequently degraded to 
mononucleotides by oligoribonuclease. (B) In B. subtilis, transcripts can be degraded from 
the 5’-end through the 5’–3’ exonuclease activity of RNase J1, or they can be first 
endonucleolytically cleaved. Since the 5’–3’ exonuclease activity of RNase J1 is blocked by 
5’-PPP, before this cleavage the recently discovered BsRppH removes the pyrophosphate. 
The endonucleolytic cleavage can be either performed by RNase J1/RNase J2 or RNase Y. 
The breakdown products can be then further degraded by the 3’–5’ exonucleases, PNPase 
and RNase R (unprotected 3’-ends), or by the 5’–3’ exonuclease activity of RNase J1 (newly 
generated monophosphorylated 5’-ends). RNase J1 is able to fully degrade its RNA 
substrates to mononucleotides. The final products released by RNase R and PNPase are 
further degraded by the oligoribonuclease homologues in B. subtilis. Here we represent 
ribonucleases acting independently. However some of these enzymes can act together in 
degradation complexes. For instance in E. coli the degradosome (RNase E, PNPase, RhlB 
and enolase) and in B. subtilis the putative complex formed by RNase J1/J2, RNase Y, 
PNPase, the RNA helicase CshA and two glycolytic enzymes. 
 
An alternative mechanism involving different endonucleases 
Despite its essential role in E. coli RNA turnover, RNase E homologues 
are absent in numerous bacterial species. This is the case of the model organism B. 
subtilis and is a common characteristic of the low G/C content Gram-positive 
bacteria. For quite some time, a good candidate that could have the analogous 
role of RNase E was not found, leaving no clue for the process of B. subtilis RNA 
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degradation. One answer came from the discovery of two different ribonucleases, 
the paralogous RNase J1 and J2, which are present in almost all bacteria lacking 
RNase E (Even et al., 2005). Curiously, both RNase E and RNase J1 orthologs have 
been found in Sinorhizobium meliloti (Madhugiri and Evguenieva-Hackenberg, 
2009). Although there is no sequence homology, the RNase J enzymes share a 
similar architecture with RNase E (de la Sierra-Gallay et al., 2008) and exhibit 
equivalent endonucleolytic activity. RNase J1, which is essential for cell viability, 
is involved in RNA turnover (Mäder et al., 2008) (Figure 1B). Surprisingly, this 
enzyme is also able to catalyse the exonucleolytic degradation of RNA in the 5’-3’ 
direction (Mathy et al., 2007). To date this is the only 5’-exonuclease known in 
prokaryotes and its discovery has had important implications in the RNA decay 
model. The exonucleolytic decay from the 5’-end may explain the stabilizing 
effect conferred by 5’-stem-loops, 5’-protein binding, 5’-ribosome stalling and the 
presence of a 5’-triphosphate in B. subtilis (Bechhofer, 2009). It has been suggested 
that this dual-function enzyme (alone or in complex with RNase J2) catalyses not 
only the endonucleolytic cleavage of an RNA substrate but also continues the 
degradation of the generated 5’-end by switching to the 5’-exonucleolytic mode 
(de la Sierra-Gallay et al., 2008). In fact, global analysis of RNase J-depleted B. 
subtilis strains showed an altered abundance for a large number of mRNA 
transcripts, indicating that this ribonuclease affects gene expression on a global 
scale (Durand et al., 2012; Mäder et al., 2008). Interestingly, only the exonucleolytic 
activity of RNase J1 is dependent on the 5’-end phosphorylation status, as it is 
blocked by triphosphorylated RNA (de la Sierra-Gallay et al., 2008). The complex 
formed by RNase J1 and J2 changes their individual cleavage activities and 
specificities (Mathy et al., 2010).  
Another insight into the RNA degradation mechanism of B. subtilis was 
the recent discovery of RNase Y, an essential single-stranded endonuclease 
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(Figure 1B), that shares extensive functional homologies with RNase E. In fact, 
several reports suggest that the predominant activity of RNase J1 is the 5’-3’ 
exonucleolytic activity (Condon, 2010; Durand et al., 2012; Lehnik-Habrink et al., 
2012; Newman et al., 2011), while RNase Y has an effect on the global mRNA half-
life in B. subtilis comparable to that of RNase E in E. coli. There are several studies 
reporting an increase of the bulk mRNA half-life in B. subtilis upon RNase Y 
deletion (Durand et al., 2012; Lehnik-Habrink et al., 2011b; Shahbabian et al., 2009). 
Like RNase E, RNase Y is sensitive to the phosphorylation state of the 5’-end, 
exhibiting a marked preference for monophosphorylated RNA. Hence, two 
essential enzymes in B. subtilis RNA decay are dependent on a 
monophosphorylated 5’-end. Indeed, it was recently discovered the existence of a 
RNA pyrophosphohydrolase in B. subtilis (BsRppH) (Richards et al., 2011). 
BsRppH was shown to remove the γ and β phosphates from the 5’-end of the 
RNA as orthophosphate (Richards et al., 2011), whereas the one from E. coli 
releases them mainly as a pyrophosphate (Deana et al., 2008). Interestingly, the 
results obtained with rppH deletion mutant suggested the existence of other(s) 
RNA pyrophosphohydrolase(s) in B. subtilis (Richards et al., 2011).  
Based on the amino acid sequence, RNase Y seems to comprise at least 
four domains: a short N-terminal trans-membrane domain (Hunt et al., 2006); a 
coiled-coil domain seemingly important for oligomerization (Lehnik-Habrink et 
al., 2011a); a KH domain required for RNA binding; and an HD domain that 
contains the catalytic site (Condon, 2003). The presence of an N-terminal trans-
membrane domain in RNase Y suggests membrane localization further extending 
the analogy to RNase E (Shahbabian et al., 2009) (Figure 1B). In fact, the proper 
membrane localization of RNase Y is essential for B. subtilis (Lehnik-Habrink et 
al., 2011a).  
Evidence for the presence of a complex involving RNase Y, RNase J1/J2, 
PNPase, the RNA helicase CshA and two glycolytic enzymes, enolase and 
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phosphofructokinase, has been reported (Commichau et al., 2009). This complex 
brings together some of the degrading activities necessary to achieve full 
degradation of an RNA molecule. The RNA fragments released by the RNase Y 
endonucleolytic cleavage could be good substrates for the 3’-exonucleolytic 
activity of PNPase and for the 5’-exonucleolytic degradation by RNase J1/J2 
(Bechhofer, 2009). This putative degradosome-like complex indicates that the 
presence of such an RNA degradative machine may be a common feature in 
prokaryotes, even those that lack an RNase E homologue. Nonetheless, the 
existence of this complex in B. subtilis is still controversial. The presence of a 
degradosome-like complex in this organism has been challenged by the failure of 
isolating it as a complex in its native state and by the absence of detection of 
degradosome interactions in yeast two- and three-hybrid screens (Mathy et al., 
2010). However, these screens failed to detect also the established self-interactions 
of the RNase J1 and J2 (Commichau et al., 2009; de la Sierra-Gallay et al., 2008; 
Newman et al., 2011). Accordingly, the current knowledge does not yet allow 
accurate conclusions about the presence or absence of an RNA degradosome in 
this bacterium. 
 
ROLE OF RNA DEGRADATION IN QUALITY CONTROL 
Gene mutation, DNA damage, or transcriptional errors may generate 
damaged mRNAs that are unsuitable for protein synthesis. Additionally, 
translational frame-shifting can also lead to aberrant proteins, whose 
accumulation may be detrimental to the cell. Hence, bacteria have evolved 
efficient quality control mechanisms engaged in the rapid degradation of these 
abnormal transcripts and proteins. 
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One of the common errors is the presence of a premature stop codon in 
some messages, which produces a truncated protein. In E. coli the fast 
degradation of messages carrying a premature stop codon is thought to begin 
with a 5’-independent RNase E cleavage at internal sites exposed by the 
premature release of ribosomes (Baker and Mackie, 2003). The resulting RNA 
molecules are further degraded through the pathways described above. 
Messages without an in-frame stop codon may lead to ribosome stalling 
at the 3’-end, significantly affecting translational efficiency. An elegant 
surveillance pathway, termed trans-translation, targets deficient proteins and 
mRNA for degradation while rescuing stalled ribosomes (see (Keiler, 2008; 
Richards et al., 2008) for a review). This process relies on the association of two 
molecules: a sRNA called transfer-messenger RNA (tmRNA), and a small RNA-
binding protein (SmpB), whose homologues have been identified in every 
sequenced eubacterial genomes. Some situations that delay the progress of 
ribosomes during translation were also observed to elicit tagging by the trans-
translation machinery in a process that involves RNase II (Garza-Sánchez et al., 
2009; Richards et al., 2008). 
The rapid removal of the defective messages that lead to ribosome 
stalling is of utmost importance in the prevention of future stalling events. RNase 
R is associated with tmRNA and SmpB and is involved in the tmRNA-mediated 
decay (Karzai and Sauer, 2001) as well as in the processing of tmRNA (Cairrão et 
al., 2003). The mechanism that influences the loading of RNase R onto the 
defective mRNAs was recently highlighted, whereby RNase R was shown to be 
recruited through interactions mediated by its C-terminal lysine-rich domain in a 
SmpB-tmRNA-dependent manner (Ge et al., 2010). Indeed, this domain was 
previously suggested as being involved in interactions with SmpB (Liang and 
Deutscher, 2010). 
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Finally, errors in macromolecular processes like tRNA and rRNA 
synthesis also occur. Li and co-workers had shown that an aberrant precursor 
tRNA molecule is degraded by a mechanism that involves PAP I and PNPase (Li 
et al., 2002), leading to the proposition that polyadenylation could serve as a 
signal to promote degradation of defective tRNAs. PNPase and RNase R have 
been implicated in the removal of defective rRNAs (Cheng and Deutscher, 2003). 
 
STRUCTURAL DETERMINANTS OF RNA DEGRADING ENZYMES 
The intrinsic degradative nature of ribonucleases and the fact that they 
share the cellular environment with a pool of different types of RNA molecules 
raises some questions: How do these ‘molecular killers’ specifically select their 
targets? What are the structural determinants that allow these enzymes to spare 
some molecules while dictating the destruction of others? As underlined above 
there are several features of the RNA molecules that are key factors in 
determining their fate. The interplay between the structural determinants of the 
enzymes and their specific degradation preferences, depending on the 
characteristics of each RNA molecule, seems to dictate the final decision. 
RNase E 
RNase E, the main endonuclease of numerous species including E. coli, 
organizes its catalytic domain, as a dimer of dimers in a final homotetramer 
quaternary structure (Callaghan et al., 2005) (Figure 2). Each protomer contains 
the following structural domains: S1, RNase H, DNase I and a small domain that 
is responsible for dimer–dimer interaction. The arrangement of the domains 
within each dimer resembles the blades and handles of an open pair of scissors. 
The crystal structure explains some features of the enzyme and suggests a 
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mechanism for RNA recognition and cleavage (Koslover et al., 2008). The 
influence of 5’-phosphorylation is a consequence of the pocket formed between 
the S1 and the RNase H subdomains, which binds 5’-monophosphorylated RNA 
and promotes downstream degradation. After binding, a conformational change 
induced by the movement of the RNA-binding domains clamps the substrate 
down and organizes the active site (Koslover et al., 2008). The catalytic site 
contains conserved residues of the DNase I domain and a single metal-binding 
site that coordinates an Mg2+ ion implicated in catalysis. The internal flexibility 
within the quaternary structure may be related to the deformation required to 
accommodate structured RNA for processing by internal entry. An amphipathic 
segment (called segment A) at the C-terminal region of RNase E directs the 
enzyme to the inner membrane (Khemici et al., 2008). It was recently published 
the existence of another RNase E-membrane binding interaction involving the 
catalytic domain of the enzyme (Murashko et al., 2012). The N-terminal RNase E 
membrane binding alters its enzymatic activity by increasing the substrate 
affinity, and affects the secondary structure of the catalytic domain stabilizing the 
folding state of the protein (Murashko et al., 2012). Membrane localization of this 
enzyme could be determinant for spatial discrimination of the RNA substrates. 
RNase III 
E. coli RNase III is the prototype of the RNase III family of enzymes, 
which includes eukaryotic enzymes such as Dicer and Drosha. The bacterial 
enzymes are the simplest, containing an N-terminal endonuclease domain 
(NucD) characterized by a 9-residue consensus sequence known as the RNase III 
signature motif, and a double-stranded RNA binding domain (dsRBD) in the C-
terminus. The enzyme is active in the homodimeric form and the crystal structure 
of the Aquifex aeolicus RNase III endonuclease domain shows that dimerization 
creates a large valley that accommodates dsRNA (Figure 2). The catalytic centers 
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are found in the dimer interface, one at each end of the valley. Although dsRNA 
binding is governed by the combined dsRBD of the dimer, the NucD domains 
contribute to substrate specificity (Gan et al., 2008). Substrate selection consists of 
a combination of structural and sequence elements, such as the strength of base 
pairing, the occurrence of specific nucleotide pairs and the helix length (Pertzev 
and Nicholson, 2006). Several conserved residues in the catalytic centers were 
shown to be essential for catalysis, which involves amino acids from both 
subunits, and thus, dimerization of the NucD domains is necessary for RNase III 
function (see (Gan et al., 2006) and references therein). The crystal structure 
indicates that a single RNA cleavage event occurs on each strand of the dsRNA 
within each cleavage site, generating products with a two-base 3’-overhang. Mg2+ 
is required for the formation of a catalytical competent protein–RNA complex 
and two divalent cations are coordinated by each active site. When Mg2+ is absent 
the RNA is bound outside the catalytic valley (Gan et al., 2008). Indeed, RNase III 
is also known to be involved in the control of gene expression by binding a 
dsRNA molecule without cleaving. In this non-catalytic functional form the 
enzyme plays the role of a dsRNA-binding protein (Blaszczyk et al., 2004).  
RNase J 
RNase J is unique among bacterial RNases in that it possesses both endo- 
and 5’–3’ exonucleolytic activity (de la Sierra-Gallay et al., 2008). The crystal 
structure of an RNase J homolog of T. thermophilus (sharing 43% and 39% 
sequence identity with B. subtilis RNase J1 and J2, respectively) was determined 
in the closed state, unable to accommodate the bulk of an RNA structure (de la 
Sierra-Gallay et al., 2008) (Figure 2). More recently, the structures of T. 
thermophilus RNase J in complex with short RNA oligomer and of B. subtilis 
RNase J1 with an open conformation suitable for binding substrate RNA were 
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reported (Dorléans et al., 2011; Newman et al., 2011). In both structures, while 
there are small differences in the detail of RNA binding, the general mode of 
binding and the path taken by the RNA is the same.  
The enzyme is active as a dimer in solution, and each monomer contains 
three distinct domains: a metallo-β-lactamase core, a β-CASP and a C-terminal 
domain. This last domain may be involved in substrate recognition and 
maintenance of the dimeric state. Two Zn2+ ions, essential for catalysis, are 
coordinated in an octahedral environment by residues located deep in the cleft 
between the β-lactamase core and the β-CASP domain. Specific attack of 5’-
monophosphorylated transcripts is related to a binding pocket near the catalytic 
center that precludes the accommodation of a 5’-triphosphorylated substrate. 
Only one catalytic center was obvious from the structures, suggesting that a 
single active site is responsible for the dual activity of RNase J. In fact, the model 
of B. subtilis RNase J1 bound to RNA contains a significant region of unoccupied 
space at the free 5’-end of the RNA perhaps explaining how both endonuclease 
and 5’-to-3’ exonuclease activities are incorporated in the same active site 
(Newman et al., 2011). Indeed, the 5’-monophosphate generated after the 
endonucleolytic cleavage may be directly placed in the binding pocket with a 
single translocation of the RNA molecule, allowing RNase J to start the 
exonucleolytic degradation. In both B. subtilis and T. thermophilus “open” state 
structures it is evident the existence of two channels that allow the 5’-3’ 
exonucleolytic activity of RNase J1 (Dorléans et al., 2011; Newman et al., 2011). 
There is an RNA binding tunnel formed between the β-CASP and metallo-β-
lactamase domains into which the 5’-terminus of the substrate enters to access the 
active site, and a negatively charged RNA exit channel on the other side of the 
ribonuclease to evacuate the cleaved nucleotides. Consistent with the absence of 
sequence specificity by RNase J, most of its contacts with the RNA involve sugar-
phosphate backbone rather than the bases (Newman et al., 2011).  
Introduction 
 
 
23 
RNase II 
E. coli RNase II is the prototype of the RNase II family of enzymes, a 
widespread family that also includes RNase R and the catalytic subunit of the 
eukaryotic exosome, Rrp44/Dis3. The overall crystallographic structure of E. coli 
RNase II reveals a monomeric protein with four domains: three RNA binding 
domains comprising CSD1 and CSD2 in the N-terminal region, and an S1 fold at 
the C-terminus; and one RNB catalytic domain in the central region, which is a 
hallmark of the RNase II family of proteins (Amblar et al., 2006; Frazão et al., 2006; 
Zuo et al., 2006) (Figure 2). The RNA binding domains are grouped together in 
one side of the structure, and play a role in the RNA substrate selection and 
binding (Frazão et al., 2006; Matos et al., 2009).  
Interestingly, a truncated enzyme lacking all the RNA binding domains is 
still able to degrade RNA (Matos et al., 2009; Vincent and Deutscher, 2009b). The 
structure of the enzyme in complex with an RNA molecule reveals two main non-
contiguous interaction points between the protein and the RNA fragment. A 10-
nucleotide segment is the shortest RNA able to retain both contacts, explaining 
why RNase II becomes distributive on substrates shorter than 10 nt (Frazão et al., 
2006). A single amino acid change in the catalytic region alters the final end-
product from 4 to 10 nt, probably due to loosening of the RNA substrate at the 
catalytic site (Barbas et al., 2008). The access to the catalytic pocket is restricted to 
single-stranded RNAs by steric hindrance, explaining the inability of RNase II to 
degrade dsRNA. A specific interaction with ribose rings precludes DNA cleavage 
(Frazão et al., 2006). Several residues in the catalytic region are important for 
catalysis (Amblar and Arraiano, 2005; Barbas et al., 2008; Barbas et al., 2009; Frazão 
et al., 2006); however, only Asp209, which is involved in the coordination of Mg2+, 
is essential (Barbas et al., 2008). Interestingly, substitution of one conserved 
glutamine gives rise to an enzyme with highly increased RNA-binding and 
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exonucleolytic activity (120-times higher), consequently called ‘super-enzyme’ 
(Barbas et al., 2009).  
RNase R 
RNase R shares a similar domain organization with RNase II, and a three-
dimensional model of this enzyme has been proposed based on the structure of 
RNase II (Barbas et al., 2008). Besides the domains identified in RNase II, RNase R 
also contains a helix-turn-helix in the N-terminus (Domingues et al., 2009), and a 
highly basic region after the S1 fold at the C-terminus (Vincent and Deutscher, 
2009b). The RNB domain of RNase R alone is sufficient to bind and degrade an 
RNA duplex (Matos et al., 2009; Vincent and Deutscher, 2009b). Paradoxically, 
when the RNA-binding domains are present in the wild-type enzyme a short 3’-
overhang is necessary in order to initiate degradation. These domains are 
essential for binding and recruitment of 3’-tailed RNA molecules. The two CSD 
domains appear to play a role on the recognition of the substrates for 
degradation, whereas the S1 domain is most likely required to position substrates 
for efficient catalysis (Matos et al., 2009; Vincent and Deutscher, 2009b). The RNA-
binding regions (S1, CSD1, and most importantly CSD2) have been suggested to 
possess intrinsic helicase activity (Awano et al., 2010), a hypothesis that still needs 
further experimental support. Mutation analysis in the nuclease domain 
identified important residues for the nuclease activity and for substrate binding, 
which may contribute to the ability of RNase R to degrade structured RNAs 
(Matos et al., 2009; Matos et al., 2011; Vincent and Deutscher, 2009a). Nevertheless, 
only the resolution of its three-dimensional structure will allow full 
understanding of its remarkable mode of action. 
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PNPase 
PNPase belongs to the PDX family of exonucleases, which also includes 
the core of the exosome in archaea and eukaryotes (Pruijn, 2005). The crystal 
structures of Streptomyces antibioticus, Caulobacter crescentus and E. coli PNPase 
reveal a homotrimeric subunit organization with a ring-like architecture 
(Hardwick et al., 2012; Nurmohamed et al., 2009; Shi et al., 2008; Symmons et al., 
2000) (Figure 2). This structure closely resembles the doughnut-like shape of the 
archaeal and the eukaryotic exosomes (Pruijn, 2005). Each PNPase monomer 
comprises two RNase PH domains (PH1 and PH2) forming the catalytic site 
(PNPase core). While the C-terminal RNase PH domain catalyses the 
phosphorolytic attack of RNA, the N-terminal domain contributes to the ring-like 
quaternary structure of the trimeric PNPase assembly (Symmons et al., 2000). 
These two domains are connected by an α-helical domain. Several mutations 
introduced into the PNPase core have been shown to influence phosphorolytic 
and polymerase activities of the enzyme (Briani et al., 2007; Jarrige et al., 2002). In 
addition, two RNA-binding domains S1 and KH have been found in the C-
terminus. These domains are required not only for proper binding, but also 
contribute to the formation of a more stable trimeric structure (Amblar et al., 2007; 
Matus-Ortega et al., 2007; Shi et al., 2008). In the quaternary structure, the RNA-
binding domains are grouped in one face of the trimer, while the active site is 
located in the opposite side. The association of the three subunits encloses a 
central channel through which the RNA molecule travels in the direction of the 
active site. A properly constricted channel and the conserved basic residues in the 
neck region play critical roles in trapping RNA for processive degradation. RNA 
translocation is dynamic, and PNPase undergoes conformational changes at the 
central channel and its neighbouring regions, while directing the RNA to the 
active center (Hardwick et al., 2012; Nurmohamed et al., 2009; Shi et al., 2008; 
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Symmons et al., 2000). Mg2+ is required for PNPase enzymatic activity, though 
Mn2+ can also support catalysis. The metabolite citrate has recently been shown to 
directly modulate the enzyme’s activity, connecting RNA degradative pathways 
with the central metabolism (Nurmohamed et al., 2011). Moreover, PNPase was 
recently shown to be directly activated by the second messenger c-di-GMP 
(Tuckerman et al., 2011).   
 
In this section, it were highlighted the structural features of the 
ribonucleases that are specifically involved in the recognition of a given RNA 
molecule. In light of the enzymes’ spatial architecture, it was covered how both 
the sequence and structural elements within the transcript regulate both its rate of 
decay and the primary nucleases involved. Furthermore, it was shown that some 
ribonucleases can also be influenced by metabolites and by the spatial 
compartmentalization within the cell, which may modulate their access to 
different RNA molecules. 
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FIGURE 2 - Structures of RNA degrading enzymes in complex with RNA substrates. On 
the top of the image are shown the crystal structures of endonucleases (catalytic domain of 
E. coli RNase E, PDB ID 2C4R, on the left; A. aeolicus RNase III, PDB ID 2NUF, on the right). 
The crystal structures of exonucleases are on the bottom (E. coli RNase II, PBD ID 2IX1, on 
the left; E. coli PNPase, PDB ID 3GCM, on the right). The crystal structure of T. thermophilus 
RNase J (PDB ID 3BK2), which has a dual function as endo- and exonuclease, is in the 
middle. RNA substrates in complex with the enzymes are coloured in orange and the 
metal ions that assist catalysis are shown as red spheres. Purple spheres denote the Zn2+ 
ions important for maintenance of the principal dimers in the RNase E quaternary 
structure. Otherwise the colours are unrelated to the functional domains of the enzymes, 
but represent different protomers in the quaternary structures except in RNase II, which is 
active as a monomer. In this case, each colour identifies a different domain (CSD1 and 
CSD2 are shown in cyan and light blue, respectively; S1 is shown in dark blue and the 
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catalytic domain RDB is coloured in dark cyan). A model for RNase R has been proposed 
but the structure is not yet available. However functional and structural data available 
indicates that the structure will be quite similar to RNase II. Structures were drawn using 
PyMOL (http://pymol.sourceforge.net). 
 
OTHER PLAYERS 
Polyadenylation 
Polyadenylation is a post-transcriptional event that involves the addition 
of untemplated adenosine residues to the 3’-ends of RNA substrates. This 
widespread phenomenon occurs in bacteria, organelles, archaea, and in the 
nucleus and cytoplasm of eukaryotic cells. Eukaryotic poly(A) tails, present in the 
majority of mRNAs, are usually long, uniform in length and have traditionally 
been viewed as a stabilizing element. However, recent studies have also shown 
evidence of a polyadenylation-induced decay of non-functional RNAs in 
eukaryotes (Houseley and Tollervey, 2009). Prokaryotic polyadenylated 
transcripts are generally low in abundance and poly(A) tails are very short and 
unstable. This fact, together with a lack of evidence for a physiological role, made 
polyadenylation in bacteria almost overlooked for several years after its 
discovery. It has been estimated that less than 2% of total RNA in E. coli is 
polyadenylated. Despite this intriguingly low percentage, a transcriptome 
comparison between the wild-type and a strain defective in polyadenylation has 
indicated that the majority of transcripts (∼90%) undergo some degree of 
polyadenylation during exponential growth, either as full-length transcripts or 
decay intermediates (Mohanty and Kushner, 2006). The rapid turnover of 
polyadenylated mRNAs accounts in part for their low abundance. 
Poly(A) tails provide a single-stranded extension region that works like a 
‘toe-hold’ upon which exonucleases can bind and initiate decay (Dreyfus and 
Régnier, 2002) (Figure 1A). Polyadenylation therefore facilitates exonucleolytic 
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activity. Paradoxically, the higher affinity of RNase II for these poly(A) stretches 
has been shown to protect mRNAs from degradation, as this enzyme degrades 
the tails that allow PNPase and RNase R to proceed through secondary structures 
(Marujo et al., 2000; Mohanty and Kushner, 2003).  
Initially identified 50 years ago in E. coli (August et al., 1962), Poly(A) 
Polymerase I is responsible for approximately 90% of the polyadenylating activity 
in the cell (Mohanty and Kushner, 2011). The enzyme catalyzes the addition of 
homopolymeric poly(A) tails (15–30 nt long in average) to 3’- hydroxyl termini of 
RNA molecules using ATP as a substrate (Mohanty and Kushner, 2006; Mohanty 
et al., 2004; O'Hara et al., 1995). However, deletion of its cognate gene (pcnB) has 
only a moderate effect on growth (Cao and Sarkar, 1992) and does not abolish all 
the polyadenylating activity in the cell (Mohanty and Kushner, 2000). PNPase can 
also synthesize A-rich heteropolymeric extensions through its reverse activity 
(synthetic instead of degrading) (Mohanty and Kushner, 2000) although to a 
much lesser extent. This PNPase activity has recently been shown to change in 
response to adjustments of cyclic-di-GMP levels in an O2-dependent way 
(Tuckerman et al., 2011). In many prokaryotic organisms, archaea, and organelles 
of prokaryotic origin lacking a PAP I protein, polyadenylation has been shown to 
be carried out by PNPase (Slomovic and Schuster, 2011). It has been speculated 
that the evolutionary precursor of PNPase was the first enzyme to produce these 
tails. Much later, PAP I would have been acquired by bacteria such as E. coli. The 
enzyme, already specific for ATP (the ‘energy currency’ of the cell), produced the 
dominant homopolymeric poly(A) tails. B. subtilis, in which as much as 15–25% of 
total RNA was estimated to be polyadenylated (Gopalakrishna et al., 1981), lacks 
an identifiable PAP I homologue. Nonetheless, similar polyadenylated and 
heteropolymeric ends have been observed at the 3’-ends of RNA isolated from 
wild-type and PNPase mutant strains, indicating that PNPase is not the only 
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enzyme responsible for the addition of nucleotides to the 3’-end of RNAs in this 
organism (Campos-Guillén et al., 2005). 
Regarding the nature of the poly(A) tail, several observations indicate 
that transcripts which terminate in a Rho-dependent fashion tend to contain only 
heteropolymeric tails generated by PNPase. On the other hand, Rho-independent 
transcription terminators serve as polyadenylation signals for PAP I (Mohanty 
and Kushner, 2006; Mohanty et al., 2004). Moreover, heteropolymeric tails are 
mainly added to breakdown products, whereas poly(A) tails are added to both 
breakdown and full-length transcripts (Mohanty and Kushner, 2011). In 
stationary phase, the addition of heteropolymeric tails is predominant over the 
homopolymeric tails commonly found in exponentially growing cells (Cao and 
Sarkar, 1997). The lack of energy resources in stationary phase could be a reason 
for this choice, since the generation of adenylated tails at the expense of several 
ATP molecules is more justifiable under exponential growth (Cao and Sarkar, 
1997).  Moreover, polyadenylation promotes high mRNA turnover rates which 
are characteristic of the exponential phase (Mohanty and Kushner, 2000).  
In both bacteria and organelles, RNA breakdown products generated by 
endonucleolytic cleavages are considered the most favoured substrates for 3’-
tailing (Goodrich and Steege, 1999; Haugel-Nielsen et al., 1996; Lupold et al., 1999; 
Perrin et al., 2004). Single-stranded segments at either 5’- or 3’-end of RNA 
molecules and monophosphorylation at an unpaired 5’-terminus were reported to 
increase the RNA susceptibility to polyadenylation by PAP I (Feng and Cohen, 
2000). This suggests that the endonucleolytically-generated RNA fragments 
containing single-stranded monophosphorylated 5’-termini would be preferential 
substrates for 3’-end polyadenylation. However, this is not always required as 
transient poly(A) tails have been found at the native 3’-ends of RNA molecules 
(Dreyfus and Régnier, 2002). In E. coli, the low level of PAP I (32–50 molecules per 
cell) is also likely to be a limiting factor in substrate selection (Mohanty and 
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Kushner, 2006; Mohanty et al., 2004). PAP I over-synthesis is highly toxic, which 
may be the reason for such a low enzyme level (Cao and Sarkar, 1992; Mohanty 
and Kushner, 1999). 
It has long been presumed that 3’-polyadenylation was only restricted to 
mRNAs, nevertheless PAP I and PNPase can polyadenylate almost any RNA 
species, including rRNAs, tRNAs, and sRNAs. Interestingly, while the tails found 
on rRNAs resemble the ones found on mRNAs, the tails on tRNAs and sRNAs 
tend to be very short (1–8 nt) (Argaman et al., 2001; Xu et al., 1993). A few sRNAs 
have been reported to be destabilized by polyadenylation (Argaman et al., 2001; 
Dam Mikkelsen and Gerdes, 1997; Reichenbach et al., 2008; Söderbom et al., 1997; 
Viegas et al., 2007). Polyadenylation was also implicated in the promotion of the 
exonucleolytic degradation of defective tRNAs (Li et al., 2002). A defective 
tRNATRP does not accumulate to the normal wild-type levels due to the rapid 
degradation of its precursor. Using PAP I and/or PNPase mutant strains, it has 
been proposed that polyadenylation of the defective precursor serves as a signal 
to promote its fast degradation by PNPase (Li et al., 2002).  
PAP I has been reported to have physical interactions with Hfq, PNPase, 
RNase E, and the RNA helicase RhlB (Mohanty et al., 2004; Raynal and Carpousis, 
1999), which suggests that the polymerase could act as part of a multiprotein 
complex (Mohanty et al., 2004). It has been demonstrated in E. coli that PAP I is 
localized either in the membrane or in cytosol, depending on the growth phase 
(Carabetta et al., 2009; Jasiecki and Wegrzyn, 2005). Such localization may, 
however, be indirect through a loose association with RNase E (Khemici et al., 
2008; Liou et al., 2001). The release of PAP I from the membrane in the transition 
from the exponential to the stationary phase has been found to be dependent on 
the adaptor protein SprE (RssB), previously known for its role in governing the 
stability of the alternate σ factor RpoS (Carabetta et al., 2009). SprE has also been 
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reported to be required to maintain the association of PAP I and Hfq with the 
degradosome during stationary phase (Carabetta et al., 2010). In addition, 
microarray data have revealed that polyadenylation and turnover of specific E. 
coli transcripts can be modulated by SprE (Carabetta et al., 2009). 
Hfq 
Hfq is an RNA chaperone known to be involved in the stabilization 
and/or degradation of many RNAs. This widespread and highly abundant post-
transcriptional regulator belongs to the Sm/Lsm family of RNA binding proteins. 
The active form of Hfq has a doughnut-shape homohexameric ring structure that 
displays the highest affinity for short single-stranded stretches of adenines and 
uridines adjacent to stem-loop structures (Kajitani et al., 1994). The protein has 
three RNA-binding sites: the proximal site, which preferably binds to the 3’-
hydroxyl group of the sRNA composed by the uridine-rich terminator (Otaka et 
al., 2011; Sauer and Weichenrieder, 2011); the distal site, specific for poly(A) 
stretches (Mikulecky et al., 2004); and a lateral site that is largely responsible for 
binding of the sRNA body (Sauer et al., 2012). Therefore, the sRNA is anchored in 
the proximal site via its 3’-terminal uridine-rich terminator end, whereas the 
sRNA body wraps around the ring and is protected by the interaction with 
several of the lateral sites. The distal site assists mRNA targeting by the 
Hfq/sRNA complex (Sauer et al., 2012). This protein can directly interact with PAP 
I and/or change its activity from distributive to processive (Hajnsdorf and 
Régnier, 2000; Mohanty et al., 2004) (Figure 1A). Actually, Hfq targets many 
mRNAs for degradation by binding to their poly(A) tails and stimulating 
polyadenylation (Folichon et al., 2003; Hajnsdorf and Régnier, 2000). 
Paradoxically, Hfq stabilizes sRNAs, probably because its binding protects them 
from ribonuclease attack as there is an overlapping of recognition sites between 
Hfq and RNase E (Folichon et al., 2003). Hfq has also been shown to interact with 
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PNPase and RNase E (Mohanty and Kushner, 2011; Mohanty et al., 2004; Morita et 
al., 2005). The formation of variable ribonucleoprotein complexes between RNase 
E and Hfq/sRNAs specifically destabilizes the mRNA target (Morita et al., 2005). 
The pleiotropic phenotype of hfq null mutants reveals that this protein 
acts on several pathways of E. coli metabolism (Johansen et al., 2006; Tsui et al., 
1994). In Salmonella enterica serovar Typhimurium, the deletion of hfq attenuates 
the ability of the model pathogen to infect mice, to invade epithelial cells, to 
secrete virulence factors and to survive inside cultured macrophages (Sittka et al., 
2007). This fact was recently confirmed using the insect model Galleria mellonella 
(Viegas et al., 2012). In fact, it was shown that Hfq controls the expression of 
almost a fifth of all Salmonella genes, including the master regulator of SPI-1 
invasion genes (hilD) and also the flagellar master regulator (fhlDC) (Sittka et al., 
2008).  
Hfq is currently recognized as a key factor in regulation by sRNAs. This 
protein promotes sRNAs interaction with their mRNA targets (see details in the 
next subsection) (Viegas and Arraiano, 2008; Waters and Storz, 2009), although 
the precise mechanism by which Hfq brings mRNAs and sRNAs together is not 
completely understood. The Hfq binding may unfold or weaken RNA secondary 
structures, allowing sRNAs to access their targets (Geissmann and Touati, 2004; 
Moll et al., 2003). Alternatively, the simultaneous interaction between the sRNA 
with the Hfq proximal and lateral sites, and the mRNA with its distal site, may 
raise the local concentrations of the two RNAs, thereby increasing the probability 
of sRNA–mRNA interaction (Link et al., 2009). When the interaction between the 
two RNA molecules is stable, Hfq dissociates or is proteolytically removed from 
the complex (Moll et al., 2003).  
While the focus of study has long been on E. coli Hfq, a role in sRNA-
mediated regulation extends to distant bacteria (Lybecker et al., 2010; Nielsen et 
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al., 2010). Intriguingly, a growing number of bacteria such as Burkholderia 
cenocepacia are now known to contain multiple Hfq proteins (Ramos et al., 2011).  
RNA regulators 
RNA regulators have been extensively studied over the last years because 
of their high importance in the post-transcriptional regulation of bacterial gene 
expression. They have become another important factor to consider in the global 
picture of RNA turnover. Their action can directly trigger the degradation of 
specific mRNAs, thus changing gene expression. 
The mechanisms of regulation by these RNA molecules are very complex 
and reports of different modes of action are becoming increasingly common in 
the literature. Therefore, RNA regulators are divided in different classes 
depending on their mode of action. Some interact with a protein to modify its 
activity by mimicking and thus competing with RNA or DNA targets. For 
instance, CsrB and CsrC tightly regulate the activity of the global post-
transcriptional regulator CsrA by binding and sequestering several of these 
proteins simultaneously (Babitzke and Romeo, 2007). Another well-known 
protein-binding sRNA is the E. coli 6S RNA which was found to tightly bind and 
inhibit the housekeeping form of RNA polymerase (σ70-RNAP). The interaction 
between 6S and σ70 holoenzyme, which occurs mainly during stationary phase of 
growth, inhibits the transcription from certain σ70 promoters (Wassarman, 2007a; 
Wassarman, 2007b).  
The vast majority of the small RNAs belongs to the class of antisense 
sRNAs that act by directly base-pairing with their mRNA targets. Antisense 
sRNAs can act either in cis or in trans depending on their genomic location in 
relation to their mRNA target(s). MicA sRNA is the only known case of a sRNA 
in E. coli which targets both in cis and in trans (Gogol et al., 2011; Rasmussen et al., 
2005; Udekwu, 2010; Udekwu et al., 2005). Cis-encoded sRNAs are transcribed 
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from the same locus, but in the opposite sense sharing extended regions of 
complete complementarity with theirs targets. The best known examples are 
those involved in the replication of plasmids such as the antisense RNA CopA 
that inhibits the replication of plasmid R1 (Givskov and Molin, 1984; Stougaard et 
al., 1981) and the copy number regulator of the plasmid ColE1 RNAI (Lin-Chao 
and Cohen, 1991). Other example of cis-encoded sRNAs are those involved in the 
repression of genes that encode potentially toxic proteins (Fozo et al., 2008; Gerdes 
and Wagner, 2007). This type of sRNAs was also found to be associated with 
bacteriophages and transposons and a few of them have been identified in the 
bacterial chromosome (for a review (Brantl, 2007)). Nevertheless, the bulk of 
antisense sRNAs are trans-encoded, being transcribed from a distinct locus. 
Almost all of the sRNAs of this class are expressed under specific growth 
conditions ranging from limiting iron (Fur-repressed RyhB sRNA), oxidative 
stress (OxyR-activated OxyS sRNA), outer membrane stress (σE-induced MicA 
and RybB sRNAs), elevated glycine (GcvA-induced GcvB sRNA), high glucose-6-
phosphate concentrations (SgrR-activated SgrS sRNA) and glucose starvation 
(CRP-repressed Spot42 sRNA and CRP-activated CyaR sRNA) (reviewed in 
(Görke and Vogel, 2008; Gottesman, 2005; Papenfort and Vogel, 2009)). In contrast 
to the cis-encoded, the trans-encoded sRNAs display a limited and often non-
contiguous target complementarity. This limited complementarity not only 
allows a single sRNA to act on several different targets (Papenfort and Vogel, 
2009), but also consents several sRNAs to act on the same target presumably 
under different stress conditions (Battesti et al., 2011). As the complementarity of 
trans-encoded sRNAs with the respective targets is imperfect they typically 
require Hfq for target interaction and/or intracellular stability. Hfq-dependent 
antisense regulation is widespread in Gram-negative bacteria, but only one 
example was reported in Gram-positive bacteria in L. monocytogenes (Nielsen et 
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al., 2010). The trans-encoded sRNAs usually exhibit a structure composed by three 
different domains: the first region, often called seed region, is highly conserved 
and is involved on the base-pairing to target RNAs; the second domain is the 
binding site for Hfq; and the third region comprises a structured 3’-end followed 
by poly(U) that promotes the Rho-independent transcription termination and 
protects the sRNA against 3’-exonucleases. The poly(U) region at the 3’-end can 
also be recognized by Hfq, possibly serving as a loading site (Otaka et al., 2011; 
Sauer and Weichenrieder, 2011) (Figure 3A). 
The result of the sRNA/target pairing can be one of the following: 
inhibition of translation; mRNA degradation; stimulation of translation; and 
stabilization of the mRNA (Gottesman and Storz, 2011). Despites few cases are 
known, examples of gene expression activation by sRNAs were reported, in many 
cases by preventing or overcoming the formation of an inhibitory secondary 
structure. For instance, the translation of the rpoS mRNA is positively regulated 
by the action of the sRNAs DsrA, RprA, and ArcZ (Majdalani et al., 1998; 
Majdalani et al., 2002; Soper et al., 2010). However, the majority of these trans-
encoded sRNAs usually act to repress translation and/or accelerate the mRNA 
degradation. Binding of the sRNA usually sequesters the ribosome binding site 
and, consequently, prevents the 30S ribosome loading. Following translational 
repression, the mRNA target often becomes substrate for RNase E or RNase III 
(Caron et al., 2010; Massé et al., 2003b). This initial cleavage occurs not only in the 
vicinity of the sRNA/mRNA interaction (Pfeiffer et al., 2009; Rasmussen et al., 
2005; Udekwu et al., 2005) but also at distal sites downstream of the interaction 
(Prévost et al., 2011). Interestingly, the RNA degradosome was shown to interact 
with the 70S ribosome and also with polysomes (Tsai et al., 2012). This recent 
discovery led to the proposition that the degradosome may rest “passively” on a 
ribosome, moving from one to the next as they move along in a polysome 
assembly. When a sRNA/Hfq complex forms on the emerging 5′-end of the 
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transcript, it could be bound by the “passive” degradosome assembly. In this 
position, the degradosome is poised to trigger cleavage of transcripts as they 
emerge from the end of the polysome. The action of sRNAs is, however, not 
limited to the RBS. Recognition of the target upstream of its 5’-UTR (Darfeuille et 
al., 2007; Sharma et al., 2007; Vecerek et al., 2007) and binding inside the coding 
sequence of the mRNA target (Bouvier et al., 2008; Papenfort et al., 2010; Pfeiffer et 
al., 2009) has also been reported (Figure 3B).  
 
 
FIGURE 3 – Properties of trans-encoded base-pairing sRNAs. A) Diagram showing the 
structure of Hfq-binding sRNAs. B) Diagram showing the different positions at which 
sRNAs can block ribosome binding. Adapted from (Storz et al., 2011). 
 
In addition to the protein-binding and to the base-pairing sRNAs there 
are two other types of RNA regulators, the riboswitches and CRISPRs sRNAs. 
The riboswitches are sequences usually found within the 5’-UTR of the mRNA 
Chapter 1 
 
38 
that they regulate and which can adopt different conformations in response to 
environmental signals. These include stalled ribosomes, uncharged tRNAs, 
elevated temperatures and/or small molecule ligands (for a review (Breaker, 2012; 
Smith et al., 2010)). The more recently discovered group of RNA regulators, 
CRISPR RNAs, function as a prokaryotic immune system, in that they provide 
resistance to exogenous genetic elements such as plasmids and bacteriophages 
(Bhaya et al., 2011; van der Oost et al., 2009).  
The different types of small RNA molecules serve as diverse regulators of 
gene expression that impact almost every aspect of bacterial physiology. 
Accordingly, the study of these RNAs is a crucial step to understand the gene 
regulation in bacteria.  
 
REGULATION OF RNASES 
As effectors that rapidly modulate the levels of RNAs, the expression of 
RNases must be tightly regulated in a process that responds to many different 
signals and which may relevantly affect RNA turnover rates. This regulation is 
known to occur in several ways. RNases can regulate their own levels (auto-
regulation) and/or be regulated by other ribonucleases (cross-regulation). 
Additionally, their intracellular bulk level can be affected by the medium 
composition and other environmental factors that alter the cell growth rate. These 
and other approaches of regulation of the degradative ribonucleolytic machinery 
in prokaryotes are discussed below in further detail. 
Auto-regulation and cross-regulation 
Both RNase E (Jain and Belasco, 1995) and RNase III (Bardwell et al., 1989) 
have the ability to control the decay of their own mRNAs, thereby regulating 
their own expression and maintaining the enzyme levels within a narrow range. 
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In both cases, a cleavage that occurs in the 5’-UTR region of the mRNA promotes 
their decay. PNPase is able to regulate its own expression as well, but in an 
RNase III-dependent manner (Portier et al., 1987). PNPase acts in concert with 
RNase III to degrade a double-stranded region in the 5’-end of pnp mRNA. The 
removal of this region impairs translation and allows further degradation of pnp 
transcript by RNase E (Carzaniga et al., 2009). PNPase expression is also regulated 
by RNase II (Zilhão et al., 1996a). This latter case constitutes an interesting 
example of cross-regulation: in the absence of RNase II, PNPase levels are 
increased, while PNPase overexpression leads to a decrease in RNase II activity. 
PNPase controls RNase II activity by degrading its mRNA (Zilhão et al., 1996a). 
RNase III and RNase E endonucleases are also involved in the control of RNase II 
expression (Zilhão et al., 1995b). While RNase III regulates RNase II by affecting 
PNPase levels, RNase E directly intervenes in the degradation of rnb mRNA. 
RNase E is also the main enzyme responsible for the processing of rnr transcripts 
encoding RNase R (Cairrão and Arraiano, 2006).  
Regulation by environmental conditions and other cellular 
modulations 
RNase E is responsible for many processes of RNA decay and 
maturation. Therefore, the enzyme must be tightly regulated because any change 
in the level of its expression has important cellular repercussions. As discussed 
above, the 5’-end phosphorylation state, folding and translation of a given mRNA 
substrate can modulate the RNase E cleavage efficiency by altering the enzyme’s 
accessibility to the transcript. In addition, RraA and RraB (regulators of RNase 
activity A and B, respectively), interact with RNase E to inhibit its activity (Gao et 
al., 2006; Lee et al., 2003). In addition to these factors, environmental conditions 
such as temperature and medium composition have been reported to directly 
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affect the activity and cellular concentration of RNase E (Barlow et al., 1998; 
Georgellis et al., 1992; Le Derout et al., 2002). As a consequence, the RNA 
processing and stability of specific transcripts is affected (Barlow et al., 1998; 
Georgellis et al., 1992; Le Derout et al., 2002).  
RNase R is a ribonuclease whose levels also change in response to 
different environmental stimuli (Chen and Deutscher, 2005). These include the 
entry into stationary phase (2-fold), heat-shock (∼2-fold), and cold-shock (7–8 
fold) (Andrade et al., 2006; Cairrão et al., 2003; Chen and Deutscher, 2005). From 
the different stress conditions analyzed, cold-shock treatment results by far in the 
highest up-regulation effect over RNase R. This marked increase in RNase R 
levels is probably related to its ability to overcome RNA secondary structures, 
whose formation is thermodynamically favoured under low temperatures. 
Northern blot analysis of the transcript’s decay has indicated an increase in rnr 
stability during cold-shock (Cairrão et al., 2003). Moreover, Western blot analysis 
of RNase R degradation after translational arrest has revealed that the protein 
itself is highly stabilized under cold-shock, stationary-phase and growth in 
minimal medium (Liang and Deutscher, 2010).  It has been shown that the 
tmRNA–SmpB system can be responsible for the low stability of the RNase R 
protein in exponential-phase cells, through the interaction with the region 
encompassing the S1 domain and the C-terminus of the exonuclease (Liang and 
Deutscher, 2010). This process was recently elucidated by the finding that a post-
translational modification of RNase R, that specifically occurs in exponential 
phase, leads to a tighter binding of tmRNA and SmpB (Liang and Deutscher, 
2012a; Liang et al., 2011). These two later components stimulate the binding of 
two proteases (Lon and HslUV) to the N-terminal region of RNase R promoting 
its degradation (Liang and Deutscher, 2012b). Albeit to a lower level, growth at 
low temperatures also induces PNPase expression, which is an essential enzyme 
in this condition (Piazza et al., 1996; Zangrossi et al., 2000). Moreover, certain 
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mutations of the PNPase RNA binding domains have been shown to confer a 
cold-sensitive phenotype (Briani et al., 2007; García-Mena et al., 1999; Matus-
Ortega et al., 2007). 
Like RNase R, RNase II stability is post-translationally regulated. 
Deletion of gmr (gene modulating RNase II), a gene that lies just downstream of 
rnb, causes the accumulation of this exonuclease by increasing the protein 
stability more than 2-fold (Cairrão et al., 2001). RNase II is also more abundant in 
rich medium compared to minimal medium and is sensitive to the nitrogen 
content of the medium. This regulation is abolished in a gmr mutant (Cairrão et 
al., 2001). One possible explanation is that the PAS domain of Gmr protein can act 
as a sensor, which monitors nutrients in the growth medium and carries the 
signals to the proteolytic enzymes responsible for RNase II degradation. 
Interestingly, beyond being regulated post-transcriptionally (at the level of 
mRNA and protein), RNase II has two promoters and its expression is also 
controlled at the transcriptional level (Zilhão et al., 1995a; Zilhão et al., 1993; 
Zilhão et al., 1996b).  
Polyadenylation is implicated in the destabilization of a variety of 
transcripts but it also arises as a factor controlling RNases levels in the cell. A 
high intracellular level of poly(A) tails stabilizes pnp and rne transcripts, thereby 
leading to increased PNPase and RNase E levels, respectively (Mohanty and 
Kushner, 2002). 
The activity of RNases represents a checkpoint on RNA regulation. 
Accordingly, their expression has to be tightly regulated in different ways, as 
small variations on their levels may have a tremendous impact on global RNA 
decay. 
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CONCLUDING REMARKS 
RNA degradation is an intricate mechanism and a process that plays a 
fundamental role in the regulation of gene expression. The steady-state level of a 
given transcript is dependent on a high level of coordination between the 
different players involved in transcription and degradation. This complex 
network permits a rapid response to challenging conditions, and it is therefore 
not surprising that RNA degradation is not exclusively deterministic but is also 
controlled by external stimuli. RNA decay is a major link in the chain of bacterial 
adaptation, a key for survival and development. In this chapter, I aimed at 
providing an up-to-date picture of RNA stability/decay and its control in 
prokaryotes. It involves numerous players and relies on several features. 
However, the main effectors are ribonucleases, whose diversity, structures, 
targets, and modes of action can vary significantly, providing multiple solutions 
for a similar issue. Ribonucleases can act independently, or in a concerted way, as 
well as in higher order protein complexes such as the degradosome. Their activity 
can be modulated by regulatory proteins. Besides this regulatory network, the 
fate of an RNA molecule is intimately related to its sequence and structural 
features. Indeed, the characteristics of an mRNA molecule can determine 
ribosomal pausing, targeting by sRNAs, and also elect which RNases will be able 
to act. 
Novel players that influence RNA stability are still being discovered. 
These new findings not only increase our knowledge of this topic but often 
challenge the conventional models. For instance, the finding of the RNA 
pyrophosphohydrolase RppH in E. coli revealed an alternative pathway for 
degradation. The homologue in B. subtilis was just recently proposed (Richards et 
al., 2011). The ability of the RNase J enzymes to cleave RNA in the 5’–3’ direction 
has also restructured the conventional view of RNA decay in prokaryotes. 
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Another example is the discovery of sRNAs as essential regulators of mRNA 
stability, which has significantly altered the established models of RNA turnover. 
Degradation of these small molecules is in turn directed by RNases and other 
factors, namely polyadenylation. Their degradation can alter the concentration of 
the target mRNA by directly modifying the cellular concentration of the sRNA. 
There are also indications of the existence of a cellular 
compartmentalization in bacteria, which could help to synchronize regulatory 
events. Certain mRNAs have been shown to migrate to particular cellular 
domains where their future protein products are required (Nevo-Dinur et al., 
2011). In another study the mRNAs studied exhibited limited dispersion from 
their site of transcription. In this latter case the chromosome was proposed to be a 
spatial organizer of mRNA and related processes (Montero Llopis et al., 2010). 
Different mRNAs were studied and this may account for these apparently 
divergent observations. The identification of additional players and regulatory 
processes is essential for fully understanding RNA decay. Although there has 
been tremendous progress in our understanding of the posttranscriptional control 
of RNA stability and decay, the continuing discovery of new processes illustrates 
that the intricacies of RNA degradation are still far from being completely 
understood, and a remarkable amount remains to be learned. 
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AIM OF THIS DISSERTATION 
  This dissertation is mainly focused on the involvement of two small non-
coding RNAs, MicA and SraL, in the post-transcriptional regulation of gene 
expression in Salmonella Typhimurium.  
 MicA is one of the best and most extensively studied sRNAs in Gram-
negative bacteria. It was firstly identified in a global E. coli sRNA screen, and 
observed to accumulate as a small transcript (70 nt) when cells stopped growing 
(Argaman et al., 2001). Afterwards, MicA was also detected in Salmonella cells in 
the same conditions (Figueroa-Bossi et al., 2006; Papenfort et al., 2006; Viegas et al., 
2007). We have previously studied the influence of several RNases and also PAP I 
in the stability of MicA (Viegas et al., 2007). The stability of this sRNA was shown 
to be mainly affected by PNPase, RNase III and RNase E through the 
degradosome complex. In the first part of this Doctoral work we aimed to 
investigate more deeply the contribution of the two main Salmonella 
endoribonucleases in the decay of this sRNA. To this purpose, we studied the 
degradation of MicA in mutants for these RNases. We have expressed and 
purified both RNase E and RNase III from Salmonella and studied the direct 
contributions of these RNases in the degradation of this sRNA. Two targets have 
been described in Salmonella for MicA, ompA and lamB mRNAs (Bossi and 
Figueroa-Bossi, 2007; Papenfort et al., 2006). Therefore, the same experiments 
were also performed using MicA coupled with its targets, lamB and ompA 
mRNAs.  
 In the second and third part of this Doctoral work we intended to study 
the role of SraL in Salmonella Typhimurium. This sRNA was firstly identified in E. 
coli in the same global screen as MicA (Argaman et al., 2001). Afterwards, SraL 
was also identified in Salmonella cells in late stationary phase of growth (Viegas et 
al., 2007). We have shown that this sRNAs is post-transcriptionally regulated by 
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PNPase and also by the degradosome. However, the greatest effect in the SraL 
stability was observed when using the PAP I mutant strain (Viegas et al., 2007). 
Since we already had studied the post-transcriptional regulation of this sRNA one 
of our goals was to study how it is transcriptionally regulated. To this purpose, 
we performed the analysis of the SraL promoter sequence and investigated our 
predictions through several experimental approaches. Since the biological 
function of this sRNA was not described yet, our second aim was to identify its 
targets. In order to address this question we performed global proteomic and 
bioinformatic analyses. We then validated the results obtained with these 
approaches by Northern blot and RT-PCR experiments.  
 In summary, the work developed in this Dissertation aimed to deeply 
understand the role of two important sRNAs in Salmonella Typhimurium. MicA 
sRNA had already been shown to be a very important regulator in Gram-negative 
bacteria. The work developed during this Dissertation reveals more details about 
the post-transcriptional regulation of MicA and its targets. Moreover, it also 
discloses the importance of the expression of SraL in the cell, so far unknown, by 
revealing how its expression is triggered and also one of the biological functions 
of this sRNA.    
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ABSTRACT 
MicA is a trans-encoded small non-coding RNA, which down-regulates 
porin-expression in stationary-phase. In this work, we focus on the role of 
endoribonucleases III and E on S. Typhimurium sRNA MicA regulation. RNase 
III is shown to regulate MicA in a target-coupled way, while RNase E is 
responsible for the control of free MicA levels in the cell. We purified both 
Salmonella enzymes and demonstrated that in vitro RNase III is only active over 
MicA when in complex with its targets (whether ompA or lamB mRNAs). In vivo, 
MicA is demonstrated to be cleaved by RNase III in a coupled way with ompA 
mRNA. On the other hand, RNase E is able to cleave unpaired MicA and does not 
show a marked dependence on its 5’ phosphorylation state. The main conclusion 
of this work is the existence of two independent pathways for MicA turnover. 
Each pathway involves a distinct endoribonuclease, having a different role in the 
context of the fine-tuned regulation of porin levels. Cleavage of MicA by RNase 
III in a target-dependent fashion, with the concomitant decay of the mRNA 
target, strongly resembles the eukaryotic RNAi system, where RNase III-like 
enzymes play a pivotal role. 
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INTRODUCTION 
Small non-coding RNAs (sRNAs) play very important roles in post-
transcriptional control of gene expression. MicF was the first trans-encoded 
antisense sRNA described and was discovered a little more than a quarter-
century ago as a regulator of the E. coli ompF mRNA (Mizuno et al., 1984). 
Following the advent of systematic genome wide sRNA searches, the total 
number of known sRNAs in E. coli and the model pathogen Salmonella enterica 
serovar Typhimurium has grown to well over a hundred (Livny and Waldor, 
2007).  
 An extensive network of trans-antisense sRNAs have been shown to 
down-regulate the expression of several OMPs. While in some cases the same 
sRNA regulates multiple omp mRNAs (Guillier and Gottesman, 2006; Papenfort et 
al., 2006), in other cases the same omp mRNA is target of multiple sRNAs 
(Douchin et al., 2006; Johansen et al., 2006; Papenfort et al., 2006). OMPs are 
embedded within the outer membrane, which together with the peptidoglycan 
layer and the inner membrane form the bacterial cell envelope, the first barrier of 
defence against external aggressions. Coordination in the expression of omp genes 
seems critical for proper envelope assembly, and accounts for the existence of so 
many sRNAs to regulate OMP mRNAs. 
To survive in a changing environment, bacteria must constantly adjust 
the nature and abundance of surface components. Any condition that unbalance 
OMP levels activates the response of the transcription factor σE (Alba and Gross, 
2004; Ruiz and Silhavy, 2005) that triggers transcription of a set of genes, which 
collectively help the bacterium to recover from the stress condition. MicA and 
RybB are two of the σE activated genes in stationary phase, whose role is to 
immediately limit OMP synthesis (Figueroa-Bossi et al., 2006; Johansen et al., 2006; 
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Papenfort et al., 2006). We have analysed the expression of MicA sRNA in wild-
type cells at different phases of growth in LB and minimal media. In this 
experiment, we also included two growth conditions known to induce the two 
major Salmonella virulence regions, i.e. the Salmonella Pathogenicity Islands 1 and 
2. The virulence genes encoded by SPI-1 facilitate the entry of Salmonella into non-
phagocytic cells. The genes of SPI-2 encode virulence factors for intra-
macrophage survival and systemic disease. MicA became detectable at early 
stationary phase of growth in LB medium, and strongly accumulated when 
growth further slowed down (Figure 1A). Interestingly, MicA levels under SPI-1 
and SPI-2 inducing conditions were comparable to those in stationary phase 
(Figure 1A). 
Both MicA and RybB act in the same fashion: they inhibit protein 
synthesis by base pairing to the translation initiation region of their mRNA 
targets in an Hfq-dependent manner, followed by the subsequent degradation of 
the mRNA. Although sRNAs generally modulate translational initiation by 
interfering with 30S ribosome loading, alterations of target mRNA levels are also 
often observed (Vogel and Wagner, 2007; Waters and Storz, 2009). A few studies 
performed in E. coli suggest that RNase cleavage of target mRNAs may be 
directly coupled to the degradation of the sRNA that is regulating the process, 
with both RNAs being degraded upon sRNA action (Afonyushkin et al., 2005; 
Massé et al., 2003; Vogel et al., 2004). 
 RNases can have a major impact on sRNAs regulatory pathways by 
performing a key role in the biogenesis and processing of sRNAs, as well as in 
controlling their cellular levels through regulation of their turnover (Andrade and 
Arraiano, 2008; Arraiano et al., 2010; Massé et al., 2003; Morita et al., 2005; Viegas 
and Arraiano, 2008; Viegas et al., 2007). In E. coli, and presumably in many other 
Gram-negative bacteria, including Salmonella, mRNA decay is normally initiated 
by an endonucleolytic cleavage mainly performed by RNase E (Carpousis et al., 
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2009) and, sometimes by RNase III (Conrad and Rauhut, 2002), followed by 
exoribonucleolytic degradation (Andrade et al., 2009; Arraiano et al., 2010). In E. 
coli, both endoribonucleases have also been implicated in the decay of sRNAs, 
upon translational silencing (Kaberdin and Blasi, 2006).  
We have previously reported specific contributions of several Salmonella 
ribonucleases on the turnover of different sRNAs, namely MicA sRNA (Viegas et 
al., 2007). MicA turnover was seen to be significantly dependent on the 
degradosome complex and PNPase (Figure 1B). We have also seen that in the 
absence of the double stranded-specific RNase III this sRNA is extremely stable 
(Figure 1C). At that time we hypothesized that this regulation of MicA by RNase 
III could involve the interaction with its target, since MicA forms an extended 
RNA duplex when binding to the mRNA that is close to the length ideal for 
RNase III substrates.  
In this work, we have cloned and purified for the first time Salmonella 
RNase III and RNase E and have demonstrated that both endoribonucleases are 
responsible for the control of MicA sRNA levels. The role of the double stranded-
specific endoribonuclease III over MicA only occurs through a target-dependent 
pathway, whether in vitro or in vivo. By contrast, the single stranded-specific 
endoribonuclease E is able to efficiently degrade free MicA sRNA. A model is 
proposed to explain the cooperation of both enzymes in the cell in order to 
achieve the fine-tuned control of the post-transcriptional regulator MicA. 
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FIGURE 1 - Analysis of MicA turnover and expression under different growth 
conditions. (A) Northern blot analysis of sRNA expression in Salmonella SL1344 grown 
under different conditions as indicated in figure labels. (B) RNase E and PNPase mutations 
highly affect the stability of MicA sRNA. (C) Comparison of the effects of 
endoribonucleases G and III and PAP I in MicA stability. Adapted from (Viegas et al., 
2007). 
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EXPERIMENTAL PROCEDURES 
Oligonucleotides 
All oligonucleotides used in this study are listed in the Supplementary 
Table S1 and were synthesized by STAB Vida, Portugal. 
Bacterial strains 
All bacterial strains and plasmids used in this study are listed in the 
Tables 1 and 2, respectively. All Salmonella strains used are isogenic derivates of 
the wild-type Salmonella enterica serovar Typhimurium strain SL1344. The OmpA- 
(CMA-552), LamB- (CMA-554) and MicA- (CMA-555) mutants were constructed 
using the primer pairs pSV-104/pSV-105, pSV-108/pSV-109 and pSV-146/pSV-147, 
respectively, and following the λ-red recombinase method (Datsenko and 
Wanner, 2000), with few modifications, as previously described (Viegas et al., 
2007). All chromosomal mutations were subsequently transferred to a fresh 
SL1344 background by P22 HT105/1 int-201 transduction (Schmieger, 1971). The 
chloramphenicol-resistance cassette of plasmid pKD3 replaces nucleotides -190 to 
+1064 of the ompA gene, -20 to +1339 of lamB and +8 to +78 of micA. All gene 
deletions were verified by colony PCR using the primer pairs pSV-106/pSV-107 
for ompA, pSV-110/pSV-111 for lamB and pSV-148/pSV-149 for micA. The S. 
Typhimurium RNase III deficient strain (CMA-551) was obtained by P22 
transduction from SA5303 strain (Mattatall and Sanderson, 1998) and is 
tetracycline resistant. The double mutants were constructed using the same 
transduction method. 
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TABLE 1 - List of strains used in this work 
 
 
TABLE 2 - List of plasmids used in this work 
Plasmid Comments Origin/Marker Reference 
pKD3 
Template for mutants construction; 
carries chloramphenicol-resistance 
cassete 
oriR/AmpR 
(Datsenko and 
Wanner, 2000) 
pKD46 
Temperature-sensitive λ-red 
recombinase expression plasmid 
oriR101/AmpR 
(Datsenko and 
Wanner, 2000) 
pCP20 
Temperature-sensitive FLP 
recombinase expression plasmid 
AmpR, CmR 
(Datsenko and 
Wanner, 2000) 
pET-15b 
Inducible expression vector, N-
terminal His Tag 
AmpR Novagen 
pSVDA-01 pET-15b encoding His-RNase III AmpR This study 
pSVDA-02 pET-15b encoding His-RNase E AmpR This study 
Strain Relevant Markers / Genotype Source/Reference 
S. Typhimurium, 
SL1344 
StrR hisG rpsL xyl 
(Hoiseth and 
Stocker, 1981) 
CMA-537 SL1344 rne-537 (∆rne::CmR) 
(Viegas et al., 
2007) 
CMA-551 SL1344 rnc-14::∆Tn10, (TcR) This study 
CMA-552 SL1344 ompA (∆ompA::CmR) This study 
CMA-554 SL1344 lamB (∆lamB::CmR) This study 
CMA-555 SL1344 micA (∆micA::CmR) This study 
CMA-556 SL1344 rnc-14 micA (rnc-14::∆Tn10/∆micA::CmR) This study 
CMA-557 SL1344 rnc-14 ompA (rnc-14::∆Tn10/∆ompA::CmR) This study 
CMA-558 SL1344 rnc-14 rne-537 ( rnc-14::∆Tn10/∆rne::CmR) This study 
E. coli BL21(DE3) F- ompT hsd SB(rb-mb-) gal dcm (DE3) 
(Studier and 
Moffatt, 1986) 
E. coli 
BL21(DE3)recA 
rnc105 
F- ompT hsd SB(rb-mb-) gal dcm (DE3) recA rnc105 
(Amarasinghe et 
al., 2001) 
E. coli DH5α 
recA1 endA1 gyrA96 thi-hsdR17 New England 
Biolabs supE44 relA1 lacZYA-arg FU169 f80dLacZDM15 
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Bacterial growth 
All strains were grown in LB broth at 37ºC with agitation throughout this 
study. SOC medium was used to recover transformants after heat shock (in the 
case of E. coli) or electroporation (in the case of Salmonella), before plating. Growth 
medium was supplemented with the following antibiotics when appropriate: 
ampicillin (150 g/ml), chloramphenicol (25 g/ml), streptomycin (90 g/ml) and 
tetracycline (25 g/ml). 
RNA extraction and Northern blot analysis 
Overnight cultures were diluted 1/100 in fresh LB medium and grown 
until 6 h after OD600 of 2 (OD2+6h). Culture samples were collected, mixed with 1 
volume of stop solution [10 mM Tris (pH 7.2), 25 mM NaNO3, 5 mM MgCl2, 500 
g/ml chloramphenicol] and harvested by centrifugation (10 min, 6000 g, 4ºC). 
For stability experiments, rifampicin (500 g/ml) and nalidixic acid (20 g/ml) 
were added to cells grown in LB at 37ºC, with agitation, till OD2+6. Incubation 
was continued and culture aliquots were withdrawn at the time-points indicated 
in the respective figures. RNA was isolated using the phenol/chlorophorm 
extraction method, precipitated in ethanol, resuspended in water and quantified 
on a Nanodrop 1000 machine (Nanodrop Technologies). 
For northern blot analysis, 15 g of total RNA was separated under 
denaturing conditions either by 8.3 M urea / 8% polyacrylamide gel in TBE buffer 
or by 1.3% agarose MOPS / formaldehyde gel. For polyacrylamide gels, transfer 
of RNA onto Hybond-N+ membranes (GE Healthcare) was performed by 
electroblotting (1 h 50 min, 24 V, 4ºC) in TAE buffer. For agarose gels, RNA was 
transferred to Hybond-N+ membranes by capillarity using 20% SSC as transfer 
buffer. In both cases, RNA was UV cross-linked to the membrane immediately 
after transfer. Membranes were then hybridized in RapidHyb Buffer (GE 
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Healthcare) at 68ºC for riboprobes and 43ºC in the case of oligoprobes and DNA 
probes. After hybridization, membranes were washed as described (Viegas et al., 
2007). Signals were visualized by PhosphorImaging (Storm Gel and Blot Imaging 
System, Amersham Bioscience) and analysed using the ImageQuant software 
(Molecular Dynamics). 
Hybridization probes 
Primers for templates amplification are listed in Supplementary Table S1. 
Labelling of the riboprobes and oligoprobes was performed as described (Viegas 
et al., 2007). The riboprobes were obtained using the primer pair pSV-118/pSV-141 
for MicA and pSV-142/pSV-143 for ompA. The DNA probe for 16S rRNA was 
generated using the primer pair pSV-144/pSV-145 and “Amersham 
MegaprimeTM DNA Labelling Systems” (GE Healthcare), according to the 
supplier instructions. 
Construction of recombinant proteins 
To overexpress Salmonella RNase E and RNase III proteins, the rne and rnc 
coding regions were amplified with primer pairs pSV-124/pSV-125 and pSV-
129/pSV-130, respectively. The N-terminal region (comprising residues 1–522), 
corresponding to the catalytic domain of RNase E, was purified. In E. coli, the N-
terminal half of RNase E (residues 1–498) was reported to be sufficient for the 
ribonuclease activity (McDowall and Cohen, 1996). The purified PCR products 
were double digested with BamHI and NdeI and ligated to the pET-15b vector 
previously digested with the same enzymes, yielding plasmids pSVDA-01 (rnc) 
and pSVDA-02 (rne). These plasmids were first cloned into E. coli DH5α and were 
subsequently transformed into BL21(DE3) strain in the case of pSVDA-02, and 
BL21(DE3) rnc105 recA (Amarasinghe et al., 2001) in the case of pSVDA-01 
construction. This derivative strain of BL21(DE3), carrying an RNase III mutation, 
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was used because it blocks the auto-regulation of Salmonella RNase III by the 
endogenous E. coli homologue, resulting in a higher yield of the enzyme upon 
overexpression. All constructs were confirmed by DNA sequencing at STAB 
Vida. 
Overexpression and purification of Salmonella RNase E and RNase 
III proteins 
The BL21(DE3) strain and derivative, containing the recombinant 
plasmids of interest, were grown in 100 ml of LB medium supplemented with 
ampicillin (150 g/ml) to an OD600 of 0.5. At this point, protein expression was 
induced by addition of 1 mM of IPTG for 3 h at 37ºC. Cells were then harvested 
by centrifugation and the pellets stored at -80ºC. The culture pellets expressing 
RNase III or RNase E were resuspended in 3 ml of Buffer A (20 mM Tris-HCl pH 
8, 500 mM NaCl, 20 mM imidazole pH 8). Suspensions were lysed using a French 
Press at 900 psi in the presence of 0.1 mM of PMSF. After lysis, the crude extracts 
were treated with 125 U of Benzonase (Sigma) to degrade the nucleic acids and 
clarified by a 30 min centrifugation at 10000 g, 4ºC. The histidine tagged 
recombinant proteins were purified by affinity chromatography, using the ÄKTA 
FPLCTM System (GE Healthcare). The clarified extracts were loaded into a HisTrap 
HP Sepharose 1 ml column equilibrated in Buffer A. Protein elution was achieved 
in Buffer A with a linear imidazole gradient (from 20 to 500 mM). The fractions 
containing mostly the protein of interest, free of contaminants, were pooled. 
Eluted proteins were buffer exchanged with Desalting Buffer [10 mM Tris-HCl 
(pH 8), 3 mM MgCl2, 100 mM NaCl, 1 mM DTT] and concentrated by 
centrifugation at 4ºC with Amicon Ultra Centrifugal Filter Devices (Millipore), 
with a molecular mass cut-off of 10 kDa (RNase III) or 50 kDa (RNase E). Proteins 
were quantified using the Bradford Method (Bradford, 1976) and stored at -20ºC 
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in Desalting Buffer containing 50% (v/v) glycerol. The purity of the enzymes was 
analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS–
PAGE) and revealed >90% homogeneity. 
In vitro transcription and activity assays 
DNA templates for the in vitro transcription were generated by PCR 
using chromosomal DNA from S. Typhimurium SL1344 strain. The phage T7 
RNA polymerase promoter sequence was included in the forward primer 
sequences. micA was amplified with the primer pair pSV-116/pSV-117, ompA with 
pSV-122/pSV-123 and lamB with pSV-120/pSV-121. For the synthesis of the 
internally labelled 5’ triphosphate MicA, in vitro transcription was carried out 
using the purified PCR product as template in the presence of an excess of [32P]-α 
–UTP over unlabelled UTP with ‘Riboprobe in vitro Transcription System’ 
(Promega) and T7 RNA polymerase. MicA substrate bearing 5’ monophosphate 
was obtained by adding an 8-fold excess of GMP over the other ribonucleotides to 
the in vitro transcription reaction. Non-radioactive molecules were transcribed in 
the same conditions but using equimolar concentrations of all four 
ribonucleotides. MicA transcripts were purified by electrophoresis on an 8.3 M 
urea / 10% polyacrylamide gel. The gel slice was crushed and the RNA eluted 
with elution buffer [3 M ammonium acetate pH 5.2, 1 mM EDTA, 2.5% (v/v) 
phenol pH 4.3], overnight at room temperature. The RNA was ethanol 
precipitated and resuspended in RNase free water. For the synthesis of the 5’-
end-labelled MicA or ompA, in vitro transcription was carried out using the 
corresponding PCR product as template. MicA and ompA transcripts were run on 
a 10 or 6% polyacrylamide gel, respectively, identified by ethidium bromide 
(EtBr) staining and cut out from the gel. The RNA was eluted from the gel slice as 
described above. The RNA substrates were end-labelled with [32P]-γ-ATP at 37ºC 
for 1 h, with 10 units of T4 polynucleotide kinase (Fermentas) using the supplier 
Regulation of the small regulatory RNA MicA by ribonuclease III: a target-dependent pathway 
 
 
81 
exchange buffer and again purified from gel as above. The yield of the labelled 
substrates (cpm/l) was determined by scintillation counting. 
The hybridization between labelled and unlabelled substrates was always 
performed in a 1:40 molar ratio in the Tris component of the activity buffer by 
incubation for 10 min at 80ºC, followed by 45 min at 37ºC. The activity assays 
were done in a final volume of 50 l containing the activity buffer {for RNase III 
[30 mM Tris-HCl pH 8, 160 mM NaCl and 0.1 mM DTT] and for RNase E [25 mM 
Tris-HCl pH 7.5, 5 mM MgCl2, 60 mM KCl, 100 mM NH4Cl, 0.1 mM DTT and 5% 
(v/v) glycerol]} and ~10000 cpm of substrate. In the case of the activity assays with 
RNase III, 10 mM of MgCl2 was added to the reaction mixture. As a control, prior 
to the beginning of each assay an aliquot was taken and was incubated until the 
end of the assay (without the enzyme). The reactions were started by the addition 
of the enzyme at a concentration of 500 nM, and further incubated at 37ºC in the 
case of RNase III and 30ºC for RNase E (Chelladurai et al., 1991; Jiang et al., 2000). 
Samples were withdrawn at the time-points indicated in the respective figures, 
and the reactions were stopped by the addition of formamide-containing dye 
supplemented with 10 mM EDTA. Reaction products were resolved in a 7 M urea 
/ 15% or 8% polyacrylamide gel as indicated in the respective figure legends. 
Signals were visualized by PhosphorImaging and analyzed using ImageQuant 
software (Molecular Dynamics). 
OMPs extraction and analysis 
The membrane protein fraction from late stationary phase cultures 
(OD2+6h) was extracted as described (Matsuyama et al., 1984). OMPs were 
analysed on 4% urea–SDS–12% polyacrylamide gel. Gels were stained overnight 
with Coomassie Brilliant Blue. 
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RESULTS 
Detection of MicA sense transcripts in an RNase III- mutant 
We have previously studied MicA sRNA turnover in S. Typhimurium 
and have analysed the particular contribution of several RNases to the decay of 
this sRNA. 
We have found that the dsRNA-specific endoribonuclease III has a 
remarkable impact on the stability of MicA sRNA. In the wild-type, MicA sRNA 
has a half-life of ~6 min (Viegas et al., 2007). In an RNase III- mutant, there was a 
dramatic stabilization of the sRNA (no significant decay in >2 h), with the 
concomitant accumulation of a degradation intermediate, very stable, which was 
absent in the wild-type (Viegas et al., 2007) (see Figure 1C). In an RNase E mutant 
MicA was also stabilized, but the small stable intermediate was not detected (see 
Figure 1B). 
We were interested in clarifying the nature of this small intermediate. For 
this purpose we have compared the bands pattern of isogenic RNase III+ and 
RNase III- strains, by northern blot analysis, with different probes. We have used 
a probe antisense (AS1) or sense (S1) to the 5’-end of MicA, which corresponds to 
the region of interaction with its targets (Bossi and Figueroa-Bossi, 2007; 
Rasmussen et al., 2005; Udekwu et al., 2005). The same short MicA sRNA stable 
intermediate of ~45 nt (indicated by an asterisk in the figures) was detected with 
the antisense probe (AS1) only in the RNase III- strain (Figure 2A, left panel). 
When using the MicA sense probe (S1) we have also detected in this mutant a 
smaller transcript with approximately the same size (Figure 2A, right panel). Both 
species (sense and antisense) have a remarkably long half-life (Figure 2B). It was 
also detected with the sense probe another band with the size corresponding to 
that of MicA full transcript (74 nt). None of the bands observed with the sense 
probe were visible in the wild-type or the RNase E mutant (rne-537). Moreover, 
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the presence of these ‘sense transcripts’ is MicA dependent, since they were not 
detected in an RNase III- / MicA- strain. 
The fact that the smaller transcript is equally present when using a sense 
or antisense probe and uniquely when RNase III is absent suggests that it is one 
strand of a stable dsRNA remnant of the MicA-target mRNA paired species. This 
smaller intermediate probably arises due to the previous activity of other 
degrading enzyme(s) but only accumulates in the absence of RNase III by virtue 
of its double stranded character. RNase E is probably a good candidate since the 
level of the smaller intermediate is decreased in an RNase III- mutant that is also 
impaired for degradosome formation - RNase III- / rne-537 (Figure 2C). For 
instance, cleavage of MicA and ompA mRNA (a main target of MicA) by RNase E 
(Udekwu et al., 2005) together with exoribonucleolytic degradation of both RNAs 
may explain why the antisense and sense transcripts have approximately the 
same size. 
In order to confirm that the smaller transcripts correspond to a stable 
dsRNA remnant of the MicA-target mRNA paired species, we have used two 
other MicA sense probes differently located along the MicA transcript (Figure 
2D). For each sense probe used, the correspondent antisense probe, 
complementary to MicA, was also designed. The location of each of the probes in 
the MicA sequence is indicated in the figure below the respective images. A 
transcript having the same size was detected whether with the sense probes S1 
and S2, or with the corresponding AS1 and AS2 antisense probes. However, we 
have not obtained any signal when using a sense probe located in the 3’-end of 
MicA (S3), while the MicA full transcript could still be detected with the 
corresponding antisense probe (AS3). 
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FIGURE 2 - Analysis of MicA sense and antisense species in single and double RNase 
III- and rne-537 mutants. Total cellular RNA was extracted from the S. Typhimurium 
strains indicated and analyzed by northern blot. 15 g of RNA (each lane) were separated 
on an 8% PAA / 8.3 M urea gel. The gel was then blotted to a Hybond-N+ membrane and 
hybridized with the corresponding probes. Details of RNA extraction and northern blot 
procedure are described in “Experimental Procedures” section. In each case, the membrane 
was stripped and then probed for 5S rRNA (pSV-139) as loading control. The radiolabelled 
marker 10 bp DNA Step Ladder (Promega) is on the left side. The respective sizes are 
represented in nucleotides (full MicA is 74 nt long). The asterisk indicates the fragment 
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that specifically accumulates in RNase III- strain. The probes used are indicated in the 
corresponding image. The arrow in each picture indicates the localization and direction of 
the probes in MicA sRNA: antisense (AS), represented by a dashed arrow; sense (S), 
represented by a solid arrow. The sequence of the probes is indicated in Supplementary 
Table S1. (A) Total RNA from S. Typhimurium wild-type and mutant derivatives RNase 
III-, rne-537 and RNase III-/MicA- was hybridized with MicA antisense (AS1) and sense (S1) 
probes. The double mutant (RNase III-/MicA-) and the RNase E mutant (rne-537) were used 
as controls. (B) Comparison of the stability of both MicA sense and antisense species in the 
absence of RNase III. Total cellular RNA from wild-type and RNase III- mutant was 
extracted at the time-points (min) indicated on top, after transcription arrest. RNA samples 
were analyzed as described above using an antisense probe to the full MicA sequence 
(upper panel) or a sense probe (lower panel). (C) Total RNA from S. Typhimurium wild-
type and mutant derivatives RNase III-, rne-537 and RNase III-/rne-537 was hybridized with 
MicA antisense (AS1) and sense (S1) probes. (D) Total RNA from wild-type and RNase III- 
mutant strains was hybridized with two other differently located antisense and sense 
probes, as indicated in the pictures below each image. 
 
These results strongly indicate that the small degradation intermediate 
should correspond to a remnant of a duplex MicA-target mRNA. The lack of 
signal when using S3 (located in the 3’-end of MicA) further suggests that the 
duplex formation is confined to the 5’-end of MicA. This observation is in 
agreement with previous reports, which indicate that the interaction site is 
located in the 5’-end of the sRNA, at least for the two known targets of MicA 
(Bossi and Figueroa-Bossi, 2007; Rasmussen et al., 2005; Udekwu et al., 2005). 
MicA cleavage by RNase III is facilitated by base-pairing with its 
mRNA target(s) 
The results presented in Figure 2 suggest that the cleavage of MicA by 
RNase III occurs in a target-dependent fashion. Taking this into account, together 
with the fact that RNase III is a double-stranded-specific endoribonuclease, led us 
to compare in vitro the activity of the enzyme both over MicA transcript alone or 
in complex with its mRNA targets. Until now only two targets for this sRNA have 
been described in Salmonella, ompA and lamB mRNAs. MicA was reported to act 
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over the translation initiation region of both molecules (Bossi and Figueroa-Bossi, 
2007; Rasmussen et al., 2005; Udekwu et al., 2005). In order to study the activity of 
Salmonella RNase III over MicA, we have cloned and purified the Salmonella 
enzyme as described in the “Experimental Procedures” section. An SDS-PAGE 
gel with the purified Salmonella RNase III is shown in Figure 3.  
 
 
FIGURE 3 – SDS-PAGE analysis of the purified RNase III protein. Protein sample was 
visualized by Coomassie Brilliant Blue Staining. Molecular weight marker (Precision Plus 
Protein Pre-stained Standards – Bio-Rad) is shown on the left side of each image. Purified 
recombinant Salmonella RNase III (~27.5 kDa) was separated on a 15% polyacrylamide gel. 
 
Activity assays were performed by incubating the purified Salmonella 
RNase III with α32P-labelled MicA alone or in combination with the unlabelled 5’-
UTR of ompA or lamB mRNAs. Since it has been shown that MicA is also able to 
bind ompA mRNA without the help of Hfq (Udekwu et al., 2005), this protein was 
not included in the activity assays. MicA alone was found to be resistant to RNase 
III cleavage (Figure 4A). By contrast, in conditions favouring the hybridization of 
the sRNA transcript with each one of the target molecules, we could see the 
increasing accumulation of specific reaction products simultaneously with the 
disappearance of the substrate. This indicates that the formation of the sRNA-
target mRNA complex promotes the RNase III cleavage of MicA. 
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The extension and location of MicA interaction with ompA or lamB 
mRNAs has been predicted to be slightly different (Bossi and Figueroa-Bossi, 
2007; Udekwu et al., 2005). Since RNase III cleaves dsRNA, the different 
interaction between MicA and the two targets could be in the origin of the distinct 
cleavage pattern induced by ompA or lamB. In order to identify the cleavage 
points generated by RNase III on the MicA-ompA and MicA-lamB hybrids, in vitro 
assays were performed as described above, but using 5’-end-labelled MicA in 
combination either with the unlabelled 5’-UTR of ompA or lamB. The results are 
shown in Figure 4B. RNase III cleavage generates two main fragments of 22 and 
23 nt on MicA-ompA hybrid, and 21 and 25 nt on MicA-lamB. Since in this 
experiment MicA was 5’-end-labelled, the size of these fragments indicates the 
distance from the cleavage point to the 5’-end of MicA. The higher molecular 
weight bands observed only when MicA was internally labelled (Figure 4A) 
correspond to 3’-end fragments, since they are not detected in the cleavage of 5’-
end-labelled MicA. A representation of the hybridization regions showing the 
RNase III cleavage positions in MicA sequence is presented in Figure 4C. All the 
cleavage positions are located inside the predicted region of interaction with each 
target, strongly supporting our hypothesis that RNase III is responsible for the 
coupled MicA-target degradation. 
According to our proposal, cleavage of MicA is coupled with the mRNA 
target cleavage. In this sense the same kind of activity assays were carried out in 
order to check the direct activity of RNase III over the corresponding region of 
ompA mRNA. For this, the purified Salmonella RNase III was incubated with the 
5’-end-labelled UTR of ompA (172 nt) alone or in combination with unlabelled 
MicA. As shown in Figure 4D although RNase III is able to cleave free ompA, a 
faster disappearance of the substrate when the hybrid ompA-MicA was used 
indicates that it is cleaved more efficiently. Moreover, the cleavage event gives 
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rise to specific degradation products that were not observed after incubation with 
ompA alone (Figure 4D). Among these products, we could observe the 
accumulation of fragments in the range of 113–130 nt, which is the expected size 
of fragments generated by cleavage inside the hybridization region with MicA 
(Figure 4C). The other products with a higher molecular weight probably arise 
due to alterations in the secondary structure of ompA after the duplex formation, 
which could generate a new dsRNA region suitable for RNase III. However, we 
cannot extrapolate to the in vivo situation, since these assays were performed with 
a truncated version of ompA. The ability of RNase III to preferentially cleave the 
hybrid ompA-MicA in the region corresponding to the hybridization between the 
two molecules is another evidence for the coupled degradation of the target and 
the sRNA. 
Taken together, our results indicate that MicA decay in vivo is highly 
dependent on RNase III and its cleavage by this enzyme in vitro is triggered upon 
base-pairing with its target mRNAs. 
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FIGURE 4 - In vitro cleavage of sRNA MicA or ompA 5’-UTR by RNase III. The 
radioactively labelled substrate was incubated with 500 nM of Salmonella RNase III. 
Aliquots withdrawn at the time-points indicated above each lane were analyzed on a 7 M 
urea / 15% or 8% PAA gel for MicA or ompA, respectively. The first two lanes of each 
reaction correspond to the controls without the protein at time zero (0) and at the end of 
the reaction time (150). The radiolabelled Decade Marker RNA (Ambion) is indicated by 
‘M’. The arrows in the figure indicate specific degradation products. (A) Assays performed 
with internally labelled MicA in the absence (-) (left panel) or in the presence (+) of a molar 
excess of ompA (middle panel) or lamB (right panel) unlabelled transcripts (5’-UTR 
sequence). (B) Assays performed with 5’-end-labeled MicA in the presence (+) of a molar 
excess of ompA (left panel) or lamB (right panel) unlabelled transcripts (5’-UTR sequence). 
The bands that are already observed in the absence of the enzyme (control reactions) arise 
due to the radiolysis of the substrate. (C) Proposed interaction regions of ompA and lamB 
mRNAs with MicA [adapted from (Bossi and Figueroa-Bossi, 2007)]. The Shine–Dalgarno 
regions of ompA and lamB are indicated. The arrows indicate the RNase III cleavage sites 
on MicA as determined on A and B. (D) Assays performed with 5’-end-labelled ompA in 
the absence (-) (on the left) or in the presence (+) (right panel) of a molar excess of 
unlabelled MicA. On the left side of the marker (M) radiolabelled transcripts of known 
sizes were included (a) 130 nt; (b) 120 nt and (c) 95 nt. The arrows in the figure indicate the 
degradation products located inside the hybridization region. 
ompA expression is regulated by RNase III and is dependent on 
MicA 
OmpA is a very abundant porin highly expressed in the exponential 
phase of growth. In stationary phase MicA is present at high levels and is the 
principal posttranscriptional down-regulator of the ompA mRNA (Rasmussen et 
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al., 2005; Udekwu et al., 2005). Since our results indicate that MicA degradation by 
RNase III is target-dependent and we have observed the concomitant degradation 
of the ompA target mRNA in vitro, we analysed the effect of an RNase III- 
mutation on the levels of ompA mRNA in stationary phase. The RNase III- mutant 
shows an increment of almost 14-fold in ompA mRNA level in comparison to the 
wild-type (Figure 5A). A strong increase in the OmpA protein level was also 
observed. This suggests that the reduced levels of ompA mRNA observed in 
stationary phase in the wild-type (RNase III+) are probably due to the cleavage 
and destabilization of the message by RNase III. This cleavage should be 
suppressed when RNase III is absent. This result strongly indicates that RNase III 
is implicated in the degradation of the ompA mRNA. On the other hand, the 
constant levels of OmpC and OmpD between the wild-type and RNase III-, 
further suggest that RNase III is not involved in the turnover of their messages 
and that the control of these proteins levels in the cell follows a different 
pathway. Interestingly, Papenfort et al. (Papenfort et al., 2006) have shown that 
MicA sRNA is also not involved in the control of ompC or ompD levels, while 
affecting ompA. 
Since the degradation of both the sRNA MicA and the ompA target 
mRNA is dependent on RNase III, we have checked whether the RNase III 
regulation of ompA expression was also MicA dependent. Therefore, we have 
analysed the expression of ompA in a MicA- mutant strain. In stationary phase, 
MicA base-pairs with the 5’-UTR of ompA preventing ribosome binding and 
destabilizing the entire ompA mRNA (Rasmussen et al., 2005; Udekwu et al., 2005). 
Accordingly, when the regulator is absent (MicA- mutant) the levels of ompA 
mRNA should be elevated. We observed an increase of about 7-fold in ompA 
mRNA levels when MicA is absent (Figure 5A). This result confirms that the 
control of ompA mRNA levels is dependent on MicA. However, the fact that in 
the absence of RNase III ompA mRNA levels are still higher than in the MicA- 
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mutant indicates that RNase III may also have a role in ompA expression by an 
alternative pathway not involving MicA. In fact we show that RNase III is also 
able to cleave ompA in vitro in the absence of MicA. Additionally ompA mRNA 
may also be under the control of another sRNA in an RNase III dependent way. 
If RNase III and MicA affect the ompA message through the same 
regulatory pathway, the combined absence of both would not result in a 
cumulative effect. In order to clarify this we have constructed and tested the effect 
of the double mutant RNase III-/MicA- on the ompA mRNA levels. As shown in 
Figure 5A, in the double RNase III-/MicA- mutant the ompA levels are reduced in 
comparison with the RNase III- single mutant, demonstrating that MicA and 
RNase III act over ompA message through a common pathway. 
 
FIGURE 5 - Regulation of ompA and MicA expression in different mutant strains. 
Northern blot and SDS–PAGE analysis of RNA and protein samples extracted from wild-
type and mutant strains as indicated on top of each lane. Details of experimental 
procedures are described in “Experimental Procedures” section. (A) (Upper panel) 
Analysis of steady-state ompA mRNA levels by northern blot. 15 g of RNA (each lane) 
were resolved in a 1.3% formaldehyde-agarose gel. The gel was then blotted to a Hybond-
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N+ membrane and hybridized with the corresponding ompA riboprobe. Full-length 
transcripts were quantified using a Molecular Dynamics PhosphorImager. The amount of 
RNA found in wild-type was set as one. The ratio between each strain and the wild-type is 
depicted (relative levels). A representative membrane is shown and values indicated 
correspond to the average of several northern blot experiments with RNAs from at least 
two independent extractions. The membrane was stripped and then probed for 16S rRNA 
as loading control. (ND) Non-detectable. (Middle panel) MicA sRNA levels analysis by 
northern blot. 15 g of RNA from the same mutants were separated on an 8% PAA / 8.3 M 
urea. The gel was then blotted to a Hybond-N+ membrane and hybridized with the 
corresponding MicA riboprobe. The membrane was stripped and then probed for 5S 
rRNAs, as loading control. (Lower panel) Outer membrane protein fraction analysis by 4% 
urea–SDS–12% polyacrylamide gel electrophoresis. The positions of the OmpC, OmpD and 
OmpA bands are indicated. An OmpA- mutant was used as control. (B) Comparison of the 
levels of MicA sense species on the wild-type, RNase III- and the double RNase III-/OmpA- 
strains. The experimental procedure was similar to the one described in (A). The arrow on 
MicA sRNA picture indicates the localization and direction of the probe (S1). Loading 
control of the RNA was done with 5S rRNA probe and is represented below. Sizes were 
estimated using the radiolabelled 10 bp DNA Step Ladder (Promega), on the left side of the 
membrane. 
Detection of the ‘sense transcripts’ in the RNase III- mutant 
depends on ompA 
Taken together, the results presented here point out that ompA is 
subjected to MicA-coupled degradation by RNase III. Since we had indications 
that the ‘sense transcripts’ detected in the RNase III- mutant are remnants of the 
sRNA-target complex (see Figure 2), we have investigated if these ‘sense-
transcripts’ corresponded to ompA mRNA fragments. Indeed, in the absence of 
both RNase III and ompA, the levels of these ‘sense transcripts’ are largely 
reduced when compared with those of the single RNase III- mutant (Figure 5B). 
This means that the detection of these ‘sense transcripts’ is related with the 
presence of ompA, strongly suggesting that this mRNA might be one of the targets 
degraded by RNase III in conjunction with MicA. 
The fact that the ‘sense transcripts’ are still detectable in the absence of 
ompA indicates that this mRNA might not be the only candidate for the MicA-
coupled degradation. However, in a LamB- mutant (the other known target of 
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MicA) we did not observe, under our experimental conditions, a significant 
alteration in the level of the ‘sense transcripts’ (data not shown). Furthermore, in 
the absence of both ompA and lamB targets, the ‘sense transcripts’ could still be 
slightly observed (data not shown), indicating that other MicA targets subjected 
to the same type of regulation should exist in the cell. 
RNase E cleaves ‘free MicA’ sRNA in vitro 
We have demonstrated that the sRNA MicA degradation is influenced by 
RNase III. However, this seems to happen only in the presence of the target 
mRNA. As we have shown in vitro, the enzyme was not able to cleave MicA 
alone. Thus, the question of how is free MicA degraded remains to be answered. 
In vivo experiments have shown a large impact of an RNase E mutant on the 
levels and stability of full MicA sRNA (Viegas et al., 2007). However, these results 
concern studies undertaken with the rne-537 mutant derivative (Viegas et al., 
2007). Since this mutant only prevents degradosome formation, without totally 
abolishing the enzyme activity, we were also interested in clarifying the role of 
the catalytic activity of RNase E on the decay of MicA. Moreover, it has been 
shown that -A/U rich sequences together with adjacent stem-loop structures can 
comprise recognition sites for RNase E (Kaberdin et al., 2000; Mackie, 1998). The 
sequence of the sRNA MicA matches these characteristics. Therefore, we have 
analyzed the ability of this endoribonuclease to cleave MicA sRNA transcript, in 
vitro. For this purpose we have cloned and purified the amino-terminal region of 
Salmonella RNase E. The homologous region in E. coli RNase E is known to be 
responsible for the catalytic activity of the enzyme (McDowall and Cohen, 1996). 
The results of the purification of the N-terminal segment of Salmonella RNase E 
are shown in Figure 6A.  
Chapter 2 
 
94 
 
FIGURE 6 – In vitro study of MicA sRNA cleavage by RNase E. (A) SDS-PAGE analysis 
of the purified proteins. Protein sample was visualized by Coomassie Brilliant Blue 
Staining. Molecular weight marker (Precision Plus Protein Pre-stained Standards – Bio-Rad) 
is shown on the left side of each image. Purified N-terminal region of Salmonella RNase E 
(~64 kDa) was separated on a 10% polyacrylamide gel. (B) α-32P-labelled MicA transcript, 
5’ monophosphate (left panel) or 5’ triphosphate (right panel), was incubated with 500 nM 
of purified Salmonella RNase E (residues 1–522) at 30ºC. Aliquots withdrawn at the time-
points indicated above each lane were analyzed on a 15% PAA / 7 M urea gel. The two first 
lanes of each reaction correspond to the controls without the protein both withdrawn at 
time zero and at the end of the reaction time. 
 
In vitro assays with the purified protein were performed over uniformly 
labelled MicA transcript. It was seen before that RNase E preferentially cleaves 
RNAs with a 5’ monophosphate group over those endowed with a 5’ 
triphosphate (Celesnik et al., 2007; Lin-Chao and Cohen, 1991; Mackie, 1998; 
Mackie, 2000). Thus, in the activity assays we have used as substrate both the 
monophosphate and the triphosphate MicA transcripts. Our results show that 
RNase E is able to cleave both substrates in vitro (Figure 6B), though the efficiency 
of cleavage was superior over monophosphorylated MicA. This is in agreement 
with the recent report that E. coli RNase E is also active over some triphosphate 
substrates (Kime et al., 2010). 
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We have previously shown that in cells in which the degradosome 
scaffold of RNase E was deleted the degradation of MicA is slower (>4-fold 
stabilization) (Viegas et al., 2007). This suggests that, in vivo, RNase E may need 
the cooperation of other degradosome components in the decay of this transcript. 
Indeed it was previously shown in E. coli and Salmonella that the absence of 
PNPase, the exoribonucleolytic component of the degradosome, has a remarkable 
impact over the stability of MicA sRNA (Andrade and Arraiano, 2008; Viegas et 
al., 2007). However, the high ability of RNase E to cleave MicA in vitro indicates 
that the enzyme per se should importantly contribute for the in vivo degradation 
of free MicA. 
 
DISCUSSION 
Stress conditions that unbalance OMP levels activate the σE response, a 
complex set of changes normally devoted to protect the cell envelope from 
environmental challenges (Rowley et al., 2006). The transcription factor σE triggers 
the synthesis of the sRNAs that control OMP levels (Johansen et al., 2006; 
Papenfort et al., 2006). Upon down-regulation of OMPs and the relief of 
membrane stress, the high sRNA levels have to be brought back to normal 
amounts. MicA sRNA is a σE-dependent porin down-regulator whose 
transcription is activated in stationary-phase (Figueroa-Bossi et al., 2006; Johansen 
et al., 2006; Papenfort et al., 2006). Under this context, we were interested in 
studying the regulation of MicA cellular levels and determining the enzymes 
involved in this process. 
MicA was previously found to be highly stabilized in cells lacking a 
functional RNase III (Viegas et al., 2007). However, RNase III is not able to cleave 
MicA in vitro, suggesting that MicA alone is not a substrate for this enzyme. 
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Indeed, we demonstrate that RNase III is only able to cleave MicA in vitro when it 
base-pairs with its target(s). RNase III is a specific double-stranded RNA 
endoribonuclease, which plays multiple roles in the processing of rRNA and 
mRNA (Nicholson, 1999) and its activity has also been demonstrated over several 
sRNA-target complexes formed by cis-antisense sRNAs (Gerdes et al., 1992; 
Jerome et al., 1999; Krinke and Wulff, 1987; Simons and Kleckner, 1988). In these 
complexes, there is a perfect complementarity between the RNA partners, which 
constitutes a preferred substrate for RNase III, and avoids the need for Hfq. The 
limited complementary between trans-encoded sRNAs and their targets typically 
requires the help of the bacterial RNA chaperone Hfq. The trans-encoded sRNA 
MicA was shown to be dependent on Hfq both for stability and target 
degradation (Rasmussen et al., 2005; Udekwu et al., 2005; Viegas et al., 2007). It is 
generally assumed that Hfq binds both the regulator and the target RNA, 
favouring their interaction. Moreover, Hfq enhances the stability of many sRNAs 
in vivo, by protecting them from degradation (Storz et al., 2005). Curiously, IstR-1 
from E. coli and RNAIII from S. aureus are two trans-encoded sRNAs that act 
independently of Hfq and were also seen to be cleaved by RNase III in a target-
coupled mechanism (Boisset et al., 2007; Darfeuille et al., 2007; Huntzinger et al., 
2005; Vogel et al., 2004). Here we describe, in Salmonella, the first example of a 
system controlled by an Hfq-dependent trans-sRNA that involves the coupled 
degradation of the sRNA-target mRNA by RNase III. 
 In RNase III- cells, besides the high stabilization of MicA, a very stable 
smaller degradation intermediate is also observed. In agreement with the in vitro 
results, we have obtained several indications that this degradation intermediate 
corresponds to a remnant of a dsRNA complex formed by MicA and its target(s): 
(i) It is only detected in the RNase III- mutant (deficient for dsRNA degradation), 
where it is extremely stable by virtue of its double stranded character. When 
RNase III is present, dsRNA complexes are cleaved to products that are either 
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further degraded or too small to be detected by northern blot; (ii) This small 
intermediate is visible with both antisense MicA probes and sense probes 
complementary to the targets and (iii) The level detected with sense probes is 
highly reduced in the absence of OmpA (a main MicA target). Thus, this remnant 
species should indicate the region of interaction between MicA and its targets. 
Since a strong signal is detected with the 5’ probes and no signal at all is obtained 
with the probes located in the 3’-end, this region corresponds to the 5’ half of 
MicA. In fact, it is known that MicA interacts through its 5’-end sequence with its 
two targets described till now (Bossi and Figueroa-Bossi, 2007; Rasmussen et al., 
2005; Udekwu et al., 2005). Accordingly, the RNase III cleavage sites determined 
in vitro on both MicA-ompA and MicA-lamB hybrids are located in the 5’ half of 
MicA, inside the respective predicted hybridization region, which strongly 
correlates with the in vivo observations. This result is further confirmed by the 
fact that RNase III also cleaves the ompA 5’-UTR inside the same region, 
demonstrating that both molecules are cleaved together. 
 In the absence of both ompA and RNase III the level of the ‘sense 
transcripts’ is strongly decreased. The fact that these bands are still visible, 
despite at very low levels, may be related with the formation of complexes 
between MicA and other target(s), whose degradation should also be RNase III-
dependent. We demonstrate that in vitro RNase III is also able to cleave the 
complex MicA-lamB. However, in vivo, whether in the absence of lamB or of both 
lamB and ompA we could still detect the sense transcripts referred above (data not 
shown). This means that probably besides lamB mRNA other Salmonella MicA 
targets (not yet identified) may exist in stationary-phase. In E. coli, expression of 
phoPQ has recently been shown to be repressed by MicA upon activation of σE 
(Coornaert et al., 2010). In fact, MicA is a trans-encoded sRNA highly conserved in 
Enterobacteriaceae (Vogel and Papenfort, 2006). Trans-encoded sRNAs generally 
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establish short and imperfect interactions with its mRNA targets (~10–25 nt) 
(Kawamoto et al., 2006; Waters and Storz, 2009), allowing the regulation of 
multiple targets by the same sRNA. For example, RybB sRNA controls more than 
17 mRNAs, 10 of which encode OMPs, including ompA. 
 Upon MicA accumulation in stationary phase, the sRNA binds to ompA 
mRNA blocking ribosome binding and translation initiation. This releases the 
mRNA from the ‘protection’ by the ribosomes and leads to degradation of the 
ribosome-free mRNA by the concerted action of endo- and exoribonucleases 
(Arraiano et al., 2010). In line with previous-work (Melefors and von Gabain, 
1988; Vytvytska et al., 1998), RNase E is thought to be the endoribonuclease 
responsible for the decay of ompA mRNA after the blockage of ribosome loading 
caused by MicA binding (Rasmussen et al., 2005; Udekwu et al., 2005). In this 
report, we show that additionally the binding of MicA to ompA renders both 
RNAs susceptible to RNase III cleavage. We have demonstrated that this 
endoribonuclease is essential for ompA repression and, in agreement with 
previous studies (Rasmussen et al., 2005; Udekwu et al., 2005), we observed a 
relieve of ompA repression in the absence of MicA. Both effects were seen to occur 
in a concerted way. The RNase III pathway has the advantage of simultaneously 
controlling the levels of the sRNA, whose function after the repression of the 
target will no longer be necessary in the cell. In addition RNase III cleavage 
makes the repression irreversible. From a physiological point of view, the 
existence of two distinct pathways may enhance the cell response in stress 
conditions allowing a fine-tuned balance of OmpA levels needed to keep the 
envelop integrity. Moreover by having two alternative degradation pathways the 
cell warrants the metabolism of molecules no longer needed. This may be crucial 
in stationary phase, which is characterized by limited resources. 
 Interestingly, the ompA levels in the double mutant (RNase III-/MicA-) are 
not restored to those observed in the MicA- mutant. This can be due to a direct 
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effect of RNase III over ompA. Indeed we show that in vitro RNase III is able to 
cleave ompA even in the absence of the sRNA. Alternatively, other(s) player(s) can 
be involved in the RNase III-mediated regulation of ompA. At least two other 
trans-encoded regulatory sRNAs (RseX and RybB) have been described as 
additional ompA regulators (Douchin et al., 2006; Papenfort et al., 2006). 
 We have just described a pathway for degradation of MicA sRNA that 
involves target binding and is dependent on RNase III. Our results show that 
RNase III cleaves MicA when hybridized with the targets. The question then 
arises how the levels of free MicA are brought back to normal when the cell no 
longer needs it. Our previous results in vivo, showed a high stabilization of MicA 
in an RNase E deletion mutant lacking the C-terminal region (Viegas et al., 2007). 
This may suggest that RNase E needs the cooperation of other degradosome 
components in the degradation of MicA. In fact, we have previously shown that 
PNPase, the exonucleolytic component of the degradosome, has a great impact 
over the stability of this sRNA in Salmonella. According to the results presented 
here, the catalytic domain of RNase E also shows, in vitro, a high efficiency in the 
cleavage of this sRNA. This single stranded endoribonuclease seems to play an 
important role in the regulation of the abundance of free MicA. 
 For each sRNA the characterization of its turnover has to be analyzed 
from two different perspectives: the independent, and the dependent of target 
interaction. The later can be similar or not, whether the sRNA decay is influenced 
or not by the respective target(s). Taken together, the results presented in this 
study indicate the existence of two different pathways for MicA sRNA turnover, 
each one involving a specific endoribonuclease. According to the model proposed 
in Figure 7, when MicA is free, RNase E seems to take the control by efficiently 
degrading the sRNA. However, if MicA is interacting with the targets the target-
dependent pathway of degradation predominates. This mechanism involves a 
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double stranded endoribonuclease that is able to degrade both the target and the 
sRNA, simultaneously.  
 Cleavage by RNase III within the sRNA–mRNA duplex and the 
subsequent decay of the mRNA intermediate by the cell machinery could rather 
resemble the RNAi scenario in eukaryotic organisms. RNase III-like enzymes are 
known to have a pivotal role in eukaryotic small noncoding RNA function and 
biogenesis (Arraiano et al., 2010). Hence, it is not surprising that RNase III would 
also be a main player in the control of prokaryotic sRNA expression and function, 
broadening the enzyme’s global role in the regulation of gene expression. 
 
 
FIGURE 7 - Schematic representation of the two degradation pathways followed by 
MicA. RNase E and RNase III are represented by scissors and pliers, respectively. The two 
different pathways for MicA degradation are shown on the left side. The possible 
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associations of MicA with its targets are also depicted. In the wild-type, MicA and the 
targets should be fully degraded as a result of both degradation pathways in cooperation 
with the exoribonucleolytic activity. In the RNase III- mutant, the MicA-target dependent 
degradation by RNase III is blocked. As a result, some degradation intermediates are 
stabilized and can be detected, namely the target and MicA strands that have interacted 
but could not be cleaved by RNase III. ompA being the main target of MicA, its species are 
over-represented. When additionally the ompA target mRNA is absent, the respective 
degradation intermediate is no longer present in the cell and, as a consequence, there is a 
reduced level of transcripts detected with probes complementary to MicA-targets. 
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SUPPLEMENTARY INFORMATION 
Supplementary Tables 
SUPPLEMENTARY TABLE S1 - List of oligonucleotides used in this work. The 
restriction and T7 sequences in the primers used for cloning procedures and for riboprobe 
synthesis, respectively, are shown in bold and underlined. 
 
 
 
Oligo Sequence 5' to 3'* 
pSV-104 CAGACGGAAACTTAAGCCTGCGGCTGAGTTACCACGTCTTTAACGCCTTTAACGATTGTGTAGGCTGGAGCTGCTTC 
pSV-105 CGATTTATCATCTGAAACTGTTAAATGATGTGTATATCCGTCATGTTTTTTTCGGTCCATATGAATATCCTCCTTAG 
pSV-106 TGCGAGAACGCTTGTCAGAA 
pSV-107 ACAGGCGTTATTAGGCAAG 
pSV-108 CGAAACGCAAAACCATTCGCAGTTTTAGAAGGTGGCAGCGTTTAAAGAAAAGGTGTAGGCTGGAGCTGCTTC 
pSV-109 GCGCCCCTCGTTACGTCAGATGACCATCGTATTACCACCAGATTTCCATCGGTCCATATGAATATCCTCCTTAG 
pSV-110 GTCGTCGTCTGCATCAAGAG 
pSV-111 GCCTTATTCGGCTTACAAGC 
pSV-146 AAATAAACTGAACTCTTTGTTCCGGGGCGAGTCTGAGTATATGAAAGACGTGTAGGCTGGAGCTGCTTC 
pSV-147 GGCGGATACCGAGCCGTTTGCCGCGTGGCTTGCAAAACACGCCTGACCCAGGTCCATATGAATATCCTCCTTAG 
pSV-148 AGAGCCGCTGGAGATTTTAC 
pSV-149 TGGCATTTAGTCACCTCCG 
pSV-116 GAAATTAATACGACTCACTATAGGAAAGACGCGCATTTGTTAT 
pSV-117 AAAAAGGCCACTCACGGAGTG 
pSV-120 CCGTGGAAATCGACAGCCATTGCCTGAGCGGACATTAC 
pSV-121 GGGCCTAATACGACTCACTATAGCTCAGGAGATAGAATGATGATTACTCTGC 
pSV-122 GGTAATACGACTCACTATAGGCCAGGGGTGCTCGGCATAA 
pSV-123 GCCAGTGCCACTGCAATCGCGATA 
pSV-124 GGAATTCCATATGAAAAGAATGTTAATCAACGCG 
pSV-125 CGCGGATCCCTACGTGGCGACGCTAACCG 
pSV-126 TAATACGACTCACTATAGGG 
pSV-127 TGCTAGTTATTGCTCAGCGG 
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Oligo Sequence 5' to 3'* 
pSV-128 GTGCGTACCGCGGGCGTGGG 
pSV-129 GGAATTCCATATGAACCCCATCGTAATTAATC 
pSV-130 CGCGGATCCTCATTCCAACTCCAGTTTTTTC 
pSV-131 TAATACGACTCACTATAGGG 
pSV-132 GTTAAATTGCTAACGCAGTCA 
pSV-133 ACAAATGCGCGTCTTTC 
pSV-134 TCATCGCTGAAAACAG 
pSV-135 AGGCCACTCACGGAGTG 
pSV-118 GAAAGACGCGCATTTGT 
pSV-137 CCTGTTTTCAGCGAT 
pSV-138 CACTCCGTGAGTGGCCT 
pSV-139 CTACGGCGTTTCACTTCTGAGTTC 
pSV-141 GTTTTTTTTTAATACGACTCACTATAGGGAGGCACGGAGTGGCCAAA 
pSV-142 GGGCCTAATACGACTCACTATAGGGACCAGGTGTTATCTTTCGGAGCGGCCTGCGC 
pSV-143 CAGCATAAGCCGTAGATATCGG 
pSV-144 ACGGCTACCTTGTTACGACTT 
pSV-145 AGAGTTTGATCCTGGCTCAG 
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ABSTRACT 
In the last years, the study of a growing number of small non-coding 
RNAs in several prokaryotic organisms has unveiled unsuspected layers of 
regulation in a variety of cellular processes. In this chapter, we studied the role of 
SraL sRNA in Salmonella Typhimurium. This highly conserved sRNA was shown 
to be mostly expressed in late stationary phase of growth, the condition chosen 
for the study of its biological role. SraL appears to regulate some enzymes 
involved in carbohydrates metabolism, namely in the TCA cycle and oxidative 
phosphorylation pathways. Moreover, the expression of this sRNA was shown to 
be dependent on the glucose concentration of the growth medium. This analysis 
also suggested the regulation of additional targets involved in other processes. 
This regulation seems to occur by the base-pairing of the sRNA with the mRNA 
of its target(s). Thus, SraL seems to belong to the class of the trans-encoded 
sRNAs. This study represents the first attempt to unveil the role of SraL sRNA in 
Salmonella Typhimurium. 
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INTRODUCTION 
Small non-coding RNAs have emerged as crucial components of the 
regulatory repertoires of both eukaryotic and prokaryotic organisms. These RNA 
molecules, which typically range from 50 to 250 nucleotides in length, constitute 
the most abundant class of post-transcriptional regulators in bacteria. They are 
often expressed under specific growth, stress or virulence conditions (Storz et al., 
2011). The most extensively studied sRNAs, often called antisense trans-encoded 
sRNAs, are those that regulate mRNAs by short and imperfect base-pairing 
interactions (Waters and Storz, 2009). The interaction between the sRNA and its 
target(s) may result in different effects. The most common effect described so far 
is the inhibition of translation of the targeted mRNA (Storz et al., 2011). In this 
case, the sRNA binding to the mRNA occurs in the vicinity of the Shine-Dalgarno 
sequence, preceding the translational start codon. After the translational 
repression, the mRNA often becomes substrate for RNase E or RNase III (Caron et 
al., 2010; Massé et al., 2003).  
The development of new RNomic techniques triggered the identification 
of a plethora of sRNAs in the last years (Sittka et al., 2008; Sridhar et al., 2010; 
Vogel et al., 2003; Wassarman et al., 2001; Zhang et al., 2003). SraL (also known as 
RyjA) is a 140-nucleotides antisense sRNA firstly described in 2001 in two 
exhaustive genetic studies, in which a combination of different approaches was 
used in order to identify novel sRNAs in E. coli (Argaman et al., 2001; Wassarman 
et al., 2001). Subsequently, this sRNA was also detected in Salmonella enterica 
serovar Typhimurium (Ortega et al., 2012; Viegas et al., 2007). SraL sRNA is 
localized between the genes encoding soxR (Amábile-Cuevas and Demple, 1991) 
and a putative glutathione S-transferase (STM4267) but it is transcribed in the 
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opposite strand. Moreover, SraL seems to belong to the Hfq-dependent sRNAs 
group since in the absence of Hfq this sRNA was destabilized (Viegas et al., 2007). 
In this work, we have made the first attempts to investigate the biological 
role of SraL in Salmonella, since no targets were yet discovered for this sRNA. A 
proteomic analysis using Salmonella SraL mutant and SraL overexpressing strains 
detected the variation of the expression of several proteins involved in the 
metabolism of carbohydrates and also in protein folding. Interestingly, we also 
show that this sRNA is regulated by the levels of glucose in the cell. The 
relevance of the regulation of SraL over some of these putative targets is 
discussed in this chapter.  
   
EXPERIMENTAL PROCEDURES 
Oligonucleotides 
All oligonucleotides used in this study are listed in the Table S1 in the 
“Supplementary Information” section, and were synthesized by STAB Vida. 
Bacterial strains and plasmids 
All bacterial strains and plasmids used in this study are listed in the Table 
1 and Table 2, respectively. All Salmonella strains used are isogenic derivates of 
the wild-type Salmonella enterica serovar Typhimurium strain SL1344. The sraL 
(CMA-651) null mutant was constructed using the primer pair pIS-001/pIS-002 
and following the -red recombinase method (Datsenko and Wanner, 2000) with 
few modifications, as previously described (Viegas et al., 2007). All chromosomal 
mutations were subsequently transferred to a fresh genetic background (SL1344 
strain) by P22 HT105/1 int-201 transduction (Schmieger, 1971). The 
chloramphenicol-resistance cassette of plasmid pKD3 replaces nucleotides -9 to 
 Discovering the role of the small RNA SraL in Salmonella Typhimuirum 
 
 
117 
+120 of the sraL gene. The gene deletion was verified by colony PCR using the 
primer pair pIS-003/pIS-004.  
For construction of pISVA-01 plasmid expressing SraL, a PCR fragment 
containing the entire sraL sequence was amplified from SL1344 chromosome 
using the primer pair pIS-009/pIS-010. The resultant PCR fragment carrying a 5’-
phosphate was cleaved with KpnI and ligated into the constitutive pZE12luc 
plasmid (blunt/KpnI site) (Lutz and Bujard, 1997). In this plasmid, the initiation 
site of the encoded RNA lies at position +1 of the constitutive PLlacO promoter of 
pZE12luc plasmid.  
Competent E. coli DH5α cells (New English Biolabs) were used for 
cloning procedures during plasmid construction.  
 
TABLE 1 - List of strains used in this work 
 
TABLE 2 - List of plasmids used in this work 
Strain Relevant Markers / Genotype Source/Reference 
S. Typhimurium, 
SL1344 
StrR hisG rpsL xyl 
(Hoiseth and 
Stocker, 1981) 
CMA-651 SL1344 sraL (∆sraL::CmR) This study 
E. coli DH5α 
recA1 endA1 gyrA96 thi-hsdR17 New England 
Biolabs supE44 relA1 lacZYA-arg FU169 f80dLacZDM15 
Plasmid Comments Origin/Marker Reference 
pKD3 
Template for mutants construction; 
carries chloramphenicol-resistance 
cassete 
oriR/AmpR 
(Datsenko and 
Wanner, 2000) 
pKD46 
Temperature-sensitive λ-red 
recombinase expression plasmid 
oriR101/AmpR 
(Datsenko and 
Wanner, 2000) 
pZE12Luc 
PLlacO promoter; constitutive 
expression plasmid 
ColE1/AmpR 
(Lutz and Bujard, 
1997) 
pISVA-001 
pZE12luc derivative; PLlacO promoter; 
constitutive plasmid expressing SraL 
ColE1/AmpR This study 
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Bacterial growth 
All bacterial strains were grown in LB broth at 37ºC and 220 r.p.m. 
throughout this study. SOC medium was used to recover transformants after heat 
shock (in the case of E. coli) or electroporation (in the case of Salmonella), before 
plating. Conditions indicated as ‘SPI-1 and SPI-2 inducing conditions’ 
corresponded to growth in high salt (0.3 M NaCl) LB medium with low oxygen in 
sealed Falcon tubes, as described for SPI-1 induction (Sittka et al., 2007), and in 
PCN minimal medium (1 mM phosphate buffer, pH 5.8) as described for SPI-2 
induction (Lober et al., 2006). 
Growth medium was supplemented with the following antibiotics when 
appropriate: ampicillin (150 µg/ml), chloramphenicol (25 µg/ml) and 
streptomycin (90 µg/ml). For heat shock treatment, cells grown at 30ºC to an 
OD600 of 0.5 were transferred to 42ºC for 15 min. For cold shock treatment, 
cultures at an OD600 of 0.5 were transferred from 37ºC to 10ºC for 30 min and 4 h.  
RNA extraction, Northern blot and Reverse Transcription-PCR 
(RT-PCR) analyses 
Overnight cultures were diluted 1/100 in fresh medium and grown to the 
indicated cell densities at OD600 (growth medium and conditions are detailed in 
the respective figure legends). Culture samples were collected, mixed with 1 
volume of stop solution (10 mM Tris pH 7.2, 25 mM NaNO3, 5 mM MgCl2, 500 
µg/ml chloramphenicol), and harvested by centrifugation (10 min, 6000 g, 4ºC). 
RNA was isolated using the phenol/chlorophorm extraction method, precipitated 
in ethanol, resuspended in water and quantified on a Nanodrop 1000 machine 
(NanoDrop Technologies). The quality of the RNA was checked by agarose gel 
electrophoresis.  
For Northern blot analysis, 15 µg of total RNA was separated under 
denaturing conditions either by 8.3 M urea / 6% polyacrylamide gel in TBE buffer 
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or by 1.3% agarose MOPS / formaldehyde gel. For polyacrylamide gels, transfer 
of RNA onto Hybond-N+ membranes (GE Healthcare) was performed by 
electroblotting (1 h 50 min, 24 V, 4ºC) in TAE buffer. For agarose gels, RNA was 
transferred to Hybond-N+ membranes by capillarity using 20x SSC as transfer 
buffer. In both cases, RNA was UV crosslinked to the membrane immediately 
after transfer. Membranes were then hybridized in PerfectHyb Buffer (Sigma) at 
68ºC for riboprobes and 43ºC in the case of oligoprobes. After hybridization, 
membranes were washed as previously described (Viegas et al., 2007). Signals 
were visualized by PhosphorImaging (Storm Gel and Blot Imaging System, 
Amersham Bioscience) and analyzed using the ImageQuant software (Molecular 
Dynamics).  
RT-PCR reactions were performed using total RNA with the OneStep RT-
PCR kit (Quiagen). Reactions were mainly carried out according to the supplier’s 
instructions. Modifications were introduced regarding the amount of RNA and 
number of PCR cycles, depending on gene expression levels. The primer pairs 
used for the analysis of the different putative targets are indicated in the 
Supplementary Table S1 in the “Supplementary Information” section. As a 
control, 16S rRNA was amplified with specific primers pIS-018/pIS-019. Prior to 
RT-PCR, all RNA samples were treated with Turbo DNA free Kit (Ambion). 
Control experiments, run in the absence of reverse transcriptase, yielded no 
product. 
Hybridization probes 
Primers for templates amplification are listed in Supplementary Table S1 
in the “Supplementary Information” section. The riboprobes were obtained using 
the primer pairs pIS-021/pIS-022, pIS-043/pIS-044, pIS-045/pIS-046, pIS-047/pIS-
048, pIS-049/pIS-050, pIS-051/pIS-052 and pIS-017/pIS-054 for SraL, MicA, GlpD, 
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SfcA, RfbH, NuoG and Tig, respectively. 5S rRNA and 16S rRNA were detected 
by the 5’-end-labelled oligonucleotides pIS-023 and pIS-024, respectively. 
Riboprobes were generated from PCR fragments (a T7 RNA polymerase 
promoter sequence was added by the antisense primer) in the presence of an 
excess of [32P]-α-UTP over unlabelled UTP using the T7 RNA polymerase from 
Promega. DNA oligonucleotides were labelled with [32P]-γ-ATP using T4 
polynucleotide kinase (Fermentas). All labelled probes were purified over G50 
columns (GE Healthcare) to remove unincorporated nucleotides prior to 
hybridization. 
Proteomic analysis 
For the proteomic analysis, overnight cultures were diluted 1/100 in fresh 
LB medium and grown until 6h after OD600 of 2. Then, 2 OD units of each culture 
were transferred to a tube containing 0.25 volumes of stop solution (5% phenol / 
95% ethanol) and kept on ice for 30 min. Cells were sedimented by centrifugation 
for 10 min at 3200 g 4ºC, washed with stop solution, centrifuged again and stored 
at -80ºC. Pellets were lysed in Laemmli sample buffer (1.3% SDS, 10%, v/v, 
glycerol, 50 mM Tris/HCl, 1.8% β-mercaptoethanol, pH 6.8) and the total protein 
estimated using the Bradford reagent (Bio-Rad). Approximately 30 g of total 
protein (corresponding to approximately 0.3 ODs) were run in SDS-PAGE 12% 
gel. Loading equivalence among the samples was confirmed by checking GroEL 
by western blot analysis. Five slices from mid-run gels were submitted to in-gel 
tryptic digestion, and the tryptic peptide mixtures processed for protein 
identification by liquid chromatography-tandem mass spectrometry as described 
(García-del Portillo et al., 2011). 
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Sequence retrieval and alignments 
BlastN was used for sequence retrieval 
(http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi) of the following genome 
sequences: Salmonella enterica serovar Typhimurium LT2 (NC_003197), Salmonella 
enterica serovar Typhi Ty2 (NC_004631), Salmonella bongori NCTC 12419 
(NC_015761), Shigella boydii CDC 3083-94 (NC_010658), Shigella flexneri 2a str. 301 
(NC_004337), Shigella dysenteriae Sd197 (NC_007606), Escherichia coli K12 
(NC_000913), Citrobacter rodentium ICC168 (NC_013716), Citrobacter koseri ATCC 
BAA-895 (NC_009792), Enterobacter sp. 638 (NC_009436), Klebsiella pneumoniae 342 
(NC_011283). Alignments were made using ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
 
RESULTS AND DISCUSSION 
SraL sRNA is conserved among several enteric bacteria 
SraL sRNA (also known as RyjA) was first discovered in two 
independent studies in E. coli in which the use of comparative genomics and 
microarrays allowed the identification of novel sRNAs (Argaman et al., 2001; 
Wassarman et al., 2001). More recently, it was confirmed that this sRNA is also 
expressed in S. Typhimurium (Ortega et al., 2012; Viegas et al., 2007). 
Since SraL expression was detected in both E. coli and S. Typhimurium 
we performed an extensive search of SraL gene over the genomes of other enteric 
bacteria using BlastN tool. This sRNA was shown to be highly conserved, being 
identified in bacteria such as Shigella, Citrobacter and Klebsiella (Figure 1).  
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FIGURE 1 - Alignment of the sraL gene including the upstream promoter region in 
several enterobacteria. All nucleotides are coloured regarding their degree of conservation 
(red: high conservation; blue: partial conservation; black: little or no conservation). The 
asterisks (*) below the sequences are indicating the nucleotides conserved between all the 
species analysed. The putative -10 and -35 boxes of the sraL promoter are indicated 
(Argaman et al., 2001). “+1” marks the transcriptional start site. The Rho (ρ)-independent 
terminator is indicated by arrows. STM: Salmonella enterica serovar Typhimurium; STY: 
Salmonella enterica serovar Typhi; SBO: Salmonella bongori; SBD: Shigella boydii; SFL: Shigella 
flexneri; SDR: Shigella dysenteriae; ECO: Escherichia coli; CRT: Citrobacter rodentium; CKO: 
Citrobacter koseri; ENT: Enterobacter; KPN: Klebsiella pneumoniae. 
 
Using the MFold program (http://mfold.rna.albany.edu/?q=mfold) (Zuker, 
2003) we predicted related secondary structures for SraL sRNA of several enteric 
bacteria. The most stable predicted structure of the sRNA in S. Typhimurium is 
shown in Figure 2A. Despite some small differences, the majority of SraL 
structures represented show a high resemblance and all contain the same Rho-
independent terminator (Figure 2A-F). There are evidences that this Rho-
independent terminator contributes also to the stabilization of the sRNAs (Abe 
and Aiba, 1996; Aiba et al., 1991). 
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FIGURE 2 – SraL sRNA structures predicted by Mfold program (Zuker, 2003) of (A) 
Salmonella Typhimurium; (B) Shigella flexneri; (C) Escherichia coli; (D) Citrobacter koseri; (E) 
Enterobacter; (F) Klebsiella pneumoniae. 
 
We have compared the expression of S. Typhimurium SraL under 
different growth conditions. When cells are grown in LB at 37ºC, SraL is mostly 
detected upon entry in stationary phase of growth (Figure 3). The highest 
expression of the sRNA was achieved in the growth for 6h after OD2. Moreover, 
this sRNA is also expressed in conditions that induce the expression of the genes 
of the Salmonella pathogenicity island 2, indicating a possible role of SraL in 
Salmonella virulence (Figure 3). More specifically, SraL seems to be necessary after 
internalization of this bacterium into host cells since its expression is much higher 
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under SPI-2 inducing conditions. In fact, it was recently shown that SraL is 
expressed in intracellular bacteria located inside fibroblasts at 24h post-infection 
(Ortega et al., 2012). SraL is also expressed in cells subjected to heat shock, cells 
grown for 4h under cold-shock and also under SPI-1 inducing conditions, but at 
much lower levels (Figure 3).  
 
FIGURE 3 – Analysis of SraL sRNA expression under different growth conditions. Cells 
were grown in LB at 37ºC till OD600 of 0.5 (OD0.5), 1 (OD1), 2 (OD2), 3 h after OD2 
(OD2+3h) and 6 h after OD2 (OD2+6h). Cells were also grown under conditions of 
induction of SPI-1 and SPI-2 genes. For heat and cold shock, cells were grown in LB till 
OD600 of 0.5 and then subjected to cold shock (10ºC) for 30 min and 4 h (CS 30’ and CS 4h, 
respectively) and heat shock (42ºC) for 15 min (HS 15’). 15 g of total RNA were run on a 
6% PAA / 8.3 M urea gel. SraL was detected using a riboprobe; probing for 5S rRNA was 
used as a loading control. 
Proteomic analysis of cells with different SraL expression levels 
Although there are a few studies about SraL, the biological function of 
this sRNA was not yet revealed. To identify SraL targets we analyzed in parallel 
the proteome of S. Typhimurium wild-type, a sraL null mutant and a sraL 
overexpressing strain. Proteomic analysis had already been employed to identify 
several targets of other sRNAs, such as the well-known MicA sRNA that was seen 
to down-regulate ompA mRNA levels (Rasmussen et al., 2005; Udekwu et al., 2005) 
and Spot42 sRNA which overexpression specifically reduced the synthesis of 
GalK  in E. coli (Moller et al., 2002). We performed this analysis using cells in late 
stationary phase of growth, the condition in which this sRNA is mostly expressed 
(Figure 3) (Viegas et al., 2007). For this analysis, we have first constructed a sraL 
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null mutant strain in which we deleted the entire sequence of the gene and also 
an overexpressing strain in which the SraL gene was cloned into a constitutive 
expression plasmid. We have observed that, under our growth conditions, these 
strains have no significant differences in growth in comparison with the wild-
type strain (data not shown). By Northern blot analysis we could confirm the 
absence of SraL in the mutant strain and also its overexpression in the strain 
carrying the SraL overexpressing plasmid (Figure 4). 
 
FIGURE 4 – Analysis of SraL sRNA 
expression. Total cellular RNA was 
extracted from the S. Typhimurium strains 
grown in LB at 37ºC till 6 h have passed 
after they reached OD600 of 2. 15 g of RNA 
were separated on a 6% PAA / 8.3 M urea 
gel. The gel was then blotted to a Hybond-
N+ membrane and hybridized with the 
corresponding SraL riboprobe. Probing for 
5S rRNA confirmed equal loading. 
 
 
A total of 713 proteins were identified in our proteomic analysis and 
quantified across the three strains analyzed (see Supplementary Table S2 in 
“Supplementary Information” section). The majority of the proteins mostly 
affected by the change of SraL levels in the cell are those involved in the 
metabolism of carbohydrates (Table 3). Therefore, SraL sRNA seems to be 
implicated somehow in the carbohydrate metabolism, especially in the pathways 
that involve glucose. In fact, other sRNAs have been implicated in the control of 
making and breaking of sugars (Görke and Vogel, 2008).  
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TABLE 3 – List of the proteins mostly affected by the change of SraL levels in the cell 
    awild-type SL1344 strain 
    b SraL deletion mutant 
    c SraL overexpressing strain 
RT-PCR analysis of cells with and without SraL expression 
 Several trans-encoded sRNAs base-pair with their mRNA target(s) at the 
RBS, thus blocking translation by preventing ribosome binding. In most cases 
where ribosome binding is blocked, an associated decrease in the stability of the 
mRNA is also observed, possibly as an indirect result of the blocking of ribosome 
entry. Since the expression of several proteins was affected by the different levels 
of SraL in the cell we performed a screening in which we compared the mRNA 
expression levels of the putative targets between the wild-type and the SraL 
deletion mutant strain, using RT-PCR and Northern blot analyses (Figure 5). 
  Unique peptides 
Identified Proteins Acession # wta ∆SraLb pSraLc 
Aerobic sn-glycerol-3-phosphate dehydrogenase 
(GlpD) 
STM3526 21 25 18 
Trigger factor (Tig) STM0447 14 20 11 
Malate synthase A (AceB) STM4183 10 17 7 
NAD-linked malate dehydrogenase (SfcA) STM1566 10 15 9 
Putative fructose-1,6-biphosphate aldolase (YneB) STM4078 8 5 9 
Succinate-semialdehyde dehydrogenase I (GabD) STM2791 7 5 11 
CDP-6deoxy-D-xylo-4-hexulose-3-dehydrase 
(RfbH) 
STM2090 8 10 5 
NADH dehydrogenase I chain G (NuoG) STM2323 7 10 4 
Putative inner membrane protein (YhjG) STM3610 4 8 1 
Anaerobic sn-glycerol-3-phosphate 
dehydrogenase (GlpC) 
STM2286 2 9 0 
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FIGURE 5 – Analysis of SraL putative targets by RT-PCR and Northern blot. Total 
cellular RNA was extracted from the S. Typhimurium strains indicated grown in LB at 
37ºC till 6 h after OD600 of 2. (A) RT-PCR experiments were carried out using primers 
specific for the several putative targets over total RNA extracted from the wild-type and 
SraL deletion mutant, as indicated in each lane. RT-PCR primers specific for 16S rRNA 
shows that there were not significant variations in the amount of RNA used in each 
sample. (B)  15 g of total RNA were separated on a 1.3% formaldehyde / agarose gel. The 
gel was then blotted to a Hybond-N+ membrane and hybridized with the corresponding 
riboprobes. The membrane was stripped and then probed for 16S rRNA as loading control. 
GlpD: aerobic sn-glycerol-3-phosphate dehydrogenase; Tig: trigger factor; AceB: malate 
synthase A; SfcA: NAD-linked malate dehydrogenase; YneB: putative fructose-
1,6,biphosphate aldolase; GabD: succinate-semialdehyde dehydrogenase I; RfbH: CDP-
6deoxy-D-xylo-4-hexulose-3-dehydrase; NuoG: NADH dehydrogenase I chain G; YhjG: 
putative inner membrane protein; GlpC: anaerobic sn-glycerol-3-phosphate 
dehydrogenase.  
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Indeed, the mRNA expression level relative to some of the putative 
targets was also affected when comparing the wild-type with the SraL deletion 
mutant strain. Thus, the regulation of SraL over these putative targets seems to 
occur by base-pairing of the sRNA with the mRNA of its targets, that is 
subsequently reflected in the protein levels. This fact is in agreement with our 
previous results in which SraL was shown to be an Hfq-dependent sRNA (Viegas 
et al., 2007).  
The results obtained by the proteomic, RT-PCR and Northern blot 
analyses seem to indicate that SraL is involved directly or indirectly on the 
metabolism of carbohydrate in the conditions tested. Several of its putative 
targets perform important functions in several metabolic pathways, namely TCA 
or Krebs cycle (sfcA), oxidative phosphorylation (nuoG) and also the alternative 
glyoxylate pathway (aceB). Carbohydrates provide cells not only with energy but 
also with building blocks for synthesis of all macromolecules. It is therefore not 
surprising that the uptake and metabolism of carbohydrates are extensively 
regulated at all levels. In fact, it was already reported the existence of several 
sRNAs that control the sugar metabolism at various levels (for a review see 
(Görke and Vogel, 2008). At stationary phase cells stop growing and the 
metabolism slows. In this growth phase, the carbohydrates’ concentration is 
much lower than in exponential phase. Therefore, the enzymes involved in the 
carbohydrates metabolism should be less needed and consequently less 
produced. sRNAs are key regulators that promote an efficient and fast 
downregulation of gene expression under specific growth conditions. SraL is 
possibly one of the post-transcriptional regulators of bacterial sugar pathways. 
Moreover, SraL sRNA seems to regulate the synthesis of the LPS O-antigen 
(encoded by rfbH), an important virulence determinant of Salmonella (Gantois et 
al., 2009), which may explain the SraL expression under SPI-1 and SPI-2 inducing 
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conditions. This sRNA also appears to control the expression of the protein 
folding chaperone Trigger factor (tig).  
Our analyses revealed the existence of several SraL putative targets, 
pointing the involvement of this sRNA in some common metabolic pathways in 
the cell. The veracity of these targets has to be confirmed with further studies. In 
chapter 4, the regulation of SraL over tig mRNA is more deeply studied.  
The levels of SraL sRNA are affected by glucose  
In the course of the experiments and since SraL seems to affect the 
expression of several enzymes related with glucose metabolism, we investigated 
the influence of glucose in the SraL expression levels. For this purpose, we grew 
S. Typhimurium wild-type cells until late stationary phase (OD2+6h), we then 
added 0.2% of glucose and several samples were collected over 30 min. In the 
conditions tested, the expression of SraL seemed to be dependent on glucose. 
Upon addition of glucose in the medium, SraL expression decreased over time 
(Figure 6). We used MicA sRNA as a control since this sRNA is also highly 
expressed in late stationary phase. In contrast with SraL, the expression of MicA 
sRNA remained relatively constant over time. Interestingly, Spot42 sRNA was 
previously shown to be indirectly regulated by glucose. This sRNA is subject to 
repression by the cAMP-CRP complex in the absence of glucose (Polayes et al., 
1988; Sahagan and Dahlberg, 1979). When glucose is present, Spot42 sRNA 
selectivity inhibits the synthesis of GalK, a protein encoded in the galETKM 
operon which converts galactose to the glycolytic intermediate glucose-1-
phosphate (Moller et al., 2002). 
The biological function of SraL sRNA was not yet revealed. Along this 
chapter we performed the first attempts to investigate targets of this sRNA. The 
proteomic, RT-PCR and Northern blot analyses seem to indicate that this sRNA is 
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involved in the metabolism of the carbohydrates. Moreover, SraL was shown to 
be negatively affected by glucose. Nevertheless, it has to be further clarified 
whether this regulation is direct or indirect.  
 
FIGURE 6 - Analysis of SraL expression in the presence of glucose. Total cellular RNA 
was extracted from the wild-type S. Typhimurium strain grown in LB at 37ºC till late 
exponential phase (OD2+6h), then glucose was added to a final concentration of 0,2% and 
the culture grew for more 30 min. Samples were taken at the minutes indicated in the 
figure. 15 g of RNA were separated on a 6% PAA / 8.3 M urea gel. The gel was then 
blotted to a Hybond-N+ membrane and hybridized with the corresponding SraL and MicA 
riboprobe. Probing for 5S rRNA confirmed equal loading. 
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SUPPLEMENTARY INFORMATION 
Supplementary Tables 
SUPPLEMENTARY TABLE S1 - List of oligonucleotides used in this work. The 
restriction sequences in the primers used for cloning procedures are shown in bold. T7 
sequences in the primers used for riboprobe synthesis are underlined. 
 
Oligo Sequence 5' to 3' 
pIS-001 ATTTCGGCTAAAAAATCAGCATTTCGCTGGCGAACAGGGCGTCGTCGCTTAGTGTAGGCTGGAGCTGCTTC 
pIS-002 CATGCACTCGGCCATCGGGCTGAGCTCACCTAAAACTAAAGCGCCGCTAAGTGGTCCATATGAATATCCTCCTTAG 
pIS-003 GTTTTTCTCGAGATGCGCTGCGAAC 
pIS-004 GTTTTTTCTAGAAGATGATTAACATGCACTCG 
pIS-009 ATCAACACAAACCGGAACCTC 
pIS-010 GTTTTTGGTACCCACTCGGCCATCGGGCTG  
pIS-016 (tig-RT1) CAGCTCCAGAGCCTGTTTC 
pIS-017 (tig-RT2) GAAGAGTTCGAAGGCGGCAAAG 
pIS-018 AGGCGGTCTGTCAAGTCGGATG 
pIS-019 ACAGCCATGCAGCACCTGTCTC 
pIS-021 ATCAACACAAACCGGAAC 
pIS-022 GTTTTTTTTTTAATACGACTCACTATAGGGAGGTAAGGGCGCTTTAGTTTG 
pIS-023 CTACGGCGTTTCACTTCTGAGTTC 
pIS-025 (rfbH-RT1) AGCGAGCTCTCAAACCTGGTG 
pIS-026 (rfbH-RT2) GAGGAAGTGATCCCAATTGCTG 
pIS-027 (nuoG-RT1) GGTGAGGATGTCACTCAGACC 
pIS-028 (nuoG-RT2) CGGGCAATCATAGTAATACCG 
pIS-029 (aceB-RT1) AAAGCGCTGCTCGCTAAAGG 
pIS-030 (aceB-RT2) ATGCGCAATCCACGTGCCGTC 
pIS-031 (glpC-RT1) TGCATCCAGTTTGCGCCATAG 
pIS-032 (glpC-RT2) AAGCCAGTGCGCCAGTTGCTTG 
pIS-033 (sfcA-RT1) CTTCCCGTTGTGCTGGATGTC 
pIS-034 (sfcA-RT2) GCTGGAGATTGTCGCATTTCTG 
pIS-035 (glpD-RT1) TATGTACGATCACCTCGGCAAACG 
pIS-036 (glpD-RT2) CCTGCTTCTGATTATGGACG 
pIS-037 (yhjG-RT1) TATGCTGGCGCTACGCAGCGAAAG 
pIS-038 (yhjG-RT2) GTTTCGACTGCTCAGCGTCTTTC 
pIS-039 (yneB-RT1) GCGCCGCTCTTTGAATATGCTG 
pIS-040 (yneB-RT2) CCAATGCTTCACGTTCAGGC 
pIS-041(gabD-RT1) CTGCTGGTGATTAAACAGCCC 
pIS-042 (gabD-RT2) CGCCGTCCTGAACATACAATC 
pIS-043 GTTTTTTTTTAATACGACTCACTATAGGGAGGCACGGAGTGGCCAAA 
pIS-044 GAAAGACGCGCATTTGT 
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Oligo Sequence 5' to 3' 
pIS-045 TATGTACGATCACCTCGGCAAACG 
pIS-046 GTTTTTTTTTTAATACGACTCACTATAGGGTCGATATC TTCCGCTTCGAC 
pIS-047 CTTCCCGTTGTGCTGGATGTC 
pIS-048 GTTTTTTTTTTAATACGACTCACTATAGGGGAGCAAAT CTCATCACGATAGC 
pIS-049 AGCGAGCTCTCAAACCTGGTG 
pIS-050 GTTTTTTTTTTAATACGACTCACTATAGGGGCATCACAGCAGTCTTCAATC 
pIS-051 GGTGAGGATGTCACTCAGACC 
pIS-052 GTTTTTTTTTTAATACGACTCACTATAGGATATCATCCAGACGGGTGTCATCC 
pIS-054 GTTTTTTTTTTAATACGACTCACTATAGGGTCAGTTCC GGCAGTTCGCGTTCTTC 
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SUPPLEMENTARY TABLE S2 - List of the proteins analysed by proteomic analysis in 
wild-type (wt), SraL deletion mutant (dSraL) and SraL overexpressing strain (pSraL).  
# Identified Proteins (713) Accession  pSraL WT dSraL 
1 new outer membrane protein predicted bacterial porin (nmpC) STM1572 13 13 13 
2 protein chain elongation factor EF-Tu (duplicate of (tufA) STM3445 22 19 21 
3 putative hydrogenase, membrane component (ompA) .  STM1070 16 17 18 
4 outer membrane protein 1b (ibc), porin (ompC) STM2267 13 15 17 
5 chaperone Hsp60 with peptide-dependent ATPase activity (mopA) STM4330 27 30 31 
6 flagellar biosynthesis flagellin, filament structural protein (fliC) STM1959 26 24 24 
7 glycerol kinase (glpK) STM4086 25 29 28 
8 stress response DNA-binding protein starvation (dps) STM0831 15 13 15 
9 outer membrane protein W colicin S4 receptor; (ompW) STM1732 4 4 6 
10 putative cytoplasmic protein (yciF) STM1729 9 10 9 
11 malate dehydrogenase (mdh)  STM3359 15 18 16 
12 phosphoglyceromutase 1 (gpmA)  STM0772 9 10 13 
13 outer membrane protease, receptor for phage OX2 (ompX)  STM0833 11 11 10 
14 glycerophosphodiester phosphodiesterase, periplasmic (glpQ)  STM2282 17 20 18 
15 cell invasion protein (sipC) STM2884 18 21 21 
16 chaperone Hsp70 in DNA biosynthesis/cell division (dnaK) STM0012 35 30 29 
17 phosphoglycerate kinase (pgk) STM3069 19 17 19 
18 50S ribosomal subunit protein L5 (rplE) STM3428 10 10 9 
19 enolase (eno)  STM2952 15 12 15 
20 sn-glycerol-3-phosphate dehydrogenase (aerobic) (glpD) STM3526 18 21 25 
21 peptidyl-prolyl cis/trans isomerase, trigger factor a molecular (tig)  STM0447 11 14 20 
22 2-oxoglutarate dehydrogenase (sucB)  STM0737 6 7 7 
23 phosphoenolpyruvate carboxykinase (pckA)  STM3500 20 19 18 
24 catalase hydroperoxidase HPII(III), RpoS dependent (katE)  STM1318 20 17 18 
25 membrane-bound ATP synthase, F1 sector, beta-subunit (atpD)  STM3865 15 15 19 
26 ATP-dependent protease, Hsp 100, part of novel (clpB) STM2660 28 26 28 
27 GTP cyclohydrolase I (folE) STM2193 2 0 0 
28 glyceraldehyde-3-phosphate dehydrogenase A (gapA)  STM1290 14 16 14 
29 30S ribosomal subunit protein S7, initiates assembly (rpsG)  STM3447 11 9 11 
30 PhoP regulated: reduced macrophage survival (pagC)  STM1246 9 10 10 
31 putative NAD-dependent aldehyde dehydrogenase  STM4519 20 15 17 
32 pyruvate dehydrogenase, decarboxylase component (aceE) STM0152 20 22 24 
33 aconitate hydratase 2 (acnB)  STM0158 21 20 27 
34 protein chain elongation factor EF-G, GTP-binding (fusA)  STM3446 19 20 19 
35 30S ribosomal subunit protein S9 (rpsI)  STM3344 5 3 5 
36 citrate synthase (gltA) [4.1.3.7]  STM0730 18 14 14 
37 50S ribosomal subunit protein L22 (rplV) STM3435 10 8 9 
38 30S ribosomal subunit protein S4 (rpsD) STM3416 12 15 14 
39 aldehyde dehydrogenase B (lactaldehyde dehydrogenase) (aldB)  STM3680 10 13 11 
40 alcohol dehydrogenase, propanol preferring (adhP)  STM1567 10 10 10 
41 50S ribosomal subunit protein L1, regulates synthesis (rplA) STM4150 10 11 9 
42 iron-dependent alcohol dehydrogenase (adhE)  STM1749 18 23 20 
43 chaperone Hsp90, heat shock protein C 62.5 (htpG) STM0487 20 21 21 
44 aspartate ammonia-lyase (aspartase) (aspA) STM4326 12 16 17 
45 membrane-bound ATP synthase, F1 sector, alpha-subunit (atpA)  STM3867 13 12 16 
46 3-oxoacyl-[acyl-carrier-protein] synthase I (fbaB)  STM2141 15 13 12 
47 putative catalase .  STM1731 14 11 12 
48 fructose-bisphosphate aldolase (fba)  STM3068 8 8 10 
49 malate synthase A (aceB)  STM4183 7 10 17 
50 aconitate hydratase 1 (acnA) STM1712 17 15 18 
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51 superoxide dismutase, iron (sodB)  STM1431 4 4 4 
52 putative Ser protein kinase (yeaG) STM1285 15 17 16 
53 putative oxidoreductase (yghA) STM3157 10 11 10 
54 30S ribosomal subunit protein S2 (rpsB) STM0216 12 12 11 
55 cell invasion protein (sipA) STM2882 16 21 14 
56 Salmonella outer protein: homologous to ipgD of (sopB) STM1091 13 19 14 
57 sensory histitine protein kinase, transduces signal between (cheA)  STM1921 11 13 11 
58 putative cytoplasmic protein (yciE) STM1730 9 9 7 
59 ABC superfamily (periplasm)(oppA) STM1746 14 14 13 
60 flagellar biosynthesis filament capping protein (fliD) STM1960 15 15 13 
61 2-oxoglutarate dehydrogenase (decarboxylase component) (sucA)  STM0736 14 19 15 
62 50S ribosomal subunit protein L19 (rplS) STM2673 5 5 5 
63 succinyl-CoA synthetase, beta subunit (sucC)  STM0738 13 13 14 
64 bacterioferrin, an iron storage homoprotein (bfr) STM3443 5 5 4 
65 hyperosmotically inducible periplasmic protein (osmY) STM4561 9 6 7 
66 RNA polymerase, alpha subunit (rpoA)  STM3415 10 9 9 
67 isocitrate dehydrogenase in e14 prophage, specific for (icdA)  STM1238 9 10 12 
68 response regulator in two-component regulatory system (phoP)  STM1231 7 8 8 
69 isocitrate lyase (aceA)  STM4184 13 7 15 
70 glutathionine S-transferase (gst)  STM1451 10 8 9 
71 cell invasion protein (sipB)  STM2885 11 15 13 
72 putative cytoplasmic protein (yaeH)  STM0211 9 7 9 
73 DNA-binding, ATP-dependent protease la cleaves RcsA and (lon)  STM0450 10 14 12 
74 transaldolase A (talA)  STM2473 7 12 12 
75 glutaredoxin 2 (grxB)   STM1165 9 11 10 
76 transaldolase B (talB)  STM0007 8 9 9 
77 30S ribosomal subunit protein S5 (rpsE)   STM3423 4 5 5 
78 NAD-linked malate dehydrogenase (sfcA)  STM1566 9 10 15 
79 succinate dehydrogenase, flavoprotein subunit (sdhA)  STM0734 12 14 11 
80 putative thiol - alkyl hydroperoxide reductase  STM0402 6 7 5 
81 methyl accepting chemotaxis protein II (cheM) STM1919 13 15 11 
82 putative molecular chaperone (small heat shock protein) STM1251 7 6 6 
83 trehalase, periplasmic (treA)  STM1796 13 12 12 
84 RNA polymerase, beta subunit (rpoB)  STM4153 8 18 14 
85 conjugative transfer: surface exclusion (traT)  PSLT103 5 6 6 
86 gluconate-6-phosphate dehydrogenase, decarboxylating (gnd)  STM2081 12 11 16 
87 pyruvate dehydrogenase (aceF)  STM0153 10 14 12 
88 putative NADP-dependent oxidoreductase (yncB)  STM1589 8 8 6 
89 succinate dehydrogenase, Fe-S protein (sdhB)  STM0735 6 8 5 
90 phosphoenolpyruvate synthase (pps)  STM1349 12 12 13 
91 50S ribosomal subunit protein L9 (rplI) STM4394 6 6 5 
92 50S ribosomal subunit protein L13 (rplM) STM3345 9 7 7 
93 chaperone Hsp10, affects cell division (mopB) STM4329 4 4 4 
94 putative fructose-1,6-bisphosphate aldolase (yneB) STM4078 9 8 5 
95 putative ABC superfamily (atp_bind) transport protein (yjjK)  STM4581 13 11 12 
96 flagellar biosynthesis, hook-filament junction protein 1 (flgK)  STM1183 11 11 12 
97 DNA-binding protein HLP-II (HU, BH2, HD, NS) (hns)  STM1751 5 7 7 
98 adenylosuccinate synthetase (purA)  STM4366 11 12 11 
99 pyruvate formate lyase I, induced anaerobically (pflB)  STM0973 9 13 13 
100 succinyl-CoA synthetase, alpha subunit (sucD)  STM0739 8 7 8 
101 putative ABC superfamily (peri_perm) (yneA) STM4077 11 11 9 
102 50S ribosomal subunit protein L4, regulates expression (rplD) STM3439 4 6 4 
103 lipoamide dehydrogenase (NADH) (lpdA)  STM0154 6 10 9 
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104 glycine tRNA synthetase, beta subunit (glyS)  STM3655 10 11 8 
105 DNA-binding protein with chaperone activity (stpA) STM2799 8 7 9 
106 lysine tRNA synthetase, constitutive (lysS)  STM3040 8 13 9 
107 3-deoxy-D-manno-octulosonic acid 8-P synthetase (kdsA)  STM1772 8 9 8 
108 uracil phosphoribosyltransferase (upp)  STM2498 7 7 7 
109 transcription termination factor Rho polarity suppressor (rho) STM3917 7 9 7 
110 fumarase C (fumarate hydratase Class II) (fumC)  STM1469 8 10 6 
111 Salmonella iron transporter: fur regulated (sitA) STM2861 5 5 3 
112 outer membrane channel specific tolerance to colicin (tolC) STM3186 12 8 9 
113 sn-glycerol 3-phosphate transport protein (ugpB) STM3557 9 10 12 
114 putative LysM domain (ygaU)  STM2795 9 6 7 
115 aspartate aminotransferase (aspC)  STM0998 8 11 10 
116 NADH dehydrogenase I chain C,D (nuoC)  STM2326 10 8 8 
117 putative periplasmic protein (ydgA) STM1466 9 8 8 
118 50S ribosomal subunit protein L16 (rplP) STM3433 4 4 4 
119 membrane-bound ATP synthase, F0 sector, subunit b (atpF)  STM3869 11 9 8 
120 30S ribosomal subunit protein S13 (rpsM) STM3418 6 6 6 
121 trp-repressor binding protein (wraB) STM1119 6 6 6 
122 sn-glycerol-3-phosphate dehydrogenase (anaerobic) (glpA) STM2284 4 9 8 
123 50S ribosomal subunit protein L6 (rplF)  STM3425 10 9 10 
124 superoxide dismutase, manganese (sodA)  STM4055 8 5 7 
125 putative methyl-accepting chemotaxis protein STM3138 3 8 8 
126 phosphoglucomutase (pgm)  STM0698 6 7 7 
127 fumarate reductase, anaerobic, flavoprotein subunit (frdA)  STM4343 9 8 9 
128 putative resistance protein, osmotically inducible (osmC)  STM1563 7 7 6 
129 putative inner membrane protein (elaB)  STM2311 0 3 3 
130 aminoacyl-histidine dipeptidase (peptidase D) (pepD)  STM0316 9 7 7 
131 valine tRNA synthetase (valS)  STM4475 6 4 6 
132 phosphopentomutase (deoB)  STM4569 9 5 5 
133 pyruvate kinase I (formerly F), fructose stimulated (pykF)  STM1378 8 9 10 
134 putative cytoplasmic protein (yajQ) STM0435 7 7 7 
135 succinate-semialdehyde dehydrogenase I (gabD)  STM2791 11 7 5 
136 ATP-dependent zinc-metallo protease (hflB)  STM3296 8 8 8 
137 acetyl-CoA synthetase (acs)  STM4275 8 11 10 
138 50S ribosomal subunit protein L3 (rplC) STM3440 6 5 5 
139 isoaspartyl dipeptidase (iadA)  STM4512 6 6 5 
140 putative ABC superfamily transport protein (possibly (yehZ) STM2165 6 7 6 
141 glutamate tRNA synthetase, catalytic subunit (gltX)  STM2415 7 8 7 
142 nucleoside channel receptor of phage T6 and (tsx) STM0413 6 4 8 
143 3-oxoacyl-[acyl-carrier-protein] synthase I (fabB)  STM2378 7 8 8 
144 30S ribosomal subunit protein S1 (rpsA)  STM0981 5 9 3 
145 glucosephosphate isomerase (pgi)  STM4221 7 6 6 
146 PTS family, glucose-specific IIA component (crr)  STM2433 5 7 8 
147 50S ribosomal subunit protein L10 (rplJ) STM4151 4 4 4 
148 50S ribosomal subunit protein L24 (rplX) STM3429 6 7 7 
149 putative outer membrane antigen (yaeT) STM0224 9 7 13 
150 CDP-6deoxy-D-xylo-4-hexulose-3-dehydrase (rfbH)  STM2090 5 8 10 
151 ABC superfamily (peri_perm), galactose transport protein (mglB) STM2190 6 4 7 
152 tol protein required for outer membrane integrity (pal) STM0749 5 5 5 
153 putative inner membrane protein (ygaM) STM2802 3 2 3 
154 transcription pausing L factor (nusA) STM3287 7 8 5 
155 CTP synthetase (pyrG)  STM2953 5 8 6 
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156 alkyl hydroperoxide reductase (ahpC)  STM0608 5 5 5 
157 D-amino acid dehydrogenase subunit (dadA)  STM1803 3 4 4 
158 ABC superfamily (peri_perm), dipeptide transport protein (dppA)  STM3630 7 5 8 
159 peptidyl-prolyl cis-trans isomerase, survival protein (surA)  STM0092 7 9 7 
160 with HflK, part of modulator for protease (hflC)  STM4364 5 5 6 
161 subunit of cysteine synthase A and O-acetylserine (cysK)  STM2430 10 7 6 
162 protein chain elongation factor EF-Ts (tsf)  STM0217 9 5 8 
163 proline tRNA synthetase (proS)  STM0242 5 6 7 
164 General PTS family PEP-protein phosphotransferase (ptsI)  STM2432 4 7 8 
165 thiol peroxidase (tpx)  STM1682 5 6 6 
166 transketolase 2, isozyme (tktB)  STM2474 6 7 7 
167 ABC superfamily glutamine high-affinity transporter (glnH)  STM0830 8 7 6 
168 flagellar biosynthesis hook-filament junction protein (flgL)  STM1184 7 6 5 
169 transport of long-chain fatty acids sensitivity to (fadL) STM2391 8 8 8 
170 oligopeptidase A (prlC)  STM3594 6 11 8 
171 NADH dehydrogenase I chain G (nuoG)  STM2323 4 7 10 
172 phenylalanine tRNA synthetase, beta-subunit (pheT)  STM1338 4 5 7 
173 adenylate kinase (adk)  STM0488 4 5 6 
174 serine tRNA synthetase  also charges selenocystein (serS)  STM0963 7 8 8 
175 phosphotransacetylase (pta)  STM2338 5 7 9 
176 L-lactate dehydrogenase (lldD)  STM3694 7 8 7 
177 phage lambda receptor maltose high-affinity receptor (lamB)  STM4231 6 8 7 
178 50S ribosomal subunit protein L15 (rplO)  STM3421 4 5 5 
179 50 S ribosomal subunit protein L11 (rplK)  STM4149 3 4 5 
180 galactose-1-epimerase (mutarotase) (galM)  STM0773 3 0 3 
181 50S ribosomal subunit protein L2 (rplB) STM3437 3 4 6 
182 NAD synthetase, prefers NH3 over glutamine (nadE)  STM1310 6 7 8 
183 putative glutathione S-transferase (yibF) STM3684 6 5 6 
184 with HflC, part of modulator for protease (hflK) STM4363 7 7 8 
185 riboflavin synthase, beta chain (ribH)  STM0417 5 6 5 
186 response regulator in two-component regulatory (arcA)  STM4598 6 5 7 
187 putative Universal stress protein UspA and related (ybdQ)  STM0614 4 5 4 
188 universal stress protein A (uspA) STM3591 5 3 5 
189 putative chemotaxis signal transduction protein  STM2314 2 7 6 
190 methyl-accepting chemotaxis protein I, serine sensor receptor (tsr)  STM4533 2 7 7 
191 putative outer membrane lipoprotein (yaeC)  STM0245 8 6 7 
192 leucine tRNA synthetase (leuS)  STM0648 6 8 7 
193 ABC superfamily, spermidine/putrescine transporter (potD)  STM1222 7 8 6 
194 2,5-diketo-D-gluconate reductase A (yqhE)  STM3165 6 8 6 
195 serine endoprotease (degQ)  STM3348 7 6 5 
196 putative aldehyde dehydrogenase (ydcW)  STM1597 7 5 7 
197 membrane-bound ATP synthase, gamma-subunit (atpG)  STM3866 5 7 5 
198 ABC superfamily maltose transport protein, substrate (malE) .  STM4229 4 5 6 
199 asparagine tRNA synthetase (asnS)  STM1000 4 10 8 
200 murein lipoprotein, links outer and inner membranes (lpp)  STM1377 3 3 3 
201 molecular chaparone heat shock protein (grpE)  STM2681 3 2 2 
202 aminopeptidase A (pepA)  STM4477 4 5 4 
203 response regulator in two-component regulatory system (ompR)  STM3502 6 5 7 
204 isoleucine tRNA synthetase (ileS)  STM0046 4 7 8 
205 3-oxoacyl-[acyl-carrier-protein] reductase (fabG)  STM1195 6 6 7 
206 putative inner membrane lipoprotein STM3580 5 6 6 
207 Organic solvent tolerance protein (imp) STM0093 8 5 8 
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208 ABC superfamily (bind_prot), histidine transport protein (hisJ) STM2354 6 6 5 
209 acetylCoA carboxylase, carboxytransferase component (accA)  STM0232 5 5 6 
210 scaffolding protein for murein-synthesizing holoenzyme (mipA) STM1286 3 5 4 
211 stringent starvation protein A, regulator of transcription (sspA)  STM3342 4 4 5 
212 ribosome releasing factor (frr) STM0219 5 6 6 
213 ribonucleoside diphosphate reductase 1, alpha subunit (nrdA)  STM2277 3 9 6 
214 dihydrodipicolinate synthase (dapA)  STM2489 7 5 7 
215 ADP-L-glycero-D-mannoheptose-6-epimerase (rfaD)  STM3710 6 7 6 
216 SLP3_0001 undefined product 30:842 reverse MW:28469 SLP3_0001 5 8 7 
217 invasion protein outer membrane (invG)  STM2898 6 6 5 
218 NADH dehydrogenase I chain F (nuoF)  STM2324 5 5 7 
219 30S ribosomal subunit protein S3 (rpsC)  STM3434 5 6 6 
220 transketolase 1 isozyme (tktA)  STM3076 4 5 6 
221 glycoprotein/polysaccharide metabolism (ybaY)  STM0465 2 3 2 
222 ATPase component of the HslUV protease (hslU)  STM4091 6 5 6 
223 tubulin-like GTP-binding protein and GTPase, (ftsZ)  STM0133 4 8 7 
224 tol protein required for outer membrane integrity (tolB)  STM0748 5 3 6 
225 fumarate reductase, anaerobic, Fe-S protein subunit (frdB)  STM4342 5 3 6 
226 triosephosphate isomerase (tpiA)  STM4081 3 4 3 
227 putative cytoplasmic protein (yfbU) STM2335 4 3 4 
228 putative periplasmic binding transport protein (fliY)  STM1954 5 5 3 
229 DNA gyrase, subunit B (type II topoisomerase) (gyrB)  STM3835 2 6 4 
230 putative methyl-accepting chemotaxis protein  STM3216 4 7 6 
231 lipoprotein-34 (nlpB)  STM2488 6 6 6 
232 putative cytoplasmic protein (yjgA)  STM4437 7 7 6 
233 component in transcription antitermination (nusG)  STM4148 6 6 5 
234 putative oxidoreductase (ydjA)  STM1296 6 5 4 
235 putative universal stress protein (ynaF)  STM1652 6 4 4 
236 Sugar Specific PTS family, mannose-specific enzyme IIAB (manX)  STM1830 3 5 4 
237 glucose-6-phosphate dehydrogenase (zwf)  STM1886 5 6 7 
238 trehalose-6-phosphate synthase (otsA)  STM1928 7 5 8 
239 response regulator in two-component regulatory system (rcsB)  STM2270 5 8 6 
240 catabolite activator protein (CAP), cyclic AMP receptor (crp)  STM3466 4 4 7 
241 periplasmic L-asparaginase II (ansB)  STM3106 5 3 3 
242 putative sulfurtransferase (sseA)  STM2533 4 4 6 
243 N-succinyltransferase (dapD)  STM0213 4 6 3 
244 enoyl-[acyl-carrier-protein] reductase (NADH) (fabI)  STM1700 3 5 4 
245 putative serine/threonine protein kinase (yfgL)  STM2520 4 4 6 
246 protein chain initiation factor IF-2 (infB)  STM3286 0 8 5 
247 3-hydroxyacyl-coA dehydrogenase of 4-enzyme FadB (fadB)  STM3983 3 5 4 
248 phosphoribosylpyrophosphate synthetase (prsA)  STM1780 6 6 5 
249 peptidyl prolyl isomerase (cypD)  STM0452 5 6 6 
250 cell division inhibitor, a membrane ATPase, activates (minD)  STM1815 4 4 5 
251 6-phosphofructokinase II (pfkB)  STM1326 5 8 5 
252 acetyl CoA carboxylase, biotin carboxylase subunit (accC) STM3380 4 4 6 
253 putative periplasmic protein (yhcB)  STM3347 4 6 6 
254 4-aminobutyrate aminotransferase (gabT)  STM2792 5 4 5 
255 SLP2_0019 undefined product 14223:14852 forward MW:22398 SLP2_0019 4 5 3 
256 30S ribosomal subunit protein S6 (rpsF)  STM4391 4 4 3 
257 aminopeptidase N (pepN)  STM1057 3 5 6 
258 alanyl-tRNA synthetase (alaS)  STM2827 3 8 7 
259 50S ribosomal subunit protein L7/L12 (rplL) STM4152 3 4 3 
260 putative formate dehydrogenase formation protein ? Mn_fn (fdhE) STM4034 2 2 2 
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261 putative oxidoreductase (ydfG)  STM1511 5 3 4 
262 putative Histidinol phosphatase and related hydrolases of (ycdX) STM1136 3 2 4 
263 acyl carrier protein (acpP) .  STM1196 2 2 2 
264 (3R)-hydroxymyristol acyl carrier protein dehydratase (fabZ)  STM0227 5 2 3 
265 putative glutathionylspermidine synthase (ygiC)  STM3188 6 4 4 
266 FKBP-type peptidyl-prolyl cis-trans isomerase (rotamase) (fkpA)  STM3453 4 2 3 
267 tricarboxylic transport  STM2786 5 6 5 
268 glucose-1-phosphatase (agp)  STM1117 5 5 4 
269 putative transcriptional repressor (IclR family) (kdgR)  STM1842 5 5 5 
270 mannose-6-phosphate isomerase (manA)  STM1467 5 4 5 
271 paral putative transferase (maeB)  STM2472 3 6 4 
272 thioredoxin reductase (trxB)  STM0958 4 5 3 
273 putative inner membrane protein (yhjG)  STM3610 1 4 8 
274 putative outer membrane lipoprotein (slyB)  STM1445 5 4 1 
275 putative aminopeptidase (pepB)  STM2536 4 6 5 
276 putative ABC superfamily transport protein (yrbC)  STM3310 5 6 5 
277 acridine efflux pump (acrA)  STM0476 5 4 6 
278 putative ManNAc-6P epimerase (nanE)  STM3337 4 4 5 
279 sn-glycerol-3-phosphate dehydrogenase (anaerobic) (glpB)  STM2285 4 4 4 
280 putative universal stress protein (ydaA)  STM1661 5 3 3 
281 2-deoxyribose-5-phosphate aldolase (deoC)  STM4567 2 4 5 
282 heat shock protein, DnaJ and GrpE stimulates (dnaJ)  STM0013 5 3 5 
283 peptidyl-prolyl cis-trans isomerase B (rotamase B) (ppiB)  STM0536 3 4 3 
284 Flagellar synthesis: phase 2 flagellin (filament structural (fljB)  STM2771 3 3 0 
285 sigma D (sigma 70) factor of RNA (rpoD)  STM3211 3 5 5 
286 methionine tRNA synthetase (metG)  STM2155 4 5 5 
287 arginine tRNA synthetase (argS)  STM1909 0 5 4 
288 outer membrane protein 1a porin (ompF)  STM0999 4 5 3 
289 affects pool of 3-phosphoadenosine-5- (cysQ)  STM4404 4 4 5 
290 ABC superfamily, glutamate/aspartate transporter (gltI)  STM0665 4 3 3 
291 agmatinase (speB) STM3078 4 4 4 
292 SLP3_0014 undefined product 7854:8654 reverse MW:29568 SLP3_0014 5 3 4 
293 succinylornithine transaminase (astC)  STM1303 3 6 6 
294 putative GTP-binding protein (ychF)  STM1784 4 4 3 
295 methyl-accepting chemotaxis protein III, ribose and galactose (trg)  STM1626 3 6 5 
296 putative cytoplasmic protein  STM1624 3 5 5 
297 putative inner membrane protein (yebE)  STM1880 6 4 3 
298 regulator for lrp regulon and high-affinity branched-chain (lrp)  STM0959 4 5 3 
299 putative intracellular proteinase (yhbO)  STM3269 3 3 3 
300 putative thiamine pyrophosphate enzymes  STM2405 5 4 2 
301 beta-D-glucoside glucohydrolase, periplasmic (bglX)  STM2166 8 2 5 
302 paral putative periplasmic protein (yraP)  STM3267 3 5 3 
303 50S ribosomal subunit protein L14 (rplN)  STM3430 4 2 2 
304 paral putative transglycosylase (yraM)  STM3264 4 2 7 
305 periplasmic glucans biosynthesis protein (mdoG)  STM1150 6 5 4 
306 tyrosine tRNA synthetase (tyrS)  STM1449 5 4 4 
307 putative oxidoreductase (ucpA)   STM2445 4 5 5 
308 fructose-bisphosphatase (fbp)  STM4415 4 4 4 
309 transcriptional regulator of cryptic csgA gene for (crl)  STM0319 4 4 4 
310 putative glutathione S-transferase (yqjG)  STM3233 5 3 4 
311 50S ribosomal subunit protein L17 (rplQ)  STM3414 3 4 4 
312 putative cytoplasmic protein (ycbG)  STM1069 6 3 6 
313 bifunctional putative sugar nucleotide transferase domain of (rfaE)  STM3200 3 4 4 
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314 putative inner membrane protein (ydcF)  STM1640 2 3 3 
315 molybdopterin biosynthesis, protein B (moaB)  STM0803 4 3 3 
316 protein chain initiation factor IF-3 (infC)  STM1334 4 3 3 
317 threonine tRNA synthetase (thrS)  STM1333 2 5 6 
318 glycine cleavage complex protein P, glycine decarboxylase (gcvP) STM3053 2 5 5 
319 periplasmic serine protease Do, heat shock protein (htrA) STM0209 5 3 2 
320 polynucleotide phosphorylase (pnp)  STM3282 1 6 4 
321 phage shock protein negative regulatory gene for (pspA)  STM1690 0 2 3 
322 purine-nucleoside phosphorylase (deoD) STM4570 3 3 2 
323 fumarase A (fumarate hydratase class I), aerobic (fumA) STM1468 3 5 5 
324 CDP-diacylglycerol phosphotidylhydrolase (ushB)  STM4064 4 4 5 
325 acetate kinase A (propionate kinase 2) (ackA)  STM2337 4 4 4 
326 putative oxidoreductase  STM2406 4 4 4 
327 putative outer membrane lipoprotein  STM1607 3 4 5 
328 2-amino-3-ketobutyrate CoA ligase (glycine acetyltransferase) (kbl)  STM3709 4 5 3 
329 inorganic pyrophosphatase (ppa)  STM4414 4 3 3 
330 putative aminomethyltransferase (ygfZ)  STM3048 4 6 3 
331 putative glutathione S-transferase (yliJ)  STM0862 3 4 4 
332 putative ABC exporter outer membrane component homolog  STM4259 3 5 3 
333 putative cytoplasmic protein  STM1672 3 5 3 
334 putative carboxyphosphonoenolpyruvate mutase (prpB)  STM0368 3 5 3 
335 quinone oxidoreductase, NADPH dependent (qor)  STM4245 3 3 3 
336 ABC superfamily high-affinity phosphate transporter (pstS)  STM3857 5 2 5 
337 putative cytoplasmic protein  STM2789 5 5 2 
338 putative esterase (ycfP)  STM1210 2 3 4 
339 ribonucleoside-diphosphate reductase 1, beta subunit (nrdB)  STM2278 3 2 4 
340 putative periplasmic immunogenic protein (yggE)  STM3065 5 0 4 
341 sn-glycerol-3-phosphate dehydrogenase (anaerobic) (glpC)  STM2286 0 2 9 
342 amidophosphoribosyltransferase (PRPP amidotransferase) (purF)  STM2362 0 0 2 
343 serine hydroxymethyltransferase (glyA)  STM2555 4 5 3 
344 putative glycosyl hydrolase  STM1559 2 3 5 
345 putative periplasmic protein (ydgH)  STM1478 4 4 3 
346 RNA polymerase, beta prime subunit (rpoC)  STM4154 0 7 3 
347 involved in density-dependent regulation of (gcpE) STM2523 5 0 6 
348 NADH dehydrogenase I chain B (nuoB)  STM2327 4 4 4 
349 3-phosphoserine aminotransferase (serC)  STM0977 4 3 5 
350 NADH dehydrogenase I chain I (nuoI)  STM2321 3 4 4 
351 outer membrane lipoprotein (lipocalin) (blc)  STM4339 2 4 3 
352 malonyl-CoA-[acyl-carrier-protein] transacylase (fabD)  STM1194 3 3 2 
353 component of clpA-clpP ATP-dependent serine protease (clpX)  STM0449 3 2 4 
354 nucleoside diphosphate kinase (ndk)  STM2526 3 2 4 
355 molecular chaperone in protein export (secB)  STM3701 2 2 2 
356 Homolog of pipB, putative pentapeptide repeats  STM2780 3 3 2 
357 putative ABC superfamily (atp_bind) transport protein (yhbG)  STM3319 1 3 2 
358 putative uronate isomerase  STM3137 3 0 0 
359 ABC superfamily (peri_perm), D-ribose transport protein (rbsB)  STM3884 5 2 5 
360 dipeptidase for D-ala-D-ala digestion in peptidoglycan (pdgL)  STM1599 4 4 2 
361 tryptophan tRNA synthetase (trpS)  STM3481 2 1 3 
362 negative modulator of initiation of replication, inhibits (seqA)  STM0697 4 4 4 
363 glucosamine-6-phosphate deaminase (nagB)  STM0684 2 3 4 
364 GTPase domain of cell division membrane protein (ftsY)  STM3571 4 2 4 
365 ABC superfamily (bind_prot), arginine transport system (artI)  STM0890 3 4 2 
366 glycerolphosphate acyltransferase activity (plsB)  STM4235 1 4 5 
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367 thiol peroxidase, thioredoxin dependent (bcp)  STM2491 2 2 3 
368 purine-binding chemotaxis protein regulation (cheW)  STM1920 2 3 2 
369 putative cytoplasmic protein  STM1078 1 3 3 
370 putative glycosyl hydrolase  STM1558 0 3 3 
371 pyruvate kinase II, glucose stimulated (pykA)  STM1888 0 4 4 
372 sigma S (sigma 38) factor of RNA (rpoS)  STM2924 4 0 2 
373 proline dehydrogenase (putA)  STM1124 0 5 4 
374 a late step of protoheme IX synthesis (hemY)  STM3935 3 2 3 
375 galactokinase (galK)  STM0774 3 3 2 
376 putative nitrate reductase  STM3377 2 4 4 
377 chorismate pyruvate lyase (ubiC)  STM4233 2 4 4 
378 Secreted effector protein of Salmonella dublin (sopA)  STM2066 3 4 4 
379 transcription termination L factor (nusB)  STM0418 1 0 2 
380 ABC superfamily (peri_perm), molybdate transporter (modA)  STM0781 4 3 3 
381 oxaloacetate decarboxylase (eda)  STM1884 3 3 4 
382 putative pectinesterase (ybhC)  STM0786 4 2 2 
383 30S ribosomal subunit protein S8, and regulator (rpsH)  STM3426 2 3 2 
384 transcriptional repressor of iron-responsive genes (Fur family) (fur)  STM0693 3 3 3 
385 50S ribosomal subunit protein L20 (rplT)  STM1336 3 3 3 
386 putative oxidoreductase / K + channel protein (yajO)  STM0421 2 3 2 
387 outer membrane N-acetyl (apeE)  STM0570 5 3 2 
388 periplasmic protein disulfide isomerase I (dsbA)  STM3997 3 2 3 
389 putative cytoplasmic protein (ybeL)  STM0653 2 2 3 
390 putative Homolog of glutamic dehyrogenase  STM1795 2 4 2 
391 putative Phospholipid-binding protein (ybhB)  STM0792 2 3 3 
392 ABC superfamily (peri_perm), putrescine transporter (potF)  STM0877 4 2 2 
393 flavodoxin 1 (fldA)  STM0694 2 2 3 
394 SAICAR synthetase (purC) STM2487 2 3 3 
395 DNA methylase M, host modification (hsdM)  STM4525 2 2 0 
396 UDP-glucose pyrophosphorylase (galF) STM2098 4 0 3 
397 putative cellulose synthase (yhjN)  STM3618 3 1 4 
398 putative cytoplasmic protein (ybgI)  STM0711 2 3 2 
399 putative nucleic acid-binding protein, contains PIN domain  STM3033 0 0 2 
400 putative ferripyochelin binding protein (yrdA)  STM3399 3 3 4 
401 RNase E (rne)  STM1185 2 4 3 
402 rod shape-determining protein HSP70 chaperones (mreB)  STM3374 3 2 3 
403 N-acetylglucosamine-6-phosphate deacetylase (nagA)  STM0683 3 3 2 
404 catalase hydroperoxidase HPI(I) (katG)  STM4106 2 4 4 
405 ribosephosphate isomerase, constitutive (rpiA)  STM3063 3 2 5 
406 4.5S-RNP protein, GTP binding export factor, part (ffh)  STM2677 2 3 5 
407 peptidase component of the HslUV protease (hslV)  STM4092 3 2 3 
408 putative outer membrane protein  STM1328 2 2 4 
409 dehydroshikimate reductase (aroE) STM3401 2 3 2 
410 subunit of clpA-clpP ATP-dependent serine protease (clpP)  STM0448 2 2 2 
411 putative Competence-damaged protein (ydeJ)  STM1514 2 2 2 
412 putative peptide maturation protein, (pmbA)  STM4438 4 1 2 
413 phosphoheptose isomerase (ghmA)  STM0310 0 3 2 
414 transcriptional repressor of modABCD operon (modE)  STM0779 3 0 2 
415 putative nucleotide binding (ygdH)  STM2969 4 0 3 
416 transcriptional repressor for pur regulon, glyA, glnB (purR)  STM1430 2 0 0 
417 putative inner membrane protein  STM4261 0 2 2 
418 anaerobic dimethyl sulfoxide reductase, subunit A (dmsA)  STM0964 3 3 3 
419 chemotactic response CheY protein phophatase (cheZ)  STM1915 3 2 2 
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420 transcriptional regulator of aromatic aminoacid biosynthesis (tyrR)  STM1683 3 2 0 
421 threonine 3-dehydrogenase (tdh)  STM3708 2 3 3 
422 putative GTP-binding protein (yhbZ)  STM3301 3 3 3 
423 periplasmic murein tripeptide transport protein (mppA)  STM1679 2 3 3 
424 putative formate acetyltransferase (yfiD)  STM2646 2 2 3 
425 glucose-1-phosphate uridylyltransferase (galU)  STM1752 2 2 2 
426 putative cytoplasmic protein (samB)  PSLT051 2 3 4 
427 FKBP-type  peptidyl-prolyl cis-trans isomerase (rotamase) (fklB)  STM4397 3 2 3 
428 putative cytoplasmic protein  STM1324 3 3 2 
429 putative oxidoreductase (yigC)  STM3978 2 3 3 
430 putative transaldolase (talC)  STM4109 2 3 2 
431 3-ketoacyl-CoA thiolase (thiolase I, acetyl-CoA transferase) (fadA)  STM3982 2 2 3 
432 beta-hydroxydecanoyl thioester dehydrase (fabA)  STM1067 2 2 2 
433 putative integrase protein  PSLT042 2 3 2 
434 believed to be involved in assembly of (yfhP)  STM2544 2 3 2 
435 putative lipoprotein (ybjP)  STM0892 3 1 2 
436 CDP glucose 4,6-dehydratase (rfbG)  STM2091 0 4 2 
437 putative oxoacyl-(acyl carrier protein) reductase (yciK)  STM1717 4 0 3 
438 lipoprotein, cell division (nlpI)  STM3281 2 0 1 
439 D-ribulose-5-phosphate 3-epimerase (rpe)  STM3483 3 2 0 
440 putative ABC transporter periplasmic binding protein (yliB)  STM0849 3 0 5 
441 50S ribosomal subunit protein L21 (rplU)  STM3304 0 3 3 
442 aspartate tRNA synthetase (aspS)  STM1901 0 4 3 
443 2:3-cyclic-nucleotide 2-phosphodiesterase (cpdB)  STM4403 0 3 2 
444 surface presentation of antigens secretory proteins (spaO)  STM2891 0 2 2 
445 putative acetyltransferase  STM2449 2 2 1 
446 RNase I, cleaves phosphodiester bond between any (rna)  STM0617 2 2 0 
447 D-alanyl-D-alanine carboxypeptidase (dacA)  STM0637 3 3 2 
448 exonuclease III, may repair singlet oxygen induced (xthA)  STM1302 1 2 1 
449 putative inner membrane protein (yfgM)  STM2521 3 0 2 
450 3-deoxy-D-arabinoheptulosonate-7-phosphate synthase (aroG)  STM0760 2 3 3 
451 paral putative membrane protein (yfgA)  STM2524 2 3 3 
452 methyl-accepting transmembrane (tcp)  STM3577 2 3 3 
453 response regulator in two-component regulatory system (cpxR)  STM4059 3 2 3 
454 putative bacterial regulatory protein, merR family (yjdC)  STM4322 3 3 2 
455 putative transcriptional regulator (ytfJ)  STM4405 3 2 3 
456 preprotein translocase secretion protein of IISP family (secA)  STM0136 2 2 3 
457 SLP2_0011 undefined product 6669:8015 forward MW:51227 SLP2_0011 2 2 3 
458 putative cytoplasmic protein (yjbQ)  STM4250 3 1 2 
459 putative cytoplasmic protein (yggL) STM3108 2 2 2 
460 stringent starvation protein B (sspB)  STM3341 2 2 2 
461 ABC superfamily (binding protein), vitamin B12 transport (btuE)  STM1341 2 2 0 
462 L-glutamine:D-fructose-6-phosphate aminotransferase (glmS)  STM3861 0 0 3 
463 SOS response regulator, (LexA family) (lexA)  STM4237 2 0 2 
464 putative translation factor (yciO)  STM1720 2 0 2 
465 putative ATPase involved in chromosome partitioning (yhjQ)  STM3620 0 0 5 
466 6-phosphofructokinase I (pfkA)  STM4062 0 2 2 
467 histidine tRNA synthetase (hisS)  STM2522 0 2 3 
468 glutamate-1-semialdehyde aminotransferase (hemL)  STM0202 3 0 4 
469 glutamine tRNA synthetase (glnS)  STM0686 0 3 2 
470 putative DegT/DnrJ/EryC1/StrS family (yfbE)  STM2297 3 3 0 
471 a minor lipoprotein (rlpA)  STM0638 5 2 0 
472 uroporphyrinogen III methylase (hemX)  STM3936 4 0 4 
473 invasion genes transcription activator (hilA)  STM2876 0 3 4 
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474 putative enzyme with a TIM-barrel fold (yggS)  STM3100 3 0 3 
475 DNA strand exchange and recombination protein with (recA)  STM2829 0 4 2 
476 Propanediol utilization: polyhedral bodies (pudB)  STM2039 0 2 3 
477 putative S-adenosyl methionine adenyltransferase (yabC)  STM0120 0 2 3 
478 putative periplasmic protein (ydeI)  STM1515 3 0 0 
479 putative methyl-accepting chemotaxis protein  STM3152 0 3 0 
480 a minor lipoprotein (rlpB)  STM0647 3 2 2 
481 putative periplasmic protein (ybiS)  STM0837 2 3 2 
482 putative chromosome partitioning (mukE)  STM0993 3 2 2 
483 curved DNA-binding protein (cbpA)  STM1112 2 3 2 
484 integration host factor (IHF), alpha subunit (himA)  STM1339 2 2 3 
485 trehalose-6-phosphate phophatase, biosynthetic (otsB)  STM1929 3 2 2 
486 putative xylanase/chitin deacetylase  STM3132 3 2 2 
487 putative glutathione S-transferase (yghU)  STM3140 2 3 2 
488 putative phosphosugar isomerase  STM3601 2 2 3 
489 branched-chain amino-acid aminotransferase (ilvE)  STM3903 3 2 2 
490 putative alcohol dehydrogenase (yjgB)  STM4486 3 2 2 
491 putative secreted protein (yceI)  STM1157 2 2 2 
492 riboflavin synthase, alpha chain (ribE)   STM1426 2 2 2 
493 peptidyl-tRNA hydrolase (pth)  STM1783 1 2 3 
494 succinylarginine dihydrolase (astB)  STM1306 2 2 2 
495 peptide deformylase (def)  STM3406 2 2 1 
496 N-acetylneuraminate lyase (aldolase) (nanA)  STM3339 2 2 1 
497 putative tRNA/rRNA methyltransferase (yfiF)  STM2648 2 1 2 
498 1,4-alpha-glucan branching enzyme (glgB)  STM3538 2 0 0 
499 30S ribosomal subunit protein S11 (rpsK)  STM3417 3 3 0 
500 thymidine kinase (tdk)  STM1750 0 3 3 
501 Secretion system effector (sseC)  STM1400 0 4 0 
502 putative Thioredoxin-like proteins and domain (yhgI)  STM3511 1 0 3 
503 putative ATPase involved in cell division (ftsE)  STM3570 2 0 4 
504 ABC superfamily glycine/betaine/proline transport protein (proX)  STM2811 2 2 0 
505 inositol monophosphatase (suhB)  STM2546 1 2 0 
506 three acitivities: regulator of nadAB transcription, regulator (nadR)  STM4580 0 3 2 
507 unknown function in glycerol metabolism (glpX)  STM4085 0 2 2 
508 transcriptional activator of ntrL gene (osmE)  STM1311 2 0 0 
509 glycine cleavage complex protein T, (gcvT)  STM3055 2 3 0 
510 aerotaxis sensor receptor, senses cellular redox state (aer)  STM3217 2 3 0 
511 SLP1_0054 undefined product 47844:48821 reverse MW:36820 SLP1_0054 0 0 4 
512 glutamine synthetase (glnA)  STM4007 0 0 4 
513 glycogen phosphorylase (glgP)  STM3534 0 0 3 
514 outer membrane lipoprotein (lolB)  STM1778 3 0 4 
515 heat shock protein 33, redox regulated chaparone (yrfI)  STM3498 0 2 2 
516 sugar specific PTS family, enzyme IIA, also (ptsN)  STM3322 4 0 0 
517 2-oxo-3-deoxygalactonate 6-phosphate aldolase (dgoA)  STM3828 6 0 0 
518 SLP2_0012 undefined product 8294:10174 forward MW:70003 SLP2_0012 0 4 0 
519 ABC superfamily lysine/arginine/ornithine transport protein (argT)  STM2355 4 0 0 
520 glutamine amidotransferase, subunit with HisF (hisH)  STM2075 2 0 0 
521 4-methyl-5(beta-hydroxyethyl)-thiazole synthesis (thiJ)  STM0433 2 2 2 
522 lipoprotein (nlpD)  STM2925 2 2 2 
523 small heat shock protein (ibpA)  STM3809 2 2 2 
524 SLP2_0010 undefined product 5713:6315 reverse MW:22464 SLP2_0010 1 2 2 
525 phenylalanine tRNA synthetase, alpha-subunit (pheS)  STM1337 2 1 2 
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526 non-specific acid phosphatase (phoN)  STM4319 2 1 2 
527 paral putative methyltransferase tellurite resistance (tehB)  STM1608 0 0 3 
528 putative P-loop-containing kinase (yhbJ)  STM3323 2 2 0 
529 putative negative regulator (yfeD)  STM2414 1 1 1 
530 aspartate-semialdehyde dehydrogenase (asd)  STM3539 1 0 3 
531 putative oxidoreductase (ydgJ)  STM1462 0 0 4 
532 putative sarcosine oxidase (solA)  STM1160 0 0 2 
533 Secretion system effector (sseA)  STM1397 0 2 2 
534 response regulator in two-component regulatory system (narP)  STM2246 0 2 3 
535 protoporphyrin oxidase (hemG)  STM3987 0 2 2 
536 ssDNA-binding protein controls activity of RecBCD nuclease (ssb)   STM4256 0 2 2 
537 shikimate kinase I (aroK)  STM3487 0 2 1 
538 Homolog of slsA in STM  STM0950 2 0 3 
539 response regulator in two-component regulatory system with  STM4292 2 0 3 
540 sigma cross-reacting protein 27A (SCRP-27A)  STM3327 0 2 3 
541 methionine adenosyltransferase 1 (AdoMet synthetase) (metK)  STM3090 0 3 2 
542 glutathione oxidoreductase (gor)  STM3597 2 0 3 
543 periplasmic nitrate reductase, large subunit, in complex (napA)  STM2259 0 2 3 
544 proline dipeptidase (pepQ)  STM3984 0 0 3 
545 putative citrate synthase (prpC) STM0369 3 2 0 
546 threonine synthase (thrC)  STM0004 2 2 0 
547 acetylornithine deacetylase (argE)  STM4120 0 0 2 
548 outer membrane protein receptor / transporter for (fhuA)  STM0191 3 0 3 
549 putative alpha amylase   STM1560 0 3 3 
550 DNA topoisomerase type I, omega protein (topA)  STM1714 0 3 3 
551 putative enzyme (yniC)   STM1322 2 0 3 
552 outer membrane receptor for transport of vitamin (btuB)  STM4130 2 0 3 
553 cell invasion protein (prgH) STM2874 0 3 2 
554 glucokinase (glk)  STM2403 0 3 2 
555 activator of proP (proQ) STM1846 1 0 2 
556 putative flagellar biosynthesis(orgA) STM2869 2 0 2 
557 sensory histidine kinase (barA)  STM2958 0 0 3 
558 surface presentation of antigens secretory proteins (invJ)   STM2892 0 3 0 
559 putative enzymes related to aldose 1-epimerase (yeaD)  STM1289 0 0 3 
560 putative alcohol dehydrogenase (yqhD)  STM3164 0 0 2 
561 putative glutathione S-transferase STM4267 0 0 3 
562 putative outer membrane lipoprotein (ycfM) STM1207 0 2 0 
563 putative cytoplasmic protein (yceH) STM1168 0 0 1 
564 flagellar biosynthesis, hook protein (flgE)  STM1177 1 0 0 
565 ribosome-binding factor, role in processing of 10S (rbfA) STM3285 1 2 0 
566 putative Rhodanese-related sulfurtransferases (yibN) STM3703 2 0 2 
567 ecotin, a serine protease inhibitor (eco) STM2262 0 2 2 
568 adenine phosphoribosyltransferase (apt)  STM0483 0 2 2 
569 3,4 dihydroxy-2-butanone-4-phosphate synthase (ribB) STM3195 2 2 0 
570 endonuclease V (deoxyinosine 3endoduclease) (nfi)  STM4168 2 0 0 
571 putative inhibitor of septum formation (yceF)  STM1189 0 2 3 
572 pantothenate synthetase (panC)  STM0181 0 1 0 
573 tartronate semialdehyde reductase (TSAR) (garR)  STM3248 2 0 0 
574 peptide chain release factor RF-2 (prfB)  STM3041 0 2 2 
575 proline aminopeptidase P II (pepP)  STM3058 0 2 2 
576 phosphoglucosamine mutase (mrsA)  STM3294 0 2 2 
577 UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA)  STM3307 0 2 2 
578 putative helicase (rhlB) STM3914 0 2 2 
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579 phosphate starvation-inducible protein, ATP-binding (phoL)  STM0669 2 0 2 
580 carboxy-terminal protease for penicillin-binding protein 3 (prc)  STM1845 0 3 2 
581 transcriptional regulator for hemolysin (MarR family) (slyA)  STM1444 0 2 0 
582 dihydroxyacid dehydratase (ilvD)  STM3904 2 0 2 
583 uridine phosphorylase (udp)  STM3968 0 3 0 
584 cell invasion protein lipoprotein, may link inner (prgK)  STM2871 0 2 0 
585 acetylCoA carboxylase, beta subunit (accD)  STM2366 3 0 0 
586 cytidine monophosphate (CMP) kinase (cmk)  STM0980 2 2 0 
587 erythronate-4-phosphate dehyrogenase (pdxB)  STM2370 0 0 3 
588 putative cytoplasmic protein (ycfD)  STM1229 0 0 2 
589 Gifsy-2 prophage  STM1031 0 0 2 
590 cysteine tRNA synthetase (cysS)  STM0537 2 0 3 
591 regulator of length of O-antigen component of (wzzB)  STM2079 3 2 0 
592 lipoprotein precursor (vacJ)  STM2392 0 2 3 
593 dTDP-4,deoxyrhamnose 3,5 epimerase (rfbC)  STM2094 2 2 0 
594 putative LysM domain (ynhG)  STM1375 2 0 2 
595 (alpha)-aspartyl dipeptidase (pepE)  STM4190 0 2 2 
596 30S ribosomal subunit protein S10 (rpsJ)  STM3441 0 1 1 
597 putative oxidoreductase (yohF)  STM2171 0 2 1 
598 guanylate kinase (gmk)  STM3740 0 1 0 
599 3-oxoacyl-[acyl-carrier-protein] synthase II (fabF)  STM1197 1 0 2 
600 putative mannonate hydrolase  STM3135 0 0 2 
601 adenylosuccinate lyase (purB)  STM1232 0 2 0 
602 TypeIII-secreted protein effector (sopE2) STM1855 0 0 2 
603 thymidine phosphorylase (deoA)  STM4568 0 0 2 
604 membrane-bound ATP synthase, F1 sector, delta-subunit (atpH)  STM3868 0 3 0 
605 histone-like protein, located in outer membrane (hlpA)  STM0225 2 0 0 
606 nucleotide associated protein(yejK)  STM2226 2 0 0 
607 NifU homologs involved in Fe-S cluster formation (nifU)  STM2542 1 0 0 
608 cytoplasmic ferritin (ftn)  STM1935 0 2 0 
609 deoxyuridinetriphosphatase (dut)  STM3731 0 2 0 
610 flagellar biosynthesis (fliL)  STM1975 0 1 0 
611 putative arsenate reductase (yfgD)  STM2495 0 0 1 
612 transcription elongation factor, cleaves 3 nucleotide of (greA)  STM3299 0 0 2 
613 putative membrane protein, involved in stability of (yggB)  STM3067 0 0 2 
614 Fels-1 prophage putative minor tail protein  STM0918 0 2 0 
615 cob(I)alamin and cobinamide adenolsyltransferase (btuR)  STM1718 0 2 0 
616 putative inner membrane protein  STM2870 0 2 0 
617 oligoribonuclease (orn)  STM4350 0 2 0 
618 peptide methionine sulfoxide reductase (msrA)  STM4408 0 2 0 
619 dnaK suppressor protein (dksA)  STM0186 0 1 0 
620 putative RHS-family protein  STM0291 2 0 0 
621 putative Xanthosine triphosphate pyrophosphatase (yggV)  STM3103 2 0 0 
622 paral putative enzyme (yihX)  STM4026 2 0 0 
623 putative methyltransferase (menG)  STM4089 2 0 0 
624 ferrochelatase (hemH)  STM0489 0 2 0 
625 3-oxoacyl-[acyl-carrier-protein] synthase III acetylCoA (fabH)  STM1193 0 2 0 
626 glycerol-3-phosphate dehydrogenase (NAD+) (gpsA)   STM3700 0 1 0 
627 putative outer membrane or secreted lipoprotein  STM1561 2 0 0 
628 flagellar biosynthesis, component of motor switching and (fliG)  STM1970 2 0 0 
629 porphobilinogen deaminase (hemC)  STM3938 2 0 0 
630 glutathione synthetase (gshB)  STM3095 0 0 2 
631 putative sensor/kinase in regulatory system (yojN)  STM2269 2 0 0 
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632 paral putative outer membrane receptor (yncD)  STM1587 0 0 2 
633 putative inner membrane protein  STM2208 0 2 0 
634 Alanyl-alanine carboxypeptidase penicillin-binding protein (dacC)  STM0863 0 2 0 
635 N-acetyl glucosamine-1-phosphate uridyltransferase (glmU) STM3862 0 2 0 
636 sensory kinase in two-component regulatory system with (cpxA)  STM4058 3 0 0 
637 UDP-N-acetyl-muramate:alanine ligase (murC)  STM0129 2 0 0 
638 gamma-glutamate-cysteine ligase (gshA)  STM2818 2 0 0 
639 succinylglutamic semialdehyde dehydrogenase (astD)  STM1305 2 2 0 
640 cell division topological specificity factor, reverses MinC (minE) STM1816 0 2 2 
641 hydrogenase-2, large subunit (hybC)  STM3147 0 2 2 
642 RNase PH (rph)  STM3734 2 2 0 
643 small heat shock protein (ibpB)  STM3808 0 2 2 
644 putative GTP-ase, together with HflCK possibly involved (hflX)  STM4362 2 0 2 
645 UvrA with UvrBC is a DNA excision (uvrA)  STM4254 1 0 2 
646 putative glycosyl transferase (pmrF)  STM2298 0 2 1 
647 putative outer membrane lipoprotein (yceB)  STM1164 1 0 2 
648 putative cytoplasmic protein (yqiC)   STM3196 1 0 2 
649 SLP2_0021 undefined product 15468:16439 forward MW:35713 SLP2_0021 0 0 2 
650 putative SH3 domain protein (ygiM)  STM3203 0 2 0 
651 succinate dehydrogenase, cytochrome b556 (sdhC) STM0732 2 0 0 
652 Secretion system chaparone (sscA)  STM1399 0 1 0 
653 non-specific acid phosphatase/phosphotransferase, class B (aphA)  STM4249 0 0 1 
654 alpha-amylase (malS)  STM3664 0 0 1 
655 dihydropteridine reductase (nfnB)  STM0578 0 0 3 
656 putative dienelactone hydrolase family (dlhH)  STM3967 1 0 0 
657 anti sigma E (sigma 24) factor, negative (rseB)  STM2638 0 1 0 
658 phosphoenolpyruvate carboxylase (ppc)  STM4119 0 3 0 
659 UDP-sugar hydrolase 5-nucleotidase (ushA)  STM0494 0 0 2 
660 30S ribosomal subunit protein S14 (rpsN)  STM3427 0 1 0 
661 paral putative transformylase (yfbG)  STM2299 0 1 0 
662 putative Fe-S-cluster redox enzyme (yfgB)  STM2525 0 0 3 
663 putative transcriptional regulator (ybaD)  STM0415 0 0 2 
664 Gifsy-2 prophage probable regulatory protein  STM1012 0 0 2 
665 putative MutT-like protein (ymfB)  STM1235 0 2 0 
666 putative TPR-repeat-containing protein (yhjL)  STM3616 2 0 0 
667 putative carboxylase (ybgJ)  STM0712 0 0 2 
668 putative phosphatase (yfbT)  STM2334 0 0 2 
669 dUTPase (dcd)  STM2121 0 0 2 
670 putative periplasmic protein (yggN)  STM3107 0 0 2 
671 putative phosphoesterase (yfcE)  STM2347 0 2 0 
672 UDP-N-acetylglucosamine acetyltransferase (lpxA)  STM0228 0 2 0 
673 putative sugar nucleotide epimerase (yfcH)  STM2350 2 0 0 
674 dihydroxynaphtoic acid synthetase (menB)  STM2307 0 2 0 
675 cell invasion protein (sipD)  STM2883 0 2 0 
676 dTDP-glucose pyrophosphorylase (rfbA)  STM2095 0 1 0 
677 glycine tRNA synthetase, alpha subunit (glyQ)  STM3656 0 0 2 
678 SLP2_0044 undefined product 30311:31360 forward MW:39469 SLP2_0044 0 0 1 
679 putative purine nucleoside hydrolase (ybeK)  STM0661 1 0 0 
680 outer membrane phospholipase A (pldA)  STM3957 2 0 0 
681 putative hydrolase of the alpha/beta superfamily (yafA)  STM0318 0 0 2 
682 SLP1_0055 undefined product 48818:50023 reverse MW:44501 SLP1_0055 0 0 2 
683 ATP-binding subunit of serine protease (clpA)  STM0945 0 0 2 
684 DNA polymerase III, beta-subunit (dnaN)  STM3837 0 0 2 
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685 fermentative D-lactate dehydrogenase, NAD-dependent (ldhA)  STM1647 0 3 0 
686 putative outer membrane or exported  STM4242 3 0 0 
687 putative translation initiation inhibitor (yjgF)  STM4458 0 3 0 
688 SLP2_0065 undefined product 54440:55144 reverse MW:26137 SLP2_0065 0 1 0 
689 dehydroquinate synthase (aroB)  STM3486 0 0 2 
690 putative transcriptional regulator (yqgE)  STM3096 2 0 0 
691 putative cytoplasmic protein (yaeQ)  STM0239 0 0 2 
692 pyruvate dehydrogenase/oxidase (poxB)  STM0935 0 2 0 
693 RNase T, degrades tRNA, has exonuclease and (rnt)  STM1434 2 0 0 
694 putative hydrogenase-1 large subunit  STM1538 0 2 0 
695 N-methylation of lysine residues in flagellin (fliB)  STM1958 0 0 2 
696 flagellar biosynthesis basal-body MS-ring and (fliF)  STM1969 2 0 0 
697 putative hydrolase of the HAD superfamily (yedP)  STM1986 0 0 2 
698 putataive glutathione-S-transferase (yfcF)  STM2348 0 0 2 
699 ABC superfamily (bind_prot), thiosulfate transport protein (cysP)  STM2444 0 0 2 
700 sigma E (sigma 24 ) factor of (rpoE)  STM2640 0 0 2 
701 16S rRNA processing protein (rimM)  STM2675 2 0 0 
702 General PTS system, enzyme I, transcriptional regulator (ptsP)  STM3003 0 0 2 
703 putative D-mannonate oxidoreductase  STM3136 2 0 0 
704 putative periplasmic protein (yqjC)  STM3228 2 0 0 
705 putative DNA topoisomerase (yrdD)  STM3403 0 2 0 
706 putative oxidoreductase (yieF)  STM3850 0 0 2 
707 homocysteine-N5-methyltetrahydrofolate transmethylase (metH)  STM4188 0 0 2 
708 putative phosphoglyceromutase 2 (gpmB)  STM4585 0 0 2 
709 putative ABC superfamily (membrane) transport protein (ybhR)  STM0815 0 0 1 
710 putative envelope protein (envE)  STM1242 0 0 1 
711 host factor I for bacteriophage Q beta (hfq)  STM4361 1 0 0 
712 putative ABC transporter periplasmic binding protein  STM1255 0 1 0 
713 phosphatidylserine decarboxylase (psd)  STM4348 0 1 0 
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ABSTRACT 
Small non-coding RNAs (sRNAs) are usually expressed in the cell to face 
a variety of stresses. In this report we disclose the first target for SraL (also known 
as RyjA), a sRNA present in many bacteria, which is highly induced in stationary 
phase. We also demonstrate that this sRNA is directly transcribed by the major 
stress sigma factor σS (RpoS) in Salmonella enterica serovar Typhimurium. We 
show that SraL sRNA down-regulates the expression of the chaperone Trigger 
Factor (TF), encoded by the tig gene. TF is one of the three major chaperones 
which cooperate in the folding of the newly synthesized cytosolic proteins. 
Trigger factor is the only ribosome associated chaperone known in bacteria. By 
using bioinformatic tools and mutagenesis experiments, SraL was shown to 
interact with the 5’-UTR of the tig mRNA few nucleotides upstream of the Shine-
Dalgarno region. This work constitutes the first report of a small RNA affecting 
protein folding. Taking into account that both SraL and TF are very well 
conserved in enterobacteria this work will have important repercussions in the 
field.
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INTRODUCTION 
Small non-coding RNAs (sRNAs) perform a wide diversity of regulatory 
functions in both prokaryotic and eukaryotic cells. The majority of the sRNAs act 
by base pairing with mRNA targets (antisense sRNAs) or by binding to proteins 
to modify their activity (for a review see (Storz et al., 2011)). Most of the antisense 
sRNAs are trans-encoded since they are encoded in a separate locus in relation 
with the mRNA target. Consequently, these sRNAs exhibit only partial 
complementarity with the target and usually require the RNA chaperone Hfq for 
base pairing. Typically, trans-encoded sRNAs are induced under environmental 
stress conditions and also upon entry into stationary phase of growth in order to 
up- or down-regulate their target(s) (Gottesman and Storz, 2011).  
A plethora of sRNAs has been identified in the last years; for instance in 
Salmonella enterica serovar Typhimurium (S. Typhimurium) 140 sRNAs were 
reported in early stationary phase of growth by using a combination of RNA-seq 
and dRNA-seq analysis and Hfq-coIP-seq approach (Kröger et al., 2012).  
sRNAs are generally highly controlled at the transcriptional level. Nearly 
one-third of the functional characterized sRNAs contribute to the control of the 
outer membrane protein production. Part of these sRNAs is under the control of 
the sigma factor RpoE (also known as σE or σ24) (Johansen et al., 2008; Johansen et 
al., 2006; Papenfort et al., 2006; Udekwu and Wagner, 2007), which regulates gene 
expression upon the accumulation of misfolded outer membrane proteins (OMPs) 
in the periplasmic space (Mecsas et al., 1993; Missiakas et al., 1996; Raivio and 
Silhavy, 1999). However, only a few sRNAs have been reported to be transcribed 
by the sigma factor RpoS (also known as σS or σ38) (Fröhlich et al., 2012; Opdyke et 
al., 2004; Padalon-Brauch et al., 2008). This major stress sigma factor regulates 10% 
of the E. coli genes (Weber et al., 2005) and is induced under several stress 
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conditions namely the entry in stationary phase of growth (Battesti et al., 2011). 
RpoS is known to play important roles in the virulence of many bacterial 
pathogens, including S. Typhimurium (Dong and Schellhorn, 2010). 
SraL (also known as RyjA) is a 140-nucleotides antisense sRNA firstly 
described in 2001 in two genome-wide searches for new sRNAs (Argaman et al., 
2001; Wassarman et al., 2001). More recently, this sRNA was also detected in S. 
Typhimurium (Ortega et al., 2012; Viegas et al., 2007). SraL sRNA was only 
detected in cells upon entry into stationary phase (Argaman et al., 2001; Viegas et 
al., 2007; Wassarman et al., 2001), and its expression is particularly high in late 
stationary phase. Moreover, its expression was also highly detected under 
Salmonella-pathogenicity island-2 (SPI-2) inducing conditions (Viegas et al., 2007), 
which indicates a possible role for SraL in Salmonella virulence since SPI-2 genes 
are important for intra-macrophage survival and systemic disease. SraL is also 
expressed in intracellular S. Typhimurium persisting inside eukaryotic cells 
(Ortega et al., 2012). The study of the post-transcriptional regulation of SraL 
through the use of several Salmonella ribonucleases mutants showed that this 
sRNA is controlled by RNases such as PNPase and the degradosome complex 
(Viegas et al., 2007) (Figure 1A). Moreover, there was also an accumulation of a 
smear of slightly larger transcripts (most likely polyadenylated precursors) in 
both mutants (indicated as X in Figure 1A). Additionally, it was shown that PAP I 
has a major impact in the control of the stability of this sRNA and the bands 
corresponding to longer SraL molecules were absent, supporting that SraL is 
polyadenylated (Viegas et al., 2007) (Figure 1B). This fact was in agreement with 
previous 3’ RACE experiments that revealed the existence of 3’ A-tails of different 
lengths in the E. coli SraL transcript (Argaman et al., 2001). The absence of RNase 
III caused the accumulation of the larger band (indicated as X in Figure 1B). 
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FIGURE 1 – Analysis of the role of RNase E, PNPase, RNase III and PAP I in SraL 
regulation. (A) Comparison of rne-537 and PNPase mutations in SraL decay. (B) Analysis 
of the effect of RNase III and PAP I in the decay and processing of SraL transcript. 
Adapted from (Viegas et al., 2007). 
 
In this work, we have determined that RpoS (the major stationary phase 
regulator) is a transcriptional regulator of the highly conserved sRNA SraL in S. 
Typhimurium. SraL transcription is dependent on the presence of RpoS in the cell 
and we have proved that this regulation is direct since RpoS directly binds to the 
promoter of the sraL gene. We have also investigated the biological role of SraL 
since no targets were yet discovered for this sRNA. A proteomic analysis using a 
S. Typhimurium SraL null mutant and a SraL overexpressing strain detected 
Trigger Factor (TF) as a possible target. TF is one of the three major cytosolic 
chaperone proteins found in all eubacteria and assists in protein folding 
(Hesterkamp et al., 1996). This chaperone is the only ribosome associated 
chaperone known in bacteria (Hoffmann et al., 2010). By using mutational 
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analysis, we have determined that SraL represses tig mRNA through a short 
stretch of complementarity in the tig 5’-UTR near the Shine-Dalgarno region. The 
results obtained in this study constitute the first link between sRNAs and protein 
folding. 
 
EXPERIMENTAL PROCEDURES 
Oligonucleotides 
All oligonucleotides used in this study are listed in the Supplementary 
Table S1 in the “Supplementary Information” section, and were synthesized by 
STAB Vida and Sigma-Aldrich. 
Bacterial strains and plasmids 
All bacterial strains and plasmids used in this study are listed in the Table 
1 and Table 2, respectively. All Salmonella strains used are isogenic derivates of 
the wild-type Salmonella enterica serovar Typhimurium strain SL1344. The sraL 
(CMA-651) and tig (CMA-652) null mutants were constructed using the primer 
pairs pIS-001/pIS-002 and pIS-005/pIS-006, respectively, and following the -red 
recombinase method (Datsenko and Wanner, 2000) with few modifications, as 
previously described (Viegas et al., 2007). All chromosomal mutations were 
subsequently transferred to a fresh genetic background (SL1344 strain) by P22 
HT105/1 int-201 transduction (Schmieger, 1971). The chloramphenicol-resistance 
cassette of plasmid pKD3 replaces nucleotides -9 to +120 of the sraL gene and -16 
to +1303 of tig. The gene deletions were verified by colony PCR using the primer 
pair pIS-003/pIS-004 for sraL and pIS-007/pIS-008 for tig. The S. Typhimurium 
rpoS null mutant (CMA-653) was obtained by P22 transduction from SV4210 
strain (Tierrez and Garcia-del Portillo, 2004). 
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For construction of pISVA-01 plasmid expressing SraL, a PCR fragment 
containing the entire sraL sequence was amplified from SL1344 chromosome 
using the primer pair pIS-009/pIS-010. The resultant PCR fragment carrying a 5’-
phosphate at one end was cleaved with KpnI and ligated into the constitutive 
pZE12luc plasmid (blunt/KpnI site) (Lutz and Bujard, 1997). Plasmid expressing 
the mutated version of SraL (pISVA-02) was constructed using the same strategy 
but with the primer pair pIS-010/pIS-011. In these plasmids, the initiation site of 
the encoded RNA lies at position +1 of the constitutive PLlacO promoter of 
pZE12luc plasmid.  
For the rpoS complementation plasmid pISVA-03, a PCR fragment 
containing the entire rpoS sequence was amplified from SL1344 chromosome 
using the primer pair pIS-013/pIS-014 and was cloned into the XbaI and HindIII 
sites of the plasmid pWSK29 (Wang and Kushner, 1991).  
For the construction of plasmid pISVA-004 (PSraL::lacZ), a fragment of the 
5’-UTR region of SraL gene including promoter signals was amplified by PCR 
with primers pIS-014 and pIS-015 (containing the restriction sites for XbaI and 
BamHI, respectively). Both the insert and pSP417 vector were digested with XbaI 
and BamHI enzymes and ligated. 
Competent E. coli DH5α cells (New English Biolabs) were used for cloning 
procedures during plasmid construction.  
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TABLE 1 - List of strains used in this work 
 
 
 
TABLE 2 - List of plasmids used in this work 
Bacterial growth 
All strains were grown in LB broth at 37ºC and 220 r.p.m. throughout this 
study. SOC medium was used to recover transformants after heat shock (in the 
case of E. coli) or electroporation (in the case of Salmonella), before plating.  
Strain Relevant Markers / Genotype Source/Reference 
S. Typhimurium, 
SL1344 
StrR hisG rpsL xyl 
(Hoiseth and 
Stocker, 1981) 
CMA-651 SL1344 sraL (∆sraL::CmR) This study 
CMA-652 SL1344 tig (∆tig::CmR) This study 
CMA-653 SL1344 rpoS (∆rpoS::CmR) This study 
E. coli DH5α 
recA1 endA1 gyrA96 thi-hsdR17 New England 
Biolabs supE44 relA1 lacZYA-arg FU169 f80dLacZDM15 
Plasmid Comments Origin/Marker Source/Reference 
pKD3 
Template for mutants construction; 
carries chloramphenicol-resistance 
cassete 
oriR/AmpR 
(Datsenko and 
Wanner, 2000) 
pKD46 
Temperature-sensitive λ-red 
recombinase expression plasmid 
oriR101/AmpR 
(Datsenko and 
Wanner, 2000) 
pZE12Luc 
PLlacO promoter; constitutive expression 
plasmid 
ColE1/AmpR 
(Lutz and Bujard, 
1997) 
pWSK29 Constitutive expression plasmid pSC101/AmpR 
(Wang and 
Kushner, 1991) 
pSP417 lacZ transcriptional fusion vector pBR322/AmpR 
(Podkovyrov and 
Larson, 1995) 
pISVA-001 
pZE12luc derivative; PLlacO promoter; 
constitutive plasmid expressing SraL 
ColE1/AmpR This study 
pISVA-002 
pZE12luc derivative; PLlacO promoter 
constitutive plasmid expressing the 
mutated version of SraL sRNA (SraL*) 
ColE1/AmpR This study 
pISVA-003 
pWSK29 derivative; constitutive 
expression plasmid RpoS 
pSC101/AmpR This study 
pISVA-004 Transcriptional sraL-lacZ fusion pBR322/AmpR This study 
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Growth medium was supplemented with the following antibiotics when 
appropriate: ampicillin (150 µg/ml), chloramphenicol (25 µg/ml) and 
streptomycin (90 µg/ml). To apply osmotic shock, cells were grown at 37ºC to an 
OD600 of 0.3. NaCl was added to the culture at a final concentration of 0.5 M.  
RNA extraction, Northern blot and Reverse Transcription-PCR 
(RT-PCR) analysis 
Overnight cultures were diluted 1/100 in fresh medium and grown to the 
indicated cell densities at OD600 (growth medium and conditions are detailed in 
the respective figure legends). Culture samples were collected, mixed with 1 
volume of stop solution (10 mM Tris pH 7.2, 25 mM NaNO3, 5 mM MgCl2, 500 
µg/ml chloramphenicol), and harvested by centrifugation (10 min, 6000 g, 4ºC). 
RNA was isolated using the phenol/chlorophorm extraction method, precipitated 
in ethanol, resuspended in water and quantified on a Nanodrop 1000 machine 
(NanoDrop Technologies). 
For Northern blot analysis, 15 µg of total RNA was separated under 
denaturing conditions either by 8.3 M urea / 6% polyacrylamide gel in TBE buffer 
or by 1.3% agarose MOPS / formaldehyde gel. For polyacrylamide gels, transfer 
of RNA onto Hybond-N+ membranes (GE Healthcare) was performed by 
electroblotting (1 h 50 min, 24 V, 4ºC) in TAE buffer. For agarose gels, RNA was 
transferred to Hybond-N+ membranes by capillarity using 20x SSC as transfer 
buffer. In both cases, RNA was UV crosslinked to the membrane immediately 
after transfer. Membranes were then hybridized in PerfectHyb Buffer (Sigma) at 
68ºC for riboprobes and 43ºC in the case of oligoprobes. After hybridization, 
membranes were washed as previously described (Viegas et al., 2007). Signals 
were visualized by PhosphorImaging (Storm Gel and Blot Imaging System, 
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Amersham Bioscience) and analyzed using the ImageQuant software (Molecular 
Dynamics).  
RT-PCR reactions were performed using total RNA with the OneStep RT-
PCR kit (Quiagen). Reactions were mainly carried out according to the supplier’s 
instructions. Modifications were introduced regarding the amount of RNA and 
number of PCR cycles, depending on gene expression levels. The primer pair pIS-
016/pIS017 was used to analyse tig expression. As a control, 16S rRNA was 
amplified with specific primers pIS-018/pIS-019. Prior to RT-PCR, all RNA 
samples were treated with Turbo DNA free Kit (Ambion). Control experiments, 
run in the absence of reverse transcriptase, yielded no product. 
Hybridization probes 
Primers for templates amplification are listed in Table S1 in the 
“Supplementary Information” section. Labelling of the riboprobes and 
oligoprobes were performed as described (Viegas et al., 2007). The riboprobes 
were obtained using the primer pair pIS-021/pIS-022 for SraL riboprobe and pIS-
017/pIS-020 for tig riboprobe. 5S rRNA and 16S rRNA were detected by the 5’-
end-labelled oligonucleotides pIS-023 and pIS-024, respectively. 
Protein extraction and Western Blot analysis 
Bacteria were resuspended in the appropriate volume of Laemmli sample 
buffer (1.3% SDS, 10%, v/v, glycerol, 50 mM Tris/HCl, 1.8% β-mercaptoethanol, 
0.02% bromophenol blue, pH 6.8) to get ≈ 107 bacteria per μl. RpoS protein was 
detected using the mouse monoclonal anti-sigma S 1RS1 antibody (Santa Cruz 
Biotechnology) at 1:5,000 dilution in antibody dilution buffer (50 mM Tris-HCl pH 
7.5, 0.1% Tween-20, 3% BSA, 1mM sodium azide), and a goat anti-mouse 
horseradish peroxidase (HRP)-conjugated secondary antibody (Bio-Rad Life). For 
recognition of the chaperonin GroEL, an anti-GroEL rabbit polyclonal antibody 
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was used (dilution 1:10,000, Sigma) and a goat anti-mouse horseradish peroxidase 
(HRP)-conjugated secondary antibody (Bio-Rad Life). Membranes were developed 
with 1/10 diluted ECL prime reagent (GE healthcare) and visualized using the 
ChemiDoc XRS+ imaging system and the Quantity One software (Bio-Rad Life). 
β-galactosidase assays 
β-galactosidase activity was determined essentially as firstly described by 
Miller with minor modifications (Maloy, 1990). In brief, 100 μl of culture was 
added to 655 μl of cold buffer Z (100 mM Na2HPO4/NaH2PO4 pH 7, 10 mM KCl, 1 
mM MgSO4, 50 mM β-mercaptoethanol), and chloroform-SDS was used to 
permeabilize the cells. The reaction was started by the addition of the 
chromogenic substrate ortho-Nitrophenyl-β-galactoside (ONPG) to a final 
concentration of 0.8 mg/ml, conducted until it reaches a pale yellow colour at 
30ºC and stopped with Na2CO3. Prior to recording absorbance at 420 nm samples 
were cleared by centrifugation. Optical density of the bacterial culture was also 
recorded at the time of the extraction of the sample. β-galactosidase activity in 
Miller units was calculated as follows: (1,000 * A420) / (t * v * OD600), where t 
corresponds to the reaction time in minutes and v to the sample volume in ml. 
Chromatin immunoprecipitation (ChIP) assays 
10 ml of overnight grown wild–type SL1344 and isogenic rpoS mutant 
cultures were exposed to 150 μg/ml rifampicin for 30 minutes to trap RNA 
polymerase at gene promoters. Cells were subjected to chemical crosslinking in 
vivo by adding formaldehyde and phosphate buffer pH 7.6 to a final 
concentration of 1% and 10 mM, respectively. Non-crosslinked control samples of 
both strains were processed in parallel. Crosslinking was left to proceed for 30 
minutes at 37ºC with shacking and then quenched with 100 mM glycine for 30 
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min at 4ºC. Bacteria were recovered by centrifugation and washed twice with cold 
PBS. Bacterial pellets were resuspended in 1 mg/ml lysozyme in 0.2X IP buffer 
containing EDTA-free protease inhibitors cocktail (Roche) and maintained for 10 
minutes at 37ºC. One volume of 2X IP buffer (200 mM Tris-HCl pH 8.0, 600 mM 
NaCl, 4% Triton X-100) was added, and the samples sonicated in a B. Braun 
sonifier (Labsonic U model; duty cycle 0.7, output 0.49). DNA in cleared lysates 
was further digested with 0.1 U of micrococcal nuclease (New England Biolabs) and 
0.5 μg of RNase A in the presence of 5 mM CaCl2 and 0.1 mg/ml BSA for 10 
minutes at 37ºC. The digestion was stopped with 10 mM EDTA. DNA shearing 
was followed by agarose electrophoresis after reverse the crosslinking of an 
aliquot for 6 h at 65ºC.  
Prior to immunoprecipitation 1/10 volume of the total extract was taken 
to be used as input sample control. The extracts were then pre-cleared with 20 μl 
of a 50% slurry containing 1:1 mix of protein-A and protein-G sepharose (Sigma) 
in 1X IP buffer for 4 hours at 4ºC with rotation. Immunoprecipitation was carried 
out with 2 μl of monoclonal mouse anti-sigma S 1RS1 antibody (Santa Cruz 
Biotechnology) overnight at 4ºC. All samples (no-antibody or pre-clearing controls 
and immunoprecipitates) were washed once with LiCl wash buffer (250 mM LiCl, 
100 mM Tris-HCl pH 8, 2% TritonX-100), twice with 0.6 M NaCl buffer (100 mM 
Tris-HCl pH 8, 600 mM NaCl, 2% TritonX-100), twice with 1X IP buffer and once 
with TE buffer (10 mM Tris-HCl pH 8, 1 mM EDTA). To elute complexes from the 
protein-A and G sepharose, beads were resuspended in 30 l of ChIP elution 
buffer (50 mM Tris-HCl pH 8, 10 mM EDTA, 1% SDS) and incubated for 30 min at 
65ºC. The complexes were then incubated 6h at 65ºC to reverse crosslinking. Half 
of the sample was used to assess the efficiency of the immunoprecipitation by 
western blot. DNA was obtained from the other half of the sample by 
phenol/chloroform extraction, precipitated with isopropanol using 20 μg of 
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glycogen (Roche) as a carrier and the pellet dissolved in 12 μl of nuclease-free 
water.  
For real-time quantitative PCR analysis of target DNA enrichment a 1/50 
dilution sample of IP and no-antibody control were used as template. In the case 
of input and flowthrough samples we used a 1/200 dilution. Reactions were 
performed with the Power Sybr Green PCR master mix (Applied Biosystems) in a 
10 μl final volume, and run in an ABI Prism 7,500 instrument (Applied Biosystems) 
using standard reaction conditions recommended by the manufacturer (10 min at 
95°C; 45 cycles of 15 sec at 95°C and 1 min at 60°C; dissociation curve of 15 sec at 
95°C, 1 min at 60°C and a progressive temperature increase until 95°C). Each 
sample was run in triplicate. Oligonucleotides osmY-F, osmY-R, sraL-F, sraL-R, 
rnpB-F, rnpB-R, 16S-F and 16S-R were used to amplify the corresponding target 
DNA at 0.5 M final concentration and are included in the Supplementary Table 
S1 in the “Supplementary Information” section. For data analysis, the mean Ct 
value of technical replicates showing a standard deviation below 0.1 for target 
DNA was normalized to the mean Ct for rrs (16S) in the same sample (Cttarget-
Ctrrs). These values were referred to wild-type input sample and the anti-
logarithm calculated. 
Sequence retrieval and alignments 
BlastN was used for sequence retrieval 
(http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi) of the following genome 
sequences: Salmonella enterica serovar Typhimurium LT2 (NC_003197), Salmonella 
enterica serovar Typhi Ty2 (NC_004631), Salmonella bongori NCTC 12419 
(NC_015761), Shigella boydii CDC 3083-94 (NC_010658), Shigella flexneri 2a str. 301 
(NC_004337), Shigella dysenteriae Sd197 (NC_007606), Escherichia coli K12 
(NC_000913), Citrobacter rodentium ICC168 (NC_013716), Citrobacter koseri ATCC 
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BAA-895 (NC_009792), Enterobacter sp. 638 (NC_009436), Klebsiella pneumoniae 342 
(NC_011283). Alignments were made using ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
 
RESULTS 
SraL sRNA is directly regulated by RpoS (σS) 
Since SraL sRNA is conserved among Enterobacteriaceae and its 
expression is induced preferentially in stationary phase (see Chapter 3) we 
hypothesized that it could be part of the general stress response orchestrated by 
the sigma factor RpoS (σS) of the RNA polymerase that operates in this growth 
phase. To this aim, we first examined the sraL promoter in search of conserved 
sequence elements that show specific features of promoters of bona fide RpoS-
regulated genes. From the alignment of the immediately 75 nt upstream sequence 
of sraL in several enteric bacteria, we noticed some traits that are characteristic of 
an RpoS-regulated promoter (Figure 2A) (Typas et al., 2007). In this regard, we 
observed a conserved -10 box that fits well with the consensus sequence retrieved 
from experimentally determined RpoS-regulated genes including the A/T-rich 
motif downstream the -10 box (Figure 2A) (Typas et al., 2007; Weber et al., 2005). 
Moreover, the -35 box is also characteristic of an RpoS-regulated promoter. These 
observations suggested a plausible selectivity of RpoS for the sraL promoter.  
To test experimentally the putative RpoS-dependence on SraL expression, 
we compared SraL levels between the wild-type, an isogenic rpoS null mutant 
and a complemented rpoS mutant strain throughout stationary phase, the growth 
condition where SraL is highly expressed. Results presented in Figure 2B (upper 
panel) show that SraL sRNA is almost completely absent in the rpoS null mutant 
in this growth condition. In fact, reverse transcription and real-time quantitative 
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PCR revealed that in stationary phase SraL is about 500 times less abundant in the 
rpoS mutant than in the wild-type strain (data not shown). Consistently, SraL 
expression is partially restored in the rpoS mutant upon ectopic expression of a 
wild-type rpoS allele from a constitutive promoter (Figure 2B, upper panel). This 
might be due to the fact that ectopic RpoS is expressed at a much lower level in 
the complemented strain than the endogenous one in the wild-type (Figure 2B, 
lower panel). Even so, these low levels of RpoS protein suffice to restore SraL 
expression (Figure 2B). These results indicate that SraL expression in stationary 
phase is strictly dependent on RpoS activity.  
 
 
FIGURE 2 - Analysis of SraL sRNA regulation by RpoS. (A) Detail of the alignment of 
sraL gene of different Enterobacteriaceae (5’-UTR region). Consensus sequences of -10 and 
-35 boxes of RpoS, and RpoS-specific promoter sequence features located around the -10 
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core promoter element (A/T-rich discriminator) are indicated (Typas et al., 2007). Parts of 
the -35 and -10 elements that are often degenerate in RpoS-dependent promoters are 
shown in italics (the least conserved nucleotides in lower case letters) (Typas et al., 2007). Y: 
represents a C or a T. STM: Salmonella enterica serovar Typhimurium; STY: Salmonella 
enterica serovar Typhi; SBO: Salmonella bongori; SBD: Shigella boydii CDC 3083-94; SFL: 
Shigella flexneri 2a str. 301; SDR: Shigella dysenteriae Sd197; ECO: Escherichia coli K12; CRT: 
Citrobacter rodentium ICC168; CKO: Citrobacter koseri; ENT: Enterobacter sp. 638; KPN: 
Klebsiella pneumoniae 342. (B) SraL expression is dependent on RpoS. (Upper panel) SraL 
levels were detected by Northern blot using 15 g of total RNA isolated at indicated time 
points during growth from S. Typhimurium wild-type (wt) and rpoS mutant strains and 
rpoS mutant strain carrying a constitutive plasmid expressing the wild-type rpoS allele 
(pISVA-003); 5S rRNA was used as loading control. (Lower panel) RpoS protein 
expression was monitored by Western blot analysis. Samples correspond to 5 x 107 bacteria 
at the indicated time points. GroEL was used as a loading control. 
 
To further examine the SraL regulation by RpoS, we analyzed sraL 
promoter response in a transcriptional fusion to lacZ reporter gene in both wild-
type and rpoS mutant genomic backgrounds. RpoS is known to be induced during 
entry into stationary phase and/or many other stress conditions. Thus, we first 
analyzed the transcriptional activity of sraL promoter in stationary phase, and 
observed a significantly lower sraL promoter-driven β-galactosidase activity 
when RpoS is not available (Figure 3A). To rule out any possible bias derived 
from the growth phase in which these analysis were performed, we investigated 
the RpoS-dependence of sraL expression under a stress condition which triggers 
RpoS-mediated response as it is high osmolarity (Hengge-Aronis et al., 1993). 
Bacteria were grown to early exponential phase and then 0.5 M NaCl was added, 
maintaining the bacteria in these stress conditions for one hour. As a result of the 
increase in osmolarity, sraL transcriptional activity underwent an almost 3-fold 
induction in the wild-type strain while in the rpoS mutant strain the sraL 
promoter expression remained unchanged (Figure 3B). Consistently with our 
previous observations on the SraL expression pattern during bacterial growth, the 
transcriptional activity of sraL promoter is much higher in stationary phase 
(Figure 3A) than in exponential growth phase (Figure 3B). These data suggest that 
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the increase in SraL expression in stationary phase is the result of transcriptional 
regulation mediated by RpoS.  
 
FIGURE 3 - Transcriptional response of sraL promoter to RpoS. (A) Transcriptional 
activity of sraL promoter in late stationary phase. Samples from overnight grown cultures 
of wild-type SL1344 and the isogenic rpoS null mutant transformed with a plasmid 
expressing the transcriptional fusion of sraL promoter to lacZ reporter gene (pISVA-004) 
were used to assess β-galactosidase activity. (B) Transcriptional activity of sraL promoter 
upon osmotic shock. Bacterial cultures were grown to reach exponential growth phase (OD 
0.3), then NaCl was added to a final concentration of 0.5 M and let grow for one more 
hour. β-galactosidase activity was measured before (t0, white bar) and after the treatment 
(+ NaCl, black bar). A control culture with no addition of NaCl was also carried in parallel 
(Control, light grey bar). Bars correspond to the mean ± standard deviation of three 
biological replicates. ***, p<0.001 by Student’s t test; n.s., non-significant. 
 
Up to now, our analysis supports that SraL expression is regulated by 
RpoS, but it does not differentiate between a direct or indirect regulation. To 
address this question, we analyzed in vivo the existence of binding of RpoS to the 
sraL promoter by chromatin immunoprecipitation assays (ChIP) (Raffaelle et al., 
2005). In this approach, complexes are chemically crosslinked in vivo, and the 
crosslinked RpoS-DNA complexes are further enriched by immunoprecipitation. 
The extent of sraL promoter enrichment in the immunoprecipitates (IPs), which is 
indicative of the binding in vivo of the sigma factor to the promoter, is determined 
by real-time quantitative PCR. We first confirmed the suitability and the 
Chapter 4 
 
172 
specificity of the monoclonal antibody for the immunoprecipitation of RpoS. 
Immunoprecipitation of un-crosslinked wild-type and rpoS mutant bacterial 
samples revealed that the antibody has a high affinity and specificity for RpoS, 
since no immunoreactive bands were visualized in rpoS mutant IPs, while a 
strong signal around the expected molecular weight for RpoS was obtained with 
the wild-type strain (Figure 4A). Two additional bands with a lower mobility 
were also immunoprecipitated (see asterisks in Figure 4A). Nevertheless, as they 
are not detected in the rpoS mutant input or IP samples, we reasoned that these 
immunoreactive bands might correspond to RpoS aggregates rather than an 
unspecific contaminating protein. These results confirm that the antibody 
displays a high affinity for RpoS and that it can be used to precipitate specifically 
DNA-RpoS complexes in vivo in ChIP assays. To assess the specificity of the ChIP 
assay, we first used osmY promoter as a target DNA sequence (Figure 4B). OsmY 
is a periplasmic protein of unknown function previously shown to be regulated 
by RpoS and we have used here as a positive control (Hengge-Aronis et al., 1993; 
Yim et al., 1994). Consistently, we found a 10-fold enrichment of osmY sequence in 
RpoS IPs, which indicate a relative high occupancy of osmY promoter by RpoS 
(Figure 4B). Interestingly, sraL target sequence was more than a hundred times 
enriched in RpoS IPs as compared to the input, which strongly supports the 
binding of RpoS to sraL promoter in vivo (Figure 4B). The higher enrichment of 
sraL promoter in RpoS IPs compared to that of osmY suggests that the 
transcriptional activity of sraL promoter is larger at the stationary phase, which 
points out the relevance of the induction of this sRNA at this specific growth 
phase. No enrichment in rnpB sequence, used here as a negative control, was 
observed in RpoS IPs. Collectively, these results strongly support that the 
increased expression levels of SraL sRNA observed during stationary phase result 
from a transcriptional induction directly mediated by the master regulator of the 
general stress response RpoS.  
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FIGURE 4 - In vivo binding of RpoS to the sraL promoter at stationary phase. (A) Anti-
RpoS antibody immunoprecipitates the protein with high affinity and specificity. Western 
blot analysis using mouse monoclonal anti-RpoS antibody of protein samples coming from 
total extracts (Input) and immunoprecipitates either with the anti-RpoS antibody (IP) or 
with no antibody (AB-). Protein extracts were obtained from wild-type SL1344 and the 
isogenic rpoS mutant strain. The arrowhead indicates the specific band corresponding to 
RpoS. Asterisks indicate other immunoreactive bands. IgG HC and LC indicate the heavy 
and light chains of the immunoglobulin used in the immunoprecipitation, respectively. (B) 
RpoS binds to sraL promoter in vivo. Chromatin immunoprecipitation (ChIP) assay with 
anti-RpoS antibody using the wild-type SL1344 (wt) and the isogenic rpoS mutant (rpoS) 
strains. DNA extracted from the samples was employed as a template for real-time 
quantitative PCR determination of target sequences (osmY, sraL, rnpB). The amount of 
target DNA was normalized to 16S (rrs genes) within each sample, and the relative 
enrichment is referred to the input sample of wild-type strain. Note that the relative 
enrichment is represented in log10 scale. 
SraL sRNA down-regulates the expression of Trigger Factor mRNA 
Although there are a few studies about SraL sRNA, the biological 
function of this sRNA was not yet revealed. The proteome of S. Typhimurium 
wild-type, sraL null mutant and sraL overexpressing strain was analysed in order 
to identify SraL putative targets. This analysis was performed using cells in late 
stationary phase of growth, the condition in which this sRNA is more expressed 
(see Figure 3 in Chapter 3) (Viegas et al., 2007).  
As presented in Chapter 3, a total of 713 proteins were identified and 
quantified across the three strains analyzed (see Supplementary Table S2 in 
“Supplementary Information” section in Chapter 3). Among these, Trigger Factor 
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(TF, tig (gene number STM0447)) was one of the proteins most affected by the 
change of SraL levels in the cell. Besides these proteomic observations, tig mRNA 
was predicted to base pair with SraL sRNA by the IntaRNA algorithm 
(http://www.bioinf.uni-freiburg.de/Software/) (Busch et al., 2008). Trigger factor is 
found in all eubacteria and is the first chaperone encountered co-translationally 
by most of the nascent chains since it is localized in the exit of the ribosome 
tunnel (Stoller et al., 1995). This localization enables its binding to nascent 
polypeptides and prevents improper intra- and/or inter-molecular interactions of 
the chains emerging on the surface of the ribosome (Valent et al., 1995). TF was 
also shown to be a peptidyl-prolyl cis/trans isomerase (PPIase) and therefore 
accelerates proline-limited steps in protein folding with a very high efficiency 
(Hesterkamp et al., 1996; Stoller et al., 1995).  
Since TF protein level is affected by SraL sRNA in the cell (about 2-fold 
difference between the deletion mutant and the overexpressing strain, see Table 3 
in Chapter 3) we examined the tig mRNA level using the same strains. For that, 
total RNA was isolated from the wild-type cells and also from the mutant and 
overexpressing SraL strains in late stationary phase (OD2+6h). In agreement to 
the proteomic results, we could confirm by Northern blot and RT-PCR analysis 
that tig mRNA levels were in fact affected by the presence or absence of SraL 
sRNA (Figure 5, upper and middle panel). There was a 50% reduction of the tig 
mRNA levels when SraL is transcribed from an overexpressing plasmid. 
Moreover, when SraL is absent in the cell tig mRNA levels increase about 2-fold 
compared to the wild-type. Hereupon, SraL seems to negatively control either 
directly or indirectly the tig mRNA levels in the conditions tested. 
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FIGURE 5 - Regulation of tig mRNA by SraL sRNA. Total cellular RNA was extracted 
from the S. Typhimurium strains indicated grown in LB at 37ºC till 6 h after OD600 of 2. 
(Upper panel) 15 g of total RNA were separated on a 1.3% formaldehyde / agarose gel. 
The gel was then blotted to a Hybond-N+ membrane and hybridized with the 
corresponding tig riboprobe. Full-length transcripts were quantified using a Molecular 
Dynamics PhosphorImager. The amount of RNA in the wild-type was set as one. The ratio 
between the amounts of RNA of each strain and the wild-type is represented (relative 
levels). A representative membrane is shown and values indicated correspond to the 
average of several Northern blot experiments with RNAs from at least two independent 
extractions. The membrane was stripped and then probed for 16S rRNA as loading control. 
(ND) Non-detectable. (Middle panel) RT-PCR experiments were carried out with specific 
primers for tig using 75 ng of total RNA extracted from the wild-type and derivatives, as 
indicated in each lane. RT-PCR primers specific for 16S rRNA shows that there were not 
significant variations in the amount of RNA used in each sample. (Lower panel) 15 g of 
RNA were separated on a 6% PAA / 8.3 M urea gel. The gel was then blotted to a Hybond-
N+ membrane and hybridized with the corresponding SraL riboprobe. Probing for 5S 
rRNA confirmed equal loading. 
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SraL base pairs with Trigger Factor mRNA 
To further investigate the role of SraL sRNA in the regulation of tig 
mRNA we performed a bioinformatic prediction to identify the interaction region 
between the sRNA and its target by using IntaRNA (Busch et al., 2008) and 
RNAHybrid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/) (Rehmsmeier et 
al., 2004). Both algorithms were able to predict an imperfect SraL-tig interaction 
composed by two short segments (7 and 3 bp) (Figure 6A). Additionally, the 
predicted interaction between the sRNA and its target corresponds to a well 
conserved region in both RNAs (data not shown). To test whether pairing was 
direct and whether the predicted region was required, three base changes were 
introduced into a mutated version of SraL (SraL*) in the predicted base pairing 
region with the tig mRNA (Figure 6A). We ensured by bioinformatic predictions 
that these mutations do not modify the structure of the sRNA (compare the SraL 
and SraL* structures in Figure 6B). This mutation in the interaction site of the 
sRNA should obliterate the regulation of SraL over tig mRNA. In fact, the point 
mutations in the sRNA abolish the repression of tig mRNA (Figure 6C, upper 
panel). Furthermore, the Northern blot analysis presented in the Figure 6C (lower 
panel) shows that the point mutations do not compromise the expression of SraL 
sRNA. The results obtained provide additional evidence for the conclusion that 
SraL negatively regulates TF directly, by interacting with its mRNA.   
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FIGURE 6 - Analysis of the interaction between SraL sRNA and tig mRNA. (A) 
Predicted interaction region between SraL sRNA and tig mRNA. The Shine-Dalgarno 
region and the start codon of tig are indicated. Point mutations to generate SraL* allele are 
indicated. (B) S. Typhimurium SraL and SraL* sRNA structures predicted by Mfold 
program (Zuker, 2003). The mutations inserted in SraL* are highlighted. (C) Mutations of 
SraL in the interaction region with the target validate SraL-tig interaction. S. Typhimurium 
sraL mutant cells carrying plasmids for the constitutive overexpression of either SraL or 
SraL* were grown until 6 h after OD600 of 2. (Upper panel) The expression level of tig 
mRNA was determined by using a 1.3% formaldehyde / agarose gel. The amount of RNA 
in wild-type was set as one. The ratio between the RNA amount of each strain and the 
wild-type is represented (relative levels). A representative membrane is shown and values 
indicated correspond to the average of several Northern blot experiments with RNAs from 
at least two independent extractions. The membrane was stripped and then probed for 16S 
rRNA as loading control. (Lower panel) 15 g of RNA were separated on a 6% PAA / 8.3 
M urea to determine the expression level of both SraL and SraL*; probing of 5S rRNA was 
used as a loading control. 
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DISCUSSION 
Trans-encoded sRNAs are known to regulate several genes involved in 
stress responses. Computational and experimental methodologies have allowed 
the association of several of these sRNAs with important regulons of both E. coli 
and Salmonella. The RpoS regulon includes genes with functions in carbon 
metabolism, stress resistance, cell envelope integrity, morphology, stationary 
phase, and virulence (Battesti et al., 2011; Dong and Schellhorn, 2010). In this 
report we have included the SraL sRNA in the RpoS regulon since SraL was 
shown to be directly regulated by this sigma factor. An RpoS-recognized 
promoter is normally identified by a series of characteristic features (Typas et al., 
2007). The predicted SraL promoter region (Argaman et al., 2001) presents several 
of these features namely the -35 and -10 box and the extended -10 motif TAA. 
Moreover, these features are also present in the several enteric bacteria analyzed. 
Accordingly, it is possible to admit that besides its expression in several other 
enterobacterial species this sRNA is also directly transcribed by RpoS in these 
bacteria. There are only a few studies reporting the control of other sRNAs by 
RpoS (Opdyke et al., 2004; Padalon-Brauch et al., 2008). However, up to now there 
is only the case of SdsR sRNA (that controls the synthesis of the major Salmonella 
porin OmpD) which is controlled by RpoS and is conserved in a broad range of 
enteric bacteria (Fröhlich et al., 2012). Therefore, SraL constitutes the second 
example of a conserved sRNA that is controlled by RpoS. In previous work we 
had shown that SraL is post-transcriptionally controlled by ribonucleases 
(PNPase and the degradosome complex) and also by polyadenylation (Viegas et 
al., 2007). Therefore, after this report we can conclude that SraL is a tightly 
regulated sRNA both at transcriptional and post-transcriptional levels.   
After the discovery of MicF sRNA and subsequent unravelling of its 
function (Mizuno et al., 1984) more than one hundred sRNAs were identified. 
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However, the biological function of many of these sRNAs is still unknown. In this 
study we present for the first time a target for SraL sRNA. We show that SraL 
contributes to the regulation of the expression of the chaperone trigger factor in 
late stationary phase. SraL inhibits tig expression at the post-transcriptional level 
by an antisense mechanism that implicates the base pairing between a region in 
the 5’-end of SraL and a few nucleotides before the ribosome binding site of the 
tig mRNA. This interaction region between the sRNA and its target was 
confirmed by mutations in SraL sRNA that abolished the regulation. Unlike what 
it happens in many cases of riboregulation, the region of interaction between SraL 
sRNA and tig mRNA does not overlap the ribosome binding site and the tig 
mRNA start codon. However, interactions involving nucleotides in the mRNA 
leader in the vicinity of the ribosome binding site and/or the start codon have 
been also shown to inhibit translation (Babitzke and Gollnick, 2001; Chen et al., 
2004; Liu et al., 1997). Therefore, it is plausible to assume that it is also the case in 
this regulation.  
Trigger factor is one of the three major chaperones (along with DnaK and 
GroEL) which cooperate in the folding of the newly synthesized cytosolic 
proteins (Deuerling et al., 1999; Kandror et al., 1995; Lecker et al., 1989; Stoller et al., 
1995). Moreover, it was very recently reported that this chaperone can also unfold 
preformed structures and reverse premature misfolds, giving nascent chains a 
new opportunity for productive folding (Hoffmann et al., 2012). It possesses a 
peptidyl-prolyl cis/trans isomerase (PPIase) activity and accelerates proline-
limited steps in protein folding with a very high efficiency (Stoller et al., 1995). 
This reaction is often a rate-limiting step in the folding of certain polypeptides. 
Even though it is dispensable for growth, TF is a very important protein since it is 
the first chaperone encountered by the majority of nascent peptide chains due to 
its location in contact with the large subunit of the ribosomes (Stoller et al., 1995). 
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Therefore, this protein associates co-translationally with most of the nascent 
polypeptides. TF competes with DnaK in the chaperoning of newly synthesized 
peptides (Deuerling et al., 1999; Teter et al., 1999) what justifies why it is not an 
essential protein. The importance of TF for metabolism of bacteria is indicated by 
the discovery of a tig gene in Mycoplasma genitalium (Bang et al., 2000). This 
bacterium is believed to be free from genetic redundancy and thus contains only 
the minimal set of genes required for life. This chaperone appears to be the only 
PPIase of this organism (Bang et al., 2000). 
This study presents for the first time a regulatory role of SraL sRNA in S. 
Typhimurium. Despite some significant differences over the sequences of both 
SraL and tig genes in Enterobacteriaceae, the interaction region between the two 
RNAs corresponds to a very well conserved region. Thus, it is possible that this 
regulation of SraL sRNA over tig mRNA also occurs in many other enteric 
bacteria. The biological significance of the regulatory pathway involving SraL and 
TF is not totally clear. During stationary phase the overall rate of protein 
synthesis is reduced when compared to an exponentially growing culture 
(Albertson et al., 1990; Kuzj et al., 1998), concomitant with a decrease in ribosomes’ 
levels (Lambert et al., 1983). This happens because the cell avoids the production 
of unnecessary proteins when cells are not growing. Since TF is associated with 
the ribosomes and plays a key role in the folding of nascent peptides it is possible 
that it is less required in stationary phase. In fact, results from our lab have shown 
that tig mRNA levels are higher at exponential phase (data not shown). Since 
trigger factor is constitutively expressed in the cell, the RpoS induction of SraL 
sRNA under stationary phase seems to occur to avoid the superfluous production 
of this chaperone.  
Since both SraL and TF are very well conserved in enterobacteria this 
report will have a significant impact in the field. Moreover, this study constitutes 
the first report connecting small RNAs with protein folding. 
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SUPPLEMENTARY INFORMATION 
Supplementary Tables 
SUPPLEMENTARY TABLE S1 - List of oligonucleotides used in this work. The restriction 
and T7 sequences in the primers used for cloning procedures and for riboprobe synthesis, 
respectively, are shown in bold and underlined. 
Oligo Sequence 5' to 3' 
pIS-001 ATTTCGGCTAAAAAATCAGCATTTCGCTGGCGAACAGGGCGTCGTCGCTTAGTGTAGGCTGGAGCTGCTTC 
pIS-002 CATGCACTCGGCCATCGGGCTGAGCTCACCTAAAACTAAAGCGCCGCTAAGTGGTCCATATGAATATCCTCCTTAG 
pIS-003 GTTTTTCTCGAGATGCGCTGCGAAC 
pIS-004 GTTTTTTCTAGAAGATGATTAACATGCACTCG 
pIS-005 CGAAGCAAATAGCACGTGCTTGCGGAGTAGAGTTGACCGAGCACTGTGATGTGTAGGCTGGAGCTGCTTC 
pIS-006 CGTCACTGAAAGGTGACGGGTTTTTGTGCAAATTTCGTGCTTTTAACGCGGGTCCATATGAATATCCTCCTTAG 
pIS-007 GACGACAGGGAATGTGATTG 
pIS-008 GCTCTAACGCTAACACTG 
pIS-009 ATCAACACAAACCGGAACCTC  
pIS-010 GTTTTTGGTACCCACTCGGCCATCGGGCTG  
pIS-011 ATCAACACAAACCGGAACCTCCACTACCTGCTGGATATGAGGGGTGTTGACGTC 
pIS-012 GTTTTTTCTAGAGCCACCTTTTGAGTCAGAATACGC 
pIS-013 GTTTTTTAAGCTTGACAAGGGTACTTACTCGC 
pIS-014 GTTTTTCTAGAACGCCAGCTCTTCCAGCGCCCACA 
pIS-015 GTTTTGGATCCGTGTTGATACTGTAAGTGTAAGCG 
pIS-016 CAGCTCCAGAGCCTGTTTC 
pIS-017 GAAGAGTTCGAAGGCGGCAAAG 
pIS-018 AGGCGGTCTGTCAAGTCGGATG 
pIS-019 ACAGCCATGCAGCACCTGTCTC 
pIS-020 GTTTTTTTTTTAATACGACTCACTATAGGGTCAGTTCCGGCAGTTCGCGTTCTTC 
pIS-021 ATCAACACAAACCGGAAC 
pIS-022 GTTTTTTTTTTAATACGACTCACTATAGGGAGGTAAGGGCGCTTTAGTTTG 
pIS-023 CTACGGCGTTTCACTTCTGAGTTC 
pIS-024 ACGGCTACCTTGTTACGACTT 
osmY-F CATTCAGCAATGCAACCTCG 
osmY-R TTTGCTCGTAATTTGAGCTCAGG 
sraL-F AAAATCAGCATTTCGCTGGC 
sraL-R ATACTGTAAGTGTAAGCGACGACGC 
16S-F CCTGGGAACTGCATTCGAA 
16S-R TGGAATTCTACCCCCCTCTACA 
rnpB-F CCCCTATTTGGCCTTGCT 
rnpB-R GTGAAAGGGTGCGGTAAGAG 
 
 
 
 
 
 
 
 
 
Chapter 5 
 
  
 
GENERAL DISCUSSION AND FUTURE PERSPECTIVES 
 
 
Discussion and Future Perspectives 
 
189 
  
During the lifecycle of any organism, either prokaryotic or eukaryotic, the 
cells have to adjust protein synthesis in response to changes in the environment. 
The control of gene expression is crucial for adaptation, and it can occur at the 
transcriptional, post-transcriptional, translational and post-translational levels. 
This Dissertation is mainly focused on the post-transcriptional regulation of gene 
expression in Salmonella Typhimurium.  
Ribonucleases are the key enzymes responsible for the maturation, 
degradation and quality control of the RNAs (Arraiano et al., 2010). All organisms 
studied contain many RNases of many different classes, showing that these are 
very ancient and important processes. RNA degradation (one of the themes 
addressed in this Dissertation) is an essential function not only for the regulation 
of gene expression but also for the recycling of nucleotides.  
Until recently, tRNAs and rRNAs were considered the only non-coding 
RNA species. However, in the last decades it was discovered the existence of 
other type of RNAs called small non-coding RNAs. The majority of these sRNAs 
does not encode proteins and act as regulators of gene expression. However, 
there are cases of bifunctional sRNAs that act not only as riboregulators but also 
serve as mRNA templates for functional proteins (Vanderpool et al., 2011). There 
are several types of sRNAs in prokaryotic organisms that are divided in different 
classes depending on their mode of action. This Dissertation comprises work 
related with two sRNAs very well conserved in enteric bacteria, MicA and SraL.  
MicA is a trans-encoded sRNA transcribed by the sigma factor σE upon 
stress conditions that unbalance OMP levels (Figueroa-Bossi et al., 2006; Johansen 
et al., 2006; Papenfort et al., 2006; Udekwu and Wagner, 2007). There were two 
targets described for this sRNA in Salmonella, the outer membrane protein ompA 
and the maltoporin lamB. In a previous work, we have constructed several 
ribonuclease mutants in Salmonella since no RNase mutants were available in this 
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organism. We have analyzed the role of several RNases in the degradation of 
different sRNAs (Viegas et al., 2007). In order to follow our previous work, we 
have further evaluated the importance of the endoribonucleases E and III in the 
degradation of MicA sRNA. RNase E has been seen as the most important 
enzyme in the sRNA-mediated destabilization of target mRNAs (Fröhlich et al., 
2012; Kawamoto et al., 2006; Massé et al., 2003; Pfeiffer et al., 2009). However, 
reports on the important role of RNase III in this process are increasing (Kaberdin 
and Blasi, 2006; Lasa et al., 2012). By several in vitro and in vivo experiments, this 
ds-specific RNase was shown to be crucial for the degradation of MicA when it is 
coupled with its targets known in Salmonella. Moreover, even though MicA 
exhibits two stem-loop structures that could be substrates of RNase III, this 
endoribonuclease is not able to cleave free MicA. This mechanism constitutes the 
first example of a system controlled by an Hfq-dependent trans-encoded sRNA 
that involves the coupled degradation of the sRNA with its mRNA(s) target(s) by 
RNase III. Interestingly, Hfq was shown to be essential for the efficient RNase III 
cleavage of the duplex formed between MicA and its target(s) (Andrade et al., 
2012). This fact is explained by the reduced number of duplexes formed between 
the sRNA and its target(s) in the absence of Hfq. Our previous results had shown 
that an rne mutation impairing the degradosome formation strongly increased the 
stability of MicA (Viegas et al., 2007). Our in vitro results obtained using the 
purified RNase E from Salmonella, confirmed that in fact RNase E is directly 
involved in the degradation of free MicA. In summary, the first part of the work 
of this Dissertation allowed the proposition of a model for MicA decay, in which 
two different endoribonucleases exhibit different roles: RNase III is involved in 
MicA degradation when it is coupled with its target(s); and RNase E participates 
in the target-independent pathway.  
MicA has been extensively studied in the last years. Several targets were 
described for this sRNA in E. coli (Bossi and Figueroa-Bossi, 2007; Coornaert et al., 
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2010; Gogol et al., 2011; Udekwu, 2010; Udekwu et al., 2005). Indeed, this is the 
only sRNA known to control targets both in trans and in cis (Udekwu, 2010). 
MicA down-regulates targets with different functions in the cell including several 
outer membrane proteins and lipoproteins associated with the cell envelope, the 
PhoPQ TCS that regulates genes involved in several pathways, and an enzyme 
responsible for the synthesis of AI-2 a signalling molecule used in quorum 
sensing. Curiously, this sRNA was also associated with the correct biofilm 
formation in Salmonella Typhimurium. It was shown that balanced MicA levels 
are essential for mature Salmonella biofilm formation (Kint et al., 2010). The two 
MicA targets described in Salmonella, ompA and lamB mRNAs, were discovered in 
very specific conditions (Bossi and Figueroa-Bossi, 2007). Since MicA is 
significantly expressed in SPI-1 and SPI-2 inducing conditions it is probably 
involved in virulence. Actually, a recent report determined the role of MicA in 
Salmonella Typhimurium virulence. Surprisingly, the micA mutant strain was 
shown to be more virulent in mouse model than the wild-type strain (Homerova 
et al., 2011). The authors of this manuscript proposed that a possible reason for 
this result is the fact that σE is activated in the micA mutant and this sigma factor 
is essential for Salmonella infection. More work is obviously needed for a complete 
understanding of MicA function in Salmonella virulence. In fact, the major target 
of this sRNA, OmpA, was already described to be a virulence factor of several 
bacterial organisms, namely E. coli, Yersinia pestis and also S. Typhimurium 
(Bartra et al., 2012; Lee et al., 2010; Wu et al., 2009). Moreover, other described 
target of MicA, the mediator of the quorum sensing mechanism LuxS, was very 
recently shown to be important for the virulence of the avian pathogenic E. coli 
(Han et al., 2012). Taking into consideration the results obtained, a possible project 
for the near future will be the identification of MicA targets using SPI-1 and SPI-2 
inducing conditions in order understand the role of MicA in Salmonella virulence. 
Salmonella was shown to be able to invade non-phagocytic epithelial cells (Jepson 
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et al., 1995). Another important study will be to determine the effect of micA 
mutation on the invasion rate of this type of cells in vitro. Salmonella survival in 
the host is also dependent on the ability to survive and replicate inside 
macrophages. Thus, we also intend to study the role of MicA in macrophage 
survival. All these studies will help us to understand in more detail the role of 
MicA in Salmonella virulence.  
The numerous genome-wide searches performed in the last decades 
enabled the identification of a plethora of new sRNAs in several growth 
conditions. However, the biological role of numerous of these sRNAs is not yet 
revealed. SraL is one of these sRNAs that was detected in two global genetic 
studies in E. coli and which function was unknown. A major challenge in sRNA 
research concerns the identification of sRNA targets. Experimental approaches for 
this detection include standard genetic screens, gene knockouts and 
overexpression of the sRNA of interest, followed by proteomic and/or 
transcriptomic analyses. To complement the experimental procedures, several 
methods for highly sensitive bio-computational target prediction were developed. 
These algorithms either search for complementarity between sRNA and mRNA 
sequences or try to minimize the free energy of the hybridization between the two 
RNAs (Busch et al., 2008; Muckstein et al., 2006; Tjaden, 2008; Zhang et al., 2006). 
Most of the algorithms use additional data, such as the secondary structure of the 
sRNA and/or the target, or the nucleotide composition of the interacting regions. 
Even though these software programs consider several important parameters, 
they are not 100% accurate and originate many false positive and negative results. 
During the work developed in this Dissertation we have used several 
bioinformatic tools to try to predict SraL targets. However, we had to resort to a 
proteomic analysis to narrow the number of the putative targets. The conjugation 
of the data obtained using both bioinformatic and proteomic analyses 
strengthened our hypothesis. 
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Several SraL sRNA putative targets were identified in late stationary 
phase of growth. Some of the proteins most affected directly or indirectly by the 
different levels of SraL expression correspond to enzymes or subunits of enzymes 
that participate in crucial steps of carbohydrate metabolism. All organisms 
depend on carbohydrates, which provide cells with energy and the building 
blocks for biosynthesis of all macromolecules. Thus, it is predictable that all the 
pathways involved in metabolism of carbohydrates are tightly regulated. 
Moreover, organisms usually express the genes required for the utilization of a 
particular sugar substrate only if it is available in the environment. In fact, there 
are several sRNAs already implicated in the control of the sugar metabolism at 
different levels (Görke and Vogel, 2008).  
One of the putative targets that evoke our attention, not only by the 
difference in both protein and mRNA expression but also by its important cellular 
role, was the chaperone Trigger Factor (TF). Newly synthesized polypeptide 
chains of cytosolic proteins have the potential to start the folding process co-
translationally (Hartl and Hayer-Hartl, 2009). However, within the cellular 
environment they interact with a large number of molecular chaperones that 
guide the folding process. Two groups of chaperones assist the de novo folding: 
ribosome-associated chaperones that interact early with nascent chains and 
chaperones that do not associate with ribosomes and act later during translation 
or after polypeptide release (Kramer et al., 2009). TF is the only ribosome-
associated chaperone in bacteria and is found in all eubacteria analyzed. It 
accommodates the substrate in its interior, which provides a protective 
environment to prevent proteins from aggregating or degradation. In addition, 
TF can prevent premature and incorrect folding of proteins during synthesis 
(Preissler and Deuerling, 2012). During this Doctoral work, SraL was associated to 
this process. This sRNA represses tig expression at the post-transcriptional level 
possibly by competition with ribosome binding, as was shown to be the case for 
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several negatively acting sRNAs. This repression is probably accompanied by 
degradation of the mRNA. The physiological relevance of the degradation of 
target mRNAs should rely on making the gene silencing irreversible. In the near 
future, one of our aims will be to determine the RNases involved in the 
degradation of tig mRNA after the interaction with SraL sRNA. Moreover, the 
function of the Hfq protein in the tig regulation by SraL needs to be also 
addressed. In fact, this sRNA was previously shown to be destabilized in a strain 
lacking Hfq, indicating that this sRNA belongs to the group of Hfq-dependent 
sRNAs (Viegas et al., 2007). Moreover, it was also previously reported that tig 
levels changed in an Hfq mutant strain in early stationary phase of growth (Sittka 
et al., 2008). 
The interaction region between SraL and tig mRNA was bioinformatically 
predicted and confirmed by the insertion of mutations in the sRNA. This area is 
often called seed region. The optimal length and nucleotide composition of the 
bacterial seed have not been fully defined and may vary among sRNA/mRNA 
pairs. This region of the sRNAs is evolutionarily conserved, often constituting the 
most conserved region of the molecule. Curiously, the seed region of many 
sRNAs is located in their 5’-ends, suggesting that position may impact function. 
Indeed, this is the case of SraL that interacts with tig mRNA through 10 nts 
located in its 5’-end. It was also shown for other sRNAs that the seed region can 
carry the regulatory function of the sRNA by itself and that it can perform the 
same regulatory effect when fused to other sequences (Papenfort et al., 2010; 
Pfeiffer et al., 2009). This suggests that sRNAs have active regions responsible for 
base-pairing with their targets, which can perform their functions without the 
context of the rest of the molecule.  
During this Doctoral work we have revealed for the first time a biological 
function for SraL sRNA in Salmonella Typhimurium. However, taking into 
consideration the results obtained by proteomic analysis, there is a strong 
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indication of the existence of several other SraL targets in the cell. To further 
investigate this, we could use a pulse-expression approach, analysing the global 
changes of mRNA level after a transient overexpression of SraL from an inducible 
plasmid. The down- or up-regulations will suggest which mRNAs are directly 
regulated by the sRNA. SraL was shown to be highly expressed in SPI-2 inducing 
conditions and also in S. Typhimurium persisting inside eukaryotic cells (Ortega 
et al., 2012; Viegas et al., 2007). Therefore, one of the next steps will be the 
identification of functions that are targeted by SraL in Salmonella during the 
adaptation to an intracellular lifestyle inside the host eukaryotic cells. The 
transcriptomic analysis will be performed using samples obtained from both 
extracellular bacteria, grown under the SPI-2 inducing conditions, and 
intracellular bacteria.  
In a previous work we have identified several RNases responsible for the 
post-transcriptional control of SraL sRNA. In this Dissertation we identified the 
rpoS-encoded σS subunit of RNA polymerase as a transcriptional regulator of 
SraL. We showed that RpoS binds directly to the promoter of SraL and governs its 
transcription. The members of the RpoS regulon are a diverse set of genes which 
functions are related to stress management, central metabolism, rearrangements 
of cell morphology, and virulence (Hengge-Aronis, 2002). Curiously, this sigma 
factor is post-transcriptionally regulated by several sRNAs. These sRNAs are 
synthesized in response to different stresses under the control of different 
regulators, allowing the bacterium to control RpoS translation by integrating the 
response to numerous stress signals (Battesti et al., 2011). The fact that SraL sRNA 
has demonstrated to be highly regulated at both transcriptional and post-
transcriptional levels reveals that it constitutes an important riboregulator in 
specific stress conditions that trigger RpoS expression. Furthermore, the 
importance of SraL is probably not exclusive to Salmonella Typhimurium since it 
is a very well conserved sRNA in several enteric bacteria. During this 
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Dissertation, it was only studied the biological role of SraL in late stationary 
phase of growth. It will be also of interest to study and understand the expression 
of this sRNA in other stress conditions known to trigger the RpoS-mediated 
response, such as UV-radiation, acid, temperature or osmotic shock and oxidative 
stress.  
Along this Dissertation we have used Salmonella Typhimurium as a 
model organism. Salmonella is a Gram-negative and facultative intracellular 
pathogen that infects human and animals. Infections caused by Salmonella are a 
serious medical and veterinary problem worldwide, with an important incidence 
in the food industry since they are transmitted through the food chain (Mahan et 
al., 1996). Given the emergence and prevalence of bacterial strains that are 
resistant to available antibiotics there is an increasing need for alternative 
approaches to anti-microbial therapy. Interestingly, it was recently reported the 
use of artificial trans-encoded sRNAs for specific gene silencing in bacteria (Man 
et al., 2011). Thus, the study of the properties and functions of sRNAs in 
pathogenic bacteria can reveal important details that will contribute to the 
development of new strategies to combat infections by these bacteria.  
 RNases and sRNAs constitute important determinants in the regulation 
of gene expression. The study developed in this Dissertation revealed important 
information concerning the role of specific RNases and sRNAs in the post-
transcriptional control in the human pathogen Salmonella Typhimurium.  
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ABSTRACT
In pathogenic bacteria, a large number of sRNAs
coordinate adaptation to stress and expression of
virulence genes. To better understand the turnover
of regulatory sRNAs in the model pathogen,
Salmonella typhimurium, we have constructed
mutants for several ribonucleases (RNase E, RNase
G, RNase III, PNPase) and Poly(A) Polymerase I. The
expression profiles of four sRNAs conserved among
many enterobacteria, CsrB, CsrC, MicA and SraL,
were analysed and the processing and stability of
these sRNAs was studied in the constructed strains.
The degradosome was a common feature involved in
the turnover of these four sRNAs. PAPI-mediated
polyadenylation was the major factor governing SraL
degradation. RNase III was revealed to strongly
affect MicA decay. PNPase was shown to be
important in the decay of these four sRNAs. The
stability of CsrB and CsrC seemed to be independent
of the RNA chaperone, Hfq, whereas the decay of
SraL and MicA was Hfq-dependent. Taken together,
the results of this study provide initial insight into
the mechanisms of sRNA decay in Salmonella,
and indicate specific contributions of the RNA
decay machinery components to the turnover of
individual sRNAs.
INTRODUCTION
Regulatory mechanisms involving small untranslated
RNAs (sRNAs) have received considerable attention
over the past decade. Eukaryotic and prokaryotic cells
contain a wealth of these regulators with determinant
roles in the post-transcriptional control of gene expres-
sion. To date, a variety of experimental and computa-
tional approaches have identified close to hundred sRNA
genes in Escherichia coli K12 (1–3), many of which are
conserved in diverse enteric bacteria, including pathogenic
Salmonella species (4).
The mechanisms by which sRNAs modulate gene
expression are diverse, and two general modes of action
have been established, dividing regulatory RNAs into two
classes (5). The sRNAs belonging to the first class act by
interaction with a protein to modify its activity. The other
class consists of sRNAs that act by base pairing with one
or more target mRNAs. Most of these antisense RNAs
act with partial complementarity over trans-encoded
target mRNAs to modify their translation and/or
stability. Such trans-sRNAs typically require the bacterial
RNA chaperone, Hfq, both for target interaction and
for intracellular stability. It is generally assumed that
Hfq binds both the regulator and the target RNA,
favouring their interaction. Hfq enhances the stability of
many sRNAs in vivo, by protecting them from degrada-
tion (6–10).
To understand the action of regulatory sRNAs, it is
also fundamental to study the processing and turnover of
these molecules. Previous work in Escherichia coli and
other bacteria established that the sRNAs differ greatly in
stability, what is probably related with their biological
function; some are very stable with long half-lives whilst
others are turned over within few minutes (6,11). Since
ribonucleases (RNases) are key modulators of RNA
decay, the identification of the RNases that contribute
to the decay of individual sRNAs is essential for a more
general understanding of sRNA turnover in vivo.
In E. coli, the main endoribonucleases are RNase E,
RNase G and RNase III (12,13). RNase E is a single-
stranded-specific endoribonuclease with a main role in
E. colimRNA decay, being also involved in the processing
of ribosomal and transfer RNAs. RNase E is also one of
the main enzymes forming the degradosome,
a multiprotein complex involved in the decay of many
RNAs (14,15). RNase G (also known as CafA protein),
was shown to be a homologue of the N-terminal catalytic
domain of RNase E (16,17). This endoribonuclease is
involved in the 50 end-processing of 16S rRNA and also in
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mRNA degradation in E. coli. Both RNase E and RNase
G cleave single-stranded regions of structured RNAs, and
share a preference for 50 monophosphate termini and
AU-rich sequences of RNA (18). RNase III is specific for
double-stranded RNA and plays multiple roles in the
processing of rRNA and mRNA (19). This enzyme
can also affect the decay of some messages (20,21).
Exoribonucleases are enzymes that degrade RNA from
its extremity (13,22–25). PNPase, one of the main
exoribonucleases, is widespread both in the eubacteria
and eukaryotes and associates with RNase E in the
degradosome (15). Poly(A) polymerase I (PAP I) can
also modulate RNA stability by adding poly(A) tails to
the 30 end of RNAs (26–29). The Poly(A) tail provides a
‘toehold’ for the efficient exonucleolytic degradation of the
RNA (especially if this RNA is structured). PAP I can be a
main factor involved in mRNA decay and affects other
processes such as transcription and proteolysis (30,31).
In this work we report the construction, in the pathogen
Salmonella typhimurium, of mutant strains for RNase E,
G, III, PNPase and PAP I. We have investigated the
effects of these mutants on the accumulation and turnover
of four regulatory sRNAs of Salmonella (CsrB, CsrC,
MicA and SraL). CsrB and CsrC are an example of
regulatory RNAs that interact with a protein. Together
with the RNA-binding protein CsrA, they form the Csr
(Carbon Storage Regulator) complex, one of the key
regulatory circuits of virulence in Salmonella (32,33). CsrB
and CsrC sRNAs have similar structures with multiple
stem-loops that sequester several CsrA proteins impairing
their interaction with the targets (34). MicA sRNA is
expressed in numerous enterobacteria (35), and has been
shown to repress the trans-encoded ompA and lamB porin
mRNAs in E. coli and Salmonella (7,35,36). Outer
membrane protein A (OmpA) was the first and most
studied MicA target. ompA mRNA levels decrease upon
entry into stationary phase (7,35,37), concomitantly with
MicA accumulation. MicA binds to ompA mRNA
translation initiation region (TIR) interfering with ribo-
some binding (35), which most likely renders the mRNA
more accessible to endonucleolytic cleavage. SraL sRNA
was previously described in E. coli (38,39), and sraL genes
have been predicted in several enteric bacteria (4).
However, SraL function and target(s) have yet to be
elucidated.
The results obtained in this work give relevant
information about the expression of these four sRNAs
in Salmonella and identify some of the main enzymes that
are involved in their turnover, bringing initial insight into
the underlying mechanisms of sRNA decay in this
bacterial model organism.
MATERIALS AND METHODS
Bacterial strains and plasmids
All Salmonella strains used in this study are isogenic
derivatives of the wild-type Salmonella enterica serovar
Typhimurium strain SL1344. Strains and Plasmids used in
this study are listed in Table 1. The RNase mutants were
constructed following the lambda-red recombinase
method (40), with few modifications. The strain carrying
plasmid pKD46 was grown in SOC with ampicillin and
0.2% L-arabinose at 288C to an OD600 of 0.5 and then
made electrocompetent by successive washings in ice-cold
water and concentrating 400-fold in ice-cold 10% glycerol.
To construct the deletion strains, the cat chloramphenicol-
resistance gene was amplified from plasmid pKD3 with
oligonucleotides carrying 50 bp-homology extensions to
the respective target genes. For the construction of RNase
III mutant (JVS-938 strain) the Kan-resistance cassette
was amplified from pKD4 plasmid. Fifty microlitres of
competent cells were mixed with the purified PCR product
Table 1. List of strains and plasmids used in this work
Strain Relevant Markers/Genotype Source/Reference
S. typhimurium, SL1344 StrRhisG rpsL xyl (87), provided by Dirk
Bumann, MPI-IB Berlin
CMA-537 SL1344 rne-537 (rne::CmR) This study
CMA-539 SL1344 pnp-539 (pnp::CmR) This study
CMA-542 SL1344 pcnB-542 (pcnB::CmR) This study
CMA-550 SL1344 rng-550 (rng::CmR) This study
CMA-555 SL1344 ompA-555 (ompA::CmR) This study
JVS-938 SL1344 rnc-938 (rnc::KanR) This study
JVS-00255 SL1344 hfq::CmR (42)
JVS-00067 SL1344 csrB::KanR This studya
JVS-00084 SL1344 csrC::KanR This studya
E. coli DH5a recA1 endA1 gyrA96 thi-hsdR17
supE44 relA1 lacZYA-argFU169 f80dLacZDM15
New England Biolabs
Plasmid Comment Origin/Marker Reference
pSVA-5 IPTG inducible plasmid expressing PNPase pSE420/AmpR This study
pKD3 Template for mutants construction; carries chloramphenicol-resistance cassette oriRg/AmpR (40)
pKD4 Template for mutants construction; carries kanamycin-resistance cassette oriRg/AmpR (40)
pKD46 Red Helper Plasmid AmpR (40)
aJ.Vogel lab (Papenfort et al., manuscript in preparation)
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(100 ng) in a chilled cuvette (0.2 cm electrode gap)
and electroporated (18 kV cm1). Subsequently, 1ml of
pre-warmed SOC medium was added, and cells were
recovered after incubation for 1 h at 378C before selection
on LB agar plates with the appropriate antibiotics.
All mutations were moved to a fresh SL1344 background
by P22 HT105/1 int-201 transduction (41).
The mutant strains were constructed as shown in
Figure S1 of Supplementary Data. All gene deletions
were verified by PCR. C-terminal truncation of RNase
E in CMA-537 was verified by PCR and western blot
using an E. coli RNase E antiserum that cross-reacts
with Salmonella homologue (kindly provided by
A. J. Carpousis).
For construction of pSVA-5 plasmid (Table 1) expres-
sing PNPase, a PCR fragment containing the entire pnp
sequence was amplified from SL1344 chromosome and
was cloned into the XbaI and EcoRI sites of the IPTG
inducible plasmid pSE420 (Invitrogen). Competent E. coli
DH5a cells (New England Biolabs) were used for cloning
procedures during plasmid construction.
Bacterial growth
All strains were grown in Luria–Bertani (LB) broth at
378C and 220 r.p.m. throughout this study, unless stated
otherwise. SOC medium was used to recover cells after
transformation. Electroporation and heat-shock proce-
dures were used for transformation of Salmonella and
E. coli, respectively. M9 was used for experiments with
minimal medium. Conditions indicated as ‘SPI-1 and SPI-
2 inducing conditions’ corresponded to growth in high salt
medium (0.3M NaCl) with low oxygen in sealed Falcon
tubes, as described for SPI-1 induction (42), and in PCN
medium (1mM phosphate, pH 5.8) as described for SPI-2
induction (43).
Growth medium was supplemented with the following
antibiotics where appropriate: ampicillin (100mg/ml),
kanamycin (50 mg/ml), chloramphenicol (25 mg/ml) and
streptomycin (90 mg/ml).
RNA extraction and northern blot analysis
Overnight cultures were diluted 1/100 in fresh medium and
grown to the indicated cell densities at OD600 (growth
medium and conditions are detailed in the
respective figure legends). Culture samples were collected,
mixed with 0.2 volume of stop solution (5% water-
saturated phenol, 95% ethanol), and frozen in liquid
nitrogen. After thawing on ice, bacteria were pelleted by
centrifugation (2min, 16 000 r.c.f., 48C), and RNA was
isolated using the Trizol method (Invitrogen) following
the manufacture’s instructions. For stability experiments,
rifampicin (500mg ml1) and nalidixic acid (20mg ml1)
were added to cells grown in LB at 378C, 220 r.p.m., till
OD2 and/or 6 h after. Incubation was continued and
culture aliquots were withdrawn at the times indicated in
the respective figures. RNA was extracted, visualized on
agarose gel and then quantified on a Nanodrop machine
(NanoDrop Technologies).
For northern blot analysis, RNA samples were dena-
tured for 10min at 808C in RNA loading buffer (95% [v/v]
formamide, 0.1% [w/v] xylene cyanol, 0.1% [w/v] bromo-
phenol blue, 10mM EDTA), separated on 8.3M urea/6%
polyacrylamide gels, and transferred to Hybond-XL
membranes (GE Healthcare) by electroblotting
(1 h, 50V, 48C) in a tank blotter (Peqlab, Germany).
Following pre-hybridization of the membranes in Rapid-
hyb Buffer (GE Healthcare), membranes were hybridized
at 708C with riboprobes, or at 428C in the case of
oligoprobes. After hybridization, membranes were rinsed
at room temperature in a 2 SSC/0.1% SDS solution,
followed by washing in three subsequent 15min steps in
SSC (2, 1 or 0.5, respectively)/0.1% SDS solutions at
the hybridization temperature. Membranes hybridized
with the oligoprobes were rinsed in 5 SSC/0.1% SDS
solution followed by three wash steps at 428C in SSC
(5, 1 and 0.5, respectively)/0.1% SDS solutions.
Signals were visualized on a Phosphorimager (FLA-3000
Series, Fuji), and band intensities quantified with AIDA
software (Raytest, Germany).
Primer extension analysis
Total RNA was extracted as described above. Primers
CsrC-II and CsrC-IV are complementary to CsrC in
positions þ37 to þ57 and þ151 to þ170, respectively, (þ1
corresponds to RNA start site). Primer CsrB-III is
complementary CsrB in positions þ302 to þ321 relative
to CsrB start site. Primers were end-labelled using T4
polynucleotide kinase and [-32P]ATP (Fermentas).
Unincorporated [32P]-g-ATP was removed using a
MicroSpinTM G-25 Column (GE Healthcare). A total
of 2 pmol of primer was annealed to 10 mg of RNA and
cDNA was synthesized using 200U of Superscript III RT
from Invitrogen. The same labelled primer was used to
generate a corresponding DNA sequencing ladder using
the Cycle Reader DNA Sequencing Kit (Fermentas). The
PCR fragment used as template for the sequencing
reaction was amplified from SL1344 strain with primers
CsrC-IV and CsrC-seq for CsrC and CsrB-III and CsrB-
seq for CsrB. The primer extension products were
separated in parallel with the sequencing ladder on a 6%
polyacrylamide sequencing gel containing 7M urea. The
gel was dried and exposed. Signals were visualized in a
PhosphorImager (Storm Gel and Blot Imaging system,
Amersham Bioscience).
Hybridization probes
Primers for template amplification are listed in Table S1
(Supplementary Data). Standard polymerase chain
reactions were carried out on genomic DNA.
Riboprobes were generated from PCR fragments (a T7
RNA polymerase promoter sequence was added by the
antisense primer) in the presence of an excess of [32P]-a-
UTP over unlabelled UTP using the Ambion T7
polymerase Maxiscript kit. DNA oligonucleotides were
labelled with [32P]-g-ATP using T4 polynucleotide kinase
(Fermentas). All labelled probes were purified over G50
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columns (GE Healthcare) to remove unincorporated
nucleotides prior to hybridization.
RESULTS
Construction and characterization of SalmonellaRNase
mutant strains
All RNase mutants (listed in Table 1) were constructed
in the virulent Salmonella typhimurium strain, SL1344. The
sequences of the genomic regions of interest, taken from the
unfinished genome of SL1344 (http://www.sanger.ac.uk/
Projects/Salmonella), were compared with that of the
sequenced Salmonella strain LT2 (44) and found to be
identical.
Our strategy was to create Salmonella mutants similar
to those that have been characterized in E. coli (45–47).
The RNase gene sequences of both bacteria were
compared in terms of amino acids and nucleotide
sequences in order to create equivalent gene deletions.
Deletion/substitution mutants were constructed through
the replacement of part of the coding sequence by a
resistance marker (for details see Materials and Methods
section and Figure S1 in the Supplementary Data). For
RNase E, encoded by an essential gene (rne), we have
constructed a mutant, which is deleted for the C-terminal
scaffold of the enzyme (rne-537 mutation). This is the
region responsible for the protein–protein interactions in
the formation of the ribonucleolytical complex called
degradosome (48). A similar mutant exists in E. coli
(rne-131 mutation). This mutant was reported to stabilize
mRNAs, leaving rRNA processing unaffected (49). The
mutant is defective in both the interaction with the
chaperon Hfq, and the assembly of a functional degrado-
some (9,50).
Loss of RNase III function in the RNase III insertion
mutant was confirmed by a specific defect in rRNA
processing. That is, the absence of a functional RNase III
impairs rRNA processing in both E. coli and Salmonella
(51,52). In Salmonella typhimurium, RNase III promotes
the excision of intervening sequences (IVSs) causing the
fragmentation of 23S rRNA (52), which we observed to be
abrogated in the RNase III mutant strain constructed
here (data not shown).
We have compared the growth properties of the wild-
type SL1344 with RNase and PAP I mutant strains grown
in Luria broth at 378C (Figure 1). For the majority of the
mutants, the lag period necessary for recovery from
stationary phase was comparable to the wild-type strain.
Loss of RNase III resulted in the slowest growth rate
(Figure 1); the generation time of the RNase III mutant
doubled in comparison to the wild-type strain. We note
that this growth defect was even more severe on plates
since this strain took 24–36 h to form colonies of the size
formed by the wild-type strain overnight. The RNase E
and PNPase mutations also affected growth rate, causing
a slower growth. Namely, rne-537 mutant had a longer
generation time (41min) than the wild type (30min).
Regarding the RNase G deficient strain, albeit the gene-
ration time was not significantly different, the strain
reached a considerably higher cell density in stationary
phase.
Analysis of sRNA expression under different
growth conditions
Many of the sRNAs previously characterized in E. coli
K12 are induced under specific stress conditions, e.g. upon
oxidative stress (53), DNA damage (54), cold shock (55),
iron stress (56) and osmotic stress (57). However, the
steady-state levels of many of such sRNAs are also
increased in stationary phase (11,38,58). Therefore, we
first analysed the expression of the four sRNAs selected
here in wild-type cells at different phases of growth in LB
and minimal media, in order to determine conditions in
which we could study their processing and decay. We also
included two growth conditions known to induce the two
major Salmonella virulence regions, i.e. the Salmonella
Pathogenicity Islands (SPI) 1 and 2. The virulence genes
encoded by SPI-1 facilitate the entry of Salmonella into
non-phagocytic cells. SPI-1 genes are specifically expressed
in early stationary phase cultures of Salmonella grown in
standard LB medium (59), and are also highly induced by
oxygen tension and elevated osmolarity (60). The genes of
SPI-2 encode virulence factors for intra-macrophage
survival and systemic disease; these genes are upregulated,
in vitro, in minimal media with low phosphate and
magnesium concentrations (43).
The CsrB (363 nt) and CsrC (244 nt) RNAs highly
accumulated upon entry into stationary phase (in LB) and
under SPI-1 inducing conditions (Figure 2). This pattern
was in agreement with previous observations that the Csr
system represses a variety of stationary-phase genes, and
that the loss of both CsrB and CsrC significantly reduces
SPI-1 gene expression and epithelial cell invasion (33).
The blots shown in Figure 2 also indicate that these two
sRNAs are not expressed under SPI-2 inducing
Figure 1. Comparison of growth profiles of wild-type, RNase III, E, G,
PNPase and PAP I mutant strains. Strains were grown in LB medium
at 378C. The values of generation time are the result of at least three
independent growth curves.
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conditions, i.e. when the genes necessary for proliferation
of Salmonella in macrophages are transcribed.
The 74 nt sRNA MicA became detectable at early
stationary phase of growth in LB medium, and strongly
accumulated when growth further slowed down
(Figure 2), as shown previously (61,62). Interestingly,
MicA levels under SPI-1 and SPI-2 inducing conditions
were comparable to those in stationary phase.
SraL (140 nt) was not detectable before the cells reached
stationary phase (Figure 2), which is fully in line with the
late stationary phase-specific expression of SraL in E. coli
(38,58). For all the four sRNAs studied, the expression
was low at twenty-four hours of growth (24 h) as
compared to the OD2þ 6 h condition. Interestingly,
there was no substantial accumulation of these sRNAs
in minimal medium (M9), even though growth in minimal
medium constitutes a stress for the cell. Note that few
E. coli sRNAs have a high expression under this condition
(11,38,58).
In summary, all four sRNAs were significantly
expressed at OD2þ 6 h, which we have chosen as the
‘consensus’ condition to subsequently study their decay in
rifampicin-treatment experiments.
Degradosome is a major factor in sRNA turnover
in Salmonella
RNase E is the enzyme that serves as the scaffold for the
other protein components in the degradosome assembly.
The absence of degradosome assembly (C-terminal
truncation in rne-537 mutant) caused a large stabilization
of all four sRNAs studied in this work. Notably, for CsrB,
CsrC and MicA the absence of a full-length RNase E had
the strongest stabilization effect in comparison to the
other RNase mutants investigated here. Figure 3 shows
that CsrB was highly stabilized (412-fold) in this mutant
since it decayed with a half-life of 29min as compared to
2min in the wild type. The other CsrA-antagonist, CsrC
sRNA, was stabilized 4-fold. The CsrB and CsrC sRNA
decay was not strictly logarithmic; it was biphasic. The
fact that both sRNAs are highly structured, i.e. CsrB and
CsrC contain 16 and 8 stem-loops respectively, may help
explain this behaviour (32,33). Their decay is very fast at
the first minutes but at the second phase it is very slow,
which may be due to the occurrence of highly stable
intermediates during the decay. Since it was difficult to
determine an exact half-life we have chosen to compare
the stability of the sRNAs over the stage where the decay
is still logarithmic. Thus, in wild-type Salmonella, the half-
lives of CsrB and CsrC are 2min and 5min,
respectively (Figure 3).
Figure 3. RNase E mutation strongly affects sRNA stability. Northern
blot analysis of the stability of CsrB, CsrC, MicA and SraL transcripts
in wild- type and rne-537 mutant. RNA was extracted from bacteria
grown in LB medium at 378C, till 6 h after OD600 2. At this time, a
mixture of rifampicin and nalidixic acid was added to growing cells and
samples were removed at the times indicated. Total RNA was extracted
and 20 mg of RNA (each lane) was separated on a 6%PAA/8.3M
urea gel. The gel was then blotted to a Hybond-Nþ membrane and
hybridized with the corresponding sRNA riboprobe. Details of RNA
extraction and ‘northern blot’ procedure are described in Materials and
Methods section. The three first panels (CsrB, CsrC, MicA) correspond
to the same membrane that was hybridized with each of the sRNA
probes indicated. SraL was hybridized with another membrane. In each
case, the membrane was stripped and then probed for 5S RNA as
loading control. The band corresponding to the full-length transcript
was quantified and plotted versus time of extraction (in minutes) to
calculate the half-life of the sRNA. A representative membrane is
shown and the half-life values indicated correspond to the average of
several ‘northern blot’ experiments with RNAs from at least two
independent extractions.
Figure 2. Analysis of sRNA expression under different growth
conditions. Northern blot analysis of sRNA expression in Salmonella
SL1344 grown under different conditions as indicated in figure labels.
Cells were grown in LB at 378C till OD600 of 0.4 (OD0.4), 2 (OD2),
6 h after (OD2þ 6 h) and for twenty-four hours (24 h). Cells were also
grown under conditions of induction of pathogenicity islands 1 and 2
(SPI-1, SPI-2) and in minimal medium till an OD600 of 2 (M9). A total
of 2.5 mg of RNA were run on a 6% PAA/8.3M urea gel, blotted and
probed as described in Material and Methods section.
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The impairment of degradosome formation also
impacted on MicA decay, with a 5-fold stabilization of
the transcript. Similarly, SraL transcripts were also
significantly stabilized in this mutant, i.e. 4-fold
(Figure 3).
Due to the substantial effects of rne-537 mutant on the
decay of these sRNAs, we also investigated the effects of
two additional major endoribonucleases, RNase III and
G. Neither mutant substantially affected CsrB or CsrC
stability (Figure 4). However, whereas CsrC transcript
possesses two bands in the wild type, in the RNase III
mutant the larger band (240 nt) is the most prominent,
which probably means that the ribonuclease has a role in
the processing of this sRNA. Regarding MicA, RNase G
does not seem to be involved in this sRNA decay under
the growth condition assayed here. However, the loss of
RNase III activity rendered this sRNA exceptionally
stable (Figure 5A).
PNPase absence affects sRNA turnover in different ways
PNPase is the other ribonuclease component of the
degradosome. We have also investigated the effects of
the loss of this enzyme. Absence of PNPase had a large
effect on MicA stability, causing a 3.3-fold increase in
MicA half-life (Figure 5B). However, this stabilization
effect was slightly less than the one obtained in the absence
of degradosome assembly (5-fold). SraL sRNA was
stabilized to a similar degree in the absence of PNPase and
in the rne-537 mutant (3- and 4-fold, respectively;
Figure 9A). Moreover, both mutants resulted in a similar
SraL RNA pattern (see below). In contrast, absence of
PNPase resulted in a CsrB RNA pattern entirely different
from the wild-type strain. Specifically, several decay
intermediates became observable, which were not detected
in the wild-type strain. Since the growth rate can affect the
expression and processing of sRNAs, we tested whether
this alteration was maintained in another growth condi-
tion. In standard media (LB), CsrB is most highly
expressed in early stationary phase (OD600 of 2,
Figure 2). The same CsrB degradation pattern in pnp
mutant was obtained at both growth conditions
(Figure 6A). Regarding CsrC sRNA, the pattern of the
bands was also changed in the PNPase strain
(Figure 6B). Complementation of PNPase, by providing
pnp in trans from a plasmid, restored both CsrB and CsrC
degradation pattern to the wild-type characteristics
(Figure 6).
In order to analyse the origin of this different decay
pattern for CsrB and CsrC in some of the mutant strains
analysed, we have mapped the 50 end of the corresponding
breakdown products in these strains. For CsrC, we have
Figure 4. Endoribonuclease III and G do not significantly affect CsrB and CsrC turnover rates. Analysis of (A) CsrB and (B) CsrC decay in the
absence of RNase III and RNase G. The experimental procedure was similar to the one described in Figure 3. The same membrane was, in each case,
probed for 5S RNA as loading control. A representative membrane is shown and the half-life values correspond to the average of several ‘northern
blot’ experiments with RNAs from at least two independent extractions.
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used two distinct primers along the sRNA, one located
close to the terminator and the other binding at the middle
of the sRNA (primers II and IV, respectively, in
Figure 7A). In all the strains analysed, primer extension
analysis of CsrC yielded a unique extension product that
corresponded to the 50 end of full-length CsrC RNA
(Figure 7C). Interestingly, the intensity of the primer
extension signal obtained with primer IV varies among the
strains analysed. In strain RNase III, the intensity of the
larger fragment is much higher than in wild type and
PNPase. This is in full agreement to what is seen in the
northern blot (Figure 7B, full-length probe). This must be
due to the fact that the shorter fragment has a different
30 end at which primer IV (near the end of the sRNA)
cannot anneal. Therefore, the extension product in this
reaction corresponds only to the larger fragment as
opposed to what is observed with primer II, which detects
both the large and the short fragment (Figure 7C).
Therefore, we have done northern blot analysis of the
two sRNAs using different probes along the two genes, to
confirm these predictions. In the case of CsrC, the hybrid-
ization of the sRNA with a riboprobe encompassing the
entire gene gives two major products in the wild type
(Figure 7B, full-length probe). The shorter fragment is
dependent of RNase III and accumulates in PNPase
strain. When using the primer IV, located near the
terminator of the sRNA (Figure 7A), the larger band
was the only fragment detectable. This seems to result
from the fact that the shorter band has a different 30 end
and does not anneal with primer IV. With primers I, II
and III this shorter band is detected. The results from
northern blot analysis confirmed primer extension results
and showed that the intermediary fragments have the
same 50 ends but different 30 ends.
The CsrB primer located near the terminator (primer III
in Figure 8A) also gave a unique band in the primer
extension (Figure 8C). The 50 end mapped to the þ1 site of
CsrB in Salmonella. The northern blot analysis using
different probes along the CsrB RNA sequence has also
revealed that the intermediary bands that accumulate in
PNPase strain have different 30 ends. When using primer
III near the terminator, we were only able to see the band
corresponding to full-length CsrB. With primer II, anneal-
ing between nts 210 and 240 we were able to detect the full-
length band and the band corresponding to 240 nt
(Figure 8B). Primer I, annealing approximately between
the 160 and 180 nt, gave the same band pattern as with a
probe directed against the entire CsrB RNA (Figure 8B).
Polyadenylation as a determinant factor in SraL decay
Our analysis of SraL decay in several RNase mutants
and the PAP I mutant revealed several differences with
respect to the wild type. First, SraL is highly stabilized
Figure 5. Analysis of MicA turnover. (A) Comparison of the effects of endoribonucleases G and III and PAP I in MicA stability. (B) RNase E and
PNPase mutations highly affect the stability of MicA sRNA. The experimental procedure was similar to the one described in Figure 3. The same
membrane was, in each case, probed for 5S RNA as loading control. A representative membrane is shown and the half-life values correspond to the
average of several ‘northern blot’ experiments with RNAs from at least two independent extractions.
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in PAP I mutant (45-fold; Figure 9B). This large
stabilization indicates that polyadenylation is required
for the decay of this sRNA. Interestingly, 30 RACE
experiments performed in E. coli revealed the existence of
30 A-tails of different lengths in the SraL transcript (38).
The decay of SraL was also slower in the rne-537 and
PNPase mutants, with a higher stabilization in the rne-
537 (Figure 9A). The wild-type strain and both mutants
showed an accumulation of a smear of slightly larger
transcripts. This size heterogeneity was absent in pcnB
mutant (Figure 9B). Previous northern blot analysis of
SraL in E. coli also showed this effect in a PAP I mutant
(38). This data suggests that the presence of poly(A) tails
of different lengths in SraL transcript causes these discrete
differences in size. The upper band (band X in Figure 9A)
shown to accumulate in PNPase and degradosome
mutants was reduced in the wild-type strain. In PAP I
mutant, the primary SraL transcript corresponded to the
smaller band (Y), which is a defined sharp band
(Figure 9B). We predict that this is due to the absence
of transcript polyadenylation in the PAP I mutant. One
striking difference in the RNase III- mutant is that the
transcript appeared as a single defined band. The size of
this band corresponds to the larger band, X. The levels of
SraL were higher in this mutant. In spite of this, the
absence of the endoribonuclease (Figure 9B) did not
significantly change RNA stability. Alterations in tran-
scription levels should account for those differences in
steady-state levels that cannot be explained by stability,
since the amount of RNA in a cell is determined by the
balance of its transcription and degradation.
Analysis of theHfq influenceon thedecayof those smallRNAs
In order to determine the influence of Hfq on the stability
of these four sRNAs in Salmonella, we have analysed its
decay in an hfq mutant strain. As shown in Figure S2
(Supplementary Data), the absence of Hfq did not seem to
significantly affect the decay of CsrB and CsrC. In turn,
Hfq mutation strongly destabilized MicA sRNA (6-fold
decrease in half-life). Similarly, loss of Hfq function
decreased the half-life of SraL 3-fold.
DISCUSSION
Small RNA function has been studied in E. coli K12, and
comparatively little is known about these regulators in
Figure 6. Analysis of PNPase effect on CsrB and CsrC decay. Northern blot analysis of (A) CsrB and (B) CsrC transcripts decay in wild-type,
PNPase mutant and a strain where the mutation was complemented with a plasmid overexpressing PNPase. Strains were grown until 6 h after OD2.
The value of CsrC half-life in PNPase mutant was not determined (nd) since the degradation of the transcript is immediately stabilized after the first
five minutes of decay. In the first phase of the curve, the transcript decay rate is not significantly different from the wild type. Procedures in both
cases were essentially as described in Figure 3. In each case, the membrane was stripped and then probed for 5S RNA as loading control.
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other enterobacterial species. The analysis of sRNA levels
in different growth conditions has revealed that the four
sRNAs are highly expressed in late stationary-phase.
Moreover, we have obtained valuable information about
particular conditions of expression of these sRNAs in
Salmonella, probably related to its function and targets in
this bacterium. Namely, growth in SPI-1 and SPI-2
inducing media induced the expression of CsrB, CsrC,
MicA and SraL. The induction of these sRNAs under
those conditions may indicate a relation with virulence
functions. It is worthwhile mentioning that considerable
differences in the expression of sRNAs have been reported
in E. coli and Salmonella, probably related to their specific
role in each bacterium (63,64).
The Salmonella CsrB and CsrC sRNAs share strong
sequence homology with their respective E. coli counter-
parts, and have been shown to act as CsrA antagonists. In
E. coli, CsrA is foremost known as a global regulator of
carbon metabolism (65,66). In E. coli, CsrA is a global
regulator of carbon metabolism. In Salmonella, it has been
shown to regulate specialized virulence determinants not
found in E. coli (32,67). The CsrB and CsrC expression
patterns reported here are in good agreement with the
proposed function of these sRNAs as antagonists of CsrA.
This protein negatively controls the SPI-1 encoded
virulence genes that allow Salmonella to invade non-
phagocytic cells. CsrB and CsrC are upregulated in SPI-1
media as well as in early stationary phase (OD600 of 2), the
other condition known to induce the invasion genes. They
may therefore act to alleviate the CsrA repression of
invasion genes and ensure an optimal epithelial invasion
by Salmonella (63). In contrast, both sRNAs are repressed
in SPI-2 media, a condition that negatively regulates
invasion genes and induces the SPI-2 virulence factors
needed for intra-macrophage survival and systemic
disease.
SraL sRNA was originally identified in E. coli, and in
this report we show that it is also expressed in Salmonella.
Figure 7. Mapping of CsrC degradation intermediates. (A) CsrC sRNA structure representing the approximated location of the different probes used
for northern blot and primer extension. Here, I to IV indicate primers CsrC-I to CsrC-IV, respectively. CsrC secondary structure was generated using
RNADraw 1.01 based on Ref. (33). (B) Northern blot analysis of CsrC RNA in wt, PNPase and RNase III mutants, with the different probes
represented in A. The analysis was done at late stationary-phase OD2þ 6 h. (1) wild-type SL1344, (2) RNase III and (3) PNPase. (C) Primer
extension analysis using the radiolabelled primers CsrC-II and CsrC-IV, that were annealed to total RNA from SL1344 (wt) and isogenic PNPase
and RNase III mutants. The reaction product of this analysis was unique and similar for the two primers used. The asterisk () marks the
30-terminus of the extension product that is coincident with the sequence published by Ref. (33). (1) Wild-type SL1344, (2) RNase III, (3) PNPase
and (4) CsrC.
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The factors that drive sraL transcription are unknown yet.
We have observed that SraL levels are highly accumulated
in stationary phase and SPI-2 inducing conditions. The
accumulation under SPI-2 induction indicates a possible
role for this sRNA in Salmonella virulence, in particular,
after internalization of Salmonella into host cells.
Interestingly, the levels of the stationary phase-specific
MicA sRNA were also high in SPI-2 induction conditions.
Up-regulation of the sE regulon, which facilitates the
envelope stress response, was previously reported upon
macrophage infection (68), the condition that SPI-2
medium is meant to mimic. It is well established that
micA expression is strictly dependent on the alternative
sigma factor, sE (61,62,69,70). The raise of MicA levels in
SPI-2 medium may be a consequence of the induction of
sE under this condition.
Our analysis of sRNA processing and decay showed
that the degradosome is required for the decay of the
sRNAs studied here. That is, an rne mutation impairing
degradosome formation strongly increased the half-life of
the four sRNAs. Nevertheless, we observed that other
factors contribute differently to sRNA decay. We propose
that RNase E and PNPase cooperate in the decay of these
two sRNAs via the degradosome. In this model, CsrB and
CsrC decay is most probably initiated by RNase E, since
the mutation in the C-terminal scaffold of the enzyme
caused a strong stabilization of the transcripts. Moreover,
the other endoribonucleases analysed (G and III) had no
significant effect on CsrB and CsrC decay. Both sRNAs
are highly structured molecules; in Salmonella CsrB has 16
predicted stem-loops (32) and CsrC has 8 (33). Some of
these stem-loops carry the AGGA motif, similar to an
RBS, the putative recognition site for CsrA on its target
messages. Several characterized sRNAs have in its
sequence a rho-independent terminator (71). Both CsrB
and CsrC have a 30-terminal stem-loop characteristic of
rho-independent terminators. During CsrB and CsrC
decay several endonucleolytical cleavages must occur,
Figure 8. Mapping of CsrB degradation intermediates. (A) CsrB sRNA structure representing the approximated location of the different probes used
for northern blot and primer extension. A to C indicate primers CsrB-I to CsrB-III, respectively. CsrC secondary structure was generated using
RNADraw 1.01 based on Ref. (32). (B) Northern blot analysis of CsrB RNA in wt, PNPase and rne-537 mutants, with the different probes
represented in A. The analysis was done at late stationary-phase OD2þ 6 h. (1) wild-type SL1344, (2) rne-537 and (3) PNPase. (C) Primer extension
analysis using the radiolabelled primer CsrBIII that was annealed to total RNA from SL1344 (wt) and isogenic PNPase and rne-537 mutants. The
reaction product of this analysis was unique and similar for the two primers used. The asterisk () marks the 30-terminus of the extension product
that is coincident with the sequence published by Ref. (32). (1) Wild-type SL1344, (2) rne-537, (3) PNPase and (4) CsrB.
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followed by exonucleolytical cleavage by PNPase. PNPase
was shown to be a key factor in the decay of the CsrB and
CsrC sRNAs in Salmonella, similar to a recent observa-
tion in E. coli (72). The absence of this exoribonuclease
caused a considerable change of the CsrB and CsrC
degradation patterns with the concomitant accumulation
of several decay intermediates. Primer extension and
northern blot analysis of CsrB and CsrC sRNAs showed
that the accumulating intermediates have different 30 ends.
RNA degradation pathways typically require endo-
ribonucleolytic cleavages followed by the action of
non-specific 30–50 processive exoribonucleases. Exoribo-
nucleases can have different specificities over substrates
and in some cases there is the accumulation of stable
intermediates in the absence of a single exoribonuclease
(23,73,74). Purified PNPase is unable to digest through
extensive secondary structures (75). However, in vivo
association of PNPase with an RNA helicase can
contribute to PNPase degradation through highly struc-
tured RNAs. Moreover, it has been proposed that PAP I
facilitates the degradation of highly folded intermediates
by providing a 30 toehold for the progression of the
enzyme (76). However, we have seen that the loss of PAP I
activity did not affect the stability of either of these two
sRNAs (Figure S3 in Supplementary Data) indicating that
in this case, polyadenylation of these transcripts is not
necessary for exonucleolytic activity. We have mentioned
earlier that RNase III did not have an effect on CsrB and
CsrC stability. However, in the case of CsrC, the pro-
cessing of the sRNA is RNase III dependent. In the
wild-type strain, two bands are visible for this sRNA.
The second band is RNase III dependent and accumulates
in PNPase mutant. The 50 end analysis of CsrC in both
strains revealed similar 50 ends. Therefore RNase III must
initially process CsrC at one of the 30 longer stems,
generating this second band. It is not known at what level
this fragment is necessary for sRNA activity.
We have also analysed if CsrB and CsrC stability
depends on Hfq. Analysis of their decay in an hfq mutant
revealed that Hfq is not needed for the stability of these
two sRNAs. This is in agreement with E. coli data for
these two sRNAs (39,58,72). Since CsrB and CsrC belong
to the class of protein regulator sRNAs, a dependence on
Hfq was not expected.
We have also studied in detail the decay of SraL in our
mutant strains and have found that in the absence of
PNPase activity and degradosome assembly, there was a
slower decay of the sRNA with a concomitant accumula-
tion of a smear of slightly larger transcripts (most likely
polyadenylated precursors). In the PAP Imutant, SraL is
remarkably stabilized and the bands corresponding to
longer SraL molecules were absent, supporting that SraL
is polyadenylated. The absence of RNase III caused the
accumulation of a larger band of defined length. Several
internal cleavage sites were previously mapped in E. coli
SraL (38). RNase III could be the enzyme responsible for
Figure 9. The role of RNase E, PNPase, RNase III and PAPI in SraL regulation. (A) Comparison of rne-537 and PNPase mutations in SraL decay.
(B) Analysis of the effect of RNase III and PAP I in the decay and processing of SraL transcript.
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the initial cut in SraL, possibly within the SraL
terminator, which overlaps the terminator of soxR
encoded on the opposite strand. After RNase III cleavage,
RNase E and PNPase may act cooperatively in the
transcript decay with the help of PAP I polymerase. It is
known that poly(A) tails are the preferred substrate for
PNPase and accelerate the decay process. A similar
mechanism of decay was previously reported for the
degradation of the plasmid-encoded RNAI (28,77) and
for RNAs that regulate replication and partition of R1
plasmids (78,79).
According to our data, Hfq stabilizes SraL 3-fold.
Wassarman and co-workers (58) were not able to confirm
Hfq binding to SraL in their Hfq co-immunoprecipitation
analysis in E. coli. Whilst SraL mechanism and targets
have yet to be revealed, our results indicate that SraL
belongs to the group of Hfq-dependent sRNAs.
MicA turnover was seen to be significantly dependent
on degradosome and PNPase. ompA mRNA is the main
MicA target. The rate-limiting step in the decay of this
message was assigned to endoribonuclease E (80). PNPase
was also shown to be one of the exoribonucleases affecting
ompA mRNA in stationary-phase (37). This suggests that
the same enzymes are responsible for the regulation of the
sRNA and the respective target. However, other targets
are being discovered for this sRNA. A very recent report
shows that MicA downregulates expression of lamB gene
in Salmonella, also in a Hfq-dependent way (36).
Additionally, MicA may also interact with the 50 UTR
of luxS to which it is transcribed in opposite direction
(81). Interestingly, we have seen that in the absence of
RNase III MicA is extremely stable. RNase III can
recognize and cleave perfect RNA duplexes formed by
interacting RNAs. The regulation of MicA by RNase III
may involve the interaction with its target RNA, since
MicA forms an extended RNA duplex that is close to the
length ideal for RNase III substrates. This could implicate
the coupling of sRNA-target regulation, as previously
reported for RyhB sRNA (6). However, the unaltered
stability of MicA in the absence of ompA (Figure S4 in
Supplementary Data) shows that MicA degradation is
independent of ompA. Regarding Hfq influence on the
turnover of the four sRNAs analysed, MicA showed the
strongest dependence on Hfq for stability. It is known that
the MicA-dependent decay of ompA-mRNA depends on
Hfq. In vitro studies revealed that Hfq facilitates binding
of the regulatory RNA to the translational initiation
region of this target (35). Our results indicate that Hfq is
also involved in protecting MicA from degradation in
Salmonella.
Few reports have shown an involvement of endoribo-
nuclease III in bacterial sRNA decay. However, it is
known that enzymes of the RNase III family are key
players in the mechanisms of regulation of noncoding
RNAs in eukaryotes (82). These enzymes, specific for
double-stranded RNAs, are essential in the biogenesis of
the eukaryotic noncoding RNAs that participate in the
process of RNA Interference (miRNAs, siRNAs). A role
for this enzyme was also expected in bacterial sRNA
regulation. In fact, it was reported that RNase III is
responsible for the cleavage of tisAB mRNA upon IstR-1
sRNA binding, in E. coli (54,83). In addition, it was
proposed (84) that RyhB sRNA decay in vivo is dependent
on this endoribonuclease upon base pairing of the sRNA
to the 50-UTR of its mRNA target. Similarly, RNase III
also contributes to the negative control of spa (encoding
the surface protein A) and other virulence factor-encoding
mRNAs by the regulatory RNAIII in the Gram-positive
pathogen, Staphylococcus aureus (85,86). Our results in
Salmonella show that the effect of RNase III varied among
the sRNAs studied.
The Salmonella mutants deficient in enzymes that affect
sRNA and mRNA turnover will be very important for
post-transcriptional studies in this bacterial model patho-
gen. The work presented here has identified some of the
enzymes directly involved in the decay of sRNAs. We
conclude that sRNA decay cannot be easily generalized.
The role of each of the enzymes cooperating in sRNA
turnover depends on the specific sRNA and its respective
decay mechanism.
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ABSTRACT
MicA is a trans-encoded small non-coding RNA,
which downregulates porin-expression in stationary-
phase. In this work, we focus on the role of endoribo-
nucleases III and E on Salmonella typhimurium
sRNA MicA regulation. RNase III is shown to
regulate MicA in a target-coupled way, while RNase
E is responsible for the control of free MicA levels
in the cell. We purified both Salmonella enzymes
and demonstrated that in vitro RNase III is only
active over MicA when in complex with its targets
(whether ompA or lamB mRNAs). In vivo, MicA is
demonstrated to be cleaved by RNase III in a
coupled way with ompA mRNA. On the other hand,
RNase E is able to cleave unpaired MicA and does
not show a marked dependence on its 50 phosphoryl-
ation state. The main conclusion of this work is the
existence of two independent pathways for MicA
turnover. Each pathway involves a distinct endoribo-
nuclease, having a different role in the context of the
fine-tuned regulation of porin levels. Cleavage of MicA
by RNase III in a target-dependent fashion, with the
concomitant decay of the mRNA target, strongly re-
sembles the eukaryotic RNAi system, where RNase
III-like enzymes play a pivotal role.
INTRODUCTION
Small non-coding RNAs (sRNAs) play very important
roles in post-transcriptional control of gene expression.
MicF was the first trans-encoded antisense sRNA
described and was discovered a little more than a
quarter-century ago as a regulator of the Escherichia coli
ompF mRNA (1). Following the advent of systematic
genome wide sRNA searches, the total number of
known sRNAs in E. coli and the model pathogen
Salmonella enterica serovar Typhimurium has grown to
well over a hundred (2).
An extensive network of trans-antisense sRNAs have been
shown to downregulate the expression of several outer
membrane proteins (OMPs). While in some cases the same
sRNA regulates multiple omp mRNAs (3,4), in other cases
the same omp mRNA is target of multiple sRNAs (4–6).
OMPs are embedded within the outer membrane, which
together with the peptidoglycan layer and the inner
membrane form the bacterial cell envelope, the first barrier
of defense against external aggressions. Coordination in the
expression of omp genes seems critical for proper envelope
assembly, and accounts for the existence of so many sRNAs
to regulate OMP mRNAs.
To survive in a changing environment, bacteria must
constantly adjust the nature and abundance of surface
components. Any condition that unbalances OMP levels
activates the response of the transcription factor sE (7,8)
that triggers transcription of a set of genes, which collect-
ively help the bacterium to recover from the stress condi-
tion. MicA and RybB are two of the sE activated genes in
stationary phase, whose role is to immediately limit OMP
synthesis (4,6,9). Both sRNAs act in the same fashion:
they inhibit protein synthesis by base pairing to the trans-
lation initiation region of their mRNA targets in an
Hfq-dependent manner, followed by the subsequent deg-
radation of the mRNA. Although sRNAs generally
modulate translational initiation by interfering with 30S
ribosome loading, alterations of target mRNA levels are
also often observed (10,11). A few studies performed in
E. coli suggest that RNase cleavage of target mRNAs may
be directly coupled to the degradation of the sRNA that is
regulating the process, with both RNAs being degraded
upon sRNA action (12–14).
RNases can have a major impact on sRNAs regulatory
pathways by performing a key role in the biogenesis and
processing of sRNAs, as well as in controlling their
cellular levels through regulation of their turnover
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(12,15–19). In E. coli, and presumably in many other
Gram-negative bacteria, including Salmonella, mRNA
decay is normally initiated by an endonucleolytic
cleavage mainly performed by RNase E (20) and, some-
times by RNase III (21), followed by exoribonucleolytic
degradation (19,22). In E. coli, both endoribonucleases
have also been implicated in the decay of sRNAs, upon
translational silencing (23).
We have previously reported specific contributions of
several Salmonella ribonucleases on the turnover of differ-
ent sRNAs (17). In this work, we have cloned and purified
for the first time Salmonella RNase III and RNase E and
have demonstrated that both endoribonucleases are re-
sponsible for the control of MicA sRNA levels. The role
of the double stranded-specific endoribonuclease III over
MicA only occurs through a target-dependent pathway,
whether in vitro or in vivo. By contrast, the single
stranded-specific endoribonuclease E is able to efficiently
degrade free MicA sRNA. A model is proposed to explain
the cooperation of both enzymes in the cell in order to
achieve the fine-tuned control of the post-transcriptional
regulator MicA.
MATERIALS AND METHODS
Oligonucleotides
All oligonucleotides used in this study are listed in the
Supplementary Table S1 and were synthesized by STAB
Vida, Portugal.
Bacterial strains
All bacterial strains and plasmids used in this study are
listed in the Tables 1 and 2, respectively. All Salmonella
strains used are isogenic derivates of the wild-type
Salmonella enterica serovar Typhimurium strain SL1344.
The OmpA (CMA-552), LamB (CMA-554) and MicA
(CMA-555) mutants were constructed using the primer
pairs pSV-104/pSV-105, pSV-108/pSV-109 and pSV-146/
pSV-147, respectively, and following the -red recom-
binase method (24), with few modifications, as previ-
ously described (17). All chromosomal mutations were
subsequently transferred to a fresh SL1344 background
by P22 HT105/1 int-201 transduction (25). The
chloramphenicol-resistance cassette of plasmid pKD3
replaces nucleotides 190 to +1064 of the ompA gene,
20 to+1339 of lamB and+8 to+78 of micA. All gene
deletions were verified by colony PCR using the primer
pairs pSV-106/pSV-107 for ompA, pSV-110/pSV-111 for
lamB and pSV-148/pSV-149 for micA. The S. typhimurium
RNase III deficient strain (CMA-551) was obtained by
P22 transduction from SA5303 strain (26) and is tetracyc-
line resistant. The double mutants were constructed using
the same transduction method.
Bacterial growth
All strains were grown in Luria-Bertani (LB) broth at
37C with agitation throughout this study. SOC medium
(Super Optimal Broth with Catabolite Repression
medium) was used to recover transformants after heat
shock (in the case of E. coli) or electroporation (in the
case of Salmonella), before plating. Growth medium was
supplemented with the following antibiotics when appro-
priate: ampicillin (150mg/ml), chloramphenicol (25 mg/ml),
streptomycin (90mg/ml) and tetracycline (25 mg/ml).
RNA extraction and northern blot analysis
Overnight cultures were diluted 1/100 in fresh LB medium
and grown until 6 h after OD600 of 2 (OD2+6). Culture
Table 1. List of strains used in this work
Strain Relevant markers/Genotype Source/Reference
S. typhimurium, SL1344 StrRhisG rpsL xyl (56)
CMA-537 SL1344 rne-537 (rne::CmR) (17)
CMA-551 SL1344 rnc-14::Tn10 (TcR) This study
CMA-552 SL1344 ompA (ompA::CmR) This study
CMA-554 SL1344 lamB (lamB::CmR) This study
CMA-555 SL1344 micA (micA::CmR) This study
CMA-556 SL1344 rnc-14 micA (rnc-14::Tn10/micA::CmR) This study
CMA-557 SL1344 rnc-14 ompA (rnc-14::Tn10/ompA::CmR) This study
CMA-558 SL1344 rnc-14 rne-537 (rnc-14::Tn10/rne::CmR) This study
E. coli BL21(DE3) F ompT hsd SB(rb
mb) gal dcm (DE3) (57)
E. coli BL21(DE3)recA rnc105 F ompT hsd SB(rb
mb) gal dcm (DE3) recA rnc105 (27)
E. coli DH5a recA1 endA1 gyrA96 thi-hsdR17 New England Biolabs
supE44 relA1 lacZYA-arg FU169 f80dLacZDM15
Table 2. List of plasmids used in this work
Plasmid Comments Origin/Marker Reference
pKD3 Template for mutants construction; carries chloramphenicol-resistance cassete oriRg/AmpR (23)
pKD46 Temperature-sensitive -red recombinase expression plasmid oriR101/AmpR (23)
pCP20 Temperature-sensitive FLP recombinase expression plasmid AmpR, CmR (23)
pET-15b Inducible expression vector, N-terminal His Tag AmpR Novagen
pSVDA-01 pET-15b encoding His-RNase III AmpR This study
pSVDA-02 pET-15b encoding His-RNase E AmpR This study
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samples were collected, mixed with 1 volume of stop
solution [10 mM Tris (pH 7.2), 25mM NaNO3, 5mM
MgCl2, 500 mg/ml chloramphenicol] and harvested by cen-
trifugation (10min, 6000g, 4C). For stability experiments,
rifampicin (500mg/ml) and nalidixic acid (20 mg/ml) were
added to cells grown in LB at 37C, with agitation, till
OD2+6. Incubation was continued and culture aliquots
were withdrawn at the time-points indicated in the respect-
ive figures. RNA was isolated using the phenol/
chlorophorm extraction method, precipitated in ethanol,
resuspended in water and quantified on a Nanodrop 1000
machine (NanoDrop Technologies).
For northern blot analysis, 15 mg of total RNA was
separated under denaturating conditions either by 8.3M
urea/8% polyacrylamide gel in TBE buffer or by 1.3%
agarose MOPS/formaldehyde gel. For polyacrylamide
gels, transfer of RNA onto Hybond-N+ membranes (GE
Healthcare) was performed by electroblotting (1 h 50min,
24V, 4C) in TAE buffer. For agarose gels, RNA was
transferred to Hybond-N+ membranes by capillarity
using 20 SSC as transfer buffer. In both cases, RNA
was UV cross-linked to the membrane immediately after
transfer. Membranes were then hybridized in RapidHyb
Buffer (GE Healthcare) at 68C for riboprobes and 43C
in the case of oligoprobes and DNA probes. After hybrid-
ization, membranes were washed as described (17). Signals
were visualized by PhosphorImaging (Storm Gel and Blot
Imaging System, Amersham Bioscience) and analyzed
using the ImageQuant software (Molecular Dynamics).
Hybridization probes
Primers for templates amplification are listed in
Supplementary Table S1. Labeling of the riboprobes
and oligoprobes was performed as described (17). The
riboprobes were obtained using the primer pair
pSV-118/pSV-141 for MicA and pSV-142/pSV-143 for
ompA. The DNA probe for 16S rRNA was generated
using the primer pair pSV-144/pSV-145 and ‘Amersham
MegaprimeTM DNA Labeling Systems’ (GE Healthcare),
according to the supplier instructions.
Construction of recombinant proteins
To overexpress Salmonella RNase E and RNase III
proteins, the rne and rnc coding regions were amplified
with primer pairs pSV-124/pSV-125 and pSV-129/
pSV-130, respectively. The N-terminal region (comprising
residues 1–522), corresponding to the catalytic domain of
RNase E, was purified. In E. coli, the N-terminal half of
RNase E (residues 1–498) was reported to be sufficient for
the ribonuclease activity (27). The purified PCR products
were double digested with BamHI and NdeI and ligated to
the pET-15b vector previously digested with the same
enzymes, yielding plasmids pSVDA-01 (rnc) and
pSVDA-02 (rne). These plasmids were first cloned into
E. coli DH5a and were subsequently transformed into
BL21(DE3) strain in the case of pSVDA-02, and
BL21(DE3) rnc105 recA (28) in the case of pSVDA-01
construction. This derivative strain of BL21(DE3),
carrying an RNase III mutation, was used because it
blocks the autoregulation of Salmonella RNase III by
the endogenous E. coli homologue, resulting in a higher
yield of the enzyme upon overexpression. All constructs
were confirmed by DNA sequencing at STAB Vida.
Overexpression and purification of Salmonella RNase E
and RNase III proteins
The BL21 (DE3) strain and derivative, containing the re-
combinant plasmids of interest, were grown in 100ml of
LB medium supplemented with ampicillin (150mg/ml) to
an optical density at 600 nm of 0.5. At this point, protein
expression was induced by addition of 1mM of IPTG for
3 h at 37C. Cells were then harvested by centrifugation
and the pellets stored at 80C. The culture pellets ex-
pressing RNase III or RNase E were resuspended in
3ml of Buffer A (20mM Tris–HCl pH 8, 500mM NaCl,
20mM imidazole pH 8). Suspensions were lysed using a
French Press at 900 psi in the presence of 0.1mM of
PMSF. After lysis, the crude extracts were treated with
125 U of Benzonase (Sigma) to degrade the nucleic acids
and clarified by a 30min centrifugation at 10 000g, 4C.
The histidine tagged recombinant proteins were purified
by affinity chromatography, using the ÄKTA FPLCTM
System (GE Healthcare). The clarified extracts were
loaded into a HisTrap HP Sepharose 1ml column
equilibrated in Buffer A. Protein elution was achieved in
buffer A with a linear imidazole gradient (from 20 to
500mM). The fractions containing mostly the protein of
interest, free of contaminants, were pooled. Eluted
proteins were buffer exchanged with Desalting Buffer [10
mM Tris–HCl (pH 8), 3mM MgCl2, 100mM NaCl, 1mM
DTT] and concentrated by centrifugation at 4C with
Amicon Ultra Centrifugal Filter Devices (Millipore),
with a molecular mass cutoff of 10 kDa (RNase III) or
50 kDa (RNase E). Proteins were quantified using the
Bradford Method (29) and stored at 20C in Desalting
Buffer containing 50% (v/v) glycerol. The purity of the
enzymes was analyzed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS–PAGE)
and revealed >90% homogeneity.
In vitro transcription and activity assays
DNA templates for the in vitro transcription were
generated by PCR using chromosomal DNA from
S. typhimurium SL1344 strain. The phage T7 RNA poly-
merase promoter sequence was included in the forward
primer sequences. micA was amplified with the primer
pair pSV-116/pSV-117, ompA with pSV-122/pSV-123
and lamB with pSV-120/pSV-121. For the synthesis of
the internally labeled 50 triphosphate MicA, in vitro tran-
scription was carried out using the purified PCR product
as template in the presence of an excess of [32P]-a-UTP
over unlabeled UTP with ‘Riboprobe in vitro
Transcription System’ (Promega) and T7 RNA polymer-
ase. MicA substrate bearing 50 monophosphate was
obtained by adding an 8-fold excess of GMP over the
other ribonucleotides to the in vitro transcription
reaction. Non-radioactive molecules were transcribed in
the same conditions but using equimolar concentrations
of all four ribonucleotides. MicA transcripts were purified
by electrophoresis on an 8.3M urea/10% polyacrylamide
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gel. The gel slice was crushed and the RNA eluted with
elution buffer [3 M ammonium acetate pH 5.2, 1mM
EDTA, 2.5% (v/v) phenol pH 4.3], overnight at room
temperature. The RNA was ethanol precipitated and
resuspended in RNase free water. For the synthesis of
the 50-end-labeled MicA or ompA, in vitro transcription
was carried out using the corresponding PCR product
as template. MicA and ompA transcripts were run on a
10 or 6% polyacrylamide gel, respectively, identified by
ethidium bromide (EtBr) staining and cut out from the
gel. The RNA was eluted from the gel slice as described
above. The RNA substrates were end-labeled with [32P]-
g-ATP at 37C for 1 h, with 10 units of T4 polynucleotide
kinase (Fermentas) using the supplier exchange buffer and
again purified from gel as above. The yield of the labeled
substrates (cpm/ml) was determined by scintillation
counting.
The hybridization between labeled and unlabeled sub-
strates was always performed in a 1:40 molar ratio in the
Tris component of the activity buffer by incubation for
10min at 80C, followed by 45min at 37C.
The activity assays were done in a final volume of 50 ml
containing the activity buffer {for RNase III [30 mM Tris–
HCl pH 8, 160mM NaCl and 0.1mM DTT] and for
RNase E [25 mM Tris–HCl pH 7.5, 5mM MgCl2,
60mM KCl, 100mM NH4Cl, 0.1mM DTT and 5%
(v/v) glycerol]} and 10 000 cpm of substrate. In the
case of the activity assays with RNase III, 10mM of
MgCl2 was added to the reaction mixture. As a control,
prior to the beginning of each assay an aliquot was taken
and was incubated until the end of the assay (without the
enzyme). The reactions were started by the addition of the
enzyme at a concentration of 500 nM, and further
incubated at 37C in the case of RNase III and 30C for
RNase E (30,31). Samples were withdrawn at the
time-points indicated in the respective figures, and the re-
actions were stopped by the addition of formamide-
containing dye supplemented with 10mM EDTA.
Reaction products were resolved in a 7M urea/15% or 8
% polyacrylamide gel as indicated in the respective figure
legends. Signals were visualized by PhosphorImaging and
analyzed using ImageQuant software (Molecular
Dynamics).
OMPs extraction and analysis
The membrane protein fraction from late stationary phase
cultures (OD600 of 2+6h) was extracted as described (32).
OMPs were analyzed on 4% urea–SDS–12% polyacryl-
amide gel. Gels were stained overnight with Coomassie
Brilliant Blue.
RESULTS
Detection of MicA sense transcripts in an RNase III
mutant
We have previously studied MicA sRNA turnover in
S. typhimurium and have analyzed the particular contribu-
tion of several RNases to the decay of this sRNA.
We have found that the dsRNA-specific endoribonuclease
III has a remarkable impact on the stability of MicA
sRNA. In the wild-type, MicA sRNA has a half-life of
6min (17). In an RNase III mutant, there was a
dramatic stabilization of the sRNA (no significant decay
in >2 h), with the concomitant accumulation of a degrad-
ation intermediate, very stable, which was absent in the
wild-type (17). In an RNase E mutant MicA was also
stabilized, but the small stable intermediate was not
detected.
We were interested in clarifying the nature of this small
intermediate. For this purpose we have compared the
bands pattern of isogenic RNase III+ and RNase III
strains, by northern blot analysis, with different probes.
We have used a probe antisense (AS1) or sense (S1) to the
50-end of MicA, which corresponds to the region of inter-
action with its targets (33–35). The same short MicA
sRNA stable intermediate of 45 nt (indicated by an
asterisk in the figures) was detected with the antisense
probe (AS1) only in the RNase III strain (Figure 1A,
left panel). When using the MicA sense probe (S1) we
have also detected in this mutant a smaller transcript
with approximately the same size (Figure 1A, right
panel). Both species (sense and antisense) have a remark-
ably long half-life (see Figure 1B). It was also detected
with the sense probe another band with the size corres-
ponding to that of MicA full transcript (74 nt). None of
the bands observed with the sense probe were visible in the
wild-type or the RNase E mutant (rne-537). Moreover, the
presence of these ‘sense transcripts’ is MicA dependent,
since they were not detected in an RNase III/MicA
strain.
The fact that the smaller transcript is equally present
when using a sense or antisense probe and uniquely
when RNase III is absent suggests that it is one strand
of a stable dsRNA remnant of the MicA-target mRNA
paired species. This smaller intermediate probably arises
due to the previous activity of other degrading enzyme(s)
but only accumulates in the absence of RNase III by
virtue of its double stranded character. RNase E is
probably a good candidate since the level of the smaller
intermediate is decreased in an RNase III mutant that is
also impaired for degradosome formation - RNase III/
rne-537 (see Supplementary Figure S1). For instance,
cleavage of MicA and ompA mRNA (a main target of
MicA) by RNase E (33) together with exoribonucleolytic
degradation of both RNAs may explain why the antisense
and sense transcripts have approximately the same size.
In order to confirm that the smaller transcripts corres-
pond to a stable dsRNA remnant of the MicA-target
mRNA paired species, we have used two other MicA
sense probes differently located along the MicA transcript
(Figure 1C). For each sense probe used, the correspondent
antisense probe, complementary to MicA, was also
designed. The location of each of the probes in the
MicA sequence is indicated in the figure below the respect-
ive images. A transcript having the same size was detected
whether with the sense probes S1 and S2, or with the cor-
responding AS1 and AS2 antisense probes. However, we
have not obtained any signal when using a sense probe
located in the 30-end of MicA (S3), while the MicA full
transcript could still be detected with the corresponding
antisense probe (AS3).
Nucleic Acids Research, 2011, Vol. 39, No. 7 2921
Figure 1. Analysis of MicA sense and antisense species in an RNase III mutant. Total cellular RNA was extracted from the S. typhimurium strains
indicated and analyzed by northern blot. 15 mg of RNA (each lane) were separated on an 8% PAA/8.3 M urea gel. The gel was then blotted to a
Hybond-N+ membrane and hybridized with the corresponding probes. Details of RNA extraction and northern blot procedure are described in
‘Materials and Methods’ section. In each case, the membrane was stripped and then probed for 5S rRNA (pSV-139) as loading control.
The radiolabeled marker 10bp DNA Step Ladder (Promega) is on the left side. The respective sizes are represented in nucleotides (full MicA is
74 nt long). The asterisk indicates the fragment that specifically accumulates in RNase III strain. The probes used are indicated in the corresponding
image. The arrow in each picture indicates the localization and direction of the probes in MicA sRNA: antisense (AS), represented by a dashed
arrow; sense (S), represented by a solid arrow. The sequence of the probes is indicated in Supplementary Table S1. (A) Total RNA from
S. typhimurium wild-type and mutant derivatives RNase III, rne-537 and RNase III/MicA was hybridized with MicA antisense (AS1) and
sense (S1) probes. The double mutant (RNase III/MicA) and the RNase E mutant (rne-537) were used as controls. (B) Comparison of the stability
of both MicA sense and antisense species in the absence of RNase III. Total cellular RNA from wild-type and RNase III mutant was extracted at
the time-points (min) indicated on top, after transcription arrest. RNA samples were analyzed as described above using an antisense probe to the full
MicA sequence (upper panel) or a sense probe (lower panel). (C) Total RNA from wild-type and RNase III mutant strains was hybridized with two
other differently located antisense and sense probes, as indicated in the pictures below each image.
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These results strongly indicate that the small degrad-
ation intermediate should correspond to a remnant of a
duplex MicA-target mRNA. The lack of signal when using
S3 (located in the 30-end of MicA) further suggests that the
duplex formation is confined to the 50-end of MicA. This
observation is in agreement with previous reports, which
indicate that the interaction site is located in the 50-end of
the sRNA, at least for the two known targets of MicA
(33–35).
MicA cleavage by RNase III is facilitated by base pairing
with its mRNA target(s)
The results presented in Figure 1 suggest that the cleavage
of MicA by RNase III occurs in a target- dependent
fashion. Taking this into account, together with the fact
that RNase III is a double-stranded-specific endoribo-
nuclease, led us to compare in vitro the activity of the
enzyme both over MicA transcript alone or in complex
with its mRNA targets. Until now only two targets
for this sRNA have been described in Salmonella, ompA
and lamB mRNAs. MicA was reported to act over the
translation initiation region of both molecules (33–35).
In order to study the activity of Salmonella RNase III
over MicA, we have cloned and purified the Salmonella
enzyme as described in Material and Methods. The pure
enzyme used in the in vitro experiments is shown in
Supplementary Figure S2. Activity assays were performed
by incubating the purified Salmonella RNase III with
a32P-labeled MicA alone or in combination with the un-
labeled 50-untranslated region (UTR) of ompA or lamB
mRNAs. Since it has been shown that MicA is also able
to bind ompA mRNA without the help of Hfq (33), this
protein was not included in the activity assays. MicA
alone was found to be resistant to RNase III cleavage
(Figure 2A). By contrast, in conditions favoring the hy-
bridization of the sRNA transcript with each one of the
target molecules, we could see the increasing accumulation
of specific reaction products simultaneously with the dis-
appearance of the substrate. This indicates that the for-
mation of the sRNA-target mRNA complex promotes the
RNase III cleavage of MicA.
The extension and location of MicA interaction with
ompA or lamB mRNAs has been predicted to be slightly
different (33,34). Since RNase III cleaves dsRNA, the dif-
ferent interaction between MicA and the two targets could
be in the origin of the distinct cleavage pattern induced by
ompA or lamB. In order to identify the cleavage points
generated by RNase III on the MicA-ompA and MicA-
lamB hybrids, in vitro assays were performed as described
above, but using 50-end-labeled MicA in combination
either with the unlabeled 50-UTR of ompA or lamB. The
results are shown in Figure 2B. RNase III cleavage gen-
erates two main fragments of 22 and 23 nt on MicA-ompA
hybrid, and 21 and 25 nt on MicA-lamB. Since in this
experiment MicA was 50-end-labeled, the size of these
fragments indicates the distance from the cleavage point
to the 50-end of MicA. The higher molecular weight
bands observed only when MicA was internally labeled
(see Figure 2A) correspond to 30-end fragments, since
they are not detected in the cleavage of 50-end-labeled
MicA. A representation of the hybridization regions
showing the RNase III cleavage positions in MicA
sequence is presented in Figure 2C. All the cleavage pos-
itions are located inside the predicted region of interaction
with each target, strongly supporting our hypothesis that
RNase III is responsible for the coupled MicA-target
degradation.
According to our proposal, cleavage of MicA is coupled
with the mRNA target cleavage. In this sense the same
kind of activity assays were carried out in order to check
the direct activity of RNase III over the corresponding
region of ompA mRNA. For this, the purified
Salmonella RNase III was incubated with the 50-end-
labeled UTR of ompA (172 nt) alone or in combination
with unlabeled MicA. As shown in Figure 2D although
RNase III is able to cleave free ompA, a faster disappear-
ance of the substrate when the hybrid ompA-MicA was
used indicates that it is cleaved more efficiently.
Moreover, the cleavage event gives rise to specific degrad-
ation products that were not observed after incubation
with ompA alone (Figure 2D). Among these products,
we could observe the accumulation of fragments in the
range of 113–130 nt, which is the expected size of frag-
ments generated by cleavage inside the hybridization
region with MicA (see Figure 2C). The other products
with a higher molecular weight probably arise due to al-
terations in the secondary structure of ompA after the
duplex formation, which could generate a new dsRNA
region suitable for RNase III. However, we cannot ex-
trapolate to the in vivo situation, since these assays were
performed with a truncated version of ompA. The ability
of RNase III to preferentially cleave the hybrid ompA-
MicA in the region corresponding to the hybridization
between the two molecules is another evidence for the
coupled degradation of the target and the sRNA.
Taken together, our results indicate that MicA decay
in vivo is highly dependent on RNase III and its
cleavage by this enzyme in vitro is triggered upon base
pairing with its target mRNAs.
ompA expression is regulated by RNase III and is
dependent on MicA
OmpA is a very abundant porin highly expressed in the
exponential phase of growth. In stationary phase MicA is
present at high levels and is the principal post-
transcriptional downregulator of the ompA mRNA
(33,35). Since our results indicate that MicA degradation
by RNase III is target-dependent and we have observed
the concomitant degradation of the ompA target mRNA
in vitro, we analyzed the effect of an RNase III mutation
on the levels of ompA mRNA in stationary phase. The
RNase III mutant shows an increment of almost
14-fold in ompA mRNA level in comparison to the
wild-type (Figure 3A). A strong increase in the OmpA
protein level was also observed. This suggests that the
reduced levels of ompA mRNA observed in stationary
phase in the wild-type (RNase III+) are probably due to
the cleavage and destabilization of the message by RNase
III. This cleavage should be suppressed when RNase III is
absent. This result strongly indicates that RNase III is
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implicated in the degradation of the ompA mRNA. On the
other hand, the constant levels of OmpC and OmpD
between the wild-type and RNase III, further suggest
that RNase III is not involved in the turnover of their
messages and that the control of these proteins levels in
the cell follows a different pathway. Interestingly,
Paperfort et al. (4) have shown that MicA sRNA is also
not involved in the control of ompC or ompD levels, while
affecting ompA.
Since the degradation of both the sRNA MicA and the
ompA target mRNA is dependent on RNase III, we have
checked whether the RNase III regulation of ompA ex-
pression was also MicA dependent. Therefore, we have
analyzed the expression of ompA in a MicA mutant
Figure 2. In vitro cleavage of sRNA MicA or ompA 50-UTR by endoribonuclease III. The radioactivelly labeled substrate was incubated with
500 nM of Salmonella RNase III. Aliquots withdrawn at the time-points indicated above each lane were analyzed on a 7M urea/15% or 8% PAA gel
for MicA or ompA, respectively. The first two lanes of each reaction correspond to the controls without the protein at time zero (0) and at the end of
the reaction time (150). The radiolabeled Decade Marker RNA (Ambion) is indicated by ‘M’. The arrows in the figure indicate specific degradation
products. (A) Assays performed with internally labeled MicA in the absence () (left panel) or in the presence (+) of a molar excess of ompA (middle
panel) or lamB (right panel) unlabeled transcripts (50-UTR sequence). (B) Assays performed with 50-end-labeled MicA in the presence (+) of a molar
excess of ompA (left panel) or lamB (right panel) unlabeled transcripts (50-UTR sequence). The bands that are already observed in the absence of the
enzyme (control reactions) arise due to the radiolysis of the substrate. (C) Proposed interaction regions of ompA and lamB mRNAs with MicA
[adapted from (33)]. The Shine–Dalgarno regions of ompA and lamB are indicated. The arrows indicate the RNase III cleavage sites on MicA as
determined on A and B. (D) Assays performed with 50-end-labeled ompA in the absence () (on the left) or in the presence (+) (right panel) of a
molar excess of unlabeled MicA. On the left side of the marker (M) radiolabeled transcripts of known sizes were included (a) 130 nt; (b) 120 nt and
(c) 95 nt. The arrows in the figure indicate the degradation products located inside the hybridization region.
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strain. In stationary phase MicA basepairs with the
50-UTR of ompA preventing ribosome binding and
destabilizing the entire ompA mRNA (33,35).
Accordingly, when the regulator is absent (MicA
mutant) the levels of ompA mRNA should be elevated.
We observed an increase of about 7-fold in ompA
mRNA levels when MicA is absent (Figure 3A). This
result confirms that the control of ompA mRNA levels
is dependent on MicA. However, the fact that in the
absence of RNase III ompA mRNA levels are still higher
than in the MicA mutant indicates that RNase III may
also have a role in ompA expression by an alternative
pathway not involving MicA. In fact we show that
RNase III is also able to cleave ompA in vitro in the
absence of MicA. Additionally ompA mRNA may also
be under the control of another sRNA in an RNase III
dependent way.
If RNase III and MicA affect the ompA message
through the same regulatory pathway, the combined
absence of both would not result in a cumulative effect.
In order to clarify this, we have constructed and tested
the effect of the double mutant RNase III/MicA on
the ompA mRNA levels. As shown in Figure 3A, in the
double RNase III/MicA mutant the ompA levels are
reduced in comparison with the RNase III single
mutant, demonstrating that MicA and RNase III act
over ompA message through a common pathway.
Detection of the ‘sense transcripts’ in the RNase III
mutant depends on ompA
Taken together, the results presented here point out that
ompA is subjected to MicA-coupled degradation by
RNase III. Since we had indications that the ‘sense tran-
scripts’ detected in the RNase IIImutant are remnants of
the sRNA-target complex (see Figure 1), we have
investigated if these ‘sense-transcripts’ corresponded to
ompA mRNA fragments. Indeed, in the absence of both
RNase III and ompA, the levels of these ‘sense transcripts’
are largely reduced when compared with those of the
single RNase III mutant (Figure 3B). This means that
the detection of these ‘sense transcripts’ is related with the
presence of ompA, strongly suggesting that this mRNA
might be one of the targets degraded by RNase III in
conjunction with MicA.
Figure 3. Regulation of ompA and MicA expression in different mutant strains. Northern blot and SDS–PAGE analysis of RNA and protein
samples extracted from wild-type and mutant strains as indicated on top of each lane. Details of experimental procedures are described in ‘Materials
and Methods’ section. (A) (Upper panel) Analysis of steady-state ompA mRNA levels by northern blot. 15 mg of RNA (each lane) were resolved in a
1.3% formaldehyde-agarose gel. The gel was then blotted to a Hybond-N+ membrane and hybridized with the corresponding ompA riboprobe.
Full-length transcripts were quantified using a Molecular Dynamics PhosphorImager. The amount of RNA found in wild-type was set as one. The
ratio between each strain and the wild-type is depicted (relative levels). A representative membrane is shown and values indicated correspond to the
average of several northern blot experiments with RNAs from at least two independent extractions. The membrane was stripped and then probed for
16S rRNA as loading control. (ND) Non-detectable. (Middle panel) MicA sRNA levels analysis by northern blot. 15 mg of RNA from the same
mutants were separated on an 8% PAA/8.3M urea. The gel was then blotted to a Hybond-N+ membrane and hybridized with the corresponding
MicA riboprobe. The membrane was stripped and then probed for 5S rRNAs, as loading control. (Lower pannel) Outer membrane protein fraction
analysis by 4% urea–SDS–12% polyacrylamide gel electrophoresis. The positions of the OmpC, OmpD and OmpA bands are indicated. An OmpA
mutant was used as control. (B) Comparison of the levels of MicA sense species on the wild-type, RNase III and the double RNase III/OmpA
strains. The experimental procedure was similar to the one described in (A). The arrow on MicA sRNA picture indicates the localization and
direction of the probe (S1). Loading control of the RNA was done with 5S rRNA probe and is represented below. Sizes were estimated using the
radiolabeled 10bp DNA Step Ladder (Promega), on the left side of the membrane.
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The fact that the ‘sense transcripts’ are still detectable in
the absence of ompA indicates that this mRNA might not
be the only candidate for the MicA-coupled degradation.
However, in a LamB mutant (the other known target of
MicA) we did not observe, under our experimental condi-
tions, a significant alteration in the level of the ‘sense tran-
scripts’ (data not shown). Furthermore, in the absence of
both ompA and lamB targets, the ‘sense transcripts’ could
still be slightly observed (data not shown), indicating that
other MicA targets subjected to the same type of regula-
tion should exist in the cell.
RNase E cleaves ‘free MicA’ sRNA in vitro
We have demonstrated that the sRNA MicA degradation
is influenced by RNase III. However, this seems to happen
only in the presence of the target mRNA. As we have
shown in vitro, the enzyme was not able to cleave MicA
alone. Thus, the question of how is free MicA degraded
remains to be answered. In vivo experiments have shown a
large impact of an RNase E mutant on the levels and
stability of full MicA sRNA (17). However, these results
concern studies undertaken with the rne-537 mutant de-
rivative (17). Since this mutant only prevents degradosome
formation, without totally abolishing the enzyme activity,
we were also interested in clarifying the role of the cata-
lytic activity of RNase E on the decay of MicA. Moreover,
it has been shown that -A/U rich sequences together with
adjacent stem-loop structures can comprise recognition
sites for RNase E (36,37). The sequence of the sRNA
MicA matches these characteristics. Therefore, we have
analyzed the ability of this endoribonuclease to cleave
MicA sRNA transcript, in vitro. For this purpose we
have cloned and purified the amino-terminal region of
Salmonella RNase E. The homologous region in E. coli
RNase E is known to be responsible for the catalytic
activity of the enzyme (27). The results of the purification
of the N-terminal segment of Salmonella RNase E are
shown in Supplementary Figure S2. In vitro assays with
the purified protein were performed over uniformly
labeled MicA transcript. It was seen before that RNase
E preferentially cleaves RNAs with a 50 monophosphate
group over those endowed with a 50 triphosphate
(36,38–40). Thus, in the activity assays we have used as
substrate both the monophosphate and the triphosphate
MicA transcripts. Our results show that RNase E is
able to cleave both substrates in vitro (Figure 4), though
the efficiency of cleavage was superior over mono-
phosphorylated MicA. This is in agreement with the
recent report that E. coli RNase E is also active over
some triphosphate substrates (41).
We have previously shown that in cells in which the
degradosome scaffold of RNase E was deleted the degrad-
ation of MicA is slower (>4-fold stabilization) (17). This
suggests that, in vivo, RNase E may need the cooperation
of other degradosome components in the decay of this
transcript. Indeed it was previously shown in E. coli and
Salmonella that the absence of PNPase, the exoribonu-
cleolytic component of the degradosome, has a remark-
able impact over the stability of MicA sRNA (16,17).
However, the high ability of RNase E to cleave MicA
in vitro indicates that the enzyme per se should important-
ly contribute for the in vivo degradation of free MicA.
DISCUSSION
Stress conditions that unbalance OMP levels activate the
sE response, a complex set of changes normally devoted
to protect the cell envelope from environmental challenges
(42). The transcription factor sE triggers the synthesis of
the sRNAs that control OMP levels (4,6). Upon
downregulation of OMPs and the relief of membrane
stress, the high sRNA levels have to be brought back to
normal amounts. MicA sRNA is a sE-dependent porin
downregulator whose transcription is activated in
stationary-phase (4,6,9). Under this context, we were
interested in studying the regulation of MicA cellular
levels and determining the enzymes involved in this
process.
MicA was previously found to be highly stabilized in
cells lacking a functional RNase III (17). However, RNase
III is not able to cleave MicA in vitro, suggesting that
MicA alone is not a substrate for this enzyme. Indeed,
we demonstrate that RNase III is only able to cleave
MicA in vitro when it base pairs with its target(s).
RNase III is a specific double stranded RNA endoribo-
nuclease, which plays multiple roles in the processing
of rRNA and mRNA (43) and its activity has also been
demonstrated over several sRNA-target complexes
formed by cis-antisense sRNAs (44–47). In these
complexes, there is a perfect complementarity between
the RNA partners, which constitutes a preferred substrate
for RNase III, and avoids the need for Hfq. The limited
complementary between trans-encoded sRNAs and their
Figure 4. In vitro study of MicA sRNA cleavage by RNase E.
a-32P-labeled MicA transcript, 50 monophosphate (left panel) or 50 tri-
phosphate (right panel), was incubated with 500 nM of purified
Salmonella RNase E (residues 1–522) at 30C. Aliquots withdrawn at
the time-points indicated above each lane were analyzed on a 15%
PAA/7M urea gel. The two first lanes of each reaction correspond to
the controls without the protein both withdrawn at time zero and at the
end of the reaction time.
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targets typically requires the help of the bacterial RNA
chaperone Hfq. The trans-encoded sRNA MicA was
shown to be dependent on Hfq both for stability and
target degradation (17,33,35). It is generally assumed
that Hfq binds both the regulator and the target RNA,
favoring their interaction. Moreover, Hfq enhances
the stability of many sRNAs in vivo, by protecting them
from degradation (48). Curiously, IstR-1 from E. coli
and RNAIII from Staphylococcus aureus are two trans-
encoded sRNAs that act independently of Hfq and were
also seen to be cleaved by RNase III in a target-coupled
mechanism (13,49–51). Here we describe, in Salmonella,
the first example of a system controlled by a
Hfq-dependent trans-sRNA that involves the coupled deg-
radation of the sRNA-target mRNA by RNase III.
In RNase III cells, besides the high stabilization of
MicA, a very stable smaller degradation intermediate is
also observed. In agreement with the in vitro results, we
have obtained several indications that this degradation
intermediate corresponds to a remnant of a dsRNA
complex formed by MicA and its target(s): (i) It is only
detected in the RNase III mutant (deficient for dsRNA
degradation), where it is extremely stable by virtue of its
double stranded character. When RNase III is present,
dsRNA complexes are cleaved to products that are
either further degraded or too small to be detected by
northern blot; (ii) This small intermediate is visible with
both antisense MicA probes and sense probes complemen-
tary to the targets and (iii) The level detected with sense
probes is highly reduced in the absence of OmpA (a main
MicA target). Thus, this remnant species should indicate
the region of interaction between MicA and its targets.
Since a strong signal is detected with the 50 probes and
no signal at all is obtained with the probes located in the
30-end, this region corresponds to the 50 half of MicA. In
fact, it is known that MicA interacts through its 50-end
sequence with its two targets described till now (33–35).
Accordingly, the RNase III cleavage sites determined
in vitro on both MicA-ompA and MicA-lamB hybrids
are located in the 50 half of MicA, inside the respective
predicted hybridization region, which strongly correlates
with the in vivo observations. This result is further con-
firmed by the fact that RNase III also cleaves the ompA
50-UTR inside the same region, demonstrating that both
molecules are cleaved together.
In the absence of both ompA and RNase III the level of
the ‘sense transcripts’ is strongly decreased (Figure 3B).
The fact that these bands are still visible, despite at very
low levels, may be related with the formation of complexes
between MicA and other target(s), whose degradation
should also be RNase III-dependent. We demonstrate
that in vitro RNase III is also able to cleave the complex
MicA-lamB. However, in vivo, whether in the absence
of lamB or of both lamB and ompA we could still detect
the sense transcripts referred above (data not shown). This
means that probably besides lamB mRNA other
Salmonella MicA targets (not yet identified) may exist
in stationary-phase. In E. coli, expression of phoPQ
has recently been shown to be repressed by MicA upon
activation of sE (52). In fact, MicA is a trans-encoded
sRNA highly conserved in Enterobacteriacea (53).
Trans-encoded sRNAs generally establish short and im-
perfect interactions with its mRNA targets (10–25 nt)
(11,54), allowing the regulation of multiple targets by
the same sRNA. For example, RybB sRNA controls
more than 17 mRNAs, 10 of which encode OMPs,
including ompA.
Upon MicA accumulation in stationary phase, the
sRNA binds to ompA mRNA blocking ribosome
binding and translation initiation. This releases the
mRNA from the ‘protection’ by the ribosomes and leads
to degradation of the ribosome-free mRNA by the con-
certed action of endo- and exoribonucleases (19). In line
with previous-work (55,56), RNase E is thought to be the
endoribonuclease responsible for the decay of ompA
mRNA after the blockage of ribosome loading caused
by MicA binding (33,35). In this report, we show that
additionally the binding of MicA to ompA renders both
RNAs susceptible to RNase III cleavage. We have
demonstrated that this endoribonuclease is essential for
ompA repression and, in agreement with previous studies
(33,35), we observed a relieve of ompA repression in the
absence of MicA. Both effects were seen to occur in a
concerted way. The RNase III pathway has the advantage
of simultaneously controlling the levels of the sRNA,
whose function after the repression of the target will no
longer be necessary in the cell. In addition RNase III
cleavage makes the repression irreversible. From a physio-
logical point of view, the existence of two distinct
pathways may enhance the cell response in stress condi-
tions allowing a fine-tuned balance of OmpA levels needed
to keep the envelop integrity. Moreover by having two
alternative degradation pathways the cell warrants the me-
tabolism of molecules no longer needed. This may be
crucial in stationary phase, which is characterized by
limited resources.
Interestingly, the ompA levels in the double mutant
(RNase III/MicA) are not restored to those observed
in the MicA mutant. This can be due to a direct effect of
RNase III over ompA. Indeed we show that in vitro RNase
III is able to cleave ompA even in the absence of the
sRNA. Alternatively, other(s) player(s) can be involved
in the RNase III-mediated regulation of ompA. At least
two other trans-encoded regulatory sRNAs (RseX and
RybB) have been described as additional ompA regulators
(4,5).
We have just described a pathway for degradation of
MicA sRNA that involves target binding and is dependent
on RNase III. Our results show that RNase III cleaves
MicA when hybridized with the targets. The question
then arises how the levels of free MicA are brought back
to normal when the cell no longer needs it. Our pre-
vious results in vivo, showed a high stabilization of
MicA in an RNase E deletion mutant lacking the
C-terminal region (17). This may suggest that RNase E
needs the cooperation of other degradosome components
in the degradation of MicA. In fact, we have previously
shown that PNPase, the exonucleolytic component of
the degradosome, has a great impact over the stability of
this sRNA in Salmonella. According to the results pre-
sented here, the catalytic domain of RNase E also
shows, in vitro, a high efficiency in the cleavage of this
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sRNA. This single stranded endoribonuclease seems to
play an important role in the regulation of the abundance
of free MicA.
For each sRNA the characterization of its turnover has
to be analyzed from two different perspectives: the inde-
pendent, and the dependent of target interaction. The later
can be similar or not, whether the sRNA decay is
influenced or not by the respective target(s). Taken
together, the results presented in this study indicate the
existence of two different pathways for MicA sRNA
turnover, each one involving a specific endoribonuclease.
According to the model proposed in Figure 5, when MicA
is free, RNase E seems to take the control by efficiently
degrading the sRNA. However, if MicA is interacting with
the targets the target-dependent pathway of degradation
predominates. This mechanism involves a double stranded
endoribonuclease that is able to degrade both the target
and the sRNA, simultaneously.
Cleavage by RNase III within the sRNA–mRNA
duplex and the subsequent decay of the mRNA intermedi-
ate by the cell machinery could rather resemble the RNAi
scenario in eukaryotic organisms. RNase III-like enzymes
are known to have a pivotal role in eukaryotic small non-
coding RNA function and biogenesis (19). Hence, it is not
surprising that RNase III would also be a main player in
the control of prokaryotic sRNA expression and function,
broadening the enzyme’s global role in the regulation of
gene expression.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Figure 5. Schematic representation of the two degradation pathways followed by MicA. RNase E and RNase III are represented by scissors and
pliers, respectively. The two different pathways for MicA degradation are shown on the left side. The possible associations of MicA with its targets
are also depicted. In the wild-type, MicA and the targets should be fully degraded as a result of both degradation pathways in cooperation with the
exoribonucleolytic activity. In the RNase III mutant, the MicA-target dependent degradation by RNase III is blocked. As a result, some degrad-
ation intermediates are stabilized and can be detected, namely the target and MicA strands that have interacted but could not be cleaved by RNase
III. ompA being the main target of MicA, its species are over-represented. When additionally the ompA target mRNA is absent, the respective
degradation intermediate is no longer present in the cell and, as a consequence, there is a reduced level of transcripts detected with probes
complementary to MicA-targets.
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Importance and key events
of prokaryotic RNA decay:
the ultimate fate of an RNA
molecule
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RNAs are important effectors in the process of gene expression. In bacteria,
constant adaptation to environmental demands is accompanied by a continual
adjustment of transcripts’ levels. The cellular concentration of a given RNA is the
result of the balance between its synthesis and degradation. RNA degradation is
a complex process encompassing multiple pathways. Ribonucleases (RNases) are
the enzymes that directly process and degrade the transcripts, regulating their
amounts. They are also important in quality control of RNAs by detecting and
destroying defective molecules. The rate at which RNA decay occurs depends on
the availability of ribonucleases and their specificities according to the sequence
and/or the structural elements of the RNA molecule. Ribosome loading and
the 5′-phosphorylation status can also modulate the stability of transcripts. The
wide diversity of RNases present in different microorganisms is another factor
that conditions the pathways and mechanisms of RNA degradation. RNases are
themselves carefully regulated by distinct mechanisms.
Several other factors modulate RNA degradation, namely polyadenylation,
which plays a multifunctional role in RNA metabolism. Additionally, small non-
coding RNAs are crucial regulators of gene expression, and can directly modulate
the stability of their mRNA targets. In many cases this regulation is dependent
on Hfq, an RNA binding protein which can act in concert with polyadenylation
enzymes and is often necessary for the activity of sRNAs.
All of the above-mentioned aspects are discussed in the present review, which
also highlights the principal differences between the RNA degradation pathways
for the two main Gram-negative and Gram-positive bacterial models.  2011 John
Wiley & Sons, Ltd. WIREs RNA 2011 2 818–836 DOI: 10.1002/wrna.94
INTRODUCTION
Bacteria have evolved complex regulatory networksin order to adjust their physiology and survive in
face of constantly changing environmental conditions.
Maintenance of cellular functions relies on the proper
expression of genetic information, in which the RNA
molecules play a key role. Among RNAs, messenger
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Lisboa, Apartado 127, Oeiras, Portugal
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RNAs (mRNA) constitute the molecular link between
genes and proteins. Because the cellular concentration
of a given transcript depends on the rates of its
synthesis and degradation, both transcription and
degradation control the levels of each protein in the
cell. Regulating gene expression at the messenger level
is of utmost importance for guaranteeing versatility
in the context of the small genome size found in
prokaryotes where transcription and translation are
coupled. Survival and development in challenging
growth conditions require a rapid adaptation of gene
expression. In this regard, control of transcription
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and degradation of mRNA requires less energy and
proceeds much faster than translation and protein
degradation processes.1 The rate of turnover is not
related to the length of the gene; the stability
of the gene transcripts seems to be regulated by
determinants located in specific mRNA segments and
the segments that decay more rapidly can be located
anywhere in the mRNA. Moreover, distinct processing
may confer differential stability upon the fragments
of a polycistronic transcript. The complexity of
the RNA degradation process was further revealed
with the discovery of non-coding RNAs (sRNAs).
Previously overlooked, sRNAs are now known to
exert significant regulatory effect on gene expression,
and have thus attracted increasing interest due to
their regulatory functions, as well as their role in
bacterial adaptation and virulence.2,3 Furthermore,
the regulation of their cellular levels constitutes an
upstream control of gene expression.
In this article, we present the current knowledge
on prokaryotic RNA degradation mechanisms. We
discuss several questions like: which are the main
players involved? What is their mode of action? Are
there any differences between bacterial species? After
a brief overview of the genome-wide studies of RNA
decay, prokaryotic RNA degradation mechanisms are
described. We also look into the RNA features and
the structural details of ribonucleases, the enzymes
that process and degrade RNA. Finally, we focus on
additional factors which have an impact on RNA
stability. Together, these key events determine the
ultimate fate of an RNA molecule.
RNA DECAY: GLOBAL APPROACHES
The development of transcriptome analysis has
enabled the monitoring of intracellular RNA levels
at the genomic scale. The rate of degradation of
a given RNA can be estimated by determining
its half-life in the cell. Combining inhibition of
transcription with microarray technology has proven
to be a powerful tool for assessing genome-wide
mRNA decay. Most of these global studies in
microorganisms have been carried out on the model
yeast Saccharomyces cerevisiae.4–6 mRNA half-lives
ranging from 3 to more than 100 min have been
observed for this eukaryotic microorganism,5 with
a majority of transcripts displaying half-lives in the
range of 10–20 min.7 Although the available literature
is less abundant for prokaryotes, shorter half-lives,
with mean values of less than 10 min, have been
reported for the bacterial models Escherichia coli8,9
and Bacillus subtilis.10 Slightly lower values have
been obtained during the exponential growth of
Lactococcus lactis11 and Staphylococcus aureus.12
Altogether these global studies not only report average
values in the same range of magnitude but also
highlight a wide variation of half-lives among mRNAs.
Furthermore, global stabilities have been observed to
be dependent on growth conditions.11,12 For example,
the average half-life for mRNAs in L. lactis increases
from 5.8 to 19.4 min when comparing exponential
and carbon starvation phases, respectively.11 It has
also been noted that genes which share related
biological functions usually display similar messenger
decay rates.8–10 For instance, most house-keeping
genes have long half-lives. Proteins which are central
in E. coli protein–protein interaction network also
tend to be encoded by stable transcripts.13
The majority of RNA molecules are subjected to
regulation and, as is the case for mRNA, their decay
can be influenced by growth conditions. Independently
of the conditions, the two RNA categories involved
in protein synthesis, that is, ribosomal and transfer
RNAs, are considered to be more stable than mRNA.
Although sRNAs were initially believed to be rather
stable RNAs, it has since been shown that they
can also be quite susceptible to degradation.14,15
Plasmid-encoded antisense RNAs have a wide range
of half-lives, spanning from less than 2 min to more
than 32 min.16 While studies undertaken to date have
mainly focused on the identification of new sRNAs,
tools for assessing sRNA differential expression and
stability are becoming increasingly available17 and
this will greatly impact the current knowledge of gene
expression.
RNA DEGRADATION MECHANISMS
The Original Model and the Initiator
RNase E
Turnover of RNA molecules involves cleavage reac-
tions that are carried out by ribonucleases (RNases),
a diverse collection of cellular enzymes, whose func-
tions and properties have been elucidated through
the study of mutants.18,19 Although E. coli possesses
a plethora of RNases only a few are devoted to
the RNA degradation. The conventional model for
RNA decay in this bacterium usually begins with an
endonucleolytic cleavage at one or more internal sites
on the RNA molecule (Figure 1(a)). Two endonucle-
ases have been associated with the initial cleavage
event: RNase III and RNase E. However, RNase E
is believed to be the main endonuclease involved in
the RNA turnover in E. coli.18 It is a single-stranded
endonuclease that exhibits a preference for A/U-rich
regions in close proximity to stem-loops.20,21 This
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FIGURE 1 | Mechanisms of RNA decay in the Gram-negative and Gram-positive bacterial models. (a) In E. coli the decay of the majority of
transcripts starts with an endonucleolytic cleavage by RNase E. The enzyme has a preference for 5′-monophosphorylated substrates. A possible
pathway for RNase E cleavage involves a primary cleavage by the RNA pyrophosphohydrolase RppH, which converts the 5′-triphosphorylated
terminus of primary transcripts to monophosphate. However, some substrates are cleaved by RNase E regardless of the 5′-phosphorylation status,
through an alternative pathway called ‘bypass’ or ‘internal entry’, which involves the direct entry of RNase E at single-stranded sites. RNase III is
double-stranded specific and can also initiate the decay of structured RNAs. After endonucleolytic cleavage, breakdown products are ready for
exonucleolytic digestion by any of the three main exonucleases in this bacterium. Unlike RNase R, both RNase II and PNPase are sensitive to
secondary structures. Exonucleolytic activity is promoted by the 3′-polyadenylation of substrates. The activity of PAP I, the main polyadenylating
enzyme in E. coli, is modulated by the RNA-chaperone Hfq. PNPase can synthesize heteropolymeric tails that also facilitate degradation. Cycles of
polyadenylation and exonucleolytic degradation have been proposed as one way to overcome secondary structures. A minor alternative pathway in
the cell is the direct exonucleolytic degradation of full length transcripts (represented by a dashed arrow). Exonucleolytic degradation releases short
fragments which are subsequently degraded to mononucleotides by oligoribonuclease. (b) In B. subtilis, transcripts can be degraded from the 5′-end
through the 5′–3′ exonuclease activity of RNase J1, or they can be first endonucleolytically cleaved. The 5′–3′ exonuclease activity of RNase J1 is
blocked by 5′-PPP, suggesting primary phosphate removal. The endonucleolytic cleavage can be either performed by RNase J1/RNase J2 or RNase Y.
The breakdown products can be then further degraded by the 3′–5′ exonucleases, PNPase and RNase R (unprotected 3′ ends), or by the 5′–3′
exonuclease activity of RNase J1 (newly generated monophosphorylated 5′-ends). RNase J1 is able to fully degrade its RNA substrates to
mononucleotides. The final products released by RNase R and PNPase are further degraded by the oligoribonuclease homologues in B. subtilis. Here
we represent ribonucleases acting independently. However some of these enzymes can act together in degradation complexes. For instance in E. coli
the degradosome (RNase E, PNPase, RhlB and enolase) and in B. subtilis the putative complex formed by RNase J1/J2, RNase Y, PNPase, the RNA
helicase CshA and two glycolytic enzymes.
characteristic is also shown by its paralogue, RNase
G. This endonuclease, which has a strong resemblance
with the amino-terminal portion of RNase E,22 is also
involved in the degradation and processing of RNA.23
Both enzymes display higher activity over substrates
bearing a monophosphorylated than over substrates
with a triphosphorylated 5′-end.23 Nonetheless, some
substrates are cleaved by RNase E regardless of the 5′-
phosphorylation status. This occurs in molecules with
multiple single-stranded sites that allow the direct
entry of RNase E through a different pathway, called
‘bypass’ or ‘internal entry’.24,25
RppH is an RNA pyrophosphohydrolase that
removes the pyrophosphate from the 5′-termini and
preferentially acts on single-stranded RNA. The
discovery of this enzyme presented an alternative
pathway in which the initial event is non-nucleolytic.26
Conversion of 5′-triphosphate to 5′-monophosphate
by RppH provides the ideal substrate for RNase E,
and the preference of RppH for single-stranded RNA
explains why 5′-stem-loops are mediators of stability.
Ribosome loading is also known to mediate RNA
stability. A poor ribosome binding site, possibly by
increasing the distance between the actively translating
ribosomes, exposes putative internal cleavage sites and
may increase message instability.
The catalytic domain of RNase E lies in
the N-terminal region, which is highly conserved
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and essential for cell viability.27 The C-terminus
forms a scaffold for interactions with other
proteins, which together form the degradosome,
the main RNA degradative complex in E. coli. The
additional presence of a membrane-binding domain
in the C-terminal region directs this multiprotein
complex to the membrane, which is indicative
that RNA degradation is a compartmentalized
process.28 The RNA degradosome can undergo
changes in composition depending on the growth
or stress conditions.29,30 For instance, two different
RNA helicases are known to associate with
RNase E depending on the temperature.29,31 This
remodeling of the degradosome strongly affects
its RNA target spectrum.30 In E. coli under
normal growth conditions, the major components
of the degradosome, in addition to RNase E, are
the exonuclease PNPase, the helicase RhlB and
the glycolytic enzyme enolase.31,32 Pseudomonas
syringae, on the other hand, has selected RNase
R as a degradosome component, despite possessing
PNPase.33 This complex of enzymes assures the
coordination of the endo- and exonucleolytic
degradation of an RNA molecule. After the initial
endonucleolytic cleavage step the upstream fragment,
lacking the 3′-terminal hairpin, can be readily
digested by 3′-exonucleases. The activity of these
enzymes is impaired by a 3′-stem-loop, which
protects the majority of the primary transcripts.34
The downstream fragment generated after the initial
endonucleolytic cleavage is usually more prone to
degradation. It bears a monophosphorylated 5′-
end and therefore may be the ideal substrate for
an additional cleavage by RNase E. The turnover
of malEF transcript illustrates how the endo- and
exonucleolytic enzymes can act in a concerted way.
PNPase degradation of malEF is only accomplished in
the presence of RNase E and RhlB, indicating that the
degradosome participates in its degradation.35
Three exonucleases are mainly involved in RNA
decay in E. coli: PNPase, RNase R and RNase II
(Figure 1(a)). All of these enzymes degrade RNA pro-
cessively and nonspecifically from the 3′-end. While
PNPase is a phosphorolytic exonuclease yielding
nucleoside diphosphates as reaction products, both
RNase R and RNase II catalyze the hydrolysis of
the RNA substrates, producing nucleoside monophos-
phates. Among the three, only RNase R is able to
digest structured RNA by itself.34 The degrading
activity of PNPase or RNase II is stalled by the pres-
ence of secondary structures.36 However, PNPase can
also proceed through extensive folded RNA when
acting in association with other proteins. Its asso-
ciation with the helicase RhlB or integration into
the degradosome allows the unwinding of the RNA
stem-loops.37 Surprisingly, the PNPase homologue of
Thermus termophilus, whose optimal temperature is
65◦C, has been reported to completely degrade RNAs
with stable intramolecular secondary structures with-
out the aid of a helicase.38 Nonetheless, both PNPase
and RNase R require a minimal 3′-overhang of 7–10
unpaired nucleotides in order to be able to bind and
initiate digestion of an RNA molecule.39 By provid-
ing a single-stranded platform for the initiation of
the exonucleolytic attack, the degradation of RNA
molecules containing 3′-stem-loops is stimulated by
the addition of poly(A) tails to the 3′-end of the RNA
molecules (for details see ‘Polyadenylation’ section).
These poly(A) tails constitute the preferred substrate
for PNPase and RNase II.40,41
None of the three 3′-exonucleases seems to
be indispensable for E. coli growth at optimal
temperature. However the combined absence of both
PNPase and RNase II or PNPase and RNase R
is lethal for the cell, indicating some overlapping
role between these exonucleases.42 For instance,
both RNase R and PNPase are involved in the
degradation of rRNA fragments, whose accumulation
was proposed to lead to cell death.42 A transcriptome
analysis revealed that, although RNase II accounts
for 90% of exonuclease activity in the cell,
PNPase probably plays a greater role in mRNA
degradation than previously thought.43,44 RNase
II is the major exonuclease involved in E. coli
RNA decay and other enterobacteriaceae but, this
enzyme is absent in several other bacterial species,
such as B. subtilis, Legionella pneumophila and
Streptococcus pneumoniae, in which RNase R is the
only hydrolytic 3′–5′ exonuclease.45,46 In B. subtilis
the RNA decay is primarily phosphorolytic and this
major activity is attributed to PNPase.18 Regarding
the main exonucleases, PNPase is the only one
found in Streptomyces, thus constituting an essential
protein in these organisms.47 Conversely, the unique
exonuclease in Mycoplasma genitalium is RNase R,
which is thus essential.48
The degradative action of the ribonucleases
described above releases RNA fragments of 2–5
nucleotides, whose accumulation may be deleterious
to the cell.49 E. coli possesses another exonuclease,
termed oligoribonuclease, which acts as a scavenger
of these short oligoribonucleotides50 (see Figure 1(a)).
This essential enzyme processively hydrolyses RNA
in the 3′–5′ direction. Overall, oligoribonuclease is
a finishing enzyme in RNA metabolism, and the
presence of proteins with analogous functions seems
to be widespread. Two homologues, NrnA and NrnB,
have been described in B. subtilis.51
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The Case of the Double-Stranded Specific
RNase III
Even though RNase E has been considered the main
enzyme in E. coli that catalyzes the initial cleavage
event, the RNase III family of enzymes has emerged as
an important group of endonucleases in the control of
RNA stability.52 RNase III deletion in E. coli causes a
slow growth phenotype,53 while its homologue in B.
subtilis is essential for viability.54 A second B. subtilis
RNase III-like enzyme (called Mini-III) has recently
been described.55 Both enzymes seem to act mostly in
bacteriophage mRNA and rRNA processing, since no
endogenous mRNA targets are known.56
RNase III is specific for double-stranded RNA
and its role in RNA turnover has been associated with
the removal of protective stem-loop structures that act
as degradation barriers18 (Figure 1(a)). Additionally,
RNase III has recently been implicated in the decay
of sRNA/mRNA complexes, which constitute an
optimal substrate for this enzyme, upon translational
silencing.15,57 This phenomenon closely resembles
siRNA–direct RNA cleavage in eukaryotes, a process
that involves enzymes of the RNase III family.
An Alternative Mechanism Involving
Different Endonucleases
Despite its essential role in E. coli RNA turnover,
RNase E homologues are absent in numerous bacterial
species. This is the case of the model organism B.
subtilis and is a common characteristic of the low
G/C content Gram-positive bacteria. For quite some
time, a good candidate that could have the analogous
role of RNase E was not found, leaving no clue
for the process of B. subtilis RNA degradation. One
answer came from the discovery of two different
ribonucleases, RNase J1 and J2, which are present
in almost all bacteria lacking RNase E.58 Curiously,
both RNase E and RNase J1 orthologs have been
found in Sinorhizobium meliloti.59 Although there is
no sequence homology, the RNase J enzymes share
a similar architecture with RNase E60 and exhibit
equivalent endonucleolytic activity. RNase J1, which
is essential for cell viability, is involved in RNA
turnover61 (Figure 1(b)). Surprisingly, this enzyme is
also able to catalyze the exonucleolytic degradation
of RNA in the 5′–3′ direction.62 To date this is
the only 5′-exonuclease known in prokaryotes and
its discovery has had important implications in the
RNA decay model. The exonucleolytic decay from
the 5′-end may explain the stabilizing effect conferred
by 5′-stem-loops, 5′-protein binding and 5′-ribosome
stalling in B. subtilis.56 It has been suggested that
this dual-function enzyme (alone or in complex with
RNase J2) catalyzes not only the endonucleolytic
cleavage of an RNA substrate but also continues the
degradation of the generated 5′-end by switching to
the 5′-exonucleolytic mode.60 Interestingly, only the
exonucleolytic activity of RNase J1 is dependent on
the 5′-end phosphorylation status, as it is blocked by
triphosphorylated RNA.60 The complex formed by
RNase J1 and J2 changes their individual cleavage
activities and specificities.63
Another insight into the RNA degradation
mechanism of B. subtilis was the recent discovery
of RNase Y, an essential single-stranded endonuclease
(Figure 1(b)), whose deletion was reported to increase
the bulk mRNA half-life in this bacterium.64 Like
RNase E and RNase J1, RNase Y is sensitive to
the phosphorylation state of the 5′-end, exhibiting a
marked preference for monophosphorylated RNA.
Hence, two essential enzymes in B. subtilis RNA
decay are dependent on a monophosphorylated 5′-
end. Indeed, there are indications of the existence
of an RppH-like enzyme in B. subtilis (Belasco and
Condon, personal communication).
The presence of a putative N-terminal trans-
membrane domain in RNase Y suggests membrane
localization further extending the analogy to RNase
E64 (Figure 1(b)). Evidence for the presence of a
complex involving RNase Y, RNase J1/J2, PNPase,
the RNA helicase CshA and two glycolytic enzymes
has recently been reported.65 This complex brings
together some of the degrading activities necessary to
achieve full degradation of an RNA molecule. The
RNA fragments released by the RNase Y endonu-
cleolytic cleavage could be good substrates for the
3′-exonucleolytic activity of PNPase and for the 5′-
exonucleolytic degradation by RNase J1/J2.56 This
putative degradosome-like complex indicates that the
presence of such an RNA degradative machine may
be a common feature in prokaryotes, even those that
lack an RNase E homologue.
ROLE OF RNA DEGRADATION
IN QUALITY CONTROL
Gene mutation, DNA damage, or transcriptional
errors may generate damaged mRNAs that are unsuit-
able for protein synthesis. Additionally, translational
frameshifting can also lead to aberrant proteins, whose
accumulation may be detrimental to the cell. Hence,
bacteria have evolved efficient quality control mech-
anisms engaged in the rapid degradation of these
abnormal transcripts and proteins.
One of the common errors is the presence of
a premature stop codon in some messages, which
produces a truncated protein. In E. coli the fast
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degradation of messages carrying a premature stop
codon is thought to begin with a 5′-independent
RNase E cleavage at internal sites exposed by the
premature release of ribosomes.24 The resulting RNA
molecules are further degraded through the pathways
described above.
Messages without an in-frame stop codon may
lead to ribosome stalling at the 3′-end, significantly
affecting translational efficiency. An elegant surveil-
lance pathway, termed trans-translation, targets defi-
cient proteins and mRNA for degradation while
rescuing stalled ribosomes (see Refs 66 and 67 for
a review). This process relies on the association of
two molecules: a sRNA called transfer-messenger
RNA (tmRNA), and a small RNA-binding protein
(SmpB), whose homologues have been identified in
every sequenced eubacterial genomes. Some situations
that delay the progress of ribosomes during trans-
lation were also observed to elicit tagging by the
trans-translation machinery in a process that involves
RNase II.66,68
The rapid removal of the defective messages that
lead to ribosome stalling is of utmost importance
in the prevention of future stalling events. RNase
R is associated with tmRNA and SmpB and is
involved in the tmRNA-mediated decay69 as well as
in the processing of tmRNA.70 The mechanism that
influences the loading of RNase R onto the defective
mRNAs was recently highlighted, whereby RNase
R was shown to be recruited through interactions
mediated by its C-terminal lysine-rich domain in
an SmpB-tmRNA-dependent manner.71 Indeed, this
domain was previously suggested as being involved in
interactions with SmpB.72
Finally, errors in macromolecular processes like
tRNA and rRNA synthesis also occur. Li et al. had
shown that an aberrant precursor tRNA molecule
is degraded by a mechanism that involves poly(A)
polymerase and PNPase,73 leading to the proposition
that polyadenylation could serve as a signal to
promote degradation of defective tRNAs. PNPase and
RNase R have been implicated in the removal of
defective rRNAs.42
STRUCTURAL DETERMINANTS
OF THE RNA DEGRADING ENZYMES
The intrinsic degradative nature of ribonucleases and
the fact that they share the cellular environment
with a pool of different types of RNA molecules
raises some questions: How do these ‘molecular
killers’ specifically select their targets? What are the
structural determinants that allow these enzymes to
spare some molecules while dictating the destruction
of others? As underlined above there are several
features of the RNA molecules that are key factors
in determining their fate. The interplay between the
structural determinants of the enzymes and their
specific degradation preferences, depending on the
characteristics of each RNA molecule, seems to dictate
the final decision.
RNase E, the main endonuclease of numerous
species including E. coli, organizes its catalytic
domain, as a dimer of dimers in a final homotetramer
quaternary structure74 (Figure 2). Each protomer
contains the following structural domains: S1, RNase
H, DNase I and a small domain that is responsible
for dimer–dimer interaction. The arrangement of
the domains within each dimer resembles the
blades and handles of an open pair of scissors.
The crystal structure explains some features of
the enzyme and suggests a mechanism for RNA
recognition and cleavage.75 The influence of 5′-
phosphorylation is a consequence of the pocket
formed between the S1 and the RNase H subdomains,
which binds 5′-monophosphorylated RNA and
promotes downstream degradation. After binding,
a conformational change induced by the movement
of the RNA-binding domains clamps the substrate
down and organizes the active site.75 The catalytic site
contains conserved residues of the DNase I domain
and a single metal-binding site that coordinates
an Mg2+ ion implicated in catalysis. The internal
flexibility within the quaternary structure may be
related to the deformation required to accommodate
structured RNA for processing by internal entry.
An amphipathic segment at the C-terminal region of
RNase E directs the enzyme to the inner membrane.76
Membrane localization could be determinant for
spatial discrimination of the RNA substrate.
E. coli RNase III is the prototype of the RNase III
family of enzymes, which includes eukaryotic enzymes
such as Dicer and Drosha. The bacterial enzymes are
the simplest, containing an N-terminal endonuclease
domain (NucD) characterized by a 9-residue consen-
sus sequence known as the RNase III signature motif,
and a double-stranded RNA binding domain (dsRBD)
in the C-terminus. The enzyme is active in the homod-
imeric form and the crystal structure of the Aquifex
aeolicus RNase III endonuclease domain shows that
dimerization creates a large valley that accommodates
dsRNA77 (Figure 2). The catalytic centers are found
in the dimer interface, one at each end of the valley.
Although dsRNA binding is governed by the combined
dsRBD of the dimer, the NucD domains contribute
to substrate specificity.77 Substrate selection consists
of a combination of structural and sequence elements,
such as the strength of base pairing, the occurrence of
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FIGURE 2 | Structures of RNA degrading enzymes in complex with
RNA substrates. On the top of the image are shown the crystal
structures of endonucleases (catalytic domain of E. coli RNase E, PDB ID
2C4R, on the left; A. aeolicus RNase III, PDB ID 2NUF, on the right). The
crystal structures of exonucleases are on the bottom (E. coli RNase II,
PBD ID 2IX1, on the left; E. coli PNPase, PDB ID 3GCM, on the right). The
crystal structure of Thermus thermophilus RNase J (PDB ID 3BK2), which
has a dual function as endo- and exonuclease, is in the middle. RNA
substrates in complex with the enzymes are colored in orange and the
metal ions that assist catalysis are shown as red spheres. Purple spheres
denote the Zn2+ ions important for maintenance of the principal dimers
in the RNase E quarternary structure. Otherwise the colors are unrelated
to the functional domains of the enzymes, but represent different
protomers in the quaternary structures except in RNase II, which is
active as a monomer. In this case, each color identifies a different
domain (CSD1 and CSD2 are shown in cyan and light blue, respectively;
S1 is shown in dark blue and the catalytic domain RDB is colored in dark
cyan). A model for RNase R has been proposed but the structure is not
yet available. However functional and structural data available indicates
that the structure will be quite similar to RNase II. Structures were
drawn using PyMOL (http://pymol.sourceforge.net).
specific nucleotide pairs and the helix length.78 Several
conserved residues in the catalytic centers were shown
to be essential for catalysis, which involves amino
acids from both subunits, and thus, dimerization of
the NucD domains is necessary for RNase III func-
tion (see Ref 77 and references therein). The crystal
structure indicates that a single RNA cleavage event
occurs on each strand of the dsRNA within each
cleavage site, generating products with a two-base 3′-
overhang. Mg2+ is required for the formation of a
catalytical competent protein–RNA complex and two
divalent cations are coordinated by each active site.
When Mg2+ is absent the RNA is bound outside the
catalytic valley.79 Indeed, RNase III is also known
to be involved in the control of gene expression by
binding a dsRNA molecule without cleaving. In this
noncatalytic functional form the enzyme plays the role
of a dsRNA-binding protein.80
RNase J is unique among bacterial RNases in
that it possesses both endo- and 5′–3′ exonucleolytic
activity.60,81 Recent structural data shed some light
into the dual activity of Thermus thermophilus RNase
J60 (Figure 2). The enzyme is active as a dimer in
solution, and each monomer contains three distinct
domains: a metallo-β-lactamase core, a β-CASP and
a C-terminal domain. This last domain may be
involved in substrate recognition and maintenance
of the dimeric state. Two Zn2+ ions, essential for
catalysis, are coordinated by residues located deep in
the cleft between the β-lactamase core and the β-CASP
domain. Specific attack of 5′-monophosphorylated
transcripts is related to a binding pocket near the
catalytic center that precludes the accommodation of
a 5′-triphosphorylated substrate. Only one catalytic
center was obvious from the structure, suggesting that
a single active site is responsible for the dual activity of
RNase J. The distance between the 5′-monophosphate
binding pocket and the catalytic center may explain
the switching from endo- to exonucleolytic mode.
Indeed, the 5′-monophosphate generated after the
endonucleolytic cleavage may be directly placed in the
binding pocket with a single translocation of the RNA
molecule, allowing RNase J to start exonucleolytic
degradation.
E. coli RNase II is the prototype of the RNase
II family of enzymes, a widespread family that
also includes RNase R and the catalytic subunit of
the eukaryotic exosome, Rrp44/Dis3. The overall
crystallographic structure of E. coli RNase II reveals
a monomeric protein with four domains: three RNA
binding domains comprising CSD1 and CSD2 in the
N-terminal region, and an S1 fold at the C-terminus;
one RNB catalytic domain in the central region, which
is a hallmark of the RNase II family of proteins82–84
(Figure 2). The RNA binding domains are grouped
together in one side of the structure, and play a
role in the RNA substrate selection and binding.83,85
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Interestingly, a truncated enzyme lacking all the RNA
binding domains is still able to degrade RNA.85,86
The structure of the enzyme in complex with an RNA
molecule reveals two main noncontiguous interaction
points between the protein and the RNA fragment.
A 10-nucleotide segment is the shortest RNA able
to retain both contacts, explaining why RNase II
becomes distributive on substrates shorter than 10
nucleotides.83 A single amino acid change in the
catalytic region alters the final end-product from 4
to 10 nucleotides, probably due to loosening of the
RNA substrate at the catalytic site.87 The access to
the catalytic pocket is restricted to single-stranded
RNAs by steric hindrance, explaining the inability of
RNase II to degrade dsRNA. A specific interaction
with ribose rings precludes DNA cleavage.83 Several
residues in the catalytic region are important for
catalysis;83,87–89 however, only Asp209, which is
involved in the coordination of Mg2+, is essential.87
Interestingly, substitution of one conserved glutamine
gives rise to an enzyme with highly increased
RNA-binding and exonucleolytic activity (120-times
higher), consequently called ‘super-enzyme’.89
RNase R shares a similar domain organization
with RNase II, and a three-dimensional model of this
enzyme has been proposed based on the structure of
RNase II.87 Besides the domains identified in RNase
II, RNase R also contains a helix-turn-helix in the
N-terminus,46 and a highly basic region after the S1
fold at the C-terminus.86 The RNB domain of RNase
R alone is sufficient to bind and degrade an RNA
duplex.85,86 Paradoxically, when the RNA-binding
domains are present a short 3′-overhang is necessary
in order to initiate degradation. These domains are
essential for binding and recruitment of 3′-tailed RNA
molecules. The two CSD domains appear to play a role
on the recognition of the substrates for degradation,
whereas the S1 domain is most likely required
to position substrates for efficient catalysis.85,86
The RNA-binding regions (S1, CSD1, and most
importantly CSD2) have been suggested to possess
intrinsic helicase activity,90 a hypothesis that still
needs further experimental support. Mutation analysis
in the nuclease domain identified important residues
for the nuclease activity and for substrate binding,
which may contribute to the ability of RNase R to
degrade structured RNAs.85,91 Nevertheless, only the
resolution of its three-dimensional structure will allow
full understanding of its remarkable mode of action.
PNPase belongs to the PDX family of
exonucleases, which also includes the core of the
exosome in archaea and eukaryotes.92 The crystal
structures of Streptomyces antibioticus and E. coli
PNPase reveal a homotrimeric subunit organization
with a ring-like architecture93–95 (Figure 2). This
structure closely resembles the doughnut-like shape
of the archaeal and the eukaryotic exosomes.92 Each
monomer comprises two RNase PH domains (PH1
and PH2) forming the catalytic site (PNPase core),
which are connected by an α-helical domain. Several
mutations introduced into this core have been shown
to influence phosphorolytic and polymerase activities
of the enzyme.96,97 In addition, two RNA-binding
domains S1 and KH have been found in the C-
terminus. These domains are required not only for
proper binding, but also contribute to the formation
of a more stable trimeric structure.95,98,99 In the
quaternary structure, the RNA-binding domains are
grouped in one face of the trimer, while the active
site is located in the opposite side. The association of
the three subunits encloses a central channel through
which the RNA molecule travels in the direction
of the active site. A properly constricted channel
and the conserved basic residues in the neck region
play critical roles in trapping RNA for processive
degradation. RNA translocation is dynamic, and
PNPase undergoes conformational changes at the
central channel and its neighboring regions, while
directing the RNA to the active center.93–95 Mg2+ is
required for PNPase enzymatic activity, though Mn2+
can also support catalysis. The metabolite citrate has
recently been shown to directly modulate the enzyme’s
activity, connecting RNA degradative pathways with
the central metabolism.100
In this section, we have highlighted the struc-
tural features of the ribonucleases that are specifically
involved in the recognition of a given RNA molecule.
In light of the enzymes’ spatial architecture, it was
mentioned how the sequence and structural elements
within the transcript regulate both its rate of decay and
the primary nucleases involved. Furthermore, it was
shown that some ribonucleases can also be influenced
by the spatial compartmentalization within the cell,
which may modulate their access to different RNA
molecules.
OTHER PLAYERS
Polyadenylation
Polyadenylation is a post-transcriptional event
that involves the addition of untemplated adeno-
sine residues to the 3′-ends of RNA substrates.
This widespread phenomenon occurs in bacteria,
organelles, archaea, and in the nucleus and cytoplasm
of eukaryotic cells. Eukaryotic poly(A) tails, present
in the majority of mRNAs, are usually long, uniform
in length and have traditionally been viewed as a sta-
bilizing element. However, recent studies have also
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shown evidence of a polyadenylation-induced decay
of nonfunctional RNAs in eukaryotes.101 Prokary-
otic polyadenylated transcripts are generally low in
abundance and poly(A) tails are very short and unsta-
ble. This fact, together with a lack of evidence for a
physiological role, made polyadenylation in bacteria
almost overlooked for several years after its discovery.
It has been estimated that less than 2% of total RNA
in E. coli is polyadenylated. Despite this intriguingly
low percentage, a transcriptome comparison between
the wild-type and a strain defective in polyadeny-
lation has indicated that the majority of transcripts
(∼90%) undergo some degree of polyadenylation
during exponential growth, either as full-length tran-
scripts or decay intermediates.102 The rapid turnover
of polyadenylated mRNAs accounts in part for their
low abundance.
Poly(A) tails provide a single-stranded extension
region that works like a ‘toe-hold’ upon which exonu-
cleases can bind and initiate decay103 (Figure 1(a)).
Polyadenylation therefore facilitates exonucleolytic
activity. Paradoxically, the higher affinity of RNase II
for these poly(A) stretches has been shown to protect
mRNAs from degradation, as this enzyme degrades
the tails that allow PNPase and RNase R to proceed
through secondary structures.41,43
Initially identified almost 50 years ago in
E. coli,104 Poly(A) Polymerase I (PAP I) is responsible
for ∼90% of the polyadenylating activity in the cell.105
The enzyme catalyzes the addition of homopolymeric
poly(A) tails (15–30 nt long in average) to 3′-
hydroxyl termini of RNA molecules using ATP as
a substrate.102,106,107 However, deletion of its cognate
gene (pcnB) has only a moderate effect on growth108
and does not abolish all the polyadenylating activity
in the cell.109 PNPase can also synthesize A-rich
heteropolymeric extensions through its reverse activity
(synthetic instead of degrading),109 although to a
much lesser extent. This PNPase activity has recently
been shown to change in response to adjustments of
cyclic-di-GMP levels in an O2-dependent way.110 In
many prokaryotic organisms, archaea, and organelles
of prokaryotic origin lacking a PAP I protein,
polyadenylation has been shown to be carried out
by PNPase.111 It has been speculated that the
evolutionary precursor of PNPase was the first enzyme
to produce these tails. Much later, PAP I would have
been acquired by bacteria such as E. coli. The enzyme,
already specific for ATP (the ‘energy currency’ of the
cell), produced the dominant homopolymeric poly(A)
tails. B. subtilis, in which as much as 15–25% of
total RNA was estimated to be polyadenylated,112
lacks an identifiable PAP I homologue. Nonetheless,
similar polyadenylated and heteropolymeric ends have
been observed at the 3′-ends of RNA isolated from
wild-type and PNPase mutant strains, indicating that
PNPase is not the only enzyme responsible for the
addition of nucleotides to the 3′-end of RNAs in this
organism.113
Regarding the nature of the poly(A) tail, several
observations indicate that transcripts which termi-
nate in a Rho-dependent fashion tend to contain only
heteropolymeric tails generated by PNPase. On the
other hand, Rho-independent transcription termina-
tors serve as polyadenylation signals for PAP I.102,106
Moreover, heteropolymeric tails are mainly added to
breakdown products, whereas poly(A) tails are added
to both breakdown and full-length transcripts.105 In
stationary phase, the addition of heteropolymeric
tails is predominant over the homopolymeric tails
commonly found in exponentially growing cells.114
The lack of energy resources in stationary phase
could be a reason for this choice, since the gener-
ation of adenylated tails at the expense of several
ATP molecules is more justifiable under exponential
growth.114 Moreover, polyadenylation promotes high
mRNA turnover rates which are characteristic of the
exponential phase.109
In both bacteria and organelles, RNA break-
down products generated by endonucleolytic cleav-
ages are considered the most favored substrates for
3′-tailing.115–118 Single-stranded segments at either 5′-
or 3′-end of RNA molecules and monophosphory-
lation at an unpaired 5′-terminus were reported to
increase the RNA susceptibility to polyadenylation by
PAP I.119 This suggests that the endonucleolytically-
generated RNA fragments containing single-stranded
monophosphorylated 5′-termini would be preferential
substrates for 3′-end polyadenylation. However, this
is not always required as transient poly(A) tails have
been found at the native 3′-ends of RNA molecules.103
In E. coli, the low level of PAP I (32–50 molecules per
cell) is also likely to be a limiting factor in substrate
selection.102,106 PAP I over-synthesis is highly toxic,
which may be the reason for such a low enzyme
level.108,120
It has long been presumed that 3′-polyadenylat-
ion was only restricted to mRNAs, nevertheless
PAP I and PNPase can polyadenylate almost any
RNA species, including rRNAs, tRNAs, and sRNAs.
Interestingly, while the tails found on rRNAs resemble
the ones found on mRNAs, the tails on tRNAs
and sRNAs tend to be very short (1–8 nt).121,122
A few sRNAs have been reported to be destabilized
by polyadenylation.122–126 Polyadenylation was also
implicated in the promotion of the exonucleolytic
degradation of defective tRNAs.73 A defective
tRNATRP does not accumulate to the normal wild-type
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levels due to the rapid degradation of its precursor.
Using PAP I and/or PNPase mutant strains, it has
been proposed that polyadenylation of the defective
precursor serves as a signal to promote its fast
degradation by PNPase.73
PAP I has been reported to have physical interac-
tions with Hfq, PNPase, RNase E, and the RNA heli-
case RhlB,106,127 which suggests that the polymerase
could act as part of a multiprotein complex.106 It has
been demonstrated in E. coli that PAP I is localized
either in the membrane or in cytosol, depending on the
growth phase.128,129 Such localization may, however,
be indirect through a loose association with RNase
E.28,76 The release of PAP I from the membrane in the
transition from the exponential to the stationary phase
has been found to be dependent on the adaptor protein
SprE (RssB), previously known for its role in governing
the stability of the alternate σ factor RpoS.128 SprE has
also been reported to be required to maintain the asso-
ciation of PAP I and Hfq with the degradosome during
stationary phase.130 In addition, microarray data have
revealed that polyadenylation and turnover of specific
E. coli transcripts can be modulated by SprE.128
Hfq
Hfq is an RNA chaperone known to be involved in the
stabilization and/or degradation of many RNAs. This
widespread and highly abundant post-transcriptional
regulator belongs to the Sm/Lsm family of RNA
binding proteins. The active form of Hfq has a
doughnut-shape homohexameric ring structure that
displays the highest affinity for short single-stranded
stretches of adenines and uridines adjacent to stem-
loop structures.131 The protein has at least two RNA-
binding sites located in the conserved N-terminal
portion: the proximal site, which binds sRNAs and
mRNAs; and the distal site, specific for poly(A)
stretches.132 This protein can directly interact with
PAP I and/or change its activity from distributive to
processive106,133 (Figure 1(a)). Actually, Hfq targets
many mRNAs for degradation by binding to their
poly(A) tails and stimulating polyadenylation.133,134
Paradoxically, Hfq stabilizes sRNAs, probably
because its binding protects them from ribonucle-
ase attack as there is an overlapping of recognition
sites between Hfq and RNase E.135 Hfq has also been
shown to interact with PNPase and RNase E.105,106,136
The formation of variable ribonucleoprotein com-
plexes between RNase E and Hfq/sRNAs specifically
destabilizes the mRNA target.136
The pleiotropic phenotype of hfq null mutants
reveals that this protein acts on several pathways
of E. coli metabolism.137,138 Indeed, Hfq is cur-
rently recognized as a key factor in regulation by
sRNAs. This protein promotes sRNAs interaction
with their mRNA targets (see details in the next
subsection),15,139 although the precise mechanism by
which Hfq brings mRNAs and sRNAs together is
not completely understood. The Hfq binding may
unfold or weaken RNA secondary structures, allow-
ing sRNAs to access their targets.140,141 Alternatively,
the simultaneous interaction between the sRNA with
the Hfq proximal site, and the mRNA with its dis-
tal site, may raise the local concentrations of the two
RNAs, thereby increasing the probability of sRNA–m-
RNA interaction.142 When the interaction between
the two RNA molecules is stable, Hfq dissociates or
is proteolytically removed from the complex.141
sRNAs
sRNAs have been extensively studied over the last
years because of their high importance in the post-
transcriptional regulation of bacterial gene expression.
They have become another important factor to
consider in the global picture of RNA turnover. Their
action can directly trigger the degradation of specific
mRNAs, thus changing gene expression.
The mechanisms of regulation by sRNAs are
very complex and reports of different modes of action
are becoming increasingly common in the literature.
Some interact with a protein to modify its activity. For
instance, CsrB and CsrC tightly regulate the activity
of the global post-transcriptional regulator CsrA by
binding and sequestering several of these proteins
simultaneously.143 The vast majority of the small
RNAs belongs to the class of antisense sRNAs that
act by base-pairing with their mRNA targets. These
sRNAs usually bind their mRNA targets to repress
translation and/or accelerate their degradation.
Binding of the sRNA usually sequesters the ribosome
binding site (RBS) and, consequently, prevents the 30S
ribosome loading. Following translational repression,
the mRNA target often becomes substrate for RNase
E or RNase III.144 The action of sRNAs is, however,
not limited to the RBS. Recognition of the target
upstream of its 5′-UTR145–147 and binding inside the
coding sequence of the mRNA target148 has also
been reported. Although less numerous, examples of
gene expression activation by sRNAs are also known.
For instance, the translation of the rpoS mRNA is
positively regulated by the action of the sRNAs DsrA,
RprA, and ArcZ.149–151
Antisense sRNAs can act either in cis or in trans
depending on their genomic location in relation to
their mRNA target(s). MicA sRNA is the only known
case of a sRNA in E. coli which targets both in cis and
in trans.152 Cis-encoded sRNAs are transcribed from
the same locus, but in the opposite sense. The best
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known examples are those involved in the replication
of plasmids.153 Nevertheless, the bulk of antisense
sRNAs are trans-encoded, being transcribed from a
distinct locus, and these are normally induced under
stress conditions. One-third of these sRNAs repress
the synthesis of outer membrane-proteins.154 As the
complementarity of trans-encoded sRNAs with the
respective targets is imperfect they typically require
Hfq for target interaction and/or intracellular stability.
Hfq-dependent antisense regulation is widespread
in Gram-negative bacteria but only one example
was reported in the Gram-positive bacteria Listeria
monocytogenes.155
REGULATION OF RNases
As effectors that rapidly modulate the levels of RNAs,
the expression of RNases must be tightly regulated
in a process that responds to many different signals
and which may relevantly affect RNA turnover rates.
This regulation is known to occur in several ways.
RNases can regulate their own levels (autoregulation)
and/or be regulated by other ribonucleases (cross-
regulation). Additionally, their intracellular bulk level
can be affected by the medium composition and other
environmental factors that alter the cell growth rate.
These and other approaches of regulation of the
degradative ribonucleolytic machinery in prokaryotes
are discussed below in further detail.
Autoregulation and Cross-Regulation
Both RNase E156 and RNase III157 have the ability
to control the decay of their own mRNAs, thereby
regulating their own expression and maintaining the
enzyme levels within a narrow range. In both cases,
a cleavage that occurs in the 5′-UTR region of the
mRNA promotes their decay. PNPase is able to
regulate its own expression as well, but in an RNase
III-dependent manner.158 PNPase acts in concert with
RNase III to degrade a double-stranded region in the
5′-end of pnp mRNA. The removal of this region
impairs translation and allows further degradation
of pnp transcript by RNase E.159 PNPase expression
is also regulated by RNase II.160 This latter case
constitutes an interesting example of cross-regulation:
in the absence of RNase II, PNPase levels are increased,
while PNPase overexpression leads to a decrease in
RNase II activity. PNPase controls RNase II activity
by degrading its mRNA.161 RNase III and RNase
E endonucleases are also involved in the control of
RNase II expression.162 While RNase III regulates
RNase II by affecting PNPase levels, RNase E directly
intervenes in the degradation of rnb mRNA. RNase E
is also the main enzyme responsible for the processing
of rnr transcripts encoding RNase R.163
Regulation by Environmental Conditions
and Other Cellular Modulators
RNase E is responsible for many processes of RNA
decay and maturation. Therefore, the enzyme must
be tightly regulated because any change in the level
of its expression has important cellular repercussions.
As discussed above, the 5′-end phosphorylation state,
folding and translation of a given mRNA substrate
can modulate the RNase E cleavage efficiency by
altering the enzyme’s accessibility to the transcript.
In addition, RraA and RraB (regulators of RNase
activity A and B, respectively), interact with RNase
E to inhibit its activity.30,164 In addition to these
factors, environmental conditions such as tempera-
ture and medium composition have been reported to
directly affect the activity and cellular concentration
of this endonuclease.165–167 As a consequence, the
RNA processing and stability of specific transcripts is
affected.165–167
RNase R is a ribonuclease whose levels
also change in response to different environmen-
tal stimuli.168 These include the entry into station-
ary phase (2-fold), heat-shock (∼2-fold), and cold-
shock (7–8 fold).70,168,169 From the different stress
conditions analyzed, cold-shock treatment results by
far in the highest up-regulation effect over RNase R.
This marked increase in RNase R levels is probably
related to its ability to overcome RNA secondary
structures, whose formation is thermodynamically
favored under low temperatures. Northern blot analy-
sis of the transcript’s decay has indicated an increase in
rnr stability during cold-shock.70 Moreover, Western
blot analysis of RNase R degradation after transla-
tional arrest has revealed that the protein itself is
highly stabilized under cold-shock, stationary-phase
and growth in minimal medium.72 It has been shown
that the tmRNA–SmpB system can be responsible
for the low stability of the RNase R protein in
exponential-phase cells, through interaction with the
region encompassing the S1 domain and the C-
terminus of the exonuclease.72 Albeit to a lower level,
growth at low temperatures also induces PNPase
expression, which is an essential enzyme in this
condition.170,171 Moreover, certain mutations of the
PNPase RNA binding domains have been shown to
confer a cold-sensitive phenotype.97,98,172
Like RNase R, RNase II stability is post-
translationally regulated. Deletion of gmr (gene mod-
ulating RNase II), a gene that lies just downstream of
rnb, causes the accumulation of this exonuclease by
increasing the protein stability more than 2-fold.173
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RNase II is also more abundant in rich medium com-
pared to minimal medium and is sensitive to the
nitrogen content of the medium. This regulation is
abolished in a gmr mutant.173 One possible explana-
tion is that the PAS domain of Gmr protein can act
as a sensor, which monitors nutrients in the growth
medium and carries the signals to the proteolytic
enzymes responsible for RNase II degradation. Inter-
estingly, beyond being regulated post-transcriptionally
(at the level of mRNA and protein), RNase II has two
promoters and its expression is also controlled at the
transcriptional level.160,174,175
Polyadenylation is implicated in the destabiliza-
tion of a variety of transcripts but it also arises as
a factor controlling RNases levels in the cell. A high
intracellular level of poly(A) tails stabilizes pnp and
rne transcripts, thereby leading to increased PNPase
and RNase E levels, respectively.176
The activity of RNases represents a checkpoint
on RNA regulation. Accordingly, their expression has
to be tightly regulated in different ways, as small vari-
ations on their levels may have a tremendous impact
on global RNA decay.
CONCLUSIONS
RNA degradation is an intricate mechanism and a
process that plays a fundamental role in the regulation
of gene expression. The steady-state level of a given
transcript is dependent on a high level of coordination
between the different players involved in transcription
and degradation. This complex network permits a
rapid response to challenging conditions, and it is
therefore not surprising that RNA degradation is not
exclusively deterministic but is also controlled by
external stimuli. RNA decay is a major link in the
chain of bacterial adaptation, a key for survival and
development.
In this article, we aimed at providing an up-to-
date picture of RNA stability/decay and its control
in prokaryotes. It involves numerous players and
relies on several features. However, the main effectors
are ribonucleases, whose diversity, structures, targets,
and modes of action can vary significantly, providing
multiple solutions for a similar issue. Ribonucleases
can act independently, or in a concerted way, as
well as in higher order protein complexes such as
the degradosome. Their activity can be modulated by
regulatory proteins. Besides this regulatory network,
the fate of an RNA molecule is intimately related
to its sequence and structural features. Indeed, the
characteristics of an mRNA molecule can determine
ribosomal pausing, targeting by sRNAs, and also elect
which RNases will be able to act.
Novel players that influence RNA stability are
still being discovered. These new findings not only
increase our knowledge of this topic but often chal-
lenge the conventional models. For instance, the
finding of the RNA pyrophosphohydrolase RppH in
E. coli revealed an alternative pathway for degrada-
tion. The homologue in B. subtilis was just recently
proposed (Belasco and Condon, personal communi-
cation). The ability of the RNase J enzymes to cleave
RNA in the 5′–3′ direction has also restructured
the conventional view of RNA decay in prokary-
otes. Another example is the discovery of sRNAs as
essential regulators of mRNA stability, which has
significantly altered the established models of RNA
turnover. Degradation of these small molecules is in
turn directed by RNases and other factors, namely
polyadenylation. Their degradation can alter the con-
centration of the target mRNA by directly modifying
the cellular concentration of the sRNA.
There are also indications of the existence of
a cellular compartmentalization in bacteria, which
could help to synchronize regulatory events. Certain
mRNAs have been shown to migrate to particular
cellular domains where their future protein products
are required.177 In another study the mRNAs stud-
ied exhibited limited dispersion from their site of
transcription. In this latter case the chromosome was
proposed to be a spatial organizer of mRNA and
related processes.178 Different mRNAs were studied
and this may account for these apparently diver-
gent observations. The identification of additional
players and regulatory processes is essential for fully
understanding RNA decay. Although there has been
tremendous progress in our understanding of the post-
transcriptional control of RNA stability and decay,
the continuing discovery of new processes illustrates
that the intricacies of RNA degradation are still far
from being completely understood, and a remarkable
amount remains to be learned.
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63. Mathy N, Hébert A, Mervelet P, Bénard L, Dorléans
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133. Hajnsdorf E, Régnier P. Host factor Hfq of Escherichia
coli stimulates elongation of poly(A) tails by poly(A)
polymerase I. Proc Natl Acad Sci U S A 2000,
97:1501–1505.
134. Le Derout J, Folichon M, Briani F, Dehò G, Régnier
P, Hajnsdorf E. Hfq affects the length and the fre-
quency of short oligo(A) tails at the 3′ end of
Escherichia coli rpsO mRNAs. Nucleic Acids Res
2003, 31:4017–4023.
135. Folichon M, Arluison V, Pellegrini O, Huntzinger E,
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144. Massé E, Majdalani N, Gottesman S. Regulatory roles
for small RNAs in bacteria. Curr Opin Microbiol
2003, 6:120–124.
145. Darfeuille F, Unoson C, Vogel J, Wagner EG. An anti-
sense RNA inhibits translation by competing with
standby ribosomes. Mol Cell 2007, 26:381–392.
146. Sharma CM, Darfeuille F, Plantinga TH, Vogel J. A
small RNA regulates multiple ABC transporter
mRNAs by targeting C/A-rich elements inside and
upstream of ribosome-binding sites. Genes Dev 2007,
21:2804–2817.
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